[
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"FRACTURE Index","Created At":"June 20, 2024, 3:01 PM","Is Manual":"false","Dosing":"false","Updated At":"June 20, 2024, 9:08 PM","Medium Description En":"<p>Predicts fracture risk in postmenopausal women.</p>","Logic Language":"javascript","Published At":"June 20, 2024, 5:45 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,540","Short Title En":"FRACTURE Index","Cme Release Date":"","Slug":"fracture-index","Short Description En":"<p>Postmenopausal fracture risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Short Michigan Alcoholism Screening Test-Geriatric Version (SMAST-G)","Created At":"March 28, 2024, 8:58 PM","Is Manual":"false","Dosing":"false","Updated At":"April 2, 2024, 1:32 PM","Medium Description En":"<p>Screens for alcohol abuse in elderly patients.</p>","Logic Language":"javascript","Published At":"March 28, 2024, 9:02 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,515","Short Title En":"SMAST-G","Cme Release Date":"","Slug":"short-michigan-alcoholism-screening-test-geriatric-version-smast-g","Short Description En":"<p>Elderly alcohol abuse.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Eat, Sleep, Console (ESC)","Created At":"January 26, 2024, 6:25 PM","Is Manual":"false","Dosing":"false","Updated At":"January 31, 2024, 5:10 PM","Medium Description En":"<p>Assists with management of infants with neonatal abstinence syndrome (NAS).</p>","Logic Language":"javascript","Published At":"January 26, 2024, 6:32 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,500","Short Title En":"Eat, Sleep, Console (ESC)","Cme Release Date":"","Slug":"eat-sleep-console-esc","Short Description En":"<p>NAS management.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Cardiac Power Output (CPO)","Created At":"December 26, 2023, 4:33 PM","Is Manual":"false","Dosing":"false","Updated At":"January 8, 2024, 8:07 PM","Medium Description En":"<p>Calculates rate of energy output of the heart.</p>","Logic Language":"javascript","Published At":"December 26, 2023, 9:07 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,494","Short Title En":"Cardiac Power Output (CPO)","Cme Release Date":"","Slug":"cardiac-power-output-cpo","Short Description En":"<p>Heart energy output.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+04","Full Title En":"Absolute Neutrophil Count (ANC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:49 PM","Medium Description En":"<p>Frequently used to assess neutropenic fever in chemotherapy patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+04","Cme Version":"19.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"19","Short Title En":"Absolute Neutrophil Count","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"absolute-neutrophil-count-anc","Short Description En":"<p>Neutropenia (after chemotherapy).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Basal Energy Expenditure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 7:29 PM","Medium Description En":"<p>Calculates daily energy expenditure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"25","Short Title En":"Basal Energy Expenditure","Cme Release Date":"","Slug":"basal-energy-expenditure","Short Description En":"<p>Estimates minimum caloric requirements.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Bicarbonate Deficit","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 7:33 PM","Medium Description En":"<p>Calculates the total body bicarbonate deficit.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"27","Short Title En":"Bicarbonate Deficit","Cme Release Date":"","Slug":"bicarbonate-deficit","Short Description En":"<p>Calculates total body bicarb deficit.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Body Mass Index (BMI) and Body Surface Area (BSA)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:04 PM","Medium Description En":"<p>Calculates body mass index and body surface area.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"29","Short Title En":"BMI & BSA","Cme Release Date":"","Slug":"body-mass-index-bmi-body-surface-area-bsa","Short Description En":"<p>Categorizes obesity, assists some med dosing.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Calcium Correction for Hypoalbuminemia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 7:58 PM","Medium Description En":"<p>Calculates a corrected calcium level for patients with hypoalbuminemia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"31","Short Title En":"Ca Correction for Albumin","Cme Release Date":"","Slug":"calcium-correction-hypoalbuminemia","Short Description En":"<p>Corrects Ca for hypoalbuminemia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+122","Full Title En":"PSI/PORT Score: Pneumonia Severity Index for CAP","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:28 PM","Medium Description En":"<p>Estimates mortality for adult patients with community-acquired pneumonia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+122","Cme Version":"33.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Tips for COVID-19: </strong>Use after diagnosis to determine dispo.&nbsp;Inputs line up better with known COVID-19 risk factors; adjust for elderly.</p>","Favorite ID":"33","Short Title En":"PSI/PORT Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"psi-port-score-pneumonia-severity-index-cap","Short Description En":"<p>Mortality in CAP: more complex than CURB-65.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Framingham Risk Score for Hard Coronary Heart Disease","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:18 PM","Medium Description En":"<p>Estimates 10-year risk of heart attack.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>There are several distinct Framingham risk models. MDCalc uses the 'Hard' coronary Framingham outcomes model, which is intended for use in <strong>non-diabetic</strong> patients age 30-79 years with no prior history of coronary heart disease or intermittent claudication, as it is the most widely applicable to patients without previous cardiac events. See the <a href=\"https://www.framinghamheartstudy.org/fhs-risk-functions/hard-coronary-heart-disease-10-year-risk/\" target=\"_blank\" rel=\"noopener\">official Framingham website</a> for additional Framingham risk models.</p>","Before Use":"","Favorite ID":"38","Short Title En":"Framingham Risk Score (Hard Coronary Heart Disease)","Cme Release Date":"","Slug":"framingham-risk-score-hard-coronary-heart-disease","Short Description En":"<p>Heart attack risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Corrected QT Interval (QTc)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 18, 2023, 3:50 PM","Medium Description En":"<p>Corrects the QT interval for heart rate extremes (choose from Bazett, Fridericia, Framingham, Hodges, or Rautaharju formulas).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"48","Short Title En":"Corrected QT (QTc)","Cme Release Date":"","Slug":"corrected-qt-interval-qtc","Short Description En":"<p>Corrects QT interval.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Maddrey's Discriminant Function for Alcoholic Hepatitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 10:17 PM","Medium Description En":"<p>Suggests which patients with alcoholic hepatitis may have a poor prognosis and benefit from steroid administration.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"56","Short Title En":"Maddrey's Discriminant Function","Cme Release Date":"","Slug":"maddreys-discriminant-function-alcoholic-hepatitis","Short Description En":"<p>Alcoholic Hepatitis prognosis &amp; steroid treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Endotracheal Tube (ETT) Size","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 6:52 PM","Medium Description En":"<p>Estimates ET tube size based on age.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"58","Short Title En":"Pediatric ET Tube Size","Cme Release Date":"","Slug":"pediatric-endotracheal-tube-ett-size","Short Description En":"<p>Based on age.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fractional Excretion of Urea (FEUrea)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:26 PM","Medium Description En":"<p>Determines the cause of renal failure. Similar to the FENa, but can be used on patients on diuretics.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"62","Short Title En":"FEUrea","Cme Release Date":"","Slug":"fractional-excretion-urea-feurea","Short Description En":"<p>Similar to FENa; for pts on diuretics.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Glasgow Coma Scale/Score (GCS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:08 PM","Medium Description En":"<p>Coma severity based on Eye (4), Verbal (5), and Motor (6) criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"64.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note that this calculator has been updated as of May 2019 in order to add more supporting&nbsp;<a href=\"#evidence\">references</a>&nbsp;and to distinguish between the Glasgow Coma <strong>Score</strong> (total score, only applicable when all three components are testable) and the Glasgow Coma&nbsp;<strong>Scale</strong>&nbsp;(component scores, applicable if any of three components is not testable).</p>","Before Use":"","Favorite ID":"64","Short Title En":"Glasgow Coma Scale (GCS)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"glasgow-coma-scale-score-gcs","Short Description En":"<p>Objective level of consciousness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"LDL Calculated","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:50 PM","Medium Description En":"<p>Calculates LDL based on total and HDL cholesterol and triglycerides.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: the Friedewald formula is known to be inaccurate at extremely high triglyceride (<span>&gt;400 mg/dL)</span> and total cholesterol levels. If there is any question about accuracy of estimated LDL, a direct level should be measured.</p>","Before Use":"","Favorite ID":"70","Short Title En":"LDL Calculated","Cme Release Date":"","Slug":"ldl-calculated","Short Description En":"<p>From Total Chol, HDL and Trigs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Maintenance Fluids Calculations","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:05 PM","Medium Description En":"<p>Calculates maintenance fluid requirements by weight.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>While originally derived in pediatric patients, this calculator is applicable to any age. Consider using <calculator id=\"68\">ideal body weight</calculator> in obese patients.&nbsp;If not calculating based on ideal body weight, use clinical judgment for dosing. A 1-liter&nbsp;bolus may be appropriate for most patients, such as overweight adolescents and adults.</p>\n<p></p>","Before Use":"","Favorite ID":"72","Short Title En":"Maintenance Fluids","Cme Release Date":"","Slug":"maintenance-fluids-calculations","Short Description En":"<p>Fluid maintenance.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+87","Full Title En":"Mean Arterial Pressure (MAP)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 7:59 PM","Medium Description En":"<p>Calculates mean arterial pressure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+87","Cme Version":"74.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"74","Short Title En":"Mean Arterial Pressure (MAP)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"mean-arterial-pressure-map","Short Description En":"<p>Calculates MAP.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MDRD GFR Equation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 18, 2023, 8:20 PM","Medium Description En":"<p>Estimates glomerular filtration rate based on creatinine and patient characteristics.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-c2ba5481-7fff-2399-31bf-153ec0a60605\">Only for chronic kidney disease (CKD); not accurate for acute renal failure. This calculator uses the 4-variable equation from <a href=\"https://annals.org/aim/article-abstract/727341/using-standardized-serum-creatinine-values-modification-diet-renal-disease-study?volume=145&amp;issue=4&amp;page=247\" target=\"_blank\" rel=\"noopener\">Levey 2006</a>, which relied on a standardized creatinine assay.</span></p>","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same creatinine value, this calculator estimates a higher GFR for Black patients.</p>","Favorite ID":"76","Short Title En":"MDRD GFR Equation","Cme Release Date":"","Slug":"mdrd-gfr-equation","Short Description En":"<p>For CKD patients (not for AKI).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"MELD Na (UNOS/OPTN)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:54 PM","Medium Description En":"<p>Quantifies end-stage liver disease for transplant planning with sodium.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"78.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;12 years old. Note: As of January 2016, calculation of the MELD has changed. It now includes serum sodium level. See <a href=\"https://optn.transplant.hrsa.gov/media/1575/policynotice_20151101.pdf\" target=\"_blank\" rel=\"noopener\">OPTN's announcement</a>.</p>","Before Use":"<p>We&rsquo;ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. <a href=\"https://www.mdcalc.com/calc/10437/model-end-stage-liver-disease-meld?utm_source=site&amp;utm_medium=link&amp;utm_campaign=meld_12_and_older\" target=\"_blank\" rel=\"noopener\">Click here to view</a>.</p>","Favorite ID":"78","Short Title En":"MELD Na (UNOS/OPTN)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"meld-score-model-end-stage-liver-disease-12-older","Short Description En":"<p>Liver transplant planning + Na.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Oxygenation Index","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 7:47 PM","Medium Description En":"<p>Predicts outcomes, especially in pediatric patients; helps determine need for ECMO.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"80","Short Title En":"Oxygenation Index","Cme Release Date":"","Slug":"oxygenation-index","Short Description En":"<p>Determines need for ECMO.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Ins and Outs","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 8:46 PM","Medium Description En":"<p>Calculates fluid status in volume per weight &amp; volume per weight per time, for pediatrics.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"85","Short Title En":"Pediatric Ins and Outs","Cme Release Date":"","Slug":"pediatric-ins-outs","Short Description En":"<p>Fluid status.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ranson's Criteria for Pancreatitis Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:05 PM","Medium Description En":"<p>Estimates mortality of patients with pancreatitis, based on initial and 48-hour lab values.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"89","Short Title En":"Ranson's Criteria","Cme Release Date":"","Slug":"ransons-criteria-pancreatitis-mortality","Short Description En":"<p>Mortality in pancreatitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Serum Osmolality/Osmolarity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:24 PM","Medium Description En":"<p>Calculates expected serum osmolarity, for comparison to measured osmolarity to detect unmeasured compounds in the serum.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"91","Short Title En":"Serum Osmolality","Cme Release Date":"","Slug":"serum-osmolality-osmolarity","Short Description En":"<p>Screens for toxic alcohols and more.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+144","Full Title En":"San Francisco Syncope Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:15 PM","Medium Description En":"<p><span id=\"docs-internal-guid-d6fc08dd-7fff-1253-f59b-7e653d04ae85\">Predicts risk for serious outcomes at 7 days in patients presenting with syncope or near-syncope.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+144","Cme Version":"93.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-96dd8710-7fff-c43e-d2c1-fb0c495a1265\">Use in adult patients presenting with syncope or near-syncope who are back to their neurologic baseline. Do not use in patients with persistent or new neurologic deficits, alcohol or drug-related loss of consciousness, definite seizure, or transient loss of consciousness from head trauma.</span></p>","Before Use":"","Favorite ID":"93","Short Title En":"San Francisco Syncope Rule","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"san-francisco-syncope-rule","Short Description En":"<p>Syncope risk stratification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sodium Deficit in Hyponatremia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:19 PM","Medium Description En":"<p>Calculates sodium quantity missing in hyponatremia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The <calculator id=\"480\">hyponatremia correction rate calculator</calculator> can be used to pick an appropriate fluid and volume as well.</p>","Before Use":"","Favorite ID":"95","Short Title En":"Sodium Deficit in Hyponatremia","Cme Release Date":"","Slug":"sodium-deficit-hyponatremia","Short Description En":"<p>Total sodium missing in hyponatremia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"TIMI Risk Score for STEMI","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:24 PM","Medium Description En":"<p>Estimates mortality in patients with STEMI.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"99.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"99","Short Title En":"TIMI Score for STEMI","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"timi-risk-score-stemi","Short Description En":"<p>Mortailty after STEMI.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+155","Full Title En":"Stool Osmolar/Osmotic Gap","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:26 PM","Medium Description En":"<p>Determines if chronic diarrhea is osmotic or secretory in nature.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+155","Cme Version":"101.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"101","Short Title En":"Stool Osmolar/Osmotic Gap","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"stool-osmolar-osmotic-gap","Short Description En":"<p>Chronic Diarrhea: Osmotic vs Secretory.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+159","Full Title En":"TIMI Risk Score for UA/NSTEMI","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 11, 2023, 4:31 PM","Medium Description En":"<p>Estimates mortality for patients with unstable angina and non-ST elevation MI.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+159","Cme Version":"111.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"111","Short Title En":"TIMI Score for UA/NSTEMI","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"timi-risk-score-ua-nstemi","Short Description En":"<p>Mortality after UA/NSTEMI.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Free Water Deficit in Hypernatremia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 31, 2023, 3:41 PM","Medium Description En":"<p>Calculates free water deficit by estimated total body water.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"113","Short Title En":"Free Water Deficit in Hypernatremia","Cme Release Date":"","Slug":"free-water-deficit-hypernatremia","Short Description En":"<p>Free water deficit by estimated total body water.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+168","Full Title En":"Wells' Criteria for Pulmonary Embolism","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:06 PM","Medium Description En":"<p>Objectifies risk of pulmonary embolism.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+168","Cme Version":"115.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"115","Short Title En":"Wells' Score for PE","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"wells-criteria-pulmonary-embolism","Short Description En":"<p>Risk of PE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Winters' Formula for Metabolic Acidosis Compensation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:29 PM","Medium Description En":"<p>Calculates the expected pCO<sub>2</sub> compensation in a purely metabolic acidosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"117","Short Title En":"Winters' Formula","Cme Release Date":"","Slug":"winters-formula-metabolic-acidosis-compensation","Short Description En":"<p>Expected pCO<sub>2</sub> if pure metabolic acidosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"A-a O<sub>2</sub> Gradient","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:58 PM","Medium Description En":"<p>Assesses for degree of shunting and V/Q mismatch.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"243","Short Title En":"A-a O<sub>2</sub> Gradient","Cme Release Date":"","Slug":"a-a-o2-gradient","Short Description En":"<p>Shunting and V/Q Mismatch.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+42","Full Title En":"CURB-65 Score for Pneumonia Severity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:22 PM","Medium Description En":"<p>Estimates mortality of community-acquired pneumonia to help determine inpatient vs. outpatient treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+42","Cme Version":"324.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Tips for COVID-19: </strong>Use after diagnosis to determine dispo. May have some value in COVID-19.</p>","Favorite ID":"324","Short Title En":"CURB-65 Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"curb-65-score-pneumonia-severity","Short Description En":"<p>Mortality in CAP: inpatient vs outpatient.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+116","Full Title En":"Phenytoin (Dilantin) Correction for Albumin/Renal Failure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:37 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5e677159-7fff-89f3-3c2a-9cb2948925c5\">Corrects serum phenytoin level for renal failure and/or hypoalbuminemia.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+116","Cme Version":"333.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-9b286b93-7fff-0104-70b5-2b4a28d2091b\">Use in patients with albumin &le;3.2 g/dL (32 g/L).&nbsp;The &ldquo;Sheiner-Tozer Equation&rdquo; is the official name of this correction. This updated formula uses an albumin coefficient of 0.275, and 0.2 for patients with renal failure (see <a href=\"#evidence\">Evidence</a> for details).</span></p>","Before Use":"","Favorite ID":"333","Short Title En":"Phenytoin (Dilantin) Correction","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"phenytoin-dilantin-correction-albumin-renal-failure","Short Description En":"<p>Corrected phenytoin level.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Child-Pugh Score for Cirrhosis Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:53 PM","Medium Description En":"<p>Estimates cirrhosis severity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"340","Short Title En":"Child-Pugh Score","Cme Release Date":"","Slug":"child-pugh-score-cirrhosis-mortality","Short Description En":"<p>Prognosis in cirrhosis; guides treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"ABCD<sup>2</sup> Score for TIA","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 10:11 PM","Medium Description En":"<p>Estimates the risk of stroke after a suspected transient ischemic attack (TIA).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"357.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"357","Short Title En":"ABCD<sup>2</sup> Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"abcd2-score-tia","Short Description En":"<p>Stroke risk after TIA: inpt vs outpt.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+167","Full Title En":"Wells' Criteria for DVT","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:57 PM","Medium Description En":"<p>Calculates risk of DVT based on clinical criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+167","Cme Version":"362.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li><strong>Note</strong>: The Wells' Score is less useful in hospitalized patients (<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25985219\" target=\"_blank\" rel=\"noopener\">Silveira PC, 2015</a>).</li>\n<li>There are a few versions of this criteria with minor differences based on the study; this set is the most widely validated, based on&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/14507948\" target=\"_blank\" rel=\"noopener\">Wells 2003</a>.</li>\n</ul>","Before Use":"","Favorite ID":"362","Short Title En":"Wells' Score for DVT","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"wells-criteria-dvt","Short Description En":"<p>Risk of DVT based on clinical criteria.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Ottawa Knee Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:39 PM","Medium Description En":"<p>Describes criteria for knee trauma patients so low risk as not to warrant knee imaging.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"368.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"368","Short Title En":"Ottawa Knee Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"ottawa-knee-rule","Short Description En":"<p>Sensitive; rules out imaging in some.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pregnancy Due Dates Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 27, 2023, 8:36 PM","Medium Description En":"<p>Calculates pregnancy dates from last period, gestational age, or date of conception.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>Enter date of last menstrual period, gestational age (on today's date or other ultrasound date), date of conception, OR estimated due date to estimate the other dates.</li>\n<li>Only EDD is affected by cycle length &ne;28 days when calculating from LMP, EGA, and EDC.</li>\n<li>When starting with EDD, all results change depending on cycle length.</li>\n</ul>","Before Use":"","Favorite ID":"423","Short Title En":"Pregnancy Due Dates","Cme Release Date":"","Slug":"pregnancy-due-dates-calculator","Short Description En":"<p>From LMP, EGA, or date of conception.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sodium Correction Rate in Hyponatremia and Hypernatremia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"May 31, 2023, 10:16 PM","Medium Description En":"<p>Calculates recommended fluid type, rate, and volume to correct hyponatremia slowly (or more rapidly if seizing).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"480","Short Title En":"Sodium Correction Rate in Hyponatremia/Hypernatremia","Cme Release Date":"","Slug":"sodium-correction-rate-hyponatremia-hypernatremia","Short Description En":"<p>Recommends hyponatremia/hypernatremia treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Glasgow-Blatchford Bleeding Score (GBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 10:05 PM","Medium Description En":"<p>Stratifies upper GI bleeding patients who are \"low-risk\" and candidates for outpatient management.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"518.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"518","Short Title En":"Glasgow-Blatchford Bleeding Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"glasgow-blatchford-bleeding-score-gbs","Short Description En":"<p>Identifies low risk UGI bleeds.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"King's College Criteria for Acetaminophen Toxicity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 22, 2023, 9:45 PM","Medium Description En":"<p>Recommends who should be immediately referred for liver transplant.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"532.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"532","Short Title En":"King's College Criteria","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"kings-college-criteria-acetaminophen-toxicity","Short Description En":"<p>Liver Transplant after acetaminophen OD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Mangled Extremity Severity Score (MESS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:10 PM","Medium Description En":"<p>Estimates viability of an extremity after trauma, to determine need for salvage vs empiric amputation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"549.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"549","Short Title En":"MESS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"mangled-extremity-severity-score-mess-score","Short Description En":"<p>Estimates extremity viability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Acetaminophen Overdose and NAC Dosing","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:12 PM","Medium Description En":"<p>Calculates PO/IV NAC dosing for acetaminophen overdose (and nomogram to determine toxic 4 hour level).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"568.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"568","Short Title En":"NAC Dosing (Tylenol OD)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"acetaminophen-overdose-nac-dosing","Short Description En":"<p>NAC Dosing for acetaminophen OD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"New Orleans/Charity Head Trauma/Injury Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:13 PM","Medium Description En":"<p>Criteria for which patients are unlikely to require imaging after head trauma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"604.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use ONLY in patients with head injury and loss of consciousness (LOC)&nbsp;who are neurologically normal (i.e., GCS 15 and normal brief neurological exam).</p>","Before Use":"","Favorite ID":"604","Short Title En":"New Orleans Head CT Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"new-orleans-charity-head-trauma-injury-rule","Short Description En":"<p>Very sensitive, rules out imaging in some.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+12","Full Title En":"Alvarado Score for Acute Appendicitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 25, 2023, 6:25 PM","Medium Description En":"<p>Predicts likelihood of appendicitis diagnosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+12","Cme Version":"617.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"617","Short Title En":"Alvarado Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"alvarado-score-acute-appendicitis","Short Description En":"<p>Appendicitis diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"TIMI Risk Index","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:16 PM","Medium Description En":"<p>Provides mortality estimate in patients with ACS using only blood pressure, heart rate, and age.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"665","Short Title En":"TIMI Risk Index","Cme Release Date":"","Slug":"timi-risk-index","Short Description En":"<p>Mortality in ACS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hepatic Encephalopathy Grades/Stages","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:23 PM","Medium Description En":"<p>West Haven Criteria. Defines criteria for the stages of hepatic encephalopathy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"674","Short Title En":"Hepatic Encephalopathy Grades","Cme Release Date":"","Slug":"hepatic-encephalopathy-grades-stages","Short Description En":"<p>West Haven Criteria: Severity to guide treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+169","Full Title En":"Westley Croup Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:33 PM","Medium Description En":"<p>Quantifies croup severity (although mainly used for research, not clinically).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+169","Cme Version":"677.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"677","Short Title En":"Westley Croup Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"westley-croup-score","Short Description En":"<p>Croup severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Glasgow Alcoholic Hepatitis Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:34 PM","Medium Description En":"<p>Predicts mortality in patients with alcoholic hepatitis by lab results and age.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"680","Short Title En":"Glasgow Alcoholic Hepatitis Score","Cme Release Date":"","Slug":"glasgow-alcoholic-hepatitis-score","Short Description En":"<p>Mortality in alcoholic hepatitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Trauma Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 23, 2023, 9:37 PM","Medium Description En":"<p>Quantifies severity of trauma injuries based on GCS, blood pressure, and respiratory rate.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use the first set of data obtained on the patient.</p>","Before Use":"","Favorite ID":"683","Short Title En":"Revised Trauma Score","Cme Release Date":"","Slug":"revised-trauma-score","Short Description En":"<p>Severity of trauma injuries.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Canadian C-Spine Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 5, 2023, 6:50 PM","Medium Description En":"<p>Clinically clears cervical spine fracture without imaging.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"696.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"696","Short Title En":"Canadian C-Spine Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"canadian-c-spine-rule","Short Description En":"<p>More sens/spec, but more complex, than NEXUS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"NEXUS Criteria for C-Spine Imaging","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 17, 2023, 4:04 PM","Medium Description En":"<p>Clears patients from cervical spine fracture clinically, without imaging.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"703.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"703","Short Title En":"NEXUS C-Spine Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"nexus-criteria-c-spine-imaging","Short Description En":"<p>Rules out need for imaging; simple.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+117","Full Title En":"Pittsburgh Knee Rules","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 2:48 PM","Medium Description En":"<p>Defines when knee x-rays are unnecessary, based on the Pittsburgh rules.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+117","Cme Version":"1042.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,042","Short Title En":"Pittsburgh Knee Rules","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"pittsburgh-knee-rules","Short Description En":"<p>Sensitive; rules out imaging in many.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"SIRS, Sepsis, and Septic Shock Criteria","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 7:52 PM","Medium Description En":"<p>Defines the severity of sepsis and septic shock.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1096.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: sepsis definitions are evolving and difficult to finalize without a gold standard. These criteria are what is reported and the literature is listed, but note that nuances exist for all sepsis definitions and can differ locally, regionally, nationally, and internationally, as well as in clinical vs administrative vs research settings.&nbsp;<a href=\"https://jama.jamanetwork.com/article.aspx?articleid=2492881\" target=\"_blank\" rel=\"noopener\">Sepsis-3 Consensus Definitions</a>&nbsp;are frequently cited as one paradigm.</p>\n<p><calculator id=\"1977\">For patients under 18, please use the Pediatric SIRS, Sepsis, and Septic Shock Criteria</calculator>.</p>","Before Use":"","Favorite ID":"1,096","Short Title En":"SIRS & Sepsis Criteria","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"sirs-sepsis-septic-shock-criteria","Short Description En":"<p>Defines severity of sepsis and septic shock.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+62","Full Title En":"GRACE ACS Risk and Mortality Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:59 PM","Medium Description En":"<p>Estimates admission to 6 month mortality for patients with acute coronary syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+62","Cme Version":"1099.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,099","Short Title En":"GRACE ACS Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"grace-acs-risk-mortality-calculator","Short Description En":"<p>Mortality in ACS admissions.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+03","Full Title En":"ABC Score for Massive Transfusion","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 2:52 PM","Medium Description En":"<p>Predicts need for massive transfusion in trauma patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+03","Cme Version":"1228.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,228","Short Title En":"ABC Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"abc-score-massive-transfusion","Short Description En":"<p>Need for massive transfusion; calculated before labs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"TASH Score (Trauma Associated Severe Hemorrhage)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:02 PM","Medium Description En":"<p>Predicts the need for massive transfusion based on clinical and laboratory data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,236","Short Title En":"TASH Score","Cme Release Date":"","Slug":"tash-score-trauma-associated-severe-hemorrhage","Short Description En":"<p>Need for massive transfusion; calculated after labs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+71","Full Title En":"Injury Severity Score (ISS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:03 PM","Medium Description En":"<p>Standardizes severity of traumatic injury based on worst injury of 6 body systems.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+71","Cme Version":"1239.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-a1990b0d-7fff-e063-c210-886ad05b5c78\">Rate only the <em>most severe</em> injury from each body system. Used primarily in research settings, so calculation of the ISS should not delay initial management of patients with traumatic injuries. </span></p>","Before Use":"","Favorite ID":"1,239","Short Title En":"Injury Severity Score (ISS)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"injury-severity-score-iss","Short Description En":"<p>Standardizes severity of trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+151","Full Title En":"Simplified PESI (Pulmonary Embolism Severity Index)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:06 PM","Medium Description En":"<p>Predicts 30-day outcome of patients with PE, with fewer criteria than the original PESI.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+151","Cme Version":"1247.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,247","Short Title En":"Simplified PESI","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"simplified-pesi-pulmonary-embolism-severity-index","Short Description En":"<p>Mortality from PE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+124","Full Title En":"Pulmonary Embolism Severity Index (PESI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:48 PM","Medium Description En":"<p>Predicts 30-day outcome of patients with pulmonary embolism using 11 clinical criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+124","Cme Version":"1304.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,304","Short Title En":"PESI Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"pulmonary-embolism-severity-index-pesi","Short Description En":"<p>Mortality from PE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+147","Full Title En":"Shock Index","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:10 PM","Medium Description En":"<p>May be a more sensitive indicator of occult shock, especially in trauma or acute hemorrhage.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+147","Cme Version":"1316.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,316","Short Title En":"Shock Index","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"shock-index","Short Description En":"<p>Sensitive indicator of occult shock.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Anion Gap","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 7:54 PM","Medium Description En":"<p>Evaluates states of metabolic acidosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>We now have an <calculator id=\"1741\">ABG Analyzer</calculator> to help with acid-base analysis as well.</p>","Before Use":"","Favorite ID":"1,669","Short Title En":"Anion Gap","Cme Release Date":"","Slug":"anion-gap","Short Description En":"<p>Evaluates states of metabolic acidosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+105","Full Title En":"Ottawa Ankle Rule","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 18, 2023, 4:02 PM","Medium Description En":"<p>Rules out clinically significant foot and ankle fractures to reduce use of x-ray imaging.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+105","Cme Version":"1670.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,670","Short Title En":"Ottawa Ankle Rule","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"ottawa-ankle-rule","Short Description En":"<p>Rules out clinically significant foot and ankle fractures.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"PHQ-9 (Patient Health Questionnaire-9)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:58 PM","Medium Description En":"<p>Objectifies degree of depression severity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1725.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>MDCalc provides tools and content intended for use by healthcare professionals, and is not meant for use by patients. While these may be surveys or questions intended for patients, they are meant to be answered in the context of a clinician&rsquo;s medical care and not on their own to diagnose or treat any disease.</p>","Favorite ID":"1,725","Short Title En":"PHQ-9","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"phq9-patient-health-questionnaire9","Short Description En":"<p>Degree of depression severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+59","Full Title En":"GAD-7 (General Anxiety Disorder-7)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 7:56 PM","Medium Description En":"<p>Measures severity of anxiety.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+59","Cme Version":"1727.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>MDCalc provides tools and content intended for use by healthcare professionals, and is not meant for use by patients. While these may be surveys or questions intended for patients, they are meant to be answered in the context of a clinician&rsquo;s medical care and not on their own to diagnose or treat any disease.</p>","Favorite ID":"1,727","Short Title En":"GAD-7","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"gad7-general-anxiety-disorder7","Short Description En":"<p>Severity of anxiety.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+28","Full Title En":"CAGE Questions for Alcohol Use","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:43 PM","Medium Description En":"<p>Screens for excessive drinking and alcoholism.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+28","Cme Version":"1729.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,729","Short Title En":"CAGE Questions","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"cage-questions-alcohol-use","Short Description En":"<p>Screens for excessive drinking and alcoholism.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+08","Full Title En":"Adult Self-Report Scale (ASRS v1.1) for ADHD","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 22, 2023, 7:51 PM","Medium Description En":"<p>Diagnoses adult <abbr title=\"Attention Deficit-Hyperactivity Disorder\">ADHD</abbr>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+08","Cme Version":"1730.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This is intended for patients &ge;18 years old.</p>","Before Use":"","Favorite ID":"1,730","Short Title En":"Adult Self-Report Scale (ASRS)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"adult-self-report-scale-asrs-adhd","Short Description En":"<p>Diagnoses adult ADHD.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Duke Criteria for Infective Endocarditis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 5:27 PM","Medium Description En":"<p>Diagnostic criteria for endocarditis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1731.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,731","Short Title En":"Duke Criteria for IE","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"duke-criteria-infective-endocarditis","Short Description En":"<p>Diagnose endocarditis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sgarbossa's Criteria for MI in Left Bundle Branch Block","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 3:49 PM","Medium Description En":"<p>Criteria to diagnose acute MI in patients with prior LBBB.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,732","Short Title En":"Sgarbossa's Criteria for MI","Cme Release Date":"","Slug":"sgarbossas-criteria-mi-left-bundle-branch-block","Short Description En":"<p>Diagnoses acute MI in LBBB.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"LRINEC Score for Necrotizing Soft Tissue Infection","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:01 PM","Medium Description En":"<p>Screens for necrotizing soft tissue infections.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1734.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>If high suspicion for necrotizing fasciitis through clinical history and physical exam, do not calculate a LRINEC score and go straight to operative debridement. <br>Note: Use with caution, as the LRINEC Score has performed poorly in external validation, most recently in <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468074\" target=\"_blank\" rel=\"noopener\">Neeki 2017</a>.</p>","Before Use":"","Favorite ID":"1,734","Short Title En":"LRINEC Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"lrinec-score-necrotizing-soft-tissue-infection","Short Description En":"<p>Early diagnosis of nec fasc.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"BISAP Score for Pancreatitis Mortality","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:18 PM","Medium Description En":"<p>Predicts mortality risk in pancreatitis with fewer variables than Ranson's.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Data should be taken from the first 24 hours of the patient's evaluation.</p>","Before Use":"","Favorite ID":"1,735","Short Title En":"BISAP Score for Pancreatitis","Cme Release Date":"","Slug":"bisap-score-pancreatitis-mortality","Short Description En":"<p>Mortality in pancreatitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+33","Full Title En":"CIWA-Ar for Alcohol Withdrawal","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 25, 2023, 6:58 PM","Medium Description En":"<p>The CIWA-Ar objectifies severity of alcohol withdrawal.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+33","Cme Version":"1736.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,736","Short Title En":"CIWA-Ar","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"ciwa-ar-alcohol-withdrawal","Short Description En":"<p>Objectifies alcohol withdrawal severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Arterial Blood Gas (ABG) Analyzer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:36 PM","Medium Description En":"<p>Interprets ABG.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This analyzer should not substitute for clinical context. Sodium and chloride are required for <calculator id=\"1669\">anion gap</calculator> calculation.</p>","Before Use":"","Favorite ID":"1,741","Short Title En":"ABG Analysis","Cme Release Date":"","Slug":"arterial-blood-gas-abg-analyzer","Short Description En":"<p>Interprets ABG.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MELDNa/MELD-Na Score for Liver Cirrhosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:17 PM","Medium Description En":"<p>Adds sodium to the MELD model for liver cirrhosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: The Organ Procurement and Transplantation Network recently incorporated sodium into their <calculator id=\"78\">new MELD Score</calculator> as of January 2016, using a different model than MELD-Na. We recommend using the <calculator id=\"78\">new MELD Score</calculator> primarily.</p>","Before Use":"<p>We&rsquo;ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. <a href=\"https://www.mdcalc.com/calc/10437/model-end-stage-liver-disease-meld?utm_source=site&amp;utm_medium=link&amp;utm_campaign=meld_na\" target=\"_blank\" rel=\"noopener\">Click here to view</a>.</p>","Favorite ID":"1,754","Short Title En":"MELD-Na Score","Cme Release Date":"","Slug":"meldna-meld-na-score-liver-cirrhosis","Short Description En":"<p>MELD + Na: More accurate than MELD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Index of Severity for Eosinophilic Esophagitis (I-SEE)","Created At":"January 11, 2024, 4:33 PM","Is Manual":"false","Dosing":"false","Updated At":"January 16, 2024, 5:10 PM","Medium Description En":"<p>Classifies severity of eosinophilic esophagitis (EoE).</p>","Logic Language":"javascript","Published At":"January 11, 2024, 4:48 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This is one of the first scores created to calculate the disease severity of eosinophilic esophagitis (EoE). You&rsquo;ll need the patient's history of symptoms, along with their most recent EGD and pathology reports to use this score.</p>","Before Use":"","Favorite ID":"10,497","Short Title En":"I-SEE","Cme Release Date":"","Slug":"index-severity-eosinophilic-esophagitis-i-see","Short Description En":"<p>EoE severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Emergency Heart Failure Mortality Risk Grade (EHMRG)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 16, 2024, 3:39 AM","Medium Description En":"<p>Estimates 7-day mortality of emergency CHF patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score is not intended for use in dialysis-dependent patients.</p>","Before Use":"","Favorite ID":"1,755","Short Title En":"EHMRG Score","Cme Release Date":"","Slug":"emergency-heart-failure-mortality-risk-grade-ehmrg","Short Description En":"<p>Mortality of emergency CHF patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Modified NIH Stroke Scale/Score (mNIHSS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:08 PM","Medium Description En":"<p>Shortened, validated version of the NIHSS.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1756.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: numbering scheme is intentional and reflects differences from the <calculator id=\"715\">original NIHSS</calculator> (i.e., 1A, 7 and 10 are eliminated, and 3 and 4 are combined).</p>","Before Use":"","Favorite ID":"1,756","Short Title En":"Modified NIH Stroke Scale","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"modified-nih-stroke-scale-score-mnihss","Short Description En":"<p>Shortened, validated version of the NIHSS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Opioid Risk Tool (ORT) for Narcotic Abuse","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:10 PM","Medium Description En":"<p>Estimates risk of opioid-related aberrant behaviors.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool studied patients at a chronic pain clinic.</p>","Before Use":"","Favorite ID":"1,757","Short Title En":"Opioid Risk Tool (ORT)","Cme Release Date":"","Slug":"opioid-risk-tool-ort-narcotic-abuse","Short Description En":"<p>Risk of narcotic abuse/misuse.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"CRUSADE Score for Post-MI Bleeding Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:16 PM","Medium Description En":"<p>Stratifies bleeding risk after NSTEMI.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1784.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,784","Short Title En":"CRUSADE Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"crusade-score-post-mi-bleeding-risk","Short Description En":"<p>Bleeding risk after NSTEMI.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+135","Full Title En":"RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:20 PM","Medium Description En":"<p>Determine the risk of major bleeding during anticoagulant therapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+135","Cme Version":"1786.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,786","Short Title En":"RIETE Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"riete-score-risk-hemorrhage-pulmonary-embolism-treatment","Short Description En":"<p>Bleeding risk from PE anticoagulation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+00","Full Title En":"4Ts Score for Heparin-Induced Thrombocytopenia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:50 PM","Medium Description En":"<p>Differentiates patients with HIT from those with other causes of thrombocytopenia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+00","Cme Version":"1787.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,787","Short Title En":"4Ts for HIT","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"4ts-score-heparin-induced-thrombocytopenia","Short Description En":"<p>HIT vs other causes of thrombocytopenia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"HIT Expert Probability (HEP) Score for Heparin-Induced Thrombocytopenia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:21 PM","Medium Description En":"<p>Pre-test clinical scoring model for HIT based on broad expert opinion.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1789.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,789","Short Title En":"HIT Expert Probability (HEP) Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"hit-expert-probability-hep-score-heparin-induced-thrombocytopenia","Short Description En":"<p>Likelihood of HIT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Step-by-Step Approach to Febrile Infants","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:23 PM","Medium Description En":"<p>Identifies febrile infants &le;90 days old at low risk of invasive bacterial infections.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1801.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in previously healthy infants &le;90 days old presenting with fever without a source.</p>","Before Use":"","Favorite ID":"1,801","Short Title En":"Step-by-Step Approach to Fever","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"step-step-approach-febrile-infants","Short Description En":"<p>Low-risk febrile infants.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Kocher Criteria for Septic Arthritis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:24 PM","Medium Description En":"<p>Distinguishes septic arthritis from transient synovitis in a child with an inflamed hip.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1817.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,817","Short Title En":"Kocher Criteria","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"kocher-criteria-septic-arthritis","Short Description En":"<p>Septic arthritis vs transient synovitis in pediatric inflamed hip.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Surgical Apgar Score (SAS) for Postoperative Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 11, 2023, 5:35 PM","Medium Description En":"<p>Predicts postoperative risk of major complication, including death.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,826","Short Title En":"Surgical Apgar Score (SAS)","Cme Release Date":"","Slug":"surgical-apgar-score-sas-postoperative-risk","Short Description En":"<p>Predicts postoperative risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Simplified Motor Score (SMS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:27 PM","Medium Description En":"<p>Simplifies assessment of head trauma patients compared to the <calculator id=\"64\">GCS</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1832.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Score the patient's <em>best</em>&nbsp;response.</p>","Before Use":"","Favorite ID":"1,832","Short Title En":"Simplified Motor Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"simplified-motor-score-sms","Short Description En":"<p>Simplified GCS for head trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hamilton Anxiety Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:31 PM","Medium Description En":"<p>Rates level of anxiety based on clinical questions.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,843","Short Title En":"Hamilton Anxiety Scale","Cme Release Date":"","Slug":"hamilton-anxiety-scale","Short Description En":"<p>Trends anxiety over time.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Major Depression Index (MDI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:34 PM","Medium Description En":"<p>Screens for depression based on clinically significant questions.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,844","Short Title En":"Major Depression Index","Cme Release Date":"","Slug":"major-depression-index-mdi","Short Description En":"<p>Screens for depression.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Quick Inventory of Depressive Symptomatology (QIDS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:42 PM","Medium Description En":"<p>Rates depression symptoms via self-assessment, also known as QIDS-SR-16.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,845","Short Title En":"QIDS","Cme Release Date":"","Slug":"quick-inventory-depressive-symptomatology-qids","Short Description En":"<p>Trends depressions via self-assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+165","Full Title En":"Vancouver Chest Pain Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:42 PM","Medium Description En":"<p>Identifies chest pain patients who are low risk and safe for early discharge.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+165","Cme Version":"1856.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,856","Short Title En":"Vancouver Chest Pain Rule","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"vancouver-chest-pain-rule","Short Description En":"<p>2-hour rule out for low risk chest pain.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+07","Full Title En":"ADAPT Protocol for Cardiac Event Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 4:43 PM","Medium Description En":"<p>Assesses chest pain patients at 2 hours for risk of cardiac event.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+07","Cme Version":"1857.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,857","Short Title En":"ADAPT Protocol","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"adapt-protocol-cardiac-event-risk","Short Description En":"<p>2-hour rule out for low risk chest pain.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Emergency Department Assessment of Chest Pain Score (EDACS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:01 PM","Medium Description En":"<p>Identifies chest pain patients with low risk of major adverse cardiac event.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1858.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,858","Short Title En":"EDACS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"emergency-department-assessment-chest-pain-score-edacs","Short Description En":"<p>Identifies low risk chest pain, longer but more specific than HEART.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+34","Full Title En":"Confusion Assessment Method for the ICU (CAM-ICU)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:02 PM","Medium Description En":"<p>Establishes ability to detect delirium in high risk settings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+34","Cme Version":"1870.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,870","Short Title En":"CAM-ICU","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"confusion-assessment-method-icu-cam-icu","Short Description En":"<p>Monitors delirium in ICU patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+134","Full Title En":"Richmond Agitation-Sedation Scale (RASS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:03 PM","Medium Description En":"<p>Ranks agitation and possibility for sedation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+134","Cme Version":"1872.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>See Evidence for definitions of criteria.</p>","Before Use":"","Favorite ID":"1,872","Short Title En":"Richmond Agitation-Sedation Scale (RASS)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"richmond-agitation-sedation-scale-rass","Short Description En":"<p>Objectify agitation-sedation spectrum.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Modified Rankin Scale for Neurologic Disability","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 22, 2023, 7:59 PM","Medium Description En":"<p>Measures the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1890.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,890","Short Title En":"Modified Rankin Scale","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"modified-rankin-scale-neurologic-disability","Short Description En":"<p>Disability/dependence after a stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"DRAGON Score for Post-TPA Stroke Outcome","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:11 PM","Medium Description En":"<p>Predicts 3 month outcome in ischemic stroke patients receiving TPA.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1892.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,892","Short Title En":"DRAGON Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"dragon-score-post-tpa-stroke-outcome","Short Description En":"<p>Calculate before tPA; predicts long term outcome.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Barnes Jewish Hospital Stroke Dysphagia Screen","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:14 PM","Medium Description En":"<p>Assesses ability to swallow without aspiration after stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1894.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,894","Short Title En":"Barnes Jewish Hospital Stroke Dysphagia Screen","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"barnes-jewish-hospital-stroke-dysphagia-screen","Short Description En":"<p>Clears patient to swallow after stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-11 00:00:00+00+00","Full Title En":"Pediatric SIRS, Sepsis, and Septic Shock Criteria","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 22, 2023, 8:11 PM","Medium Description En":"<p>Defines the severity of sepsis and septic shock for pediatric patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-11 00:00:00+00+00","Cme Version":"1977.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: There is still debate about how to define pediatric sepsis given varying ranges of &ldquo;normal&rdquo; vital signs for ages. For patients over 18, please use the <calculator id=\"1096\">Adult SIRS, Sepsis, and Septic Shock Criteria</calculator>.</p>","Before Use":"","Favorite ID":"1,977","Short Title En":"Pediatric SIRS","Cme Release Date":"2022-10-14 00:00:00+00+00","Slug":"pediatric-sirs-sepsis-septic-shock-criteria","Short Description En":"<p>Severity of sepsis and septic shock.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+37","Full Title En":"COWS Score for Opiate Withdrawal","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 25, 2023, 6:59 PM","Medium Description En":"<p>Quantifies severity of opiate withdrawal.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+37","Cme Version":"1985.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,985","Short Title En":"COWS Score","Cme Release Date":"2022-02-22 00:00:00+00+00","Slug":"cows-score-opiate-withdrawal","Short Description En":"<p>Severity of opiate withdrawal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+43","Full Title En":"DASH Prediction Score for Recurrent VTE","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:23 PM","Medium Description En":"<p>Predicts likelihood of recurrence of first VTE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+43","Cme Version":"2011.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do NOT use in patients with active hemorrhage or signs/symptoms of VTE.</p>","Before Use":"","Favorite ID":"2,011","Short Title En":"DASH Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"dash-prediction-score-recurrent-vte","Short Description En":"<p>Predicts likelihood of recurrence of first VTE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+20","Full Title En":"AUDIT-C for Alcohol Use","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:39 PM","Medium Description En":"<p>Identifies at-risk drinkers (i.e., binge drinking) who may not be alcohol-dependent.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+20","Cme Version":"2021.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,021","Short Title En":"AUDIT-C","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"audit-c-alcohol-use","Short Description En":"<p>Screens for at-risk drinkers, not necessarily dependence.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+119","Full Title En":"POMPE-C Tool for Pulmonary Embolism Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 6:39 PM","Medium Description En":"<p>Predicts mortality for cancer patients with PE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+119","Cme Version":"2022.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,022","Short Title En":"POMPE-C Tool","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"pompe-c-tool-pulmonary-embolism-mortality","Short Description En":"<p>Mortality for cancer patients with PE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+106","Full Title En":"Padua Prediction Score for Risk of VTE","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 5, 2023, 9:52 PM","Medium Description En":"<p>Determines anticoagulation need in hospitalized patients by risk of VTE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+106","Cme Version":"2023.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,023","Short Title En":"Padua Prediction Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"padua-prediction-score-risk-vte","Short Description En":"<p>Inpatient risk of VTE, need for anticoagulation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Lille Model for Alcoholic Hepatitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 7:18 PM","Medium Description En":"<p>Predicts mortality in patients with Alcoholic Hepatitis not responding to steroid therapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The Lille Model risk stratifies patients already receiving steroids for alcoholic hepatitis treatment for 7 days to predict which will not improve and should be considered for other management strategies. All values besides 7-day bilirubin are taken from admission.</p>","Before Use":"","Favorite ID":"2,024","Short Title En":"Lille Model","Cme Release Date":"","Slug":"lille-model-alcoholic-hepatitis","Short Description En":"<p>Mortality in Alcoholic Hepatitis that's unresponsive to steroids.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HAT (Hemorrhage After Thrombolysis) Score for Predicting Post-tPA Hemorrhage","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:32 PM","Medium Description En":"<p>Assesses hemorrhage risk after tPA.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,030","Short Title En":"HAT Score","Cme Release Date":"","Slug":"hat-hemorrhage-thrombolysis-score-predicting-post-tpa-hemorrhage","Short Description En":"<p>Hemorrhage risk after tPA.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ABC/2 Formula for Intracerebral Hemorrhage Volume","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:34 PM","Medium Description En":"<p>Predicts volume of intracranial hemorrhage from CT measurements.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Measure length and width on the CT slice with the largest area of hemorrhage. NOTE: CT slices are typically measured in mm, not cm.</p>","Before Use":"","Favorite ID":"2,031","Short Title En":"ABC/2 Formula","Cme Release Date":"","Slug":"abc2-formula-intracerebral-hemorrhage-volume","Short Description En":"<p>ICH volume from CT measurements.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+153","Full Title En":"Steroid Conversion Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"May 31, 2023, 8:35 PM","Medium Description En":"<p>Converts steroid dosages using dosing equivalencies.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+153","Cme Version":"2040.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>These dose relationships only apply to oral or IV administration. Glucocorticoid potencies may differ greatly following intramuscular or intra-articular administration.</p>","Before Use":"","Favorite ID":"2,040","Short Title En":"Steroid Conversion","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"steroid-conversion-calculator","Short Description En":"<p>Steroid dosing equivalencies.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"STONE Nephrolithometry Score for Renal Calculi","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:36 PM","Medium Description En":"<p>Predicts recurrence of kidney stone based on radiological criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,044","Short Title En":"STONE Score (Post-CT, Renal)","Cme Release Date":"","Slug":"stone-nephrolithometry-score-renal-calculi","Short Description En":"<p>Predicts renal stone recurrence, after CT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Urine Anion Gap","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:38 PM","Medium Description En":"<p>Detects urine acidosis for evaluation of non-gap metabolic acidosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,045","Short Title En":"Urine Anion Gap","Cme Release Date":"","Slug":"urine-anion-gap","Short Description En":"<p>Detects urine acidosis for metabolic acidosis eval.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"UCSF-CAPRA Score for Prostate Cancer Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:40 PM","Medium Description En":"<p>Predicts outcomes of patients post-treatment for prostate cancer.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,046","Short Title En":"UCSF-CAPRA Score","Cme Release Date":"","Slug":"ucsf-capra-score-prostate-cancer-risk","Short Description En":"<p>Post-treatment outcomes for prostate cancer.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Urinary Incontinence Scale (RUIS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:41 PM","Medium Description En":"<p>Assesses urinary incontinence symptoms and monitors outcomes with treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>After asking: Do you experience and if so how much are you bothered by:</p>","Before Use":"","Favorite ID":"2,047","Short Title En":"RUIS (Urinary Incontinence) Score","Cme Release Date":"","Slug":"revised-urinary-incontinence-scale-ruis","Short Description En":"<p>Assesses for incontinence.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Gleason Score for Prostate Cancer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:41 PM","Medium Description En":"<p>Prognoses prostate cancer based on microscopic tumor appearance.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,048","Short Title En":"Gleason Score","Cme Release Date":"","Slug":"gleason-score-prostate-cancer","Short Description En":"<p>Prognoses prostate cancer.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"D'Amico Risk Classification for Prostate Cancer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:43 PM","Medium Description En":"<p>Assesses 5 year risk of treatment failure based on clinical factors.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,049","Short Title En":"D'Amico Classification","Cme Release Date":"","Slug":"damico-risk-classification-prostate-cancer","Short Description En":"<p>Assesses 5 year failure of prostate CA treatment failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Urine Output and Fluid Balance","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:45 PM","Medium Description En":"<p>Calculates urine output over a 24-hour period.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Include volume intake to get a net fluid balance calculation as well (assuming no other fluid losses), for both adult and pediatric patients.</p>","Before Use":"","Favorite ID":"2,074","Short Title En":"Urine Output","Cme Release Date":"","Slug":"urine-output-fluid-balance","Short Description En":"<p>Urine output over 24 hrs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"NEXUS Chest Decision Instrument for Blunt Chest Trauma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:46 PM","Medium Description En":"<p>Determines which patients require chest imaging after blunt trauma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"2075.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Applies to patients &ge;15 years old with blunt trauma within the past 24 hours in the ED. May be used sequentially with <calculator id=\"3815\">NEXUS Chest CT Decision Instrument</calculator> (see Next Steps for details).</p>","Before Use":"","Favorite ID":"2,075","Short Title En":"NEXUS Chest Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"nexus-chest-decision-instrument-blunt-chest-trauma","Short Description En":"<p>Blunt chest trauma decision making.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Prostate Tumor Volume & Density","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:47 PM","Medium Description En":"<p>Measures prostate tumor volume and PSA density.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,076","Short Title En":"Prostate Tumor Volume","Cme Release Date":"","Slug":"prostate-tumor-volume-density","Short Description En":"<p>Tumor volume and PSA density.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Kruis Score for Diagnosis of Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:48 PM","Medium Description En":"<p>Determines presence of IBS using clinically significant weighted criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,141","Short Title En":"Kruis Score for IBS","Cme Release Date":"","Slug":"kruis-score-diagnosis-irritable-bowel-syndrome-ibs","Short Description En":"<p>Diagnoses IBS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Manchester Score for Prognosis in Small Cell Lung Cancer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:48 PM","Medium Description En":"<p>Predicts 2 year survival of small cell lung cancer.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,142","Short Title En":"Manchester Score for Lung Cancer","Cme Release Date":"","Slug":"manchester-score-prognosis-small-cell-lung-cancer","Short Description En":"<p>2 year survival of small cell lung CA.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Sokal Index for Chronic Myelogenous Leukemia (CML)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:50 PM","Medium Description En":"<p>Predicts survival of CML based on clinical and lab information.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"2143.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use to predict prognosis at the time of CML diagnosis, before starting treatment.</p>","Before Use":"","Favorite ID":"2,143","Short Title En":"Sokal Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"sokal-index-chronic-myelogenous-leukemia-cml","Short Description En":"<p>CML survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+39","Full Title En":"Critical Care Pain Observation Tool (CPOT)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:50 PM","Medium Description En":"<p>Rates critically ill patients&rsquo; pain based on clinical observation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+39","Cme Version":"2144.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,144","Short Title En":"CPOT Pain Scale","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"critical-care-pain-observation-tool-cpot","Short Description En":"<p>Pain in critically ill patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Expanded Disability Status Scale (EDSS) / Functional Systems Score (FSS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 26, 2023, 6:01 PM","Medium Description En":"<p>Describes severity of disability in patients with MS.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,146","Short Title En":"EDSS/FSS for Multiple Sclerosis","Cme Release Date":"","Slug":"expanded-disability-status-scale-edss-functional-systems-score-fss","Short Description En":"<p>Disability severity in MS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"GAP Index for Idiopathic Pulmonary Fibrosis (IPF) Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:56 PM","Medium Description En":"<p>Provides 1, 2, and 3-year mortality estimates for IPF patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,157","Short Title En":"GAP Index for IPF","Cme Release Date":"","Slug":"gap-index-idiopathic-pulmonary-fibrosis-ipf-mortality","Short Description En":"<p>Staging and prognosis in IPF.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Breast Cancer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages breast cancer based on tumor, lymph nodes, and metastases.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. An update based on the 8th edition is currently in progress.</p>","Before Use":"","Favorite ID":"2,170","Short Title En":"TNM Breast CA Staging","Cme Release Date":"","Slug":"tnm-staging-breast-cancer","Short Description En":"Breast CA staging."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Acute Gout Diagnosis Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:57 PM","Medium Description En":"<p>Risk stratifies for gout vs non-gout arthritis and helps determine which patients benefit most from joint aspiration.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,175","Short Title En":"Acute Gout Diagnosis Rule","Cme Release Date":"","Slug":"acute-gout-diagnosis-rule","Short Description En":"<p>Risk for gout.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Disease Activity Score-28 for Rheumatoid Arthritis with ESR (DAS28-ESR)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:58 PM","Medium Description En":"<p>Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically ESR.</p>\n<p></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,176","Short Title En":"DAS28-ESR for Rheumatoid Arthritis","Cme Release Date":"","Slug":"disease-activity-score-28-rheumatoid-arthritis-esr-das28-esr","Short Description En":"<p>RA severity, specifically based on ESR.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Clinical Disease Activity Index (CDAI) for Rheumatoid Arthritis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:59 PM","Medium Description En":"<p>Determines severity of rheumatoid arthritis using only clinical data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,177","Short Title En":"CDAI for Rheumatoid Arthritis","Cme Release Date":"","Slug":"clinical-disease-activity-index-cdai-rheumatoid-arthritis","Short Description En":"<p>RA Severity, clinical data only.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Disease Activity Score-28 for Rheumatoid Arthritis with CRP (DAS28-CRP)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 9:58 PM","Medium Description En":"<p>Describes severity of rheumatoid arthritis using clinical and laboratory data, specifically CRP.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,193","Short Title En":"DAS28-CRP for Rheumatoid Arthritis","Cme Release Date":"","Slug":"disease-activity-score-28-rheumatoid-arthritis-crp-das28-crp","Short Description En":"<p>RA severity, specifically based on CRP.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Simple Disease Activity Index (SDAI) for Rheumatoid Arthritis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 24, 2023, 10:00 PM","Medium Description En":"<p>Determines severity of rheumatoid arthritis using clinical and laboratory data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,194","Short Title En":"SDAI for Rheumatoid Arthritis","Cme Release Date":"","Slug":"simple-disease-activity-index-sdai-rheumatoid-arthritis","Short Description En":"<p>RA Severity, clinical data only.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Fatigue Impact Scale (MFIS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:37 PM","Medium Description En":"<p>Measures the impact fatigue takes on a patient's daily life.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The <calculator id=\"2197\">shortened version of the MFIS</calculator> can also be used when assessing daily fatigue impact of MS.</p>","Before Use":"","Favorite ID":"2,196","Short Title En":"Modified Fatigue Impact Scale","Cme Release Date":"","Slug":"modified-fatigue-impact-scale-mfis","Short Description En":"<p>Daily fatigue impact.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Shortened Modified Fatigue Impact Scale (MFIS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:39 PM","Medium Description En":"<p>Shorter version of MFIS which measures the impact fatigue takes on a patient's daily life.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The shortened version of the MFIS uses questions 1, 9, 10, 17, and 19 from the longer version of the MFIS.</p>","Before Use":"","Favorite ID":"2,197","Short Title En":"Shortened Modified Fatigue Impact Scale","Cme Release Date":"","Slug":"shortened-modified-fatigue-impact-scale-mfis","Short Description En":"<p>Daily fatigue impact.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Disease Steps for Multiple Sclerosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:42 PM","Medium Description En":"<p>Evaluates MS disease progression based on patient&rsquo;s ambulatory ability.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,199","Short Title En":"Disease Steps for Multiple Sclerosis","Cme Release Date":"","Slug":"disease-steps-multiple-sclerosis","Short Description En":"<p>MS progression, based on ambulation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fibrosis-4 (FIB-4) Index for Liver Fibrosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 17, 2023, 7:07 PM","Medium Description En":"<p>Noninvasive estimate of liver scarring in HCV and HBV patients, to assess need for biopsy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,200","Short Title En":"FIB-4 Index","Cme Release Date":"","Slug":"fibrosis-4-fib-4-index-liver-fibrosis","Short Description En":"<p>Noninvasive estimate of liver fibrosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Veterans Aging Cohort Study (VACS) 1.0 Index","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:43 PM","Medium Description En":"<p>Estimates risk of 5-year all-cause mortality in patients with HIV and/or HCV.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,201","Short Title En":"VACS 1.0 Index","Cme Release Date":"","Slug":"veterans-aging-cohort-study-vacs-1.0-index","Short Description En":"<p>All-cause mortality for patients with HIV or HCV.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CKD Prediction in HIV+ Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:44 PM","Medium Description En":"<p>Determines probability of HIV patients developing CKD in the next 5 years, if they take tenofivir or not.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,202","Short Title En":"HIV CKD Prediction","Cme Release Date":"","Slug":"ckd-prediction-hiv-patients","Short Description En":"<p>5 year likelihood of CKD in HIV.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Absolute Lymphocyte Count (ALC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:45 PM","Medium Description En":"<p>Assesses number of lymphocytes and predicts CD4 count.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Tips for COVID-19: </strong>Use after diagnosis to determine dispo. Lymphopenia appears to be a predictor of COVID infection.</p>","Favorite ID":"2,203","Short Title En":"Absolute Lymphocyte Count","Cme Release Date":"","Slug":"absolute-lymphocyte-count-alc","Short Description En":"<p>ALC count, and predicted CD4 Count.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+54","Full Title En":"Follicular Lymphoma International Prognostic Index (FLIPI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:45 PM","Medium Description En":"<p>Estimates overall survival based on clinical information.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+54","Cme Version":"2320.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,320","Short Title En":"FLIPI for Follicular Lymphoma","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"follicular-lymphoma-international-prognostic-index-flipi","Short Description En":"<p>Overall survival from FL.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+63","Full Title En":"Groupe d'Etude des Lymphomes Folliculaires (GELF) Criteria","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 4:46 PM","Medium Description En":"<p>Determines if immediate therapy for follicular lymphoma is required.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+63","Cme Version":"2321.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,321","Short Title En":"GELF Criteria for Follicular Lymphoma","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"groupe-detude-des-lymphomes-folliculaires-gelf-criteria","Short Description En":"<p>Assesses immediate therapy need.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+19","Full Title En":"Atropine Dosing for Cholinesterase Inhibitor Toxicity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"August 25, 2023, 4:48 PM","Medium Description En":"<p>Doses atropine for cholinesterase inhibitor toxicity (prescribed drugs, nerve gas, insecticides).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+19","Cme Version":"2664.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>Use in patients with cholinergic toxicity to determine atropine bolus dose and continuous infusion rate.</li>\n<li>Not for use in treating isolated bradycardia.</li>\n<li>Not for use in AtroPen Atropine Auto-Injector dosing.</li>\n<li>In the United States, the local Poison Control Center can be reached at <a href=\"tel:+1-800-222-1222\">1-800-222-1222</a> to help guide management.</li>\n</ul>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"2,664","Short Title En":"Atropine Dosing","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"atropine-dosing-cholinesterase-inhibitor-toxicity","Short Description En":"<p>Cholinesterase inhibitor reversal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 5:25 PM","Medium Description En":"<p>Quantifies end-stage liver disease for transplant planning.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: This is the pre-2016 MELD which does not include serum sodium level, as non-US transplant societies are still using the original MELD formula. <calculator id=\"78\">The newer MELD Score is listed as &ldquo;MELD Score&rdquo;</calculator>.</p>","Before Use":"<p>We&rsquo;ve updated and combined our MELD scores into one page. Clinicians can choose the formula that best fits their needs: the original MELD score; the current MELD-Na used by UNOS/OPTN, and the 2022 MELD 3.0 score. <a href=\"https://www.mdcalc.com/calc/10437/model-end-stage-liver-disease-meld?utm_source=site&amp;utm_medium=link&amp;utm_campaign=pre_2016\" target=\"_blank\" rel=\"noopener\">Click here to view</a>.</p>","Favorite ID":"2,693","Short Title En":"MELD Score (Original)","Cme Release Date":"","Slug":"meld-score-original-pre-2016-model-end-stage-liver-disease","Short Description En":"<p>Liver transplant planning.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Renal Cell Carcinoma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages RCC based on tumor, lymph nodes, and metastases.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10122\">8th edition</calculator> is now recommended for use over this version.</p>","Before Use":"","Favorite ID":"3,011","Short Title En":"TNM RCC Staging","Cme Release Date":"","Slug":"tnm-staging-renal-cell-carcinoma","Short Description En":"RCC staging."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+97","Full Title En":"NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 5:07 PM","Medium Description En":"<p>Estimates amount of scarring in the liver based on several laboratory tests.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+97","Cme Version":"3081.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,081","Short Title En":"NAFLD Fibrosis Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"nafld-non-alcoholic-fatty-liver-disease-fibrosis-score","Short Description En":"<p>Estimates amount of liver scarring.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"AST to Platelet Ratio Index (APRI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 7:59 PM","Medium Description En":"<p>Determines the likelihood of hepatic fibrosis and cirrhosis in patients with hepatitis C.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,094","Short Title En":"APRI","Cme Release Date":"","Slug":"ast-platelet-ratio-index-apri","Short Description En":"<p>Predicts hepatitis C-related hepatic fibrosis and cirrhosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Serum Ascites Albumin Gradient (SAAG)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:08 PM","Medium Description En":"<p>Defines presence of portal hypertension in patients with ascites.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,096","Short Title En":"Serum Ascites Albumin Gradient","Cme Release Date":"","Slug":"serum-ascites-albumin-gradient-saag","Short Description En":"<p>Defines presence of portal hypertension in patients with ascites.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Original Score for Autoimmune Hepatitis (AIH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 7:59 PM","Medium Description En":"<p>Revised version of the original scoring system for the diagnosis of autoimmune hepatitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,111","Short Title En":"Revised Original AIH Score","Cme Release Date":"","Slug":"revised-original-score-autoimmune-hepatitis-aih","Short Description En":"<p>Revised version of the original scoring system for autoimmune hepatitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Infective Endocarditis (IE) Mortality Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 7, 2023, 7:42 PM","Medium Description En":"<p>Predicts mortality at 6 months in patients with infective endocarditis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3121.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,121","Short Title En":"IE Mortality Risk Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"infective-endocarditis-ie-mortality-risk-score","Short Description En":"<p>6-month Mortality from Infective Endocarditis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CEDOCS Score for Emergency Department Overcrowding","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:02 PM","Medium Description En":"<p>Estimates severity of overcrowding in community emergency departments.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,142","Short Title En":"CEDOCS","Cme Release Date":"","Slug":"cedocs-score-emergency-department-overcrowding","Short Description En":"<p>Estimates severity of overcrowding in community EDs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"NEDOCS Score for Emergency Department Overcrowding","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:02 PM","Medium Description En":"<p>Estimates severity of overcrowding in emergency departments.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,143","Short Title En":"NEDOCS","Cme Release Date":"","Slug":"nedocs-score-emergency-department-overcrowding","Short Description En":"<p>Estimates severity of overcrowding in EDs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PEDOCS Score for Pediatric Emergency Department Overcrowding","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:03 PM","Medium Description En":"<p>Estimates severity of overcrowding in pediatrics emergency departments.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,144","Short Title En":"PEDOCS","Cme Release Date":"","Slug":"pedocs-score-pediatric-emergency-department-overcrowding","Short Description En":"<p>Estimates severity of overcrowding in peds EDs.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Alberta Stroke Program Early CT Score (ASPECTS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:03 PM","Medium Description En":"<p>Determines MCA stroke severity using available CT data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3164.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>To compute the ASPECTS, 1 point is subtracted from 10 for any evidence of early ischemic change for each of the defined regions.</p>","Before Use":"","Favorite ID":"3,164","Short Title En":"ASPECTS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"alberta-stroke-program-early-ct-score-aspects","Short Description En":"<p>MCA stroke severity using CT data.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome III Diagnostic Criteria for Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:04 PM","Medium Description En":"<p>Official Rome III criteria for the diagnosis of irritable bowel syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Recurrent abdominal pain or discomfort, 3 days per month in the last 3 months (12 weeks), associated with &ge;2 of the criteria below. The criteria are fulfilled with symptoms onset 6 months prior to diagnosis.</p>","Before Use":"","Favorite ID":"3,165","Short Title En":"Rome III for IBS","Cme Release Date":"","Slug":"rome-iii-diagnostic-criteria-irritable-bowel-syndrome-ibs","Short Description En":"<p>Diagnoses IBS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RIPASA Score for Acute Appendicitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:10 PM","Medium Description En":"<p>Diagnoses appendicitis with lab values and clinical findings, especially for Asian populations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,166","Short Title En":"RIPASA Score","Cme Release Date":"","Slug":"ripasa-score-acute-appendicitis","Short Description En":"<p>Diagnoses appendicitis with lab values and clinical findings.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Manning Criteria for Diagnosis of Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:11 PM","Medium Description En":"<p>Determines likelihood of irritable bowel syndrome diagnosis based on clinically significant criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,167","Short Title En":"Manning Criteria","Cme Release Date":"","Slug":"manning-criteria-diagnosis-irritable-bowel-syndrome-ibs","Short Description En":"<p>IBS diagnostic criteria.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Karnofsky Performance Status Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:13 PM","Medium Description En":"<p>Determines ability of patient to tolerate chemotherapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>For patients &ge; 16 years old. Useful to use over time to track disease progression.</p>","Before Use":"","Favorite ID":"3,168","Short Title En":"Karnofsky Scale","Cme Release Date":"","Slug":"karnofsky-performance-status-scale","Short Description En":"<p>Chemotherapy tolerance.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Eastern Cooperative Oncology Group (ECOG) Performance Status","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:14 PM","Medium Description En":"<p>Determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy, simpler than the <calculator id=\"3168\">Karnofsky Scale</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,170","Short Title En":"ECOG Performance Status","Cme Release Date":"","Slug":"eastern-cooperative-oncology-group-ecog-performance-status","Short Description En":"<p>Chemotherapy tolerance, simpler than the Karnofsky Scale.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Lansky Play-Performance Scale for Pediatric Functional Status","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:14 PM","Medium Description En":"<p>Uses parent description of child&rsquo;s activity to assess ability and response to treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>For patients &lt; 16 years old. Useful to use over time to track disease progression.</p>","Before Use":"","Favorite ID":"3,176","Short Title En":"Lansky Scale","Cme Release Date":"","Slug":"lansky-play-performance-scale-pediatric-functional-status","Short Description En":"<p>Child activity assessment for serious illness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Clinical Pulmonary Infection Score (CPIS) for Ventilator-Associated Pneumonia (VAP)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:15 PM","Medium Description En":"<p>Assists in diagnosing ventilator-associated pneumonia by predicting benefit of pulmonary cultures.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Many reviews of the CPIS feel it should not be relied on; we include it because of its popularity but caution users to review the data on its utility first.</p>","Before Use":"","Favorite ID":"3,278","Short Title En":"CPIS for VAP","Cme Release Date":"","Slug":"clinical-pulmonary-infection-score-cpis-ventilator-associated-pneumonia-vap","Short Description En":"<p>Diagnosis of VAP by predicting benefit of pulmonary cultures.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome II Diagnostic Criteria for Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:16 PM","Medium Description En":"<p>Official Rome II criteria for the diagnosis of irritable bowel syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The <calculator id=\"4007\">Rome IV Criteria</calculator> are now recommended as an update to these criteria (May 2016).</p>","Before Use":"","Favorite ID":"3,281","Short Title En":"Rome II for IBS","Cme Release Date":"","Slug":"rome-ii-diagnostic-criteria-irritable-bowel-syndrome-ibs","Short Description En":"<p>Diagnoses IBS, Rome IV recommended.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Harmless Acute Pancreatitis Score (HAPS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:16 PM","Medium Description En":"<p>Identifies patients who do not require intensive care for their first episode of acute pancreatitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,286","Short Title En":"Harmless Acute Pancreatitis Score","Cme Release Date":"","Slug":"harmless-acute-pancreatitis-score-haps","Short Description En":"<p>Rules out ICU need for first episode of acute pancreatitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Glasgow-Imrie Criteria for Severity of Acute Pancreatitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:18 PM","Medium Description En":"<p>Determines severity of pancreatitis based on 8 laboratory values.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>These criteria are traditionally scored with values at 48 hours after admission.</p>","Before Use":"","Favorite ID":"3,287","Short Title En":"Glasgow-Imrie Pancreatitis Score","Cme Release Date":"","Slug":"glasgow-imrie-criteria-severity-acute-pancreatitis","Short Description En":"<p>Pancreatitis severity from lab values.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Glasgow Prognostic Score (GPS) for Cancer Outcomes","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:18 PM","Medium Description En":"<p>Provides cancer prognosis based on serum biomarkers.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: We recommend the <calculator id=\"3312\">Modified Glasgow Prognostic Score</calculator> over this original version.</p>","Before Use":"","Favorite ID":"3,311","Short Title En":"GPS for Cancer Outcomes","Cme Release Date":"","Slug":"glasgow-prognostic-score-gps-cancer-outcomes","Short Description En":"<p>Cancer prognosis based on biomarkers.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Prognostic Index for Cancer Outcomes","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:19 PM","Medium Description En":"<p>Predicts cancer mortality from serum biomarkers.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,313","Short Title En":"Prognostic Index for Cancer","Cme Release Date":"","Slug":"prognostic-index-cancer-outcomes","Short Description En":"<p>Predicts cancer mortality.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Pancreatic Cancer","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages pancreatic cancer based on tumor, lymph nodes, and metastases.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10178\">8th edition</calculator> is now recommended for use over this version.</p>","Before Use":"","Favorite ID":"3,314","Short Title En":"TNM Pancreatic CA Staging","Cme Release Date":"","Slug":"tnm-staging-pancreatic-cancer","Short Description En":"Pancreatic CA staging."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Khorana Risk Score for Venous Thromboembolism in Cancer Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:20 PM","Medium Description En":"<p>Predicts risk of VTE for cancer patients depending on type of cancer and other factors.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in general cancer patients&nbsp;(i.e., solid tumors and lymphomas). Do not use in&nbsp;patients with brain&nbsp;tumors or myelomas.</p>","Before Use":"","Favorite ID":"3,315","Short Title En":"Khorana Risk Score for VTE","Cme Release Date":"","Slug":"khorana-risk-score-venous-thromboembolism-cancer-patients","Short Description En":"<p>Predicts risk of VTE for cancer patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+51","Full Title En":"FeverPAIN Score for Strep Pharyngitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:54 PM","Medium Description En":"<p>Predicts likelihood of strep throat.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+51","Cme Version":"3316.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,316","Short Title En":"FeverPAIN Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"feverpain-score-strep-pharyngitis","Short Description En":"<p>Predicts likelihood of strep throat.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"VBAC Risk Score for Successful Vaginal Delivery (Flamm Model)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:20 PM","Medium Description En":"<p>Predicts likelihood of successful vaginal birth after previous caesarean section (VBAC).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,317","Short Title En":"VBAC Risk Score (Flamm)","Cme Release Date":"","Slug":"vbac-risk-score-successful-vaginal-delivery-flamm-model","Short Description En":"<p>Quantifies likelihood of vaginal birth after previous C-section.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Bishop Score for Vaginal Delivery and Induction of Labor","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:22 PM","Medium Description En":"<p>Predicts likelihood of successful vaginal delivery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,320","Short Title En":"Bishop Score","Cme Release Date":"","Slug":"bishop-score-vaginal-delivery-induction-labor","Short Description En":"<p>Likelihood of successful vaginal delivery.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Asthma Predictive Index (API)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:23 PM","Medium Description En":"<p>Determines likelihood of pediatric patients developing childhood asthma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score applies to pediatric patients &le;3 years old.</p>","Before Use":"","Favorite ID":"3,381","Short Title En":"Asthma Predictive Index","Cme Release Date":"","Slug":"asthma-predictive-index-api","Short Description En":"<p>Likelihood of childhood asthma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Asthma Predictive Index (mAPI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 8:23 PM","Medium Description En":"<p>Predicts future asthma in pediatric patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score applies to pediatric patients &le;3 years old.</p>","Before Use":"","Favorite ID":"3,382","Short Title En":"Modified Asthma Predictive Index","Cme Release Date":"","Slug":"modified-asthma-predictive-index-mapi","Short Description En":"<p>Predicts future asthma diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Asthma Severity Score (PASS) for Asthma Exacerbation Severity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:13 PM","Medium Description En":"<p>Determines pediatric asthma severity based on physical exam findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Applicable to pediatric patients 1-18 years of age.</p>","Before Use":"","Favorite ID":"3,383","Short Title En":"Pediatric Asthma Severity Score","Cme Release Date":"","Slug":"pediatric-asthma-severity-score-pass-asthma-exacerbation-severity","Short Description En":"<p>Severity of pediatric asthma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Respiratory Assessment Measure (PRAM) for Asthma Exacerbation Severity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:13 PM","Medium Description En":"<p>Measures severity of airway obstruction in pediatric patients using clinical observations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The PRAM has been used in patients 3-17 years old and works best to evaluate improvement of symptoms pre- and post-treatment.</p>","Before Use":"","Favorite ID":"3,384","Short Title En":"Pediatric Respiratory Assessment Measure","Cme Release Date":"","Slug":"pediatric-respiratory-assessment-measure-pram-asthma-exacerbation-severity","Short Description En":"<p>Asthma severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Prevention and Incidence of Asthma and Mite Allergy (PIAMA) Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:14 PM","Medium Description En":"<p>Determines risk of asthma for school age children.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,385","Short Title En":"PIAMA Risk Score","Cme Release Date":"","Slug":"prevention-incidence-asthma-mite-allergy-piama-risk-score","Short Description En":"<p>Risk of asthma for school age children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Risk Score for Asthma Exacerbation (RSE)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:14 PM","Medium Description En":"<p>Predicts likelihood of asthma exacerbation within 6 months.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,386","Short Title En":"Risk Score for Asthma Exacerbation","Cme Release Date":"","Slug":"risk-score-asthma-exacerbation-rse","Short Description En":"<p>Likelihood of asthma exacerbation within 6 months.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 8:40 PM","Medium Description En":"<p>Determines 10-year risk of heart disease or stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Our <calculator id=\"3400\">ASCVD Risk Algorithm</calculator> is a step-wise approach for all adult patients &ndash; including those with known ASCVD. This calculator is for use only in adult patients without known ASCVD and LDL 70-189 mg/dL (1.81-4.90 mmol/L).</p>","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same other inputs, this calculator estimates higher cardiovascular risk for African American patients.</p>","Favorite ID":"3,398","Short Title En":"2013 ASCVD Risk Calculator","Cme Release Date":"","Slug":"ascvd-atherosclerotic-cardiovascular-disease-2013-risk-calculator-aha-acc","Short Description En":"<p>10-year heart disease or stroke risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ASCVD (Atherosclerotic Cardiovascular Disease) Risk Algorithm including Known ASCVD from AHA/ACC","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 10:10 PM","Medium Description En":"<p>Determines 10-year risk of heart disease or stroke and provides statin recommendations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same other inputs, this calculator estimates higher cardiovascular risk for African American patients.</p>","Favorite ID":"3,400","Short Title En":"ASCVD Risk Algorithm","Cme Release Date":"","Slug":"ascvd-atherosclerotic-cardiovascular-disease-risk-algorithm-including-known-ascvd-aha-acc","Short Description En":"<p>10-year heart disease or stroke risk and statin recommendations.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immunization Schedule Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:15 PM","Medium Description En":"<p>Determines what immunizations/vaccinations are due based on a patient's age.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This is based on the CDC's dosing schedule. Clinical judgment and knowledge of past vaccinations should guide decision to provide vaccinations to patients.</p>","Before Use":"","Favorite ID":"3,401","Short Title En":"Immunization Schedule Calculator","Cme Release Date":"","Slug":"immunization-schedule-calculator","Short Description En":"<p>Immunizations due based on age.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Nonverbal Pain Scale (NVPS) for Nonverbal Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:16 PM","Medium Description En":"<p>Quantifies pain in patients unable to speak (due to intubation, dementia, etc).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>One can also use the <calculator id=\"3622\">Behavioral Pain Scale (BPS)</calculator> for Intubated Patients as an alternative to the NVPS.</p>","Before Use":"","Favorite ID":"3,621","Short Title En":"Nonverbal Pain Scale","Cme Release Date":"","Slug":"nonverbal-pain-scale-nvps-nonverbal-patients","Short Description En":"<p>Pain scale in patients unable to speak.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Behavioral Pain Scale (BPS) for Pain Assessment in Intubated Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:16 PM","Medium Description En":"<p>Quantifies pain in intubated patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>One can also use the <calculator id=\"3621\">Nonverbal Pain Scale (NVPS)</calculator> for Nonverbal Patients as an alternative to the BPS.</p>","Before Use":"","Favorite ID":"3,622","Short Title En":"Behavioral Pain Scale","Cme Release Date":"","Slug":"behavioral-pain-scale-bps-pain-assessment-intubated-patients","Short Description En":"<p>Pain scale in intubated patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) for Post-Op Pediatric Pain","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:17 PM","Medium Description En":"<p>Quantifies pain post-operatively in pediatric patients 1-5 years old.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>One can also use the <calculator id=\"3625\">Behavioral Observational Pain Scale (BOPS) for Post-Op Pediatric Pain</calculator> as an alternative to the CHEOPS.</p>","Before Use":"","Favorite ID":"3,623","Short Title En":"CHEOPS","Cme Release Date":"","Slug":"childrens-hospital-eastern-ontario-pain-scale-cheops-post-op-pediatric-pain","Short Description En":"<p>Post-op pain assessment for peds.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Behavioral Observational Pain Scale (BOPS) for Post-Op Pediatric Pain","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:17 PM","Medium Description En":"<p>Quantifies post-operative pain for children aged 1-7 years.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This pain scale is for use in patients 1-7 years old. <br><br>One can also use the <calculator id=\"3623\">Children&rsquo;s Hospital of Eastern Ontario Pain Scale (CHEOPS) for Post-Op Pediatric Pain</calculator> as an alternative to the BOPS.</p>","Before Use":"","Favorite ID":"3,625","Short Title En":"Behavioral Observational Pain Scale","Cme Release Date":"","Slug":"behavioral-observational-pain-scale-bops-post-op-pediatric-pain","Short Description En":"<p>Post-op pain scale for children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Neuropathic Pain Scale (NPS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:18 PM","Medium Description En":"<p>Quantifies severity of neuropathic pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Scores are based on patient responses to questions about pain intensity. 0 indicates no pain; 10 indicates the most pain imaginable. The NPS is only for use in patients who have already been diagnosed with neuropathic pain, and should not be used to determine IF a patient's pain is secondary to neuropathy.</p>","Before Use":"","Favorite ID":"3,626","Short Title En":"Neuropathic Pain Scale","Cme Release Date":"","Slug":"neuropathic-pain-scale-nps","Short Description En":"<p>Neuropathic pain severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Abbey Pain Scale for Dementia Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:19 PM","Medium Description En":"<p>Assesses pain in patients with advanced dementia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,627","Short Title En":"Abbey Pain Scale","Cme Release Date":"","Slug":"abbey-pain-scale-dementia-patients","Short Description En":"<p>Pain assessment in dementia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+138","Full Title En":"Rockall Score for Upper GI Bleeding (Complete)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:19 PM","Medium Description En":"<p>Determines severity of GI bleeding.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+138","Cme Version":"3642.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score for known upper GI bleed patients with a completed endoscopy. Use the <calculator id=\"3643\">Pre-Endoscopy Rockall Score</calculator> for patients who have not yet had endoscopy.</p>","Before Use":"","Favorite ID":"3,642","Short Title En":"Rockall Score (Complete)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rockall-score-upper-gi-bleeding-complete","Short Description En":"<p>Determines severity of GI bleeding.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+139","Full Title En":"Rockall Score for Upper GI Bleeding (Pre-Endoscopy)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:20 PM","Medium Description En":"<p>Determines severity of GI bleeding, prior to endoscopy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+139","Cme Version":"3643.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score for upper GI bleed patients who have NOT yet had endoscopy. Use the <calculator id=\"3642\">Complete Rockall Score</calculator> for patients who have had endoscopy.</p>","Before Use":"","Favorite ID":"3,643","Short Title En":"Rockall Score (Pre-Endoscopy)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rockall-score-upper-gi-bleeding-pre-endoscopy","Short Description En":"<p>Determines severity of GI bleeding, prior to endoscopy.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Gail Model for Breast Cancer Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:22 PM","Medium Description En":"<p>Estimates risk for breast cancer based on demographic and clinical data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3647.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The Gail Model is for use in women with no history of breast cancer, DCIS or LCIS. Other tools may be more appropriate for women with known mutations in BRCA1, BRCA2, or other hereditary syndromes associated with breast cancer. See the Evidence section for more information.</p>","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates; this calculator can be run with Race as &ldquo;Unknown,&rdquo; but users should know this defaults to the &ldquo;White&rdquo; option. Our evidence section reviews some of the issues with Race in this model.&nbsp;<a href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\" target=\"_blank\" data-saferedirecturl=\"https://www.google.com/url?q=https://www.mdcalc.com/race&amp;source=gmail&amp;ust=1632945061987000&amp;usg=AFQjCNFHRRxG7_ZvVdEhZIQz2LsJKodMKw\">See here</a> for more on our approach to addressing race and bias on MDCalc.</p>","Favorite ID":"3,647","Short Title En":"Gail Model for Breast CA Risk","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"gail-model-breast-cancer-risk","Short Description En":"<p>Breast CA risk based on demographic and clinical data.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+85","Full Title En":"Mayo Score/Disease Activity Index (DAI) for Ulcerative Colitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 25, 2023, 9:24 PM","Medium Description En":"<p>Assesses severity of ulcerative colitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+85","Cme Version":"3675.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,675","Short Title En":"Mayo DAI for Ulcerative Colitis","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"mayo-score-disease-activity-index-dai-ulcerative-colitis","Short Description En":"<p>Assesses severity of ulcerative colitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Natural History Model for Primary Sclerosing Cholangitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:15 PM","Medium Description En":"<p>Estimates survival from primary sclerosing cholangitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,676","Short Title En":"Revised Natural History Model for PSC","Cme Release Date":"","Slug":"revised-natural-history-model-primary-sclerosing-cholangitis","Short Description En":"<p>Estimates survival in primary sclerosing cholangitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pain Assessment in Advanced Dementia Scale (PAINAD)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:16 PM","Medium Description En":"<p>Assesses pain in patients with dementia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Choose the description that best fits the patient's behavior.</p>","Before Use":"","Favorite ID":"3,701","Short Title En":"PAINAD","Cme Release Date":"","Slug":"pain-assessment-advanced-dementia-scale-painad","Short Description En":"<p>Pain level in dementia patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+111","Full Title En":"Pediatric Glasgow Coma Scale (pGCS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:17 PM","Medium Description En":"<p>Assesses impaired consciousness and coma in pediatric patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+111","Cme Version":"3702.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use for children 2 years and younger only. For older children, use the standard <calculator id=\"64\">Glasgow Coma Scale (GCS)</calculator>. Note the difference between the Glasgow Coma <strong>Score</strong> (total score, only applicable when all three components are testable) and the Glasgow Coma <strong>Scale</strong> (component scores, applicable if any of three components is not testable).</p>","Before Use":"","Favorite ID":"3,702","Short Title En":"Pediatric GCS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"pediatric-glasgow-coma-scale-pgcs","Short Description En":"<p>Impaired consciousness and coma in pediatric patients.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Framingham Heart Failure Diagnostic Criteria","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:18 PM","Medium Description En":"<p>Diagnoses heart failure based on major and minor criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Select minor criteria ONLY if they cannot be explained by another comorbidity, e.g. dyspnea on exertion secondary to chronic obstructive pulmonary disease.</p>","Before Use":"","Favorite ID":"3,800","Short Title En":"Framingham HF Criteria","Cme Release Date":"","Slug":"framingham-heart-failure-diagnostic-criteria","Short Description En":"<p>Diagnoses heart failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+10","Full Title En":"AIMS65 Score for Upper GI Bleeding Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:19 PM","Medium Description En":"<p>Determines risk of in-hospital mortality from upper GI bleeding.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+10","Cme Version":"3801.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,801","Short Title En":"AIMS65","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"aims65-score-upper-gi-bleeding-mortality","Short Description En":"<p>Determines in-hospital mortality from upper GI bleeding.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Secondary Intracerebral Hemorrhage (sICH) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:20 PM","Medium Description En":"<p>Quantifies likelihood of underlying vascular etiology in patients with ICH.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3802.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,802","Short Title En":"sICH Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"secondary-intracerebral-hemorrhage-sich-score","Short Description En":"<p>Likelihood of vascular cause of ICH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MAGGIC Risk Calculator for Heart Failure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:24 PM","Medium Description En":"<p>Estimates 1- and 3- year mortality in heart failure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients (&ge;18 years). Use with caution in patients with reduced ejection fraction (not yet externally validated in this population).</p>","Before Use":"","Favorite ID":"3,803","Short Title En":"MAGGIC Risk Calculator for HF","Cme Release Date":"","Slug":"maggic-risk-calculator-heart-failure","Short Description En":"<p>Estimates 1- and 3- year heart failure mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+79","Full Title En":"LACE Index for Readmission","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:25 PM","Medium Description En":"<p>Predicts 30-day readmission or death in patients on medicine and surgery wards.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+79","Cme Version":"3805.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old.</p>","Before Use":"","Favorite ID":"3,805","Short Title En":"LACE Index","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"lace-index-readmission","Short Description En":"<p>Predicts 30-day readmission or death.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+47","Full Title En":"Estimated Ethanol (and Toxic Alcohol) Serum Concentration Based on Ingestion","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:34 PM","Medium Description En":"<p>Predicts ethanol concentration based on ingestion of alcohol.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+47","Cme Version":"3813.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Allows estimation of maximal predicted serum concentration of alcohol based on volume and concentration ingested. Assumes 0.6 L/kg volume of distribution.</p>","Before Use":"","Favorite ID":"3,813","Short Title En":"Estimated Serum Concentration of Alcohols","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"estimated-ethanol-toxic-alcohol-serum-concentration-based-ingestion","Short Description En":"<p>Predicts ethanol concentration based on ingestion of alcohol.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Bishop Score for Vaginal Delivery and Induction of Labor","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:36 PM","Medium Description En":"<p>Predicts likelihood of successful vaginal delivery with additional parameters to the original Bishop score.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Replaces effacement with cervical length, increases weightedness of cervical dilation and adds additional modifiers as compared with the original <calculator id=\"3320\">Bishop Score</calculator>.</p>","Before Use":"","Favorite ID":"3,814","Short Title En":"Modified Bishop Score","Cme Release Date":"","Slug":"modified-bishop-score-vaginal-delivery-induction-labor","Short Description En":"<p>Likelihood of successful vaginal delivery.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+102","Full Title En":"NEXUS Chest CT Decision Instrument for CT Imaging","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:37 PM","Medium Description En":"<p>Identifies blunt trauma patients with clinically significant thoracic injuries.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+102","Cme Version":"3815.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in awake, non-intubated, hemodynamically stable blunt trauma patients &ge;15 years old in whom a CT chest is considered as part of the normal diagnostic evaluation.</p>","Before Use":"","Favorite ID":"3,815","Short Title En":"NEXUS Chest CT Decision Instrument","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"nexus-chest-ct-decision-instrument-ct-imaging","Short Description En":"<p>Identifies clinically significant thoracic injuries in blunt trauma patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Simon Broome Diagnostic Criteria for Familial Hypercholesterolemia (FH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:43 PM","Medium Description En":"<p>Diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,817","Short Title En":"Simon Broome Diagnostic Criteria","Cme Release Date":"","Slug":"simon-broome-diagnostic-criteria-familial-hypercholesterolemia-fh","Short Description En":"<p>Diagnoses familial hypercholesterolemia (FH).</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Dutch Criteria for Familial Hypercholesterolemia (FH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 11, 2023, 7:41 PM","Medium Description En":"<p>Diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,818","Short Title En":"Dutch Criteria for FH","Cme Release Date":"","Slug":"dutch-criteria-familial-hypercholesterolemia-fh","Short Description En":"<p>Diagnoses familial hypercholesterolemia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+78","Full Title En":"Kawasaki Disease Diagnostic Criteria","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:47 PM","Medium Description En":"<p>Diagnoses Kawasaki Disease.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+78","Cme Version":"3819.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,819","Short Title En":"Kawasaki Disease Diagnostic Criteria","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"kawasaki-disease-diagnostic-criteria","Short Description En":"<p>Diagnoses Kawasaki Disease.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"US (MEDPED) Diagnostic Criteria for Familial Hypercholesterolemia (FH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:51 PM","Medium Description En":"<p>Diagnoses familial hypercholesterolemia using age, family history, and total cholesterol.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,820","Short Title En":"US (MEDPED) Diagnostic Criteria for FH","Cme Release Date":"","Slug":"us-medped-diagnostic-criteria-familial-hypercholesterolemia-fh","Short Description En":"<p>Diagnoses familial hypercholesterolemia.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Hepatocellular Carcinoma (HCC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages HCC based on tumor, lymph nodes, and metastases.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10116\">8th edition</calculator> is now recommended for use over this version.</p>","Before Use":"","Favorite ID":"3,822","Short Title En":"TNM HCC Staging","Cme Release Date":"","Slug":"tnm-staging-hepatocellular-carcinoma-hcc","Short Description En":"HCC staging."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Modified Response Evaluation Criteria in Solid Tumors (mRECIST)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 6:57 PM","Medium Description En":"<p>Measures treatment response, specifically to cytotoxic drugs, based on tumor shrinkage.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in liver lesions meeting the following criteria:</span></p>\n<ul>\n<li><span>Can be accurately measured in at least one dimension as 10 mm or more (measure longest diameter).</span></li>\n<li><span>Suitable for repeat measurement.</span></li>\n<li><span>Intratumoral arterial enhancement on contrast-enhanced CT or MRI.</span></li>\n</ul>","Before Use":"","Favorite ID":"3,824","Short Title En":"mRECIST","Cme Release Date":"","Slug":"modified-response-evaluation-criteria-solid-tumors-mrecist","Short Description En":"<p>Measures treatment response by HCC tumor size.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Barcelona-Clinic Liver Cancer (BCLC) Staging Classification and Treatment Guidelines","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 11, 2024, 7:02 PM","Medium Description En":"<p>Determines progression of disease and proper treatment course for patients with HCC.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,825","Short Title En":"BCLC Staging Classification","Cme Release Date":"","Slug":"barcelona-clinic-liver-cancer-bclc-staging-classification-treatment-guidelines","Short Description En":"<p>Determines progression and treatment course in HCC,</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+06","Full Title En":"Acute Decompensated Heart Failure National Registry (ADHERE) Algorithm","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:23 PM","Medium Description En":"<p>Predicts in-hospital mortality in patients with heart failure (HF).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+06","Cme Version":"3828.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,828","Short Title En":"ADHERE Algorithm","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"acute-decompensated-heart-failure-national-registry-adhere-algorithm","Short Description En":"<p>Predicts in-hospital mortality in acute decompensated HF.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Revised Cardiac Risk Index for Pre-Operative Risk","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"November 7, 2023, 8:04 PM","Medium Description En":"<p>Estimates risk of cardiac complications after noncardiac surgery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1739.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-adc7c97a-7fff-bc14-fde8-d753f368d6e7\">Note: this content was updated January 2019 to reflect the substantial body of evidence, namely external validation studies, suggesting that the original RCRI had significantly underestimated the risk (see <a href=\"#evidence\">Evidence</a> for more). </span></p>","Before Use":"","Favorite ID":"1,739","Short Title En":"Revised Cardiac Risk Index","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"revised-cardiac-risk-index-pre-operative-risk","Short Description En":"<p>Risk of major cardiac event from surgery.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"du Bois Score for Idiopathic Pulmonary Fibrosis (IPF) Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"November 7, 2023, 8:15 PM","Medium Description En":"<p>Determines 1-year mortality in IPF patients using PFT and clinical indicators.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,156","Short Title En":"du Bois Score for IPF","Cme Release Date":"","Slug":"du-bois-score-idiopathic-pulmonary-fibrosis-ipf-mortality","Short Description En":"<p>Mortality risk in IPF.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"ACR/EULAR Gout Classification Criteria","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"November 7, 2023, 8:09 PM","Medium Description En":"<p>Provides formal diagnostic criteria for gout.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The <calculator id=\"2175\">Acute Gout Diagnosis Rule</calculator>&nbsp;can help rule in or rule out gout, reducing the need for synovial fluid in highly likely patients and encouraging a broad differential in gout-unlikely patients.</p>\n<p></p>","Before Use":"","Favorite ID":"2,195","Short Title En":"ACR/EULAR Gout Criteria","Cme Release Date":"","Slug":"acr-eular-gout-classification-criteria","Short Description En":"<p>Gout diagnostic criteria.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"THRIVE Score for Stroke Outcome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"November 7, 2023, 8:38 PM","Medium Description En":"<p>Estimates prognosis after an acute ischemic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1706.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,706","Short Title En":"THRIVE Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"thrive-score-stroke-outcome","Short Description En":"<p>Prognosis after stroke; incorporates NIHSS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+65","Full Title En":"HEART Score for Major Cardiac Events","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"November 14, 2023, 8:41 PM","Medium Description En":"<p>Predicts 6-week risk of major adverse cardiac event.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+65","Cme Version":"1752.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;21 years old presenting with symptoms suggestive of ACS. Do not use if new ST-segment elevation &ge;1 mm or other new EKG changes, hypotension, life expectancy less than 1 year, or noncardiac medical/surgical/psychiatric illness determined by the provider to require admission.</p>","Before Use":"","Favorite ID":"1,752","Short Title En":"HEART Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"heart-score-major-cardiac-events","Short Description En":"<p>6-week risk of cardiac event.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Creatinine Clearance (Cockcroft-Gault Equation)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"November 29, 2023, 9:30 PM","Medium Description En":"<p>Calculates CrCl according to the Cockcroft-Gault equation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-f0783816-7fff-cd28-ba0c-6ad66ea51a27\">For use in patients with stable renal function to estimate creatinine clearance.</span></p>","Before Use":"","Favorite ID":"43","Short Title En":"Creatinine Clearance","Cme Release Date":"","Slug":"creatinine-clearance-cockcroft-gault-equation","Short Description En":"<p>Estimates creatinine clearance (kidney function).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+15","Full Title En":"APGAR Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 24, 2024, 5:24 PM","Medium Description En":"<p>Assesses neonates 1 and 5 minutes after birth.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+15","Cme Version":"23.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"23","Short Title En":"APGAR Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"apgar-score","Short Description En":"<p>Assesses neonates 1 and 5 mins postpartum.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+115","Full Title En":"PERC Rule for Pulmonary Embolism","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 24, 2024, 6:53 PM","Medium Description En":"<p>Rules out PE if no criteria are present and pre-test probability is &le;15%.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+115","Cme Version":"347.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"347","Short Title En":"PERC Rule","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"perc-rule-pulmonary-embolism","Short Description En":"<p>Clinically rules out PE (<span>&lt;</span>2%).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPEDE-VTE","Created At":"January 11, 2024, 8:18 PM","Is Manual":"false","Dosing":"false","Updated At":"January 24, 2024, 9:07 PM","Medium Description En":"<p>Predicts risk of venous thromboembolism in multiple myeloma.</p>","Logic Language":"javascript","Published At":"January 11, 2024, 8:33 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool can be used to identify those patients with multiple myeloma who are at high risk of venous thromboembolism (VTE). Make sure you know your patient&rsquo;s medication history, VTE history, and fracture history to utilize this score.</p>","Before Use":"","Favorite ID":"10,498","Short Title En":"IMPEDE-VTE","Cme Release Date":"","Slug":"impede-vte","Short Description En":"<p>VTE risk in MM.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RESECT-90","Created At":"January 30, 2024, 6:33 PM","Is Manual":"false","Dosing":"false","Updated At":"February 5, 2024, 9:53 PM","Medium Description En":"<p>Estimates 90-day mortality in lung resection patients.</p>","Logic Language":"javascript","Published At":"January 30, 2024, 10:17 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,502","Short Title En":"RESECT-90","Cme Release Date":"","Slug":"resect-90","Short Description En":"<p>Lung resection mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ideal Body Weight and Adjusted Body Weight","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 7, 2024, 9:04 PM","Medium Description En":"<p>Calculates ideal body weight (Devine formula) and adjusted body weight.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>To calculate tidal volume by ideal body weight, use the <calculator id=\"3928\">ETT Depth and Tidal Volume Calculator</calculator>.</p>","Before Use":"","Favorite ID":"68","Short Title En":"Ideal Body Weight and Adjusted Body Weight","Cme Release Date":"","Slug":"ideal-body-weight-adjusted-body-weight","Short Description En":"<p>Ideal and adjusted body weight.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+74","Full Title En":"Intracerebral Hemorrhage (ICH) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:49 PM","Medium Description En":"<p>Based on age and CT findings; estimates mortality.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+74","Cme Version":"402.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"402","Short Title En":"Intracerebral Hemorrhage (ICH) Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"intracerebral-hemorrhage-ich-score","Short Description En":"<p>Mortality in ICH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+68","Full Title En":"Hunt & Hess Classification of Subarachnoid Hemorrhage","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:50 PM","Medium Description En":"<p>Classifies severity of subarachnoid hemorrhage to predict mortality.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+68","Cme Version":"404.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"404","Short Title En":"Hunt & Hess Classification","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"hunt-hess-classification-subarachnoid-hemorrhage","Short Description En":"<p>Mortality in SAH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+99","Full Title En":"National Early Warning Score (NEWS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:55 PM","Medium Description En":"<p>Determines the degree of illness of a patient and prompts critical care intervention.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+99","Cme Version":"1873.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The NEWS2 Score is endorsed by the&nbsp;<abbr style=\"color: #ffb600;\" title=\"National Health Service\">NHS</abbr>&nbsp;(UK) as an updated version of the original NEWS.</p>","Before Use":"","Favorite ID":"1,873","Short Title En":"NEWS Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"national-early-warning-score-news","Short Description En":"<p>Severity screening of declining conditions.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+90","Full Title En":"Modified Early Warning Score (MEWS) for Clinical Deterioration","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:55 PM","Medium Description En":"<p>Determines the degree of illness of a patient.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+90","Cme Version":"1875.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Different institutions and regions may use different modifications of the MEWS. Verify that your institution uses the same points assignments listed here.</p>","Before Use":"","Favorite ID":"1,875","Short Title En":"MEWS Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"modified-early-warning-score-mews-clinical-deterioration","Short Description En":"<p>Severity screening of declining conditions.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+145","Full Title En":"SEDAN Score for Post-tPA Hemorrhage","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:56 PM","Medium Description En":"<p>Predicts risk of Symptomatic Intracerebral Hemorrhage (sICH) after tPA.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+145","Cme Version":"2039.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Applies to patients receiving tPA within 4.5 hours; does <strong>not</strong> apply to patients receiving endovascular treatment.</p>","Before Use":"","Favorite ID":"2,039","Short Title En":"SEDAN Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"sedan-score-post-tpa-hemorrhage","Short Description En":"<p>Predicts sICH risk after tPA.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"BeAM Value","Created At":"February 14, 2024, 9:16 PM","Is Manual":"false","Dosing":"false","Updated At":"February 29, 2024, 9:45 PM","Medium Description En":"<p>Calculates the difference between bedtime and AM fasting glucoses.</p>","Logic Language":"javascript","Published At":"February 14, 2024, 9:30 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to determine if adding prandial insulin to an existing regimen may be appropriate in patients with Diabetes Mellitus Type II.</p>","Before Use":"","Favorite ID":"10,506","Short Title En":"BeAM Value","Cme Release Date":"","Slug":"beam-value","Short Description En":"<p>Bedtime vs. AM glucose.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PELD Cr (Pediatric End-Stage Liver Disease)","Created At":"February 21, 2024, 3:24 PM","Is Manual":"false","Dosing":"false","Updated At":"March 1, 2024, 7:54 PM","Medium Description En":"<p>Updates PELD model as standard for pediatric liver transplant planning.</p>","Logic Language":"r","Published At":"February 21, 2024, 3:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score can be used to assign priority to liver transplant candidates younger than 12 years old. It is an update to the prior PELD score and was adopted by OPTN in July 2023.</p>","Before Use":"","Favorite ID":"10,507","Short Title En":"PELD Cr","Cme Release Date":"","Slug":"peld-cr","Short Description En":"<p>Updated peds liver transplant planning.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Thrombosis Risk Prediction Following Cast Immobilization (TRiP(cast)) Score","Created At":"April 4, 2024, 2:18 PM","Is Manual":"false","Dosing":"false","Updated At":"April 15, 2024, 9:27 PM","Medium Description En":"<p>Predicts risk of VTE in patients with lower limb trauma.</p>","Logic Language":"javascript","Published At":"April 4, 2024, 2:41 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to determine 3-month risk of VTE in adult patients with lower limb trauma that requires&nbsp;<span>immobilization.</span></p>","Before Use":"","Favorite ID":"10,516","Short Title En":"TRiP(cast) Score","Cme Release Date":"","Slug":"thrombosis-risk-prediction-cast-immobilization-trip-cast-score","Short Description En":"<p>VTE risk w/ lower limb trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Absolute Reticulocyte Count & Reticulocyte Index","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"April 16, 2024, 11:01 PM","Medium Description En":"<p>Assesses appropriate response to anemia, frequently in sickle cell patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,667","Short Title En":"Absolute Reticulocyte Count","Cme Release Date":"","Slug":"absolute-reticulocyte-count-reticulocyte-index","Short Description En":"<p>Adequacy of marrow response to anemia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+60","Full Title En":"Geneva Score (Revised) for Pulmonary Embolism","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 16, 2024, 10:18 PM","Medium Description En":"<p>Objectifies risk of PE, like Wells' score.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+60","Cme Version":"1750.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,750","Short Title En":"Geneva Score (Revised)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"geneva-score-revised-pulmonary-embolism","Short Description En":"<p>Risk of PE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HIV Needle Stick Risk Assessment Stratification Protocol (RASP)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 25, 2024, 7:01 PM","Medium Description En":"<p>Quantifies HIV exposure risk by source and exposure type and need for prophylaxis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"780","Short Title En":"HIV Needle Stick RASP","Cme Release Date":"","Slug":"hiv-needle-stick-risk-assessment-stratification-protocol-rasp","Short Description En":"<p>Quantifies exposure risk, need for prophylaxis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Veterans Aging Cohort Study-Charlson Comorbidity Index (VACS-CCI)","Created At":"February 9, 2024, 7:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 8, 2024, 8:11 PM","Medium Description En":"<p>Estimates risk of all-cause mortality in patients with comorbidities, including non-metastatic prostate cancer.</p>","Logic Language":"javascript","Published At":"February 9, 2024, 7:33 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool assists in calculating all cause mortality in the general population and in patients with non-metastatic prostate cancer.</p>","Before Use":"","Favorite ID":"10,505","Short Title En":"VACS-CCI","Cme Release Date":"","Slug":"veterans-aging-cohort-study-charlson-comorbidity-index-vacs-cci","Short Description En":"<p>Mortality for patients with comorbidities.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"CHADS<sub>2</sub> Score for Atrial Fibrillation Stroke Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:33 PM","Medium Description En":"<p>Estimates stroke risk in patients with atrial fibrillation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"40.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"40","Short Title En":"CHADS<sub>2</sub> Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"chads2-score-atrial-fibrillation-stroke-risk","Short Description En":"<p>Stroke risk in AFib.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sodium Correction for Hyperglycemia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:40 PM","Medium Description En":"<p>Calculates the actual sodium level in patients with hyperglycemia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"50","Short Title En":"Sodium Correction for Hyperglycemia","Cme Release Date":"","Slug":"sodium-correction-hyperglycemia","Short Description En":"<p>Calculates Na in hyperglycemia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Atrial Fibrillation Stroke Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:39 PM","Medium Description En":"<p>Calculates stroke risk for patients with atrial fibrillation, possibly better than the <calculator id=\"40\">CHADS₂ Score</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"801.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"801","Short Title En":"CHA₂DS₂-VASc Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"cha2ds2-vasc-score-atrial-fibrillation-stroke-risk","Short Description En":"<p>Stroke risk in afib; better than CHADS₂.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"HAS-BLED Score for Major Bleeding Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:39 PM","Medium Description En":"<p>Estimates risk of major bleeding for patients on anticoagulation to assess risk-benefit in atrial fibrillation care.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"807.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"807","Short Title En":"HAS-BLED Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"has-bled-score-major-bleeding-risk","Short Description En":"<p>Bleeding risk with AFib anticoagulation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Estimated Average Glucose (eAG) From HbA1C","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:10 PM","Medium Description En":"<p>Estimates an average glucose level from Hemoglobin A1C value.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,299","Short Title En":"Est. Avg. Glucose from HbA1C","Cme Release Date":"","Slug":"estimated-average-glucose-eag-hba1c","Short Description En":"<p>Estimates avg gluc from HbA1C.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ATRIA Stroke Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:13 PM","Medium Description En":"<p>Determines stroke risk in patients with atrial fibrillation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,842","Short Title En":"ATRIA Stroke Risk","Cme Release Date":"","Slug":"atria-stroke-risk-score","Short Description En":"<p>Stroke risk in Afib.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+88","Full Title En":"Memorial Sloan-Kettering Cancer Center (MSKCC/Motzer) Score for Metastatic Renal Cell Carcinoma (RCC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:16 PM","Medium Description En":"<p>Predicts survival based on clinical and laboratory data in metastatic RCC patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+88","Cme Version":"2153.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Use baseline factors at the start date of the current line of systemic therapy, except for the &ldquo;time of diagnosis to systemic therapy&rdquo; criterion, which is always relative to first-line therapy.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Always <calculator id=\"31\">correct calcium concentration</calculator> for low albumin before scoring.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"2,153","Short Title En":"MSKCC/Motzer Criteria for RCC","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"memorial-sloan-kettering-cancer-center-mskcc-motzer-score-metastatic-renal-cell-carcinoma-rcc","Short Description En":"<p>Predicts survival in RCC patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"SSIGN Score for Renal Cell Carcinoma (RCC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:16 PM","Medium Description En":"<p>Predicts progression of clear cell renal cell carcinoma after radical nephrectomy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,154","Short Title En":"SSIGN Score","Cme Release Date":"","Slug":"ssign-score-renal-cell-carcinoma-rcc","Short Description En":"<p>Prognosis of clear cell RCC.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Mekhail Extension of the Motzer Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:22 PM","Medium Description En":"<p>Predicts metastatic renal cell carcinoma survival, more accurately than the Motzer Score.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,007","Short Title En":"Mekhail Extension","Cme Release Date":"","Slug":"mekhail-extension-motzer-score","Short Description En":"<p>Metastatic RCC survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+70","Full Title En":"IMDC (International Metastatic RCC Database Consortium) Risk Model for Metastatic Renal Cell Carcinoma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:24 PM","Medium Description En":"<p>Predicts survival in patients with metastatic renal cell carcinoma treated with systemic therapy (also known as Heng criteria).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+70","Cme Version":"3008.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-bee24971-7fff-5e90-e787-ed8dcbb3db17\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Use baseline factors at the start date of the current line of systemic therapy, except for the &ldquo;time of diagnosis to systemic therapy&rdquo; criterion, which is always relative to first-line therapy.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Use limits of normal set by the laboratory performing the tests (for hemoglobin concentration, absolute neutrophil count, platelet count, corrected calcium concentration).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Always <calculator id=\"31\">correct calcium concentration</calculator> for low albumin before scoring.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"3,008","Short Title En":"IMDC Model for mRCC","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"imdc-international-metastatic-rcc-database-consortium-risk-model-metastatic-renal-cell-carcinoma","Short Description En":"<p>Metastatic RCC survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"UCLA Integrated Staging System (UISS) for Renal Cell Carcinoma (RCC)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:25 PM","Medium Description En":"<p>Provides 5-year disease-free prognosis for localized and metastatic RCC.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>Localized: Any T; N0; M0</li>\n<li>Metastatic: T&gt;0; N&gt;1; M&gt;1</li>\n<li>For accurate staging, see the <calculator id=\"3011\"> TNM Staging for RCC calculator</calculator></li>\n</ul>","Before Use":"","Favorite ID":"3,009","Short Title En":"UISS for RCC","Cme Release Date":"","Slug":"ucla-integrated-staging-system-uiss-renal-cell-carcinoma-rcc","Short Description En":"<p>5 year prognosis for RCC.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:25 PM","Medium Description En":"<p>Provides prognostic grading system for tumor cells based on physical cellular appearance.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,012","Short Title En":"Fuhrman Nuclear Grade","Cme Release Date":"","Slug":"fuhrman-nuclear-grade-clear-cell-renal-carcinoma","Short Description En":"<p>Prognose RCC based on cellular appearance.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HOMA-IR (Homeostatic Model Assessment for Insulin Resistance)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:26 PM","Medium Description En":"<p>Approximates insulin resistance.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,120","Short Title En":"HOMA-IR","Cme Release Date":"","Slug":"homa-ir-homeostatic-model-assessment-insulin-resistance","Short Description En":"<p>Approximates insulin resistance.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Burch-Wartofsky Point Scale (BWPS) for Thyrotoxicosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:27 PM","Medium Description En":"<p>Predicts likelihood that biochemical thyrotoxicosis is thyroid storm.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3816.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old with biochemical thyrotoxicosis.</p>","Before Use":"","Favorite ID":"3,816","Short Title En":"Burch-Wartofsky Point Scale","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"burch-wartofsky-point-scale-bwps-thyrotoxicosis","Short Description En":"<p>Determines likelihood of thyrotoxicosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+18","Full Title En":"ATRIA Bleeding Risk Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:11 PM","Medium Description En":"<p>Determines bleeding risk for patients on warfarin.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+18","Cme Version":"1718.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,718","Short Title En":"ATRIA Bleeding Risk","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"atria-bleeding-risk-score","Short Description En":"<p>Bleeding risk from warfarin.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+66","Full Title En":"HEMORR<sub>2</sub>HAGES Score for Major Bleeding Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:12 PM","Medium Description En":"<p>Quantifies risk of hemorrhage in elderly patients with AFib.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+66","Cme Version":"1785.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The HEMORR<sub>2</sub>HAGES Score was developed using ICD-9 data; while we are actively reaching out to its study authors, the terms included in the score are not defined in the study.</p>","Before Use":"","Favorite ID":"1,785","Short Title En":"HEMORR<sub>2</sub>HAGES Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"hemorr2hages-score-major-bleeding-risk","Short Description En":"<p>Bleeding risk in elderly AF.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Canadian CT Head Injury/Trauma Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 7, 2024, 4:05 PM","Medium Description En":"<p>Clears head injury without imaging.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"608.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Only apply to patients with&nbsp;<calculator id=\"64\">Glasgow Coma Scale (GCS)</calculator> 13-15 and at least one of the following:</p>\n<ul>\n<li>Loss of consciousness.</li>\n<li>Amnesia to the head injury event.</li>\n<li>Witnessed disorientation.</li>\n</ul>\n<p>Exclusion criteria:</p>\n<ul>\n<li>Age &lt;16 years.</li>\n<li>Blood thinners.</li>\n<li>Seizure after injury.</li>\n</ul>","Before Use":"","Favorite ID":"608","Short Title En":"Canadian CT Head Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"canadian-ct-head-injury-trauma-rule","Short Description En":"<p>Very sensitive, rules out imaging in many.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Revised McDonald Criteria for Multiple Sclerosis Diagnosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 29, 2024, 6:19 PM","Medium Description En":"<p>Determines presence of MS using MRI findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"2,198","Short Title En":"Revised McDonald Criteria","Cme Release Date":"","Slug":"revised-mcdonald-criteria-multiple-sclerosis-diagnosis","Short Description En":"<p>Diagnose MS from MRI findings.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Simplified Autoimmune Hepatitis (AIH) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 4, 2024, 7:20 PM","Medium Description En":"<p>Diagnoses autoimmune hepatitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with&nbsp;histological evidence of hepatitis. Do not use in&nbsp;patients with normal histology.</p>","Before Use":"","Favorite ID":"3,112","Short Title En":"Simplified AIH Score","Cme Release Date":"","Slug":"simplified-autoimmune-hepatitis-aih-score","Short Description En":"<p>AIH diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"PECARN Pediatric Head Injury/Trauma Algorithm","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 5:50 PM","Medium Description En":"<p>Predicts need for brain imaging after pediatric head injury.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"589.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: This only applies to children with <calculator id=\"64\">GCS</calculator> scores of 14 or greater.</p>","Before Use":"","Favorite ID":"589","Short Title En":"PECARN Pediatric Head Injury Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"pecarn-pediatric-head-injury-trauma-algorithm","Short Description En":"<p>Clears peds head injury without imaging.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+14","Full Title En":"APACHE II Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 5:45 PM","Medium Description En":"<p>Estimates ICU mortality.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+14","Cme Version":"1868.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"1,868","Short Title En":"APACHE II Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"apache-ii-score","Short Description En":"<p>Estimates ICU mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Mentzer Index","Created At":"June 7, 2024, 2:09 PM","Is Manual":"false","Dosing":"false","Updated At":"June 13, 2024, 7:08 PM","Medium Description En":"<p>Differentiates beta thalassemia from iron deficiency anemia.</p>","Logic Language":"javascript","Published At":"June 7, 2024, 2:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this screening tool to assist in differentiating between iron deficiency anemia (IDA) and beta thalassemia trait (BTT).</p>","Before Use":"","Favorite ID":"10,534","Short Title En":"Mentzer Index","Cme Release Date":"","Slug":"mentzer-index","Short Description En":"<p>Beta thalassemia vs. iron deficiency anemia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Glucose Infusion Rate (GIR)","Created At":"June 17, 2024, 7:59 PM","Is Manual":"false","Dosing":"true","Updated At":"June 18, 2024, 9:01 PM","Medium Description En":"<p>Quantifies the rate at which glucose is administered intravenously.</p>","Logic Language":"javascript","Published At":"June 18, 2024, 1:46 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,538","Short Title En":"GIR","Cme Release Date":"","Slug":"glucose-infusion-rate-gir","Short Description En":"<p>Intravenous glucose administration rate.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) Fasting Risk Assessment","Created At":"May 23, 2024, 1:32 PM","Is Manual":"false","Dosing":"false","Updated At":"June 18, 2024, 9:06 PM","Medium Description En":"<p>Stratifies fasting risk during Ramadan in diabetic patients.</p>","Logic Language":"javascript","Published At":"May 23, 2024, 2:42 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,522","Short Title En":"IDF-DAR Fasting Risk Assessment","Cme Release Date":"","Slug":"international-diabetes-federation-diabetes-ramadan-alliance-idf-dar-fasting-risk-assessment","Short Description En":"<p>Fasting risk during Ramadan.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MALT Lymphoma Prognostic Index (MALT-IPI)","Created At":"June 19, 2024, 6:34 PM","Is Manual":"false","Dosing":"false","Updated At":"June 20, 2024, 5:27 PM","Medium Description En":"<p>Identifies MALT lymphoma patients at risk of poor outcomes.</p>","Logic Language":"javascript","Published At":"June 19, 2024, 6:57 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,539","Short Title En":"MALT-IPI","Cme Release Date":"","Slug":"malt-lymphoma-prognostic-idex-malt-ipi","Short Description En":"<p>MALT lymphoma prognosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Canadian Diabetes Risk Assessment Questionnaire (CANRISK)","Created At":"June 17, 2024, 5:02 PM","Is Manual":"false","Dosing":"false","Updated At":"June 20, 2024, 4:14 PM","Medium Description En":"<p>Screens for undiagnosed type 2 diabetes mellitus and prediabetes.</p>","Logic Language":"javascript","Published At":"June 17, 2024, 7:52 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,537","Short Title En":"CANRISK","Cme Release Date":"","Slug":"canadian-diabetes-risk-assessment-questionnaire-canrisk","Short Description En":"<p>T2D and prediabetes screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+146","Full Title En":"Sequential Organ Failure Assessment (SOFA) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 19, 2024, 7:07 PM","Medium Description En":"<p>Predicts ICU mortality based on lab results and clinical data.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+146","Cme Version":"691.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Welcome <a href=\"https://jamanetwork.com/journals/jama/fullarticle/2492881\" target=\"_blank\" rel=\"noopener\">Sepsis-3</a>&nbsp;readers! We've also added the <calculator id=\"2654\">qSOFA Score</calculator> with a summary of the new definitions and recommendations.<br><br><strong>Use the worst value in a 24-hour period.</strong></p>","Before Use":"","Favorite ID":"691","Short Title En":"SOFA Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"sequential-organ-failure-assessment-sofa-score","Short Description En":"<p>ICU mortality from lab data.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Brief Addiction Monitor (BAM)","Created At":"May 28, 2024, 8:22 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2024, 6:44 PM","Medium Description En":"<p>Assesses substance use related behaviors.</p>","Logic Language":"javascript","Published At":"May 29, 2024, 3:23 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,525","Short Title En":"BAM","Cme Release Date":"","Slug":"brief-addiction-monitor-bam","Short Description En":"<p>Substance use behaviors.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"The Sick, Control, One, Fat, Food (SCOFF) Questionnaire","Created At":"May 23, 2024, 7:04 PM","Is Manual":"false","Dosing":"false","Updated At":"May 30, 2024, 3:44 PM","Medium Description En":"<p>Screens for eating disorders.</p>","Logic Language":"javascript","Published At":"May 23, 2024, 7:18 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,524","Short Title En":"SCOFF","Cme Release Date":"","Slug":"sick-control-one-fat-food-scoff-questionnaire","Short Description En":"<p>Eating disorder screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fibrotic NASH Index (FNI)","Created At":"February 23, 2024, 8:30 PM","Is Manual":"false","Dosing":"false","Updated At":"May 28, 2024, 7:40 PM","Medium Description En":"<p>Screens for fibrotic NASH in individuals at high risk for NAFLD.</p>","Logic Language":"javascript","Published At":"February 23, 2024, 8:38 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score consists of 3 lab values that are widely available outside of specialized hepatology clinics. Use it to screen for fibrotic nonalcoholic steatohepatitis (NASH) in high-risk patients.</p>","Before Use":"","Favorite ID":"10,508","Short Title En":"Fibrotic NASH Index (FNI)","Cme Release Date":"","Slug":"fibrotic-nash-index-fni","Short Description En":"<p>Fibrotic NASH screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Glasgow Prognostic Score (mGPS) for Cancer Outcomes","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 7, 2024, 7:19 PM","Medium Description En":"<p>Provides improved cancer prognosis over the <calculator id=\"3311\">original score</calculator>, based on serum biomarkers.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>We recommend this modified version of the score over the <calculator id=\"3311\">original GPS</calculator>.</p>","Before Use":"","Favorite ID":"3,312","Short Title En":"mGPS for Cancer Outcomes","Cme Release Date":"","Slug":"modified-glasgow-prognostic-score-mgps-cancer-outcomes","Short Description En":"<p>Cancer prognosis based on biomarkers.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ACC/AHA Heart Failure Staging","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 16, 2024, 10:14 PM","Medium Description En":"<p>Describes stages of heart failure and provides recommendations for therapy by stage.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool reflects general recommendations found in the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. For more detailed guideline statements and advanced therapies, <a href=\"https://pubmed.ncbi.nlm.nih.gov/35363499/\" target=\"_blank\" rel=\"noopener\">view</a> the full guideline.&nbsp;</p>","Before Use":"","Favorite ID":"3,826","Short Title En":"ACC/AHA Heart Failure Staging","Cme Release Date":"","Slug":"acc-aha-heart-failure-staging","Short Description En":"<p>Heart failure staging and therapy recommendations.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Obesity Surgery Mortality Risk Score (OS-MRS)","Created At":"May 15, 2024, 8:32 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2024, 8:24 PM","Medium Description En":"<p>Predicts mortality risk in patients undergoing gastric bypass surgery.</p>","Logic Language":"javascript","Published At":"May 15, 2024, 9:09 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,520","Short Title En":"OS-MRS","Cme Release Date":"","Slug":"obesity-surgery-mortality-risk-score-os-mrs","Short Description En":"<p>Gastric bypass mortality risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Light's Criteria for Exudative Effusions","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 1, 2024, 7:31 PM","Medium Description En":"<p>Provides Light's Criteria to help determine if pleural fluid is exudative.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"797.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"797","Short Title En":"Light's Criteria","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"lights-criteria-exudative-effusions","Short Description En":"<p>Pleural Effusion: Exudative vs Transudative.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"2012 EULAR/ACR Classification Criteria for Polymyalgia Rheumatica","Created At":"March 27, 2024, 8:18 PM","Is Manual":"false","Dosing":"false","Updated At":"March 28, 2024, 4:07 PM","Medium Description En":"<p>Classifies polymyalgia rheumatica by expert consensus recommendations.</p>","Logic Language":"javascript","Published At":"March 27, 2024, 8:27 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool should only be used in patients who: are &ge;50 years of age, present with bilateral shoulder pain, and who have an abnormal ESR and/or CRP.</p>","Before Use":"","Favorite ID":"10,514","Short Title En":"2012 Criteria for PMR","Cme Release Date":"","Slug":"2012-eular-acr-classification-criteria-polymyalgia-rheumatica","Short Description En":"<p>PMR classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes)","Created At":"March 4, 2024, 8:17 PM","Is Manual":"false","Dosing":"false","Updated At":"March 28, 2024, 4:02 PM","Medium Description En":"<p>Predicts 10-year CVD risk in patients with type 2 diabetes.</p>","Logic Language":"javascript","Published At":"March 4, 2024, 8:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score to predict 10-year risk of cardiovascular disease in European patients under 70 years of age and who have a history of diabetes.</p>","Before Use":"","Favorite ID":"10,510","Short Title En":"SCORE2-Diabetes","Cme Release Date":"","Slug":"score2-diabetes","Short Description En":"<p>10-yr CVD risk w/ type 2 diabetes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Shapiro Rule","Created At":"March 20, 2024, 8:49 PM","Is Manual":"false","Dosing":"false","Updated At":"March 27, 2024, 6:58 PM","Medium Description En":"<p>Indicates if an ED patient qualifies for a blood culture.</p>","Logic Language":"javascript","Published At":"March 21, 2024, 3:15 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Determines if clinician should consider obtaining a blood culture based on symptoms and clinical findings.</p>","Before Use":"","Favorite ID":"10,513","Short Title En":"Shapiro Rule","Cme Release Date":"","Slug":"shapiro-rule","Short Description En":"<p>Blood culture indication.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+108","Full Title En":"Parkland Formula for Burns","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"March 4, 2024, 3:47 PM","Medium Description En":"<p>Calculates fluid requirements for burn patients in a 24-hour period.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+108","Cme Version":"83.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with burns. Children have larger TBSA relative to weight and may require larger fluid volumes.</p>","Before Use":"","Favorite ID":"83","Short Title En":"Parkland Formula for Burns","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"parkland-formula-burns","Short Description En":"<p>Fluid requirements after burns.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ASAS Criteria for Axial Spondyloarthritis (SpA)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 15, 2024, 6:30 PM","Medium Description En":"<p>Classifies axial spondyloarthritis according to Assessment of Spondyloarthritis International Society (ASAS) criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"306","Short Title En":"ASAS Criteria for Axial SpA","Cme Release Date":"","Slug":"asas-criteria-axial-spondyloarthritis-spa","Short Description En":"<p>Axial SpA classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"GARFIELD-AF","Created At":"February 8, 2024, 6:41 PM","Is Manual":"false","Dosing":"false","Updated At":"February 22, 2024, 10:21 PM","Medium Description En":"<p>Predicts mortality, stroke, and bleeding in patients w/ and w/out anticoagulation.</p>","Logic Language":"javascript","Published At":"February 8, 2024, 6:55 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with newly diagnosed atrial fibrillation (AF) to assist in determining the risks of anticoagulation therapy.</p>","Before Use":"","Favorite ID":"10,504","Short Title En":"GARFIELD-AF","Cme Release Date":"","Slug":"garfield-af","Short Description En":"<p>Mortality, stroke, and bleeding risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+103","Full Title En":"NIH Stroke Scale/Score (NIHSS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 19, 2024, 7:53 PM","Medium Description En":"<p>Calculates the NIH Stroke Scale for quantifying stroke severity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+103","Cme Version":"715.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><strong>The NIH Stroke Scale has many caveats buried within it. If your patient has prior known neurologic deficits e.g. prior weakness, hemi- or quadriplegia, blindness, etc. or is intubated, has a language barrier, etc., it becomes especially complicated. In those cases, consult the <a href=\"https://stroke.nih.gov/resources/scale.htm\" target=\"_blank\" rel=\"noopener\">NIH Stroke Scale website</a>. MDCalc's version is an attempt to clarify many of these confusing caveats, but cannot and should not be substituted for the official protocol.</strong></p>\n<p><strong>Rules:</strong></p>\n<ul>\n<li>Score what you see, not what you think.</li>\n<li>Score the first response, not the best response (except Item 9 - Best Language).</li>\n<li>Don&rsquo;t coach.</li>\n</ul>","Before Use":"","Favorite ID":"715","Short Title En":"NIH Stroke Scale (NIHSS)","Cme Release Date":"2020-05-15 00:00:00+00+00","Slug":"nih-stroke-scale-score-nihss","Short Description En":"<p>Quantifies stroke severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Fractional Excretion of Sodium (FENa)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:29 PM","Medium Description En":"<p>Determines if renal failure is due to pre-renal or intrinsic pathology.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"60.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients taking diuretics or with known chronic kidney disease, urinary tract obstruction, or acute glomerular disease. Use <calculator id=\"62\">FEUrea</calculator> in patients on diuretics.</p>","Before Use":"","Favorite ID":"60","Short Title En":"FENa","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"fractional-excretion-sodium-fena","Short Description En":"<p>Pre-renal or intrinsic kidney failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"BUN Creatinine Ratio","Created At":"January 26, 2024, 8:39 PM","Is Manual":"false","Dosing":"false","Updated At":"February 8, 2024, 7:05 PM","Medium Description En":"<p>Measures renal function.</p>","Logic Language":"javascript","Published At":"January 26, 2024, 8:40 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,501","Short Title En":"BUN Creatinine Ratio","Cme Release Date":"","Slug":"bun-creatinine-ratio","Short Description En":"<p>Measures renal function.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Crohn's Disease Activity Index (CDAI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 24, 2024, 6:26 PM","Medium Description En":"<p>Determines the current severity of Crohn's disease.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Signs, symptoms, and history should be based on the past 7 days. Note: for abdominal pain and general well-being ratings, this calculator uses an <em>average</em> rating per day over the past 7 days. For stools, use the <em>total</em> number of soft/liquid stools over the past 7 days.</p>","Before Use":"","Favorite ID":"3,318","Short Title En":"Crohn's Disease Activity Index (CDAI)","Cme Release Date":"","Slug":"crohns-disease-activity-index-cdai","Short Description En":"<p>Determines the current severity of Crohn's disease.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Centor Score (Modified/McIsaac) for Strep Pharyngitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 7:41 PM","Medium Description En":"<p>Estimates probability that pharyngitis is streptococcal, and suggests management course.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in patients with recent onset (&le;3 days) acute pharyngitis.</p>","Before Use":"","Favorite ID":"104","Short Title En":"Centor Score (Modified/McIsaac)","Cme Release Date":"","Slug":"centor-score-modified-mcisaac-strep-pharyngitis","Short Description En":"<p>Strep throat diagnosis and treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Metroticket Calculator for Hepatocellular Carcinoma (HCC) Survival","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 4, 2024, 6:08 PM","Medium Description En":"<p>Predicts survival for patients with HCC.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,823","Short Title En":"Metroticket Calculator","Cme Release Date":"","Slug":"metroticket-calculator-hepatocellular-carcinoma-survival","Short Description En":"<p>Predicts survival for patients with HCC.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Seattle Heart Failure Model","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 26, 2023, 9:22 PM","Medium Description En":"<p>Predicts survival in heart failure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use to predict survival in patients with systolic heart failure at 1 and 5 years.</p>","Before Use":"","Favorite ID":"3,808","Short Title En":"Seattle Heart Failure Model","Cme Release Date":"","Slug":"seattle-heart-failure-model","Short Description En":"<p>Predicts survival in heart failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"qSOFA (Quick SOFA) Score for Sepsis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 8:00 PM","Medium Description En":"<p>Identifies high-risk patients for in-hospital mortality with suspected infection outside the ICU.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"2654.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use to predict mortality, NOT to diagnose sepsis, per 2021 Surviving Sepsis Guidelines.</p>","Before Use":"","Favorite ID":"2,654","Short Title En":"qSOFA","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"qsofa-quick-sofa-score-sepsis","Short Description En":"<p>In-hospital mortality in non-ICU patients with infection.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+64","Full Title En":"GWTG-Heart Failure Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:34 PM","Medium Description En":"<p>Predicts in-hospital all-cause heart failure mortality.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+64","Cme Version":"3829.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same other inputs, this calculator estimates&nbsp;lower in-hospital mortality risk in Black patients.</p>","Favorite ID":"3,829","Short Title En":"GWTG-HF Risk Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"gwtg-heart-failure-risk-score","Short Description En":"<p>Predicts in-hospital heart failure mortality.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+52","Full Title En":"Fisher Grading Scale for Subarachnoid Hemorrhage (SAH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:35 PM","Medium Description En":"<p>Rates risk of vasospasm in aSAH based on amount and distribution of blood on CT.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+52","Cme Version":"3836.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This scale only applies to aneurysmal subarachnoid hemorrhage (aSAH). We recommend using the <calculator id=\"3837\">Modified Fisher Grading Scale</calculator> based on more recent studies.</p>\n<p>Clinician must be able to identify subarachnoid hemorrhage (SAH) and major neuroanatomical landmarks on head CT.</p>","Before Use":"","Favorite ID":"3,836","Short Title En":"Fisher Grading Scale","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"fisher-grading-scale-subarachnoid-hemorrhage-sah","Short Description En":"<p>Risk of vasospasm in aSAH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+91","Full Title En":"Modified Fisher Grading Scale for Subarachnoid Hemorrhage (SAH)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:35 PM","Medium Description En":"<p>States severity of SAH based on amount and type of blood on CT with associated vasospasm risk.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+91","Cme Version":"3837.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><strong>This scale only applies to aneurysmal subarachnoid hemorrhage (aSAH).</strong></p>\n<ul>\n<li>Thin SAH is classified as &lt; 1mm in depth.</li>\n<li>Thick SAH is classified as &ge; 1mm in depth.</li>\n</ul>\n<p>Clinician must be able to identify subarachnoid hemorrhage (SAH) and major neuroanatomical landmarks on head CT.</p>","Before Use":"","Favorite ID":"3,837","Short Title En":"Modified Fisher Scale","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"modified-fisher-grading-scale-subarachnoid-hemorrhage-sah","Short Description En":"<p>SAH severity and vasospasm risk</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Michigan Risk Score for PICC-Related Thrombosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:38 PM","Medium Description En":"<p>Predicts risk of DVT in patients with peripherally inserted central catheter (PICC).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old admitted to a medical service (i.e., not surgical). Do not use in pregnant patients.</p>","Before Use":"<p>This calculator is not yet externally validated and should therefore be used with caution.</p>","Favorite ID":"3,838","Short Title En":"Michigan Risk Score","Cme Release Date":"","Slug":"michigan-risk-score-picc-related-thrombosis","Short Description En":"<p>PICC-related DVT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+94","Full Title En":"Multiple Myeloma International Staging System (ISS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:38 PM","Medium Description En":"<p>Prognosticates the severity of multiple myeloma based on routinely obtained lab values.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+94","Cme Version":"3841.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in patients recently diagnosed with multiple myeloma. Do not use in patients with relapsed myeloma, smoldering myeloma or MGUS.</p>","Before Use":"","Favorite ID":"3,841","Short Title En":"Multiple Myeloma ISS","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"multiple-myeloma-international-staging-system-iss","Short Description En":"<p>Prognosticate newly diagnosed multiple myeloma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Revised Multiple Myeloma International Staging System (R-ISS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:41 PM","Medium Description En":"<p>Prognostication tool for myeloma patients based on the genetics and other routinely used lab values in conjunction with the original ISS Staging System.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3842.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in patients recently diagnosed with multiple myeloma. Do not use in patients with relapsed myeloma, smoldering myeloma or MGUS.</p>","Before Use":"","Favorite ID":"3,842","Short Title En":"Revised Myeloma ISS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"revised-multiple-myeloma-international-staging-system-r-iss","Short Description En":"<p>Prognostication of myeloma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Ottawa Subarachnoid Hemorrhage (SAH) Rule for Headache Evaluation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:41 PM","Medium Description En":"<p>Rules out SAH in patients with headache.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3875.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This rule has very specific inclusion and exclusion criteria that must be followed closely for appropriate application:</p>\n<p><strong>Only apply in:</strong> Alert patients &ge;15 years old, new severe atraumatic headache, maximum intensity within 1 hour.</p>\n<p><strong>Do not use in:</strong> Patients with new neurologic deficits, prior aneurysm, prior SAH, known brain tumors, or chronic recurrent headaches (&ge;3 headaches of the same character and intensity for &gt;6 months).</p>","Before Use":"","Favorite ID":"3,875","Short Title En":"Ottawa SAH Rule","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"ottawa-subarachnoid-hemorrhage-sah-rule-for-headache-evaluation","Short Description En":"<p>Rules out SAH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Milan Criteria for Liver Transplantation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:44 PM","Medium Description En":"<p>Assess suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma, recommended by <a href=\"https://www.mdcalc.com/guidelines/other/treatment-hepatocellular-carcinoma\" target=\"_blank\" rel=\"noopener\">AASLD guidelines</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,900","Short Title En":"Milan Criteria","Cme Release Date":"","Slug":"milan-criteria-liver-transplantation","Short Description En":"<p>Assess suitability of patients for liver transplant.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+29","Full Title En":"Cardiac Anesthesia Risk Evaluation Score (CARE)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:51 PM","Medium Description En":"<p>Predicts mortality and morbidity after cardiac surgery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+29","Cme Version":"3903.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,903","Short Title En":"Cardiac Anesthesia Risk Evaluation Score (CARE)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"cardiac-anesthesia-risk-evaluation-score-care","Short Description En":"<p>Predicts mortality and morbidity after cardiac surgery.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Kt/V for Dialysis Adequacy","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:52 PM","Medium Description En":"<p>Quantifies both hemodialysis and peritoneal dialysis treatment adequacy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,904","Short Title En":"Kt/V","Cme Release Date":"","Slug":"kt-v-dialysis-adequacy","Short Description En":"<p>Quantifies hemodialysis/peritoneal dialysis treatment adequacy.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+84","Full Title En":"Maximum Allowable Blood Loss (ABL) Without Transfusion","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:54 PM","Medium Description En":"<p>Estimates the maximum allowable blood loss intraoperatively before transfusion should be considered.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+84","Cme Version":"3905.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,905","Short Title En":"Maximum ABL","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"maximum-allowable-blood-loss-abl-without-transfusion","Short Description En":"<p>Estimates maximum blood loss allowable intra-op before transfusion.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+48","Full Title En":"EUTOS Score for Chronic Myelogenous Leukemia (CML)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 8:55 PM","Medium Description En":"<p>Predicts outcomes after CML treatments, specifically adjusted for tyrosine kinase treatments.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+48","Cme Version":"3906.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in newly-diagnosed patients before starting therapy.</p>","Before Use":"","Favorite ID":"3,906","Short Title En":"EUTOS Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"eutos-score-chronic-myelogenous-leukemia-cml","Short Description En":"<p>CML outcomes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Duke Activity Status Index (DASI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 5, 2023, 9:28 PM","Medium Description En":"<p>Estimates functional capacity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Answers are self-reported. Provides an estimate of functional capacity, and may not be as accurate as objective measurements such as exercise stress testing.</p>","Before Use":"","Favorite ID":"3,910","Short Title En":"Duke Activity Status Index (DASI)","Cme Release Date":"","Slug":"duke-activity-status-index-dasi","Short Description En":"<p>Functional capacity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+21","Full Title En":"Bacterial Meningitis Score for Children","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:00 PM","Medium Description En":"<p>Rules out bacterial meningitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+21","Cme Version":"3911.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients aged 29 days to 19 years with <abbr style=\"color: #ffb600;\" title=\"Cerebrospinal Fluid\">CSF</abbr> WBC &ge;10 cells/&mu;L. Do not use if patient is critically ill, recently received antibiotics, has a <abbr style=\"color: #ffb600;\" title=\"Ventriculoperitoneal\">VP</abbr> shunt or recent neurosurgery, is immunosuppressed, or has other bacterial infection requiring antibiotics (including Lyme disease).</p>","Before Use":"","Favorite ID":"3,911","Short Title En":"Bacterial Meningitis Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"bacterial-meningitis-score-children","Short Description En":"<p>Likelihood of bacterial meningitis in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Barthel Index for Activities of Daily Living (ADL)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:30 PM","Medium Description En":"<p>Assesses functional independence, generally in stroke patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,912","Short Title En":"Barthel Index","Cme Release Date":"","Slug":"barthel-index-activities-daily-living-adl","Short Description En":"<p>Degree of independence for stroke rehabilitation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"MASCC Risk Index for Febrile Neutropenia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:00 PM","Medium Description En":"<p>Identifies patients at low risk for poor outcome with febrile neutropenia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3913.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in neutropenic patients (see <calculator id=\"19\">ANC</calculator> calculator) with fever at least 100.4&deg;F (38&ordm;C). Do not use in patients with acute leukemia undergoing induction chemotherapy or allogeneic hematopoietic stem cell transplant conditioning, per IDSA guidelines.</p>","Before Use":"","Favorite ID":"3,913","Short Title En":"MASCC Risk Index","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"mascc-risk-index-febrile-neutropenia","Short Description En":"<p>Low risk for poor outcome febrile neutropenia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+152","Full Title En":"SMART-COP Score for Pneumonia Severity","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:01 PM","Medium Description En":"<p>Predicts need for intensive respiratory or vasopressor support (IRVS) in community-acquired pneumonia (CAP).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+152","Cme Version":"3914.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years with clinical and radiographic findings consistent with community acquired pneumonia (CAP). Does not apply to patients with significant immunosuppression.</p>","Before Use":"<p><strong>Tips for COVID-19: </strong>Use to determine floor vs. ICU. Perhaps best performing to predict ICU admissions for CAP, but unclear applicability in COVID/viral pneumonias/ARDS.</p>\n<p></p>","Favorite ID":"3,914","Short Title En":"SMART-COP Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"smart-cop-score-pneumonia-severity","Short Description En":"<p>Pneumonia severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Forrester Heart Failure Class","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Determines severity of heart failure and predicts in-hospital mortality.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,915","Short Title En":"Forrester Heart Failure Class","Cme Release Date":"","Slug":"forrester-heart-failure-class","Short Description En":"Estimates heart failure severity and in-hospital mortality."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+24","Full Title En":"BODE Index for COPD Survival","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:02 PM","Medium Description En":"<p>Predicts survival in COPD patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+24","Cme Version":"3916.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients during acute exacerbations of COPD. Do not use to guide therapy. See When to Use for full exclusion criteria.</p>","Before Use":"","Favorite ID":"3,916","Short Title En":"BODE Index","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"bode-index-copd-survival","Short Description En":"<p>COPD survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+67","Full Title En":"Hestia Criteria for Outpatient Pulmonary Embolism Treatment","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:03 PM","Medium Description En":"<p>Identifies low-risk PE patients safe for outpatient treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+67","Cme Version":"3918.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in hemodynamically stable patients with acute pulmonary embolism (PE).</p>","Before Use":"","Favorite ID":"3,918","Short Title En":"Hestia Criteria","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"hestia-criteria-outpatient-pulmonary-embolism-treatment","Short Description En":"<p>Outpatient VTE treatment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+61","Full Title En":"Global Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:05 PM","Medium Description En":"<p>Assesses different stages of COPD and provides treatment recommendations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+61","Cme Version":"3919.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &gt;18 years of age with already-diagnosed COPD by spirometry (FEV₁/FVC &lt;0.7) with baseline symptoms and lung function. Do not use to diagnose COPD and do not use in patients with acute exacerbation.</p>","Before Use":"","Favorite ID":"3,919","Short Title En":"GOLD COPD Criteria","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"global-initiative-obstructive-lung-disease-gold-criteria-copd","Short Description En":"<p>COPD staging and recommendations.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPROVE RAM (International Medical Prevention Registry on Venous Thromboembolism Risk Assessment Model)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Estimates risk of VTE.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,920","Short Title En":"IMPROVE RAM","Cme Release Date":"","Slug":"improve-ram-international-medical-prevention-registry-venous-thromboembolism-risk-assessment-model","Short Description En":"Estimates risk of VTE."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Forrest Classification of Upper GI Bleeding","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:07 PM","Medium Description En":"<p>Stratifies severity of upper GI bleeding according to endoscopic findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3923.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,923","Short Title En":"Forrest Classification","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"forrest-classification-upper-gi-bleeding","Short Description En":"<p>Stratifies severity of upper GI bleeding.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+56","Full Title En":"Fong Clinical Risk Score for Colorectal Cancer Recurrence","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 29, 2023, 9:10 PM","Medium Description En":"<p>Predicts recurrence for colorectal cancer patients with liver metastasis after hepatic resection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+56","Cme Version":"3925.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,925","Short Title En":"Fong Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"fong-clinical-risk-score-colorectal-cancer-recurrence","Short Description En":"<p>Predicts outcome for colorectal cancer recurrence.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+109","Full Title En":"Pediatric Appendicitis Score (PAS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 6:57 PM","Medium Description En":"<p>Predicts appendicitis in children.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+109","Cme Version":"3926.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use for patients 3-18 years of age.</p>","Before Use":"","Favorite ID":"3,926","Short Title En":"Pediatric Appendicitis Score (PAS)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"pediatric-appendicitis-score-pas","Short Description En":"<p>Predicts appendicitis in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+120","Full Title En":"POSSUM for Operative Morbidity and Mortality Risk","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:31 PM","Medium Description En":"<p>Estimates morbidity and mortality for general surgery patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+120","Cme Version":"3927.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use values at the time of surgery, not admission.</p>\n<p>NOTE: The POSSUM should not be used for trauma patients.</p>","Before Use":"","Favorite ID":"3,927","Short Title En":"POSSUM Calculator","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"possum-operative-morbidity-mortality-risk","Short Description En":"<p>Estimates morbidity and mortality for general surgery patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Endotracheal Tube (ETT) Depth and Tidal Volume Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 5:29 PM","Medium Description En":"<p>Estimates depth of optimal ETT placement and target tidal volume by height.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3928.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients over 20 years old.</p>","Before Use":"","Favorite ID":"3,928","Short Title En":"ETT Depth and Tidal Volume Calculator","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"endotracheal-tube-ett-depth-tidal-volume-calculator","Short Description En":"<p>Estimates ETT depth and tidal volume.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+17","Full Title En":"Asymptomatic Myeloma Prognosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:11 PM","Medium Description En":"<p>Predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+17","Cme Version":"3929.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,929","Short Title En":"Asymptomatic Myeloma Prognosis","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"asymptomatic-myeloma-prognosis","Short Description En":"<p>Predicts risk of progression to active myeloma or amyloidosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Australian Type 2 Diabetes Risk (AUSDRISK) Assessment Tool","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 19, 2024, 3:20 PM","Medium Description En":"<p>Estimates risk of developing type 2 diabetes, mainly in Australian patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3931.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Not for use in people with diagnosed diabetes. Use for screening in adults &ge;25 years of age.</p>\n<p>Note: BMI, waist circumference, or both may be used as the obesity parameter. The study's authors recommend using waist circumference only, as it has the greatest discriminatory power.</p>","Before Use":"","Favorite ID":"3,931","Short Title En":"AUSDRISK","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"australian-type-2-diabetes-risk-ausdrisk-assessment-tool","Short Description En":"<p>Estimates diabetes risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Ulcerative Colitis Activity Index (PUCAI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Determines severity of ulcerative colitis (UC) in pediatric patients.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,933","Short Title En":"PUCAI","Cme Release Date":"","Slug":"pediatric-ulcerative-colitis-activity-index-pucai","Short Description En":"Determines severity of ulcerative colitis in peds."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Bosniak Classification System of Renal Cystic Masses","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Classification and management of complex cystic renal lesions.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>Initially described for computed tomography (CT), also utilized for magnetic resonance imaging (MRI).</li>\n<li>Do not use for patients with a history of von Hippel-Lindau syndrome (cystic renal neoplasms in these patients are malignant clear cell renal cell carcinoma).</li>\n</ul>","Before Use":"","Favorite ID":"3,934","Short Title En":"Bosniak Classification System","Cme Release Date":"","Slug":"bosniak-classification-system-of-renal-cystic-masses","Short Description En":"<p>Classification and management of complex cystic renal lesions.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+110","Full Title En":"Pediatric Asthma Score (PAS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:45 PM","Medium Description En":"<p>Stratifies asthma severity in children.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+110","Cme Version":"3935.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients under 2 years of age, in severe distress, or with clear alternative diagnosis.</p>","Before Use":"","Favorite ID":"3,935","Short Title En":"Pediatric Asthma Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"pediatric-asthma-score-pas","Short Description En":"<p>Pediatric asthma severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"International Prognostic Index for Diffuse Large B-cell Lymphoma (IPI and R-IPI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:47 PM","Medium Description En":"<p>Predicts overall and progression-free survival in DLBCL based on risk factors.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3936.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: IPI results are included for historical comparisons only. Use in CD20+ DLBCL patients. Do not use in patients with HIV, secondary malignancies, low grade lymphoproliferative disorders, or comorbidities precluding curative therapy attempt.</p>","Before Use":"","Favorite ID":"3,936","Short Title En":"IPI and R-IPI","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"international-prognostic-index-diffuse-large-b-cell-lymphoma-ipi-r-ipi","Short Description En":"<p>DLBCL survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"BWH Egg Freezing Counseling Tool (EFCT)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"November 21, 2023, 7:46 PM","Medium Description En":"<p>Predicts likelihood of live birth for elective egg freezing in women.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3937.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in women age 24&ndash;44 years undergoing fertility counseling.</p>","Before Use":"<p>This calculator is not externally validated, and as such, should be used with caution.</p>","Favorite ID":"3,937","Short Title En":"BWH Egg Freezing Counseling Tool","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"bwh-egg-freezing-counseling-tool-efct","Short Description En":"<p>Predicts likelihood of live birth for elective egg freezing in women.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Diltiazem Conversion Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Converts diltiazem from IV to oral.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,938","Short Title En":"Diltiazem Conversion","Cme Release Date":"","Slug":"diltiazem-conversion-calculator","Short Description En":"Converts diltiazem from IV to oral."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"CKD-EPI Equations for Glomerular Filtration Rate (GFR)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"July 25, 2023, 6:57 PM","Medium Description En":"<p>Estimates GFR based on serum creatinine, serum cystatin C, or both.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3939.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>For use in patients with stable kidney function. While the combined creatinine and cystatin C equation can add accuracy, cystatin c is not available in all laboratories and the creatinine-based equation is adequate for many clinical purposes.</p>\n<p>2021 CKD-EPI creatinine is currently recommended by the ASN and NKF for GFR reporting in the United States.</p>","Before Use":"<p>The 2021 CKD-EPI equation is now the recommended standard. This version does not include race, as do the 2009 and 2012 CKD-EPI creatinine and creatinine-cystatin C equations. <a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a> for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>With the 2021 equation, for the same creatinine value, the 2021 equation will estimate a lower GFR for Black patients and a higher GFR for non-Black patients.</p>","Favorite ID":"3,939","Short Title En":"CKD-EPI Equations for GFR","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"ckd-epi-equations-glomerular-filtration-rate-gfr","Short Description En":"<p>Estimates GFR.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+163","Full Title En":"Troponin-only Manchester Acute Coronary Syndromes (T-MACS) Decision Aid","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:55 PM","Medium Description En":"<p>Rules out acute coronary syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+163","Cme Version":"3942.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,942","Short Title En":"T-MACS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"troponin-manchester-acute-coronary-syndromes-t-macs-decision-aid","Short Description En":"<p>Rules out ACS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Pittsburgh Response to Endovascular therapy (PRE) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:56 PM","Medium Description En":"<p>Identifies patients with anterior circulation large vessel occlusion (LVO) strokes likely to benefit from endovascular therapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3943.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old, presenting within 8 hours of symptom onset, with anterior circulation (i.e., internal carotid, M1, or M2) LVO stroke. Measure ASPECTS using most recent CT imaging data. Apply with caution to patients with baseline morbidities.</p>","Before Use":"","Favorite ID":"3,943","Short Title En":"PRE Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"pittsburgh-response-endovascular-therapy-pre-score","Short Description En":"<p>LVO stroke patients for endovascularization.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Transtubular Potassium Gradient (TTKG)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:56 PM","Medium Description En":"<p>May help in assessment of hyperkalemia or hypokalemia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,944","Short Title En":"TTKG","Cme Release Date":"","Slug":"transtubular-potassium-gradient-ttkg","Short Description En":"<p>Hyper/hypokalemia assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Mirels’ Criteria for Prophylactic Fixation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 7:59 PM","Medium Description En":"<p>Predicts risk of pathologic fracture in patients with long bone metastasis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with known long bone metastasis. Do not use if history of fracture or previous irradiation.</p>","Before Use":"","Favorite ID":"3,946","Short Title En":"Mirels’ Criteria","Cme Release Date":"","Slug":"mirels-criteria-prophylactic-fixation","Short Description En":"<p>Fracture risk with bone mets.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Opiate Conversion Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Converts between different types and routes of opiates.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ol> <li><span>Select the opiate and route that you wish to convert </span><em><span>from</span></em><span>.</span></li> <li><span>Input the </span><em><span>total daily dose</span></em><span> in milligrams of the opiate you are converting </span><em><span>from</span></em><span>.</span></li> <li><span>Select the opiate you wish to convert <em>to</em>. The total daily dose will be displayed in the results bar. </span></li> </ol>","Before Use":"This calculator is for double-checking opiate conversion, and should NOT be used as the primary means for ordering.","Favorite ID":"3,947","Short Title En":"Opiate Conversion","Cme Release Date":"","Slug":"opiate-conversion-calculator","Short Description En":"Converts opiate dosages."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ROSE (Risk Stratification of Syncope in the Emergency Department) Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Predicts 1-month serious outcome or death in patients presenting with syncope</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,949","Short Title En":"ROSE Rule","Cme Release Date":"","Slug":"rose-risk-stratification-syncope-emergency-department-rule","Short Description En":" Morbidity and mortality in syncope patients."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CHIP (CT in Head Injury Patients) Prediction Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 8:11 PM","Medium Description En":"<p><span>Predicts intracranial traumatic CT findings in patients with minor head trauma.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients at least 16 years old presenting within 24 hours of blunt head trauma and <abbr title=\"Glasgow Coma Scale\">GCS</abbr><calculator id=\"64\"></calculator> 13&ndash;14 (or GCS 15 with at least one of the following: <abbr title=\"Loss of Consciousness\">LOC</abbr>, short-term memory deficit, amnesia, seizure, vomiting, severe headache, intoxication, anticoagulant use or history of coagulopathy, external evidence of injury above the clavicles, neurologic deficit). Note: We recommend using the <calculator id=\"608\">Canadian CT Head Rule</calculator> over other adult head trauma decision rules, as it is the most widely validated.</p>","Before Use":"","Favorite ID":"3,952","Short Title En":"CHIP Prediction Rule","Cme Release Date":"","Slug":"chip-ct-head-injury-patients-prediction-rule","Short Description En":"<p>Predicts need for CT in minor head trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CHALICE (Children's Head injury ALgorithm for the prediction of Important Clinical Events) Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 8:12 PM","Medium Description En":"<p>Predicts death, need for neurosurgical intervention or CT abnormality in children with head trauma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in children under age 16 years with history or signs of head injury. Note: We recommend using <calculator id=\"589\">PECARN</calculator> over other pediatric head trauma rules, as it is the most widely validated.</p>","Before Use":"","Favorite ID":"3,953","Short Title En":"CHALICE Rule","Cme Release Date":"","Slug":"chalice-childrens-head-injury-algorithm-prediction-important-clinical-events-rule","Short Description En":"<p>Clinically significant head injuries in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Los Angeles Prehospital Stroke Screen (LAPSS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>I<span>dentifies acute stroke patients in the field.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,958","Short Title En":"LAPSS","Cme Release Date":"","Slug":"los-angeles-prehospital-stroke-screen-lapss","Short Description En":"Acute stroke diagnosis in the field."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Cincinnati Prehospital Stroke Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Identifies stroke patients who are candidates for thrombolysis.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,960","Short Title En":"CPSS","Cme Release Date":"","Slug":"cincinnati-prehospital-stroke-scale","Short Description En":"Stroke patients for thrombolysis."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"SOAR Score for Community-Acquired Pneumonia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Stratifies pneumonia severity in older patients.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,961","Short Title En":"SOAR Score for CAP","Cme Release Date":"","Slug":"soar-score-community-acquired-pneumonia","Short Description En":"Pneumonia severity."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+149","Full Title En":"Shorr Score for MRSA Pneumonia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 8:18 PM","Medium Description En":"<p>Identifies pneumonia patients at low risk for MRSA.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+149","Cme Version":"3962.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,962","Short Title En":"Shorr Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"shorr-score-mrsa-pneumonia","Short Description En":"<p>Rules out MRSA pneumonia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Park Score for Drug Resistance in Healthcare Associated Pneumonia (HCAP)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Predicts drug resistance in hospitalized patients with pneumonia. </span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,963","Short Title En":"Park Score ","Cme Release Date":"","Slug":"park-score-drug-resistance-healthcare-associated-pneumonia-hcap","Short Description En":"Drug resistance in HCAP."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"iScore for Stroke Mortality","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Predicts mortality after hospitalization for acute ischemic stroke.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,964","Short Title En":"iScore","Cme Release Date":"","Slug":"iscore-stroke-mortality","Short Description En":"Stroke mortality."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PLAN Score for Stroke","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Predicts mortality and severe disability in acute ischemic stroke.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,965","Short Title En":"PLAN Score for Stroke","Cme Release Date":"","Slug":"plan-score-stroke","Short Description En":"Stroke mortality."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Caprini Score for Venous Thromboembolism (2005)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:42 PM","Medium Description En":"<p>Stratifies risk of VTE in surgical patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,970","Short Title En":"Caprini VTE Score","Cme Release Date":"","Slug":"caprini-score-venous-thromboembolism-2005","Short Description En":"<p>Stratifies risk of VTE in surgical patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Status Epilepticus Severity Score (STESS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stratifies severity of status epilepticus.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,972","Short Title En":"STESS","Cme Release Date":"","Slug":"status-epilepticus-severity-score-stess","Short Description En":"Status epilepticus severity."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"TNM Staging for Melanoma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages melanoma based on tumor, lymph nodes, and metastases.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3974.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is based on the 7th edition of the AJCC Cancer Staging Manual. The <calculator id=\"10113\">8th edition</calculator> is now recommended for use over this version.</p>","Before Use":"","Favorite ID":"3,974","Short Title En":"TNM Melanoma Staging","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"tnm-staging-melanoma","Short Description En":"Melanoma staging."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Hoehn and Yahr Scale for Parkinson’s Disease","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 8:25 PM","Medium Description En":"<p><span>Grades severity of symptoms in Parkinson&rsquo;s disease.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,976","Short Title En":"Modified Hoehn and Yahr Scale","Cme Release Date":"","Slug":"modified-hoehn-yahr-scale-parkinsons-disease","Short Description En":"<p>Parkinson's disease severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Schwab and England Activities of Daily Living (ADL) Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 1, 2023, 8:26 PM","Medium Description En":"<p>Grades functional status in patients with Parkinson&rsquo;s disease.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,977","Short Title En":"Schwab and England ADL Scale","Cme Release Date":"","Slug":"schwab-england-activities-daily-living-adl-scale","Short Description En":"<p>Parkinson's disease disability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Webster Rating Scale for Parkinson’s Disease","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:29 PM","Medium Description En":"<p><span>Quantifies degree of disability in Parkinson&rsquo;s disease.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,978","Short Title En":"Webster Rating Scale","Cme Release Date":"","Slug":"webster-rating-scale-parkinsons-disease","Short Description En":"<p>Parkinson's disease disability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Trunk Impairment Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:31 PM","Medium Description En":"<p><span>Quantifies disability after stroke; also validated in Parkinson&rsquo;s disease.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: Starting position is patient sitting on edge of bed or table without back or arm support.</p>","Before Use":"","Favorite ID":"3,979","Short Title En":"Trunk Impairment Scale","Cme Release Date":"","Slug":"trunk-impairment-scale","Short Description En":"<p>Parkinson's disease and stroke disability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 16, 2024, 10:41 PM","Medium Description En":"<p><span>Predicts survival after HCT in patients with hematologic malignancies, including optional age adjustment.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3980.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Entering age to obtain age-adjusted HCT-CI is optional. The original HCT-CI (without age adjustment) is still considered the standard.</span></p>","Before Use":"","Favorite ID":"3,980","Short Title En":"HCT-CI","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"hematopoietic-cell-transplantation-specific-comorbidity-index-hct-ci","Short Description En":"<p>Survival after HCT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndrome (MDS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:35 PM","Medium Description En":"<p><span>Stages patients with MDS.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3981.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use at the time of diagnosis, before starting treatment.</p>","Before Use":"","Favorite ID":"3,981","Short Title En":"IPSS-R","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"revised-international-prognostic-scoring-system-ipss-r-myelodysplastic-syndrome-mds","Short Description En":"<p>MDS staging.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"4 A’s Test for Delirium Screening","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:36 PM","Medium Description En":"<p><span>Diagnoses delirium in older patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,982","Short Title En":"4AT","Cme Release Date":"","Slug":"4-test-delirium-assessment","Short Description En":"<p>Delirium screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"6 Minute Walk Distance","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:39 PM","Medium Description En":"<p>Calculates reference values for distance walked, as a measure of functional status.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use if unstable angina or MI less than 1 month prior. Relative contraindications: resting HR over 120, systolic BP over 180, or diastolic BP over 100. Stop if any of the following occur: chest pain, intolerable dyspnea, leg cramps, staggering, diaphoresis, or pale appearance.</p>","Before Use":"","Favorite ID":"3,983","Short Title En":"6 Minute Walk Distance","Cme Release Date":"","Slug":"6-minute-walk-distance","Short Description En":"<p>Functional status.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Appendicitis Inflammatory Response (AIR) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:40 PM","Medium Description En":"<p>Diagnoses appendicitis based on clinical and laboratory findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in pediatric or adult patients with suspected appendicitis (large external validation cohort included ages 2-96 years).</p>","Before Use":"","Favorite ID":"3,984","Short Title En":"AIR Score","Cme Release Date":"","Slug":"appendicitis-inflammatory-response-air-score","Short Description En":"<p>Diagnoses appendicitis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+32","Full Title En":"Cerebral Perfusion Pressure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:41 PM","Medium Description En":"<p>Calculates blood flow to the brain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+32","Cme Version":"3985.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with an intracranial pressure monitoring device.</p>","Before Use":"","Favorite ID":"3,985","Short Title En":"CPP","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"cerebral-perfusion-pressure","Short Description En":"<p>Cerebral blood flow.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"New York Heart Association (NYHA) Functional Classification for Heart Failure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:42 PM","Medium Description En":"<p><span>Stratifies severity of heart failure by symptoms.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,987","Short Title En":"NYHA Heart Failure Classification","Cme Release Date":"","Slug":"new-york-heart-association-nyha-functional-classification-heart-failure","Short Description En":"<p>Stratifies severity of heart failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+143","Full Title En":"Rule of 7s for Lyme Meningitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:44 PM","Medium Description En":"<p><span>Distinguishes Lyme meningitis from aseptic meningitis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+143","Cme Version":"3988.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in pediatric patients (aged 2&ndash;18 years) in a Lyme endemic area with <abbr style=\"color: #ffb600;\" title=\"cerebrospinal fluid\">CSF</abbr> pleocytosis, defined as CSF WBC &ge;10 cells/mm&sup3; (corrected for CSF RBC if &gt;500 using a ratio of 1 WBC for every 500 RBC).</span></p>","Before Use":"","Favorite ID":"3,988","Short Title En":"Rule of 7s","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rule-7s-lyme-meningitis","Short Description En":"<p>Lyme meningitis diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Mallampati Classification","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:44 PM","Medium Description En":"<p>Stratifies predicted difficulty of endotracheal intubation based on anatomic features.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Position patient seated upright and direct patient to open mouth and protrude tongue fully.</p>","Before Use":"","Favorite ID":"3,989","Short Title En":"Modified Mallampati Classification","Cme Release Date":"","Slug":"modified-mallampati-classification","Short Description En":"<p>Predicted endotracheal intubation difficulty.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Killip Classification for Heart Failure","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:45 PM","Medium Description En":"<p>Quantifies severity of heart failure in ACS and predicts 30-day mortality.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,990","Short Title En":"Killip Class","Cme Release Date":"","Slug":"killip-classification-heart-failure","Short Description En":"<p>ACS mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Duke Treadmill Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:46 PM","Medium Description En":"<p>Diagnoses and prognoses suspected CAD based on the treadmill exercise test.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3991.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,991","Short Title En":"Duke Treadmill Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"duke-treadmill-score","Short Description En":"<p>CAD survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Basic Statistics Calc","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Calculates common epidemiologic values for diagnostic tests and treatments.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Select “Diagnostic Test” to calculate stats related to diagnosis (sens, spec, prevalence, LR+, LR-, PPV, NPV). Select “Treatment” to calculate stats related to treatment (RR, OR, ARR, RRR, NNT). If entering sens, spec, and prevalence, enter as percentages (e.g. 67%, not 0.67).</span></p>","Before Use":"","Favorite ID":"3,993","Short Title En":"Basic Statistics","Cme Release Date":"","Slug":"basic-statistics-calc","Short Description En":"Sens, spec, LR+, LR-, PPV, NPV, OR, RR, ARR, NNT."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Ottawa Heart Failure Risk Scale (OHFRS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:47 PM","Medium Description En":"<p>Identifies ED patients with heart failure at high risk for serious adverse events.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3994.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients presenting to the emergency department with acute dyspnea secondary to new-onset or chronic heart failure (HF), after initial intervention. Do not use prior to ED intervention. Do not use in patients who are hemodynamically unstable (see When to Use for full exclusion criteria).</p>","Before Use":"","Favorite ID":"3,994","Short Title En":"OHFRS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"ottawa-heart-failure-risk-scale-ohfrs","Short Description En":"<p>Heart failure risk (ED patients).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Abbreviated Mental Test 4 (AMT-4)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:48 PM","Medium Description En":"<p><span>Assesses mental impairment in elderly patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,995","Short Title En":"AMT-4","Cme Release Date":"","Slug":"abbreviated-mental-test-4-amt-4","Short Description En":"<p>Mental status, similar performance as AMT-10 but shorter.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+96","Full Title En":"Murray Score for Acute Lung Injury","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:50 PM","Medium Description En":"<p>Stratifies severity of acute lung injury, and is also used for ECMO patient selection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+96","Cme Version":"3996.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in patients with severe hypoxemic respiratory failure from acute respiratory distress syndrome (ARDS). May be used with other clinical factors to help select patients for extracorporeal membrane oxygenation (ECMO).</span></p>","Before Use":"<p><strong>Tips for COVID-19:</strong>&nbsp;Use to determine ECMO. Standard score for determining when ECMO indicated. Used in <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/19762075\" target=\"_blank\" rel=\"noopener\">CESAR trial</a>, a pivotal RCT in ECMO.</p>","Favorite ID":"3,996","Short Title En":"Murray Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"murray-score-acute-lung-injury","Short Description En":"<p>Acute lung injury severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Clinical Index of Stable Febrile Neutropenia (CISNE)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:51 PM","Medium Description En":"<p>Identifies febrile neutropenia patients at low risk of serious complications.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult outpatients at least 18 years old with solid tumor, fever at least 38&deg;C (100.4&deg;F) over 1 hr, and <calculator id=\"19\">neutropenia</calculator> (500 cells/mm&sup3;or fewer, or 1,000 cells/mm&sup3; with expected decrease to 500). Do not use in patients with acute organ failure, severe infection, hypotension, or other reason for admission.</p>","Before Use":"","Favorite ID":"3,997","Short Title En":"CISNE","Cme Release Date":"","Slug":"clinical-index-stable-febrile-neutropenia-cisne","Short Description En":"<p>Low-risk febrile neutropenia.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+11","Full Title En":"ALT-70 Score for Cellulitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:51 PM","Medium Description En":"<p><span>Predicts likelihood of lower extremity cellulitis over other diagnoses.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+11","Cme Version":"3998.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-08140842-c86a-1196-1d63-6569f8234bb8\">Use in adult patients presenting to the ED with a red leg and clinical concern for cellulitis. Do not use if: visible abscess/fluctuance, penetrating trauma, burn, diabetic ulcer, hardware/device, post-operative patient, or recent (within 48 hrs) IV antibiotic use.</span></p>","Before Use":"","Favorite ID":"3,998","Short Title En":"ALT-70 Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"alt-70-score-cellulitis","Short Description En":"<p>Lower extremity cellulitis diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Rapid Shallow Breathing Index (RSBI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:54 PM","Medium Description En":"<p>Predicts successful extubation, to be used only as a single component of the clinical picture.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3999.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in intubated patients breathing spontaneously who meet other clinical criteria for weaning from mechanical ventilation. The RSBI should not be the sole determinant of extubation.</p>","Before Use":"<p><strong>Tips for COVID-19:</strong> Use to determine floor vs. ICU.&nbsp;Predicts successful extubation.</p>","Favorite ID":"3,999","Short Title En":"RSBI","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"rapid-shallow-breathing-index-rsbi","Short Description En":"<p>Predicts extubation success.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"FINDRISC (Finnish Diabetes Risk Score)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 8:57 PM","Medium Description En":"<p>Identifies patients at high risk for type 2 diabetes.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,000","Short Title En":"FINDRISC","Cme Release Date":"","Slug":"findrisc-finnish-diabetes-risk-score","Short Description En":"<p>T2DM risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"San Antonio Diabetes Prediction Model (SADPM)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span>Predicts risk of developing type 2 diabetes.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,002","Short Title En":"SADPM","Cme Release Date":"","Slug":"san-antonio-diabetes-prediction-model-sadpm","Short Description En":"T2DM risk."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+25","Full Title En":"Bova Score for Pulmonary Embolism Complications","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:03 PM","Medium Description En":"<p>Predicts 30-day risk of PE-related complications in hemodynamically stable patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+25","Cme Version":"4004.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use ONLY in hemodynamically stable patients (sBP &ge;90) with confirmed acute PE (pulmonary embolism).</p>","Before Use":"","Favorite ID":"4,004","Short Title En":"Bova Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"bova-score-pulmonary-embolism-complications","Short Description En":"<p>PE complications if hemodynamically stable.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:04 PM","Medium Description En":"<p><span>Identifies low-risk women who can safely discontinue VTE treatment.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in women &ge;18 years old with unprovoked VTE. Do not use in patients with any of the following at the time of VTE diagnosis: leg fracture, lower-extremity plaster cast, immobilization &gt;3 days, general anesthesia &lt;3 months before, or cancer diagnosis within 5 years.</p>","Before Use":"","Favorite ID":"4,005","Short Title En":"HERDOO2 Rule","Cme Release Date":"","Slug":"herdoo2-rule-discontinuing-anticoagulation-unprovoked-vte","Short Description En":"<p>Stop anticoagulation in VTE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+89","Full Title En":"mMRC (Modified Medical Research Council) Dyspnea Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:04 PM","Medium Description En":"<p><span>Stratifies severity of dyspnea in respiratory diseases, particularly COPD.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+89","Cme Version":"4006.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,006","Short Title En":"mMRC Dyspnea Scale","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"mmrc-modified-medical-research-council-dyspnea-scale","Short Description En":"<p>Dyspnea severity.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+142","Full Title En":"Rome IV Diagnostic Criteria for Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:06 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of irritable bowel syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+142","Cme Version":"4007.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of irritable bowel syndrome (IBS) such as chronic and recurrent abdominal pain and/or altered bowel habits for at least 6 months.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though IBS may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of colon cancer and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"4,007","Short Title En":"Rome IV for IBS","Cme Release Date":"2020-10-21 00:00:00+00+00","Slug":"rome-iv-diagnostic-criteria-irritable-bowel-syndrome-ibs","Short Description En":"<p>Diagnoses IBS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Epworth Sleepiness Scale","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 18, 2023, 8:26 PM","Medium Description En":"<p><span>Quantifies level of daytime sleepiness.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,008","Short Title En":"Epworth Sleepiness Scale","Cme Release Date":"","Slug":"epworth-sleepiness-scale","Short Description En":"<p>Daytime sleepiness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Cincinnati Prehospital Stroke Severity Scale (CP-SSS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:06 PM","Medium Description En":"<p><span>Predicts large vessel occlusion (LVO) and severe stroke in patients with stroke symptoms.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4009.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in a hospital setting in patients with signs and symptoms of acute ischemic stroke.</span></p>","Before Use":"","Favorite ID":"4,009","Short Title En":"CP-SSS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"cincinnati-prehospital-stroke-severity-scale-cp-sss","Short Description En":"<p>LVO and severity in stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Nutrition Risk in the Critically Ill (NUTRIC) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:07 PM","Medium Description En":"<p>Identifies critically ill patients who can benefit from nutrition therapy, recommended by <a href=\"https://www.mdcalc.com/guidelines/acg/nutrition-therapy-adult-hospitalized-patient\" target=\"_blank\" rel=\"noopener\">ACG guidelines</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,011","Short Title En":"NUTRIC Score","Cme Release Date":"","Slug":"nutrition-risk-critically-ill-nutric-score","Short Description En":"<p>Nutrition in ICU.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Nutrition Risk Screening 2002 (NRS-2002)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:08 PM","Medium Description En":"<p>Predicts risk of malnutrition in hospitalized patients, recommended by <a href=\"https://www.mdcalc.com/guidelines/acg/nutrition-therapy-adult-hospitalized-patient\" target=\"_blank\" rel=\"noopener\">ACG guidelines</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,012","Short Title En":"NRS-2002","Cme Release Date":"","Slug":"nutrition-risk-screening-2002-nrs-2002","Short Description En":"<p>Malnutrition risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+129","Full Title En":"RAPID Score for Pleural Infection","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:08 PM","Medium Description En":"<p>Predicts mortality in patients with pleural infection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+129","Cme Version":"4014.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with confirmed pleural infection.</p>","Before Use":"","Favorite ID":"4,014","Short Title En":"RAPID Score (Pleural Infection)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"rapid-score-pleural-infection","Short Description En":"<p>Pleural infection mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"National Cancer Institute Common Toxicity Criteria (NCI-CTC) for Mucositis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 18, 2023, 8:24 PM","Medium Description En":"<p><span>Grades severity of radiation-induced mucositis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in patients with radiation-induced mucositis.</span></p>","Before Use":"","Favorite ID":"4,015","Short Title En":"NCI-CTC Mucositis","Cme Release Date":"","Slug":"national-cancer-institute-common-toxicity-criteria-nci-ctc-mucositis","Short Description En":"<p>Mucositis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"LENT Prognostic Score for Malignant Pleural Effusion","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 30, 2024, 6:49 PM","Medium Description En":"<p>Predicts survival in patients with malignant pleural effusion.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,010","Short Title En":"LENT Score","Cme Release Date":"","Slug":"lent-prognostic-score-malignant-pleural-effusion","Short Description En":"<p>Malignant pleural effusion survival.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Brief Resolved Unexplained Events (BRUE) Criteria for Infants","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"April 30, 2024, 7:38 PM","Medium Description En":"<p>Classifies unexplained events and replaces the Apparent Life Threatening Events (ALTE) classification.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4016.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in infants &lt;1 year old who are asymptomatic and in their normal state of health at the time of evaluation. Do not use in symptomatic patients (e.g. fever, respiratory distress) or those with obvious cause for prior symptoms.</p>","Before Use":"<p>BRUE has been updated. BRUE 2.0 has been recommended as a replacement for the older tool. <a href=\"https://www.mdcalc.com/calc/10400/brief-resolved-unexplained-events-2.0-brue-2.0-criteria-infants?utm_source=site&amp;utm_medium=link&amp;utm_campaign=brue_1\" target=\"_blank\" rel=\"noopener\"><strong>Click here to view.</strong></a></p>","Favorite ID":"4,016","Short Title En":"BRUE Criteria","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"brief-resolved-unexplained-events-brue-criteria-infants","Short Description En":"<p>Classifies unexplained events in infants.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+86","Full Title En":"McMahon Score for Rhabdomyolysis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:10 PM","Medium Description En":"<p><span>Predicts mortality or acute kidney injury (AKI) in rhabdomyolysis patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+86","Cme Version":"4017.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in patients &ge;18 years old with rhabdomyolysis (<abbr title=\"Creatine phosphokinase\" style=\"color: #ffb600;\">CPK</abbr> &gt;5,000 U/L within 72 hours of admission). Do not use in patients with pre-existing end-stage renal disease or with elevated CPK due to MI.</span></p>","Before Use":"","Favorite ID":"4,017","Short Title En":"McMahon Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"mcmahon-score-rhabdomyolysis","Short Description En":"<p>Rhabdo mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"DECAF Score for Acute Exacerbation of COPD","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:11 PM","Medium Description En":"<p>Predicts in-hospital mortality in acute COPD exacerbation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4018.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;35 years old, hospitalized with a primary diagnosis of acute exacerbation of COPD. Do not use in patients with comorbidity expected to limit survival &lt;12 months.</p>","Before Use":"","Favorite ID":"4,018","Short Title En":"DECAF Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"decaf-score-acute-exacerbation-copd","Short Description En":"<p>COPD mortality, acute exacerbation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"BAP-65 Score for Acute Exacerbation of COPD","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 6, 2023, 9:11 PM","Medium Description En":"<p>Predicts mortality in acute COPD exacerbation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4019.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &gt;40 years of age presenting to the emergency department with acute COPD exacerbation. Use the worst variables on the day of admission.</p>","Before Use":"","Favorite ID":"4,019","Short Title En":"BAP-65","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"bap-65-score-acute-exacerbation-copd","Short Description En":"<p>COPD mortality, acute exacerbation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+82","Full Title En":"Marburg Heart Score (MHS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:40 PM","Medium Description En":"<p>Rules out coronary artery disease in primary care patients with chest pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+82","Cme Version":"4022.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in an emergency setting.</p>","Before Use":"","Favorite ID":"4,022","Short Title En":"Marburg Heart Score (MHS)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"marburg-heart-score-mhs","Short Description En":"<p>Rules out CAD (primary care).</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+98","Full Title En":"Naloxone Drip Dosing","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 7:45 PM","Medium Description En":"<p>Doses naloxone for acute opioid overdose.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+98","Cme Version":"4023.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with respiratory or central nervous system depression from opioid analgesic overdose.</p>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"4,023","Short Title En":"Naloxone Drip Dosing","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"naloxone-drip-dosing","Short Description En":"<p>Opioid reversal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+50","Full Title En":"Fetal Biophysical Profile (BPP) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:45 PM","Medium Description En":"<p>Predicts need for urgent delivery based on sonographic and nonstress testing.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+50","Cme Version":"4024.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,024","Short Title En":"BPP Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"fetal-biophysical-profile-bpp-score","Short Description En":"<p>Urgent delivery.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Intraoperative Fluid Dosing in Adult Patients","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 7:47 PM","Medium Description En":"<p>Doses IV fluids intraoperatively.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4025.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients undergoing surgery who weigh &ge;20 kg and do not have conditions that could otherwise result in fluid overload such as heart failure, COPD, or kidney failure on dialysis. This calculator provides a base hourly fluid requirement, fluid deficit, and hour-by-hour fluid requirement based on surgical needs.</p>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"4,025","Short Title En":"Intraop Fluid Dosing","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"intraoperative-fluid-dosing-adult-patients","Short Description En":"<p>Doses IV fluids.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"High-dose Insulin Euglycemia Therapy (HIET)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 7:50 PM","Medium Description En":"<p>Doses insulin for calcium-channel blocker or beta blocker overdose.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4026.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with cardiac drug-induced myocardial depression (cardiogenic shock).</p>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"4,026","Short Title En":"High-dose Insulin Euglycemia Therapy (HIET)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"high-dose-insulin-euglycemia-therapy-hiet","Short Description En":"<p>Calcium-channel blocker, beta blocker reversal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+23","Full Title En":"Blast Lung Injury Severity Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:52 PM","Medium Description En":"<p>Stratifies primary blast lung injuries into three categories to guide ventilator treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+23","Cme Version":"4028.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients who have sustained blast injury and have respiratory symptoms (e.g. cough, cyanosis, dyspnea, hemoptysis).</p>","Before Use":"","Favorite ID":"4,028","Short Title En":"BLI Severity Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"blast-lung-injury-severity-score","Short Description En":"<p>Blast lung severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+171","Full Title En":"Wound Closure Classification","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:53 PM","Medium Description En":"<p>Classifies types of wound closure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+171","Cme Version":"4029.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with open wounds, with a focus on wounds resulting from trauma.</p>","Before Use":"","Favorite ID":"4,029","Short Title En":"Wound Closure Classification","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"wound-closure-classification","Short Description En":"<p>Wound closure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Bastion Classification of Lower Limb Blast Injuries","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:55 PM","Medium Description En":"<p>Stratifies blast injuries of lower limbs to guide treatment.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4030.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Identify mechanism by the most proximal extent of the injury.</p>","Before Use":"","Favorite ID":"4,030","Short Title En":"Bastion Classification","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"bastion-classification-lower-limb-blast-injuries","Short Description En":"<p>Lower limb blast injury.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hypoglycemia Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 7:55 PM","Medium Description En":"<p>Predicts 12-month risk of hypoglycemic episodes in T2DM patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,031","Short Title En":"Hypoglycemia Risk Score","Cme Release Date":"","Slug":"hypoglycemia-risk-score","Short Description En":"<p>Hypoglycemia prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Plasma Dosage","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 7:56 PM","Medium Description En":"<p>Doses plasma for transfusion in patients with active bleeding.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4033.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Absolute contraindications to transfusion of fresh frozen plasma (FFP): documented intolerance to plasma or components, congenital IgA deficiency with anti-IgA antibodies, etc. Relative contraindications: heart failure, pulmonary edema, etc. Plasma should be ABO-compatible with recipient.</p>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive transfusion information. Always double-check dosing of any drug and consult a pharmacist or clinical pathologist as necessary.</p>","Favorite ID":"4,033","Short Title En":"Plasma Dosage","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"plasma-dosage","Short Description En":"<p>Plasma transfusion dosing.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Corrected Count Increment (CCI) for Platelet Transfusion","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:38 PM","Medium Description En":"<p>Assesses adequacy of response to platelet transfusion.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4034.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,034","Short Title En":"Corrected Count Increment (CCI) ","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"corrected-count-increment-cci-platelet-transfusion","Short Description En":"<p>Platelet transfusion response.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+114","Full Title En":"Pediatric Trauma BIG Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:43 PM","Medium Description En":"<p>Stratifies severity of illness and predicts mortality in pediatric patients after trauma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+114","Cme Version":"4035.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use on admission in pediatric patients &lt;18 years old who have sustained blunt or penetrating trauma or penetrating blast injury. Use lab values obtained on admission.</p>","Before Use":"","Favorite ID":"4,035","Short Title En":"Pediatric BIG Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"pediatric-trauma-big-score","Short Description En":"<p>Pediatric trauma mortality prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"DigiFab (Digibind) Dosing for Digoxin Poisoning","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 8:47 PM","Medium Description En":"<p>Doses DigiFab in patients with confirmed digoxin poisoning or overdose.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4036.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Therapeutic range for serum digoxin level is 0.8&ndash;2.0 ng/mL (1.0&ndash;2.6 nmol/L).&nbsp;If acute poisoning and serum digoxin confirmed &gt;10 ng/mL, give empiric dose (10-20 vials). See Evidence for details.</p>\n<p>Additional considerations for treatment of digoxin toxicity include:</p>\n<ul>\n<li>Atropine 0.5 mg IV for acute toxicity if bradydysrhythmias or high degree AV block.</li>\n<li>Cautious correction of electrolyte abnormalities, specifically hypokalemia and hypomagnesemia (may result in dysrhythmias at lower serum digoxin levels).</li>\n</ul>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"4,036","Short Title En":"DigiFab (Digibind) Dosing","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"digifab-dosing-digoxin-poisoning","Short Description En":"<p>DigiFab dosing for digoxin toxicity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+53","Full Title En":"Focused Assessment with Sonography for Trauma (FAST)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:48 PM","Medium Description En":"<p>Predicts presence of pericardial or intra-abdominal injury after penetrating or blunt trauma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+53","Cme Version":"4037.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>FAST results alone should not dictate the decision to operate, and negative FAST does not exclude injury. This calculator is meant to help with interpretation of FAST findings, which are at least partially dependent on the user's sonographic technique.</p>","Before Use":"","Favorite ID":"4,037","Short Title En":"FAST","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"focused-assessment-sonography-trauma-fast","Short Description En":"<p>Blunt abdominal trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Gupta Perioperative Risk for Myocardial Infarction or Cardiac Arrest (MICA)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 10:16 PM","Medium Description En":"<p>Predicts risk of MI or cardiac arrest after surgery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4038.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use within 30 days of surgery (pre- or postoperatively). May be used in cardiac or noncardiac procedures.</p>","Before Use":"","Favorite ID":"4,038","Short Title En":"Gupta Perioperative Risk","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"gupta-perioperative-risk-myocardial-infarction-cardiac-arrest-mica","Short Description En":"<p>Periop cardiac risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Simplified Acute Physiology Score (SAPS) II","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:49 PM","Medium Description En":"<p>Estimates mortality in ICU patients, comparable to APACHE II.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use the worst values in the past 24 hours.</p>","Before Use":"","Favorite ID":"4,044","Short Title En":"SAPS II","Cme Release Date":"","Slug":"simplified-acute-physiology-score-saps-ii","Short Description En":"<p>ICU mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+27","Full Title En":"Brugada Criteria for Ventricular Tachycardia","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:50 PM","Medium Description En":"<p>Distinguishes ventricular tachycardia from supraventricular tachycardia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+27","Cme Version":"4045.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,045","Short Title En":"Brugada Criteria","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"brugada-criteria-ventricular-tachycardia","Short Description En":"<p>VT versus SVT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Antivenom Dosing Algorithm","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 8:55 PM","Medium Description En":"<p>Doses antivenom (CroFab only, not Anavip) for pit viper snakebites.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4046.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in cases of symptomatic crotalid snake envenomation (pit vipers including rattlesnakes, cottonmouths, and copperheads) in the US, for CroFab administration. Do not use in cases of coral snake envenomation or snakes not indigenous to the US. Do not use for Anavip administration, as it will result in incorrect dosing. Report all cases of suspected/confirmed envenomation to poison control (1-800-222-1222).</p>","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"4,046","Short Title En":"Antivenom Dosing Algorithm","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"antivenom-dosing-algorithm","Short Description En":"<p>Antivenom for snake bites.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+137","Full Title En":"Rochester Criteria for Febrile Infants","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:56 PM","Medium Description En":"<p>Determines whether febrile infants are low risk for serious bacterial infection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+137","Cme Version":"4049.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in febrile infants &le;60 days of age (rectal temp &ge;38<strong>&deg;</strong>C or 100.4<strong>&deg;</strong>F).</p>","Before Use":"","Favorite ID":"4,049","Short Title En":"Rochester Criteria","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"rochester-criteria-febrile-infants","Short Description En":"<p>Low-risk febrile infants.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+44","Full Title En":"Drug Resistance in Pneumonia (DRIP) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 8:56 PM","Medium Description En":"<p>Predicts risk for community-acquired pneumonia due to drug-resistant pathogens.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+44","Cme Version":"4050.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,050","Short Title En":"DRIP Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"drug-resistance-pneumonia-drip-score","Short Description En":"<p>Drug-resistant CAP risk, more accurate than Shorr Score.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+55","Full Title En":"Fomepizole Dosing","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"September 8, 2023, 8:58 PM","Medium Description En":"<p>Doses fomepizole for methanol and ethylene glycol reversal.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+55","Cme Version":"4051.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,051","Short Title En":"Fomepizole Dosing","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"fomepizole-dosing","Short Description En":"<p>Methanol and ethylene glycol reversal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+01","Full Title En":"AAP Pediatric Hypertension Guidelines","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:02 PM","Medium Description En":"<p>Diagnoses hypertension in pediatric patients; official guideline of the American Academy of Pediatrics.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+01","Cme Version":"4052.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in children aged 1-17 years.&nbsp;Not for use in patients with low blood pressure.&nbsp;Recommendations are based on&nbsp;<a href=\"https://pediatrics.aappublications.org/content/140/3/e20171904.figures-only\" target=\"_blank\" rel=\"noopener\">AAP's 2017 Clinical Practice Guideline</a>&nbsp;(Table 3).&nbsp;Note that cutoffs reported in the calculator may&nbsp;vary&nbsp;slightly from the published tables, as the calculator accommodates for ages between whole numbers (e.g. 5.5 years), and the tables use simplified values to account for ages between whole numbers.&nbsp;For children &ge;13 years of age, this calculator has been adjusted to meet definitions presented in the&nbsp;<a href=\"https://hyper.ahajournals.org/content/early/2017/11/10/HYP.0000000000000065\" target=\"_blank\" rel=\"noopener\">2017 AHA/ACC hypertension guidelines</a>&nbsp;for adults.&nbsp;</p>","Before Use":"<p>This tool has been developed in partnership with the American Academy of Pediatrics. The authors, editors, and contributors are expert authorities in the field of pediatrics. No commercial involvement of any kind has been solicited or accepted in the development of the content of this tool. Advertising does not influence editorial decisions or content. The appearance of advertising on MDCalc sites is neither a guarantee nor an endorsement by the AAP of the product, service, or company, or the claims made for the product in such advertising.</p>","Favorite ID":"4,052","Short Title En":"AAP Pediatric HTN Guidelines","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"aap-pediatric-hypertension-guidelines","Short Description En":"<p>Pediatric HTN diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Mantle Cell Lymphoma International Prognostic Index (MIPI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:02 PM","Medium Description En":"<p>Predicts survival in patients with mantle cell lymphoma.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4053.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,053","Short Title En":"MIPI","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"mantle-cell-lymphoma-international-prognostic-index-mipi","Short Description En":"<p>Mantle cell lymphoma survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+73","Full Title En":"International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:03 PM","Medium Description En":"<p>Stratifies patients with chronic lymphocytic leukemia into four risk categories.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+73","Cme Version":"4054.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,054","Short Title En":"CLL-IPI","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"international-prognostic-index-chronic-lymphocytic-leukemia-cll-ipi","Short Description En":"<p>CLL risk stratification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"RADS (Radiologist’s Score) for Smoke Inhalation Injury","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:03 PM","Medium Description En":"<p>Stratifies severity of inhalation injury on chest CT.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4055.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Requires chest CT to calculate. This tool computes RADS for a single slice; to obtain full score (average RADS per slice), add RADS for all slices and divide by number of slices.</p>","Before Use":"","Favorite ID":"4,055","Short Title En":"RADS for Smoke Inhalation Injury","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"rads-radiologists-score-smoke-inhalation-injury","Short Description En":"<p>CT severity of inhalation injury.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+02","Full Title En":"Abbreviated Injury Score (AIS) for Inhalation Injury","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:05 PM","Medium Description En":"<p>Classifies inhalation injury severity based on bronchoscopic findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+02","Cme Version":"4056.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with suspected inhalation injury undergoing flexible bronchoscopy.</p>","Before Use":"","Favorite ID":"4,056","Short Title En":"AIS (Inhalation Injury)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"abbreviated-injury-score-ais-inhalation-injury","Short Description En":"<p>Inhalation injury severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Solitary Pulmonary Nodule (SPN) Malignancy Risk Score (Mayo Clinic Model)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:05 PM","Medium Description En":"<p>Predicts malignancy risk in solitary lung nodules on chest x-ray.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients with prior lung cancer diagnosis or with history of extrathoracic cancer&nbsp;diagnosed within 5 years of nodule presentation.</p>","Before Use":"","Favorite ID":"4,057","Short Title En":"Solitary Pulmonary Nodule Malignancy Risk (Mayo)","Cme Release Date":"","Slug":"solitary-pulmonary-nodule-spn-malignancy-risk-score-mayo-clinic-model","Short Description En":"<p>Risk that lung nodule is malignant.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+93","Full Title En":"Montgomery-Asberg Depression Rating Scale (MADRS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:06 PM","Medium Description En":"<p>Stratifies severity of depressive episodes in adults.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+93","Cme Version":"4058.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adults only (&ge;18 years). Rate based on&nbsp;clinical interview with the patient. Use clinical judgment to determine&nbsp;whether the rating lies on the defined scale steps (0, 2, 4, 6 points) or between them (1, 3, 5 points, denoted as \"(Worsening symptoms)\").</p>","Before Use":"","Favorite ID":"4,058","Short Title En":"MADRS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"montgomery-asberg-depression-rating-scale-madrs","Short Description En":"<p>Depression severity in adults.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Multiple Organ Dysfunction Score (MODS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"August 7, 2023, 7:14 PM","Medium Description En":"<p>Stratifies severity of organ failure in an ICU setting.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,059","Short Title En":"MODS","Cme Release Date":"","Slug":"multiple-organ-dysfunction-score-mods","Short Description En":"<p>Organ failure severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Los Angeles (LA) Grading of Esophagitis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:07 PM","Medium Description En":"<p>Stratifies severity of esophagitis based on endoscopic findings, recommended by <a href=\"https://www.mdcalc.com/guidelines/acg/diagnosis-management-gastroesophageal-reflux-disease\" target=\"_blank\" rel=\"noopener\">ACG guidelines</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,061","Short Title En":"LA Grading of Esophagitis","Cme Release Date":"","Slug":"los-angeles-la-grading-esophagitis","Short Description En":"<p>Esophagitis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+125","Full Title En":"R Factor for Liver Injury","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:51 PM","Medium Description En":"<p>Differentiates cholestatic from hepatocellular liver injury, recommended by <a href=\"https://www.mdcalc.com/guidelines/acg/diagnosis-management-idiosyncratic-drug-induced-liver-injury\" target=\"_blank\" rel=\"noopener\">ACG guidelines</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+125","Cme Version":"4064.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use the first lab values (ALT and ALP) indicating acute liver injury to calculate the R factor.</p>","Before Use":"","Favorite ID":"4,064","Short Title En":"R Factor","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"r-factor-liver-injury","Short Description En":"<p>Cholestatic vs. hepatocellular liver injury.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Blood Volume Calculation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:09 PM","Medium Description En":"<p>Calculates total blood volume, red blood cell volume, and plasma volume.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4065.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,065","Short Title En":"Blood Volume Calculation","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"blood-volume-calculation","Short Description En":"<p>Blood and blood components volumes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+150","Full Title En":"Sickle Cell RBC Exchange Volume","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:10 PM","Medium Description En":"<p><span>Estimates the volume of donor RBCs needed for RBC exchange in patients with sickle cell disease.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+150","Cme Version":"4066.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: device manufacturers may provide separate calculations for automated exchange.</p>","Before Use":"","Favorite ID":"4,066","Short Title En":"Sickle Cell RBC Exchange Volume","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"sickle-cell-rbc-exchange-volume","Short Description En":"<p>Donor RBC volume for exchange.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"YEARS Algorithm for Pulmonary Embolism (PE)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"September 8, 2023, 9:12 PM","Medium Description En":"<p>Helps rule out pulmonary embolism; also validated in pregnant patients with clinically suspected PE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"4067.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in hemodynamically stable patients &ge;18 years old.</p>\n<p>Take note of the following exclusion criteria:</p>\n<ul>\n<li>Treatment with therapeutic doses of anticoagulants initiated 24 hours or more before eligibility assessment.</li>\n<li>Life expectancy less than 3 months.</li>\n<li>Geographic inaccessibility precluding follow-up.</li>\n<li>Pregnancy (be sure to use pregnancy-adapted YEARS algorithm in the calc).</li>\n<li>Allergy to intravenous contrast agent.</li>\n</ul>","Before Use":"","Favorite ID":"4,067","Short Title En":"YEARS Algorithm","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"years-algorithm-for-pulmonary-embolism-pe","Short Description En":"<p>PE rule-out.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Journal Impact Factor Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Calculates impact factor, based on Journal Citation Reports formula.</p>","Logic Language":"","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,093","Short Title En":"Journal IF ","Cme Release Date":"","Slug":"journal-impact-factor-calculator","Short Description En":"Calculates impact factor."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fatty Liver Index","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 15, 2023, 7:53 PM","Medium Description En":"<p>Diagnoses fatty liver using labs and exam findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,001","Short Title En":"Fatty Liver Index","Cme Release Date":"","Slug":"fatty-liver-index","Short Description En":"<p>Fatty liver diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+141","Full Title En":"Rome IV Diagnostic Criteria for Functional Dyspepsia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 18, 2023, 3:34 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional dyspepsia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+141","Cme Version":"10002.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with symptoms suggestive of functional dyspepsia such as chronic and recurrent epigastric pain, discomfort, fullness, burning and early satiety for at least 6 months.</p>\n<p>Patients with any of the following features must be evaluated clinically for other diagnoses even though functional dyspepsia may be present:</p>\n<ul>\n<li dir=\"ltr\">Signs or symptoms of GI bleeding.</li>\n<li dir=\"ltr\">Unexplained iron deficiency anemia.</li>\n<li dir=\"ltr\">Unintentional weight loss.</li>\n<li dir=\"ltr\">Palpable abdominal mass or lymphadenopathy on exam.</li>\n<li dir=\"ltr\">Family history of gastric cancer and no recent upper endoscopy.</li>\n<li dir=\"ltr\">Dysphagia.</li>\n<li dir=\"ltr\">Persistent vomiting.</li>\n</ul>","Before Use":"","Favorite ID":"10,002","Short Title En":"Rome IV for Functional Dyspepsia","Cme Release Date":"2020-10-21 00:00:00+00+00","Slug":"rome-iv-diagnostic-criteria-functional-dyspepsia","Short Description En":"<p>Functional dyspepsia diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+140","Full Title En":"Rome IV Diagnostic Criteria for Functional Constipation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 18, 2023, 3:35 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional constipation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+140","Cme Version":"10003.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with symptoms suggestive of constipation for at least the last 3 months.</p>\n<p>Patients with any of the following features must be evaluated clinically for other diagnoses even though functional constipation may be present:</p>\n<ul>\n<li>Signs or symptoms of gastrointestinal bleeding.</li>\n<li>Unexplained iron deficiency anemia.</li>\n<li>Unintentional weight loss.</li>\n<li>Palpable abdominal mass or lymphadenopathy on exam.</li>\n<li>Family history of colon cancer and have not had age-appropriate colon cancer screening.</li>\n<li>Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</li>\n<li>Sudden or acute onset of new change in bowel habit.</li>\n</ul>","Before Use":"","Favorite ID":"10,003","Short Title En":"Rome IV for Functional Constipation","Cme Release Date":"2020-10-21 00:00:00+00+00","Slug":"rome-iv-diagnostic-criteria-functional-constipation","Short Description En":"<p>Constipation diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+75","Full Title En":"Intrauterine RBC Transfusion Dosage","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 3:37 PM","Medium Description En":"<p>Estimates volume of donor RBCs needed for intrauterine transfusion (IUT).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+75","Cme Version":"10004.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult your institution's blood bank or a pharmacist as necessary.</p>","Favorite ID":"10,004","Short Title En":"Intrauterine RBC Transfusion Dosage","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"intrauterine-rbc-transfusion-dosage","Short Description En":"<p>Donor RBCs for IUT.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+41","Full Title En":"Cryoprecipitate Dosing for Fibrinogen Replacement","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 3:38 PM","Medium Description En":"<p>Estimates volume of cryoprecipitate recommended for fibrinogen replacement.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+41","Cme Version":"10005.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.</p>","Favorite ID":"10,005","Short Title En":"Cryo Dosing (Fibrinogen Replacement)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"cryoprecipitate-dosing-fibrinogen-replacement","Short Description En":"<p>Cryoprecipitate dosing.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+100","Full Title En":"Neonatal Partial Exchange for Polycythemia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 3:48 PM","Medium Description En":"<p>Estimates the volume of whole blood to remove and volume of crystalloid to infuse in neonatal polycythemia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+100","Cme Version":"10006.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult your institution's blood bank or a pharmacist&nbsp;as necessary.</p>","Favorite ID":"10,006","Short Title En":"Neonatal Partial Exchange","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"neonatal-partial-exchange-polycythemia","Short Description En":"<p>Neonate blood extraction and crystalloid replacement.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+132","Full Title En":"Revised Schwartz Equation for Glomerular Filtration Rate (GFR) (2009)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 18, 2023, 8:34 PM","Medium Description En":"<p>Estimates GFR in pediatric patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+132","Cme Version":"10008.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,008","Short Title En":"Revised Schwartz Equation (2009)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"revised-schwartz-equation-glomerular-filtration-rate-gfr-2009","Short Description En":"<p>Estimated GFR (peds).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Peripheral Blood Stem Cell Collection","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 8:36 PM","Medium Description En":"<p>Estimates CD34+ yield using pre-apheresis peripheral blood absolute CD34 blood count.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10009.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a pharmacist when necessary.&nbsp;It is important that clinical decisions are made only from laboratory results on validated instruments.&nbsp;</p>","Favorite ID":"10,009","Short Title En":"Peripheral Blood Stem Cell Collection","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"peripheral-blood-stem-cell-collection","Short Description En":"<p>CD34+ yield.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Maternal-Fetal Hemorrhage Rh(D) Immune Globulin Dosage","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 8:37 PM","Medium Description En":"<p>Calculates amount of RhIG to be administered to the mother, at the time of delivery, to prevent hemolytic disease of the fetus and newborn (HDFN).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10010.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a clinical pathologist or pharmacist when necessary.</p>","Favorite ID":"10,010","Short Title En":"RhIG (RhoGAM) Dosing","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"maternal-fetal-hemorrhage-rhd-immune-globulin-dosage","Short Description En":"<p>RhIG for HDFN.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+130","Full Title En":"RBC Units to Screen for Compatibility","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 18, 2023, 8:38 PM","Medium Description En":"<p>Estimates number of donor RBC units to screen to obtain a desired number of antigen-negative units.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+130","Cme Version":"10011.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,011","Short Title En":"RBC Compatibility Testing","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rbc-units-screen-compatibility","Short Description En":"<p>Donors to antigen type.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Donor Lymphocyte Infusion (DLI) Volume","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 18, 2023, 8:40 PM","Medium Description En":"<p>Estimates volume of whole blood to process by apheresis to yield an appropriate DLI dosage.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10012.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,012","Short Title En":"DLI Volume","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"donor-lymphocyte-infusion-dli-volume","Short Description En":"<p>Estimates DLI dosage.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Therapeutic Plasmapheresis Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 18, 2023, 8:40 PM","Medium Description En":"<p>Estimates amount of a substance (e.g. antibody) remaining in the intravascular space after a given number of plasma volume exchanges.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10013.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,013","Short Title En":"Therapeutic Plasmapheresis","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"therapeutic-plasmapheresis-calculator","Short Description En":"<p>Removal of a substance by plasma exchange.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPACT Score for Outcomes in Head Injury","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:51 PM","Medium Description En":"<p>Predicts 6-month mortality and unfavorable outcomes after moderate to severe traumatic brain injury (TBI).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use for patients &ge;14 years old with <calculator id=\"64\">GCS</calculator> &le;12 (moderate and severe TBI). Use data from the first 24 hours of admission.</p>","Before Use":"","Favorite ID":"10,014","Short Title En":"IMPACT Score","Cme Release Date":"","Slug":"impact-score-outcomes-head-injury","Short Description En":"<p>TBI outcomes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"EPIPHANY Index for Pulmonary Embolism (PE) in Cancer","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts risk of serious complications in cancer patients with pulmonary embolism.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adults (&gt;18 years) with cancer and PE (symptomatic or incidental) confirmed on imaging (i.e., CT, CT angiography, V/Q scan). Do not use if PE diagnosed &gt;1 month before cancer diagnosis, or if PE diagnosed &gt;1 month since completing chemotherapy.</p>","Before Use":"","Favorite ID":"10,015","Short Title En":"EPIPHANY Index","Cme Release Date":"","Slug":"epiphany-index-pulmonary-embolism-pe-cancer","Short Description En":"PE complications in cancer patients. "},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Dual Antiplatelet Therapy (DAPT) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:52 PM","Medium Description En":"<p><span id=\"docs-internal-guid-b2a1d016-dbee-e68c-d348-1ff720e39263\">Predicts which patients will benefit from prolonged DAPT after coronary stent placement.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,016","Short Title En":"DAPT Score","Cme Release Date":"","Slug":"dual-antiplatelet-therapy-dapt-score","Short Description En":"<p>Prolonged (&gt;1 year) dual antiplatelet therapy after PCI.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Bristol Stool Form Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:52 PM","Medium Description En":"<p><span id=\"docs-internal-guid-6be1099f-dbd7-885a-f227-dfd37a91e3fb\">Classifies stool (correlates with intestinal transit time).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,017","Short Title En":"Bristol Stool Scale","Cme Release Date":"","Slug":"bristol-stool-form-scale","Short Description En":"<p>Stool classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"AKIN Classification for Acute Kidney Injury (AKI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:54 PM","Medium Description En":"<p>Classifies severity of acute kidney injury, similar to RIFLE Criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Patients on renal replacement therapy (RRT) are considered to be stage 3 regardless of whether they meet formal criteria.</p>","Before Use":"","Favorite ID":"10,018","Short Title En":"AKIN Classification","Cme Release Date":"","Slug":"akin-classification-acute-kidney-injury-aki","Short Description En":"<p>Acute kidney injury classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RIFLE Criteria for Acute Kidney Injury (AKI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:55 PM","Medium Description En":"<p><span id=\"docs-internal-guid-e63a6a94-d71e-205e-1af3-65462f3682ce\">Classifies severity of acute kidney injury, similar to AKIN Classification.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: the original paper refers to \"acute renal failure\", but the generally-accepted term currently is \"acute kidney injury\", which is reflected in this calculator.&nbsp;</p>","Before Use":"","Favorite ID":"10,019","Short Title En":"RIFLE Criteria","Cme Release Date":"","Slug":"rifle-criteria-acute-kidney-injury-aki","Short Description En":"<p>Acute kidney injury classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+05","Full Title En":"ACTION ICU Score for Intensive Care in NSTEMI","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:56 PM","Medium Description En":"<p><span id=\"docs-internal-guid-8d89269d-bcb7-f6d1-c8ac-540878579c2a\">Predicts risk of NSTEMI complications requiring ICU care.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+05","Cme Version":"10020.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in emergency patients with NSTEMI.</p>","Before Use":"<p>This calculator is not externally validated, and as such, should be used with caution.</p>","Favorite ID":"10,020","Short Title En":"ACTION ICU Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"action-icu-score-intensive-care-nstemi","Short Description En":"<p>Critical NSTEMI complications.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ARISCAT Score for Postoperative Pulmonary Complications","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:30 PM","Medium Description En":"<p><span id=\"docs-internal-guid-da7013b9-e0bf-ea28-dafc-e150e8e57140\">Predicts risk of pulmonary complications after surgery, including respiratory failure. </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,022","Short Title En":"ARISCAT Score","Cme Release Date":"","Slug":"ariscat-score-postoperative-pulmonary-complications","Short Description En":"<p>Post-op pulmonary complications.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Leiden Clinical Prediction Rule for Undifferentiated Arthritis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:56 PM","Medium Description En":"<p><span id=\"docs-internal-guid-e044c1e4-efd3-3f90-4ea8-652e204fa6b8\">Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,023","Short Title En":"Leiden Rule for Arthritis","Cme Release Date":"","Slug":"leiden-clinical-prediction-rule-undifferentiated-arthritis","Short Description En":"<p>Rheumatoid arthritis diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ASA Physical Status/ASA Classification","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:57 PM","Medium Description En":"<p><span id=\"docs-internal-guid-1a2c1ef0-f972-99c5-06f6-33a1d528437f\">Classifies health of patients prior to surgery.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,024","Short Title En":"ASA Physical Status","Cme Release Date":"","Slug":"asa-physical-status-asa-classification","Short Description En":"<p>Pre-op classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Ocular Hypertension Treatment Study (OHTS) Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:58 PM","Medium Description En":"<p>Identifies patients that may benefit from therapy to lower intraocular pressure (IOP).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10025.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,025","Short Title En":"OHTS Calculator","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"ocular-hypertension-treatment-study-ohts-calculator","Short Description En":"<p>Primary open angle glaucoma prevention.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Wexler and Lok Formula for PCO<sub>2</sub>","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Calculates required minute ventilation for a given PCO<sub>2</sub>.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,026","Short Title En":"Wexler and Lok Formula for PCO<sub>2</sub>","Cme Release Date":"","Slug":"wexler-lok-formula-pco2","Short Description En":"Minute ventilation from PCO₂."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Recognition of Stroke in the Emergency Room (ROSIER) Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 5:58 PM","Medium Description En":"<p><span id=\"docs-internal-guid-27b79b1d-ffc3-b826-e4e4-cf5aea7cc813\">Distinguishes between acute stroke and stroke mimics.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,027","Short Title En":"ROSIER Scale","Cme Release Date":"","Slug":"recognition-stroke-emergency-room-rosier-scale","Short Description En":"<p>Acute stroke recognition.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CART (Cardiac Arrest Risk Triage) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:04 PM","Medium Description En":"<p><span id=\"docs-internal-guid-f8745c4f-954a-d4b8-5a16-ada0f7532a26\">Predicts risk of in-hospital cardiac arrest.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,029","Short Title En":"CART","Cme Release Date":"","Slug":"cart-cardiac-arrest-risk-triage-score","Short Description En":"<p>In-hospital cardiac arrest.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CholeS Score for Duration of Laparoscopic Cholecystectomy","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:05 PM","Medium Description En":"<p>Predicts operative time of laparoscopic cholecystectomy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,030","Short Title En":"CholeS Score","Cme Release Date":"","Slug":"choles-score-duration-laparoscopic-cholecystectomy","Short Description En":"<p>Lap chole duration.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"REACH-B Score for Hepatocellular Carcinoma (HCC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:05 PM","Medium Description En":"<p><span id=\"docs-internal-guid-14d4eb64-1b2f-9c96-0e41-d04b34e2ca3b\">Estimates risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,031","Short Title En":"REACH-B Score","Cme Release Date":"","Slug":"reach-b-score-hepatocellular-carcinoma-hcc","Short Description En":"<p>HCC risk in hep B.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"GO-FAR (Good Outcome Following Attempted Resuscitation) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:08 PM","Medium Description En":"<p>Predicts survival to discharge with good outcome after in-hospital cardiac arrest.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use pre-arrest information to calculate.</p>","Before Use":"","Favorite ID":"10,033","Short Title En":"GO-FAR Score","Cme Release Date":"","Slug":"go-far-good-outcome-following-attempted-resuscitation-score","Short Description En":"<p>Survival and good outcome after cardiac arrest.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"SLICC Criteria for Systemic Lupus Erythematosus (SLE) 2012","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:08 PM","Medium Description En":"<p>Provides criteria for diagnosis of SLE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Criteria are cumulative; i.e., any history counts and findings need not be present concurrently.</p>","Before Use":"","Favorite ID":"10,034","Short Title En":"SLICC Criteria for Lupus 2012","Cme Release Date":"","Slug":"slicc-criteria-systemic-lupus-erythematosus-sle-2012","Short Description En":"<p>Systemic lupus erythematosus diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"DIRE Score for Opioid Treatment","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:09 PM","Medium Description En":"<p>Predicts compliance with opioid treatment for chronic noncancer pain.<br><span id=\"docs-internal-guid-292a06cf-1d7a-9e6f-0dea-ad73bcf0c7e8\"></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,035","Short Title En":"DIRE Score","Cme Release Date":"","Slug":"dire-score-opioid-treatment","Short Description En":"<p>Opioid treatment compliance.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"ASCOD Algorithm for Ischemic Stroke","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span id=\"docs-internal-guid-1984779d-22f6-1296-4b89-d6d861d8920d\">Assigns phenotype in patients with ischemic stroke of uncertain causes.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,036","Short Title En":"ASCOD Algorithm for Ischemic Stroke","Cme Release Date":"","Slug":"ascod-algorithm-ischemic-stroke","Short Description En":"Ischemic stroke phenotype."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Acute Graft-vs-Host-Disease (GVHD) Grading","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 6:10 PM","Medium Description En":"<p>Grades severity of GVHD post stem cell transplant.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,037","Short Title En":"Acute GVHD Grading","Cme Release Date":"","Slug":"acute-graft-vs-host-disease-gvhd-grading","Short Description En":"<p>GVHD severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Braden Score for Pressure Ulcers","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:21 PM","Medium Description En":"<p>Identifies patients at risk for pressure ulcers.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,038","Short Title En":"Braden Score","Cme Release Date":"","Slug":"braden-score-pressure-ulcers","Short Description En":"<p>Pressure ulcer risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CASPAR Criteria for Psoriatic Arthritis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:24 PM","Medium Description En":"<p>Provides criteria for psoriatic arthritis diagnosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,039","Short Title En":"CASPAR Criteria for PsA","Cme Release Date":"","Slug":"caspar-criteria-psoriatic-arthritis","Short Description En":"<p>Psoriatic arthritis diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Duval/CIBMTR Score for Acute Myelogenous Leukemia (AML) Survival","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:27 PM","Medium Description En":"<p><span id=\"docs-internal-guid-b31c1b3f-b490-1063-03ed-94f006599a06\">Predicts overall survival in AML patients with relapsed/refractory disease undergoing myeloablative transplant.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10040.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-0cc06959-ce3b-dee0-9f16-93dc0a7ea4c5\">Use in patients with relapsed or refractory active AML for whom hematopoietic stem cell transplant (HSCT) is being considered. Do not use in patients with chronic myelogenous leukemia (CML) in blast crisis.</span></p>","Before Use":"","Favorite ID":"10,040","Short Title En":"Duval/CIBMTR Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"duval-cibmtr-score-acute-myelogenous-leukemia-aml-survival","Short Description En":"<p>AML survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Cytokine Release Syndrome (CRS) Grading","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:28 PM","Medium Description En":"<p>Assesses severity of CRS in patients on immunotherapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10041.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-7ee9c317-ce34-44e3-05d3-b365d29a8aca\">Use in patients receiving immunotherapy for cancer.</span></p>","Before Use":"","Favorite ID":"10,041","Short Title En":"Cytokine Release Syndrome (CRS) Grading","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"cytokine-release-syndrome-crs-grading","Short Description En":"<p>CRS severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hamilton Depression Rating Scale (HAM-D)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:32 PM","Medium Description En":"<p><span id=\"docs-internal-guid-114cbea3-381b-393c-1b6a-ab98f66cfd03\">Stratifies severity of depression, similar to <calculator id=\"1725\">PHQ-9</calculator>.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The original HAM-D has 21 items, but scoring is based only on the first 17.</p>","Before Use":"","Favorite ID":"10,043","Short Title En":"HAM-D","Cme Release Date":"","Slug":"hamilton-depression-rating-scale-hamd","Short Description En":"<p>Depression severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Montreal Cognitive Assessment (MoCA)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:34 PM","Medium Description En":"<p>Screens for mild cognitive impairment and Alzheimer's disease.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10044.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,044","Short Title En":"Montreal Cognitive Assessment (MoCA)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"montreal-cognitive-assessment-moca","Short Description En":"<p>Cognitive impairment screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Kidney Failure Risk Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:36 PM","Medium Description En":"<p>Predicts progression to kidney failure in patients with chronic kidney disease (CKD).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,045","Short Title En":"Kidney Failure Risk Calculator","Cme Release Date":"","Slug":"kidney-failure-risk-calculator","Short Description En":"<p>Kidney failure risk in CKD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Denver HIV Risk Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:39 PM","Medium Description En":"<p><span id=\"docs-internal-guid-125e6dda-3cff-e8b3-7d5e-c66fe3b515ca\">Predicts probability of undiagnosed HIV infection. </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same other inputs, this calculator estimates higher risk of HIV prevalence in Hispanic and Black patients.</p>","Favorite ID":"10,046","Short Title En":"Denver HIV Score","Cme Release Date":"","Slug":"denver-hiv-risk-score","Short Description En":"<p>HIV risk screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ankylosing Spondylitis Disease Activity Score with CRP (ASDAS-CRP)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:40 PM","Medium Description En":"<p><span id=\"docs-internal-guid-e1d21e46-4857-c7ef-80f1-50b95f726f1a\">Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically CRP.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,047","Short Title En":"ASDAS-CRP for Ankylosing Spondylitis","Cme Release Date":"","Slug":"ankylosing-spondylitis-disease-activity-score-crp-asdas-crp","Short Description En":"<p>AS severity based on CRP.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Finnegan Neonatal Abstinence Score (NAS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:41 PM","Medium Description En":"<p>Stratifies severity of opioid withdrawal in newborns.<br><span id=\"docs-internal-guid-f800958c-6187-0d76-d5ea-599b9b7a56dc\"></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The NAS should be monitored over time; protocols for management based on scoring may differ by institution but some studies&nbsp;suggest monitoring&nbsp;every 3-4 hours.&nbsp;</p>","Before Use":"","Favorite ID":"10,048","Short Title En":"Neonatal Abstinence Score (NAS)","Cme Release Date":"","Slug":"modified-finnegan-neonatal-abstinence-score-nas","Short Description En":"<p>Opioid withdrawal in newborns.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Age-Adjusted ESR/CRP for Rheumatoid Arthritis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:43 PM","Medium Description En":"<p><span id=\"docs-internal-guid-86e0fad3-6219-da53-5968-383032692b47\">Calculates age-adjusted ESR and CRP in adult patients with rheumatoid arthritis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,049","Short Title En":"Age-Adjusted ESR/CRP for RA","Cme Release Date":"","Slug":"age-adjusted-esr-crp-rheumatoid-arthritis","Short Description En":"<p>Adjusted ESR/CRP calculation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ankylosing Spondylitis Disease Activity Score with ESR (ASDAS-ESR)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:44 PM","Medium Description En":"<p><span id=\"docs-internal-guid-0cc0b060-628d-851d-1f65-10609e42a29b\">Stratifies severity of ankylosing spondylitis (AS) using clinical and laboratory data, specifically ESR.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,050","Short Title En":"ASDAS-ESR for Ankylosing Spondylitis","Cme Release Date":"","Slug":"ankylosing-spondylitis-disease-activity-score-esr-asdas-esr","Short Description En":"<p>AS severity based on ESR.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HOSPITAL Score for Readmissions","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 21, 2023, 7:48 PM","Medium Description En":"<p><span id=\"docs-internal-guid-ba449b99-6b0d-f111-12a0-0804a15d62f1\">Predicts 30-day potentially avoidable hospital readmissions.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,051","Short Title En":"HOSPITAL Score","Cme Release Date":"","Slug":"hospital-score-readmissions","Short Description En":"<p>Readmission prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Liver Decompensation Risk after Hepatectomy for Hepatocellular Carcinoma (HCC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 3:52 PM","Medium Description En":"<p><span id=\"docs-internal-guid-71c59796-899e-b7d6-fe35-932124eb5f77\">Predicts risk of liver decompensation after hepatectomy for hepatocellular carcinoma (HCC). </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,052","Short Title En":"Liver Decompensation Risk","Cme Release Date":"","Slug":"liver-decompensation-risk-hepatectomy-hepatocellular-carcinoma-hcc","Short Description En":"<p>Post-hepatectomy decompensation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Binet Staging System for Chronic Lymphocytic Leukemia (CLL)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 3:53 PM","Medium Description En":"<p><span id=\"docs-internal-guid-66ececc1-89dd-c40b-2b6d-dee1321efd45\">Stages chronic lymphocytic leukemia, similar to <calculator id=\"10054\">Rai Staging System</calculator>.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,053","Short Title En":"Binet Staging for CLL","Cme Release Date":"","Slug":"binet-staging-system-chronic-lymphocytic-leukemia-cll","Short Description En":"<p>CLL stage classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Rai Staging System for Chronic Lymphocytic Leukemia (CLL)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 3:54 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5cc76905-8a8b-bef3-f00a-bcb7a45691ad\">Stages chronic lymphocytic leukemia, similar to <calculator id=\"10053\">Binet Staging System</calculator></span>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-e542ee75-d76f-541d-cb2f-1985c4781009\">Use in patients with lymphocytosis (absolute lymphocytes &ge;15,000/mm<sup>3</sup> in blood and &ge;40% lymphocytes in marrow). Lymph nodes, spleen, and liver are considered enlarged if palpable on exam.</span></p>","Before Use":"","Favorite ID":"10,054","Short Title En":"Rai Staging for CLL","Cme Release Date":"","Slug":"rai-staging-system-chronic-lymphocytic-leukemia-cll","Short Description En":"<p>CLL stage classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+148","Full Title En":"Shock Index, Pediatric Age-Adjusted (SIPA)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 4:07 PM","Medium Description En":"<p><span id=\"docs-internal-guid-b41eb2c7-d790-fe45-f5d2-4914b4cc307b\">Predicts mortality in children with blunt trauma.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+148","Cme Version":"10058.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-ddc33812-d780-1de8-3f67-d7d1f36d4980\">Use in blunt trauma patients 4-16 years of age.</span></p>","Before Use":"","Favorite ID":"10,058","Short Title En":"Shock Index, Pediatric Age-Adjusted (SIPA)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"shock-index-pediatric-age-adjusted-sipa","Short Description En":"<p>Shock in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PEDIS Score for Diabetic Foot Ulcers","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 4:12 PM","Medium Description En":"<p><span id=\"docs-internal-guid-9f698d85-8f4f-ea0a-9989-865d391dc8aa\">Predicts 6-month risk of amputation and mortality in diabetic foot ulcers.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in an inpatient setting in patients with diabetic foot ulcer of any duration. Do not use in patients with secondary diabetes or those with foot ulcers caused by autoimmune disease or malignancy.</p>","Before Use":"","Favorite ID":"10,059","Short Title En":"PEDIS Score","Cme Release Date":"","Slug":"pedis-score-diabetic-foot-ulcers","Short Description En":"<p>Diabetic ulcer outcomes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+166","Full Title En":"Visual Acuity Testing (Snellen Chart)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 25, 2023, 6:48 PM","Medium Description En":"<p><span id=\"docs-internal-guid-85a9a863-953c-ed3a-9136-4eb7c1868d4d\">Assess binocular and monocular visual acuity. </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+166","Cme Version":"10060.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li dir=\"ltr\">Ensure proper room lighting and set phone brightness to 100%.</li>\n<li dir=\"ltr\">Hold the screen 4 feet (1.2 m) from the patient (approximately the end of a standard hospital bed if patient is sitting upright).</li>\n<li dir=\"ltr\">Test each eye independently. The patient should completely cover the opposite eye.</li>\n<li dir=\"ltr\">See <a href=\"#pearls-pitfalls\">Pearls/Pitfalls</a> for further instructions.</li>\n</ul>","Before Use":"<p>This calculator is intended as a convenient screener for visual acuity to be used on a mobile device and should <em><strong>not&nbsp;</strong></em>be used as a replacement for in-office testing. Evidence for smartphone apps for Snellen visual acuity is limited, and currently no app has been found to be accurate to within at least one line of formal visual acuity testing (and further validation is required).&nbsp;Variation in screen resolution and text size may impact accuracy.</p>","Favorite ID":"10,060","Short Title En":"Snellen Chart","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"visual-acuity-testing-snellen-chart","Short Description En":"<p>Visual acuity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Color Vision Screening (Ishihara Test)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 25, 2023, 4:13 PM","Medium Description En":"<p>Assess for red-green color blindness.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10061.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-67f60c91-9522-a6fe-0cf3-8d49b0600d81\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Ensure proper room lighting and phone brightness.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Wear any glasses necessary for near vision.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Hold screen at a comfortable reading distance (~30 inches or 75 cm).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Test each eye independently.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,061","Short Title En":"Ishihara Test","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"color-vision-screening-ishihara-test","Short Description En":"<p>Color blindness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Fleischner Society Guidelines for Incidental Pulmonary Nodules","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:19 PM","Medium Description En":"<p><span id=\"docs-internal-guid-75dc5fec-aaeb-9cf2-4a58-c105fabdc83c\">Provides guidelines for management of solid and subsolid pulmonary nodules.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-1707ff55-aaec-ab68-f189-c5d31820ce87\">Use in patients &ge;35 years old with incidental pulmonary nodules on CT imaging. Do not use for lung cancer screening or in patients with known primary cancer or immunosuppression.&nbsp;</span>Use most suspicious nodule as guide to management.&nbsp;</p>","Before Use":"","Favorite ID":"10,062","Short Title En":"Fleischner Guidelines for Pulmonary Nodules","Cme Release Date":"","Slug":"fleischner-society-guidelines-incidental-pulmonary-nodules","Short Description En":"<p>Pulmonary nodule management.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Licurse Score for Renal Ultrasound","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:25 PM","Medium Description En":"<p>Predicts probability of hydronephrosis on renal ultrasonography (RUS) requiring urologic intervention in adult patients with acute kidney injury.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,063","Short Title En":"Licurse Score","Cme Release Date":"","Slug":"licurse-score-renal-ultrasound","Short Description En":"<p>Hydronephrosis probability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Wexner Score for Obstructed Defecation Syndrome (ODS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:35 PM","Medium Description En":"<p><span id=\"docs-internal-guid-a8c5d2f9-abe5-b261-9620-1dfc86e57837\">Stratifies severity of fecal incontinence.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,064","Short Title En":"Wexner Score","Cme Release Date":"","Slug":"wexner-score-obstructed-defecation-syndrome-ods","Short Description En":"<p>Fecal incontinence severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Steinhart Model for Acute Heart Failure (AHF) in Undifferentiated Dyspnea","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:36 PM","Medium Description En":"<p><span id=\"docs-internal-guid-8bfbb402-adcc-b0d3-fa65-ca82efa2e5b2\">Diagnoses acute heart failure with NT-proBNP in undifferentiated dyspneic patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,065","Short Title En":"Steinhart Model for AHF","Cme Release Date":"","Slug":"steinhart-model-acute-heart-failure-ahf-undifferentiated-dyspnea","Short Description En":"<p>AHF diagnosis with NT-proBNP.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"DIPSS (Dynamic International Prognostic Scoring System) for Myelofibrosis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:41 PM","Medium Description En":"<p>Estimates survival in patients with primary myelofibrosis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,066","Short Title En":"DIPSS","Cme Release Date":"","Slug":"dipss-dynamic-international-prognostic-scoring-system-myelofibrosis","Short Description En":"<p>Primary myelofibrosis survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Canadian Cardiovascular Society (CCS) Angina Grade","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:54 PM","Medium Description En":"<p>Classifies severity of angina.<br><span id=\"docs-internal-guid-99576084-d7a0-844a-5ba4-6287575db490\"></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,067","Short Title En":"CCS Angina Grade","Cme Release Date":"","Slug":"canadian-cardiovascular-society-ccs-angina-grade","Short Description En":"<p>Angina severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 8:57 PM","Medium Description En":"<p>Diagnoses steatohepatitis, based on histology, in NAFLD patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients who have had liver biopsy for NAFLD.&nbsp;The score should not be used as a surrogate for NASH diagnosis (see&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079483/\" target=\"_blank\" data-saferedirecturl=\"https://www.google.com/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079483/&amp;source=gmail&amp;ust=1543344851892000&amp;usg=AFQjCNH_2CcQB5GkbqWP1ufrcE0Qm-XdZg\" rel=\"noopener\">Brunt and Kleiner 2011</a>&nbsp;for details).</p>","Before Use":"","Favorite ID":"10,068","Short Title En":"NAFLD Activity Score","Cme Release Date":"","Slug":"nafld-non-alcoholic-fatty-liver-disease-activity-score","Short Description En":"<p>Histologic diagnosis of steatohepatitis in NAFLD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Harvey-Bradshaw Index (HBI) for Crohn's Disease","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:02 PM","Medium Description En":"<p><span id=\"docs-internal-guid-7ecc3e57-d817-3aaa-f8ab-0ccbf78e28f5\">Stratifies severity of Crohn's disease.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,069","Short Title En":"Harvey-Bradshaw Index (HBI)","Cme Release Date":"","Slug":"harvey-bradshaw-index-hbi-crohns-disease","Short Description En":"<p>Crohn's disease severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:07 PM","Medium Description En":"<p><span id=\"docs-internal-guid-7b66b5af-facb-4f1a-50cb-ad20b021bca4\">Predicts survival in HCC patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,070","Short Title En":"ALBI Grade for HCC","Cme Release Date":"","Slug":"albi-albumin-bilirubin-grade-hepatocellular-carcinoma-hcc","Short Description En":"<p>HCC survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"REVEAL Registry Risk Score 2.0 for Pulmonary Arterial Hypertension (PAH)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:08 PM","Medium Description En":"<p>Predicts survival in patients with pulmonary arterial hypertension.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This score was updated to reflect new literature published in 2019 with subsequent validation in 2020. New and/or revised variables include hospitalizations in the last 6 months and eGFR/renal insufficiency. Other previously existing variables were also studied and modified as supported in literature. Please see references listed in&nbsp;<a href=\"#evidence\">Evidence</a> for further details.</p>","Favorite ID":"10,071","Short Title En":"REVEAL Score 2.0 for PAH","Cme Release Date":"","Slug":"reveal-registry-risk-score-pulmonary-arterial-hypertension-pah","Short Description En":"<p>PAH survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Geneva Risk Score for Venous Thromboembolism (VTE) Prophylaxis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:09 PM","Medium Description En":"<p><span id=\"docs-internal-guid-9f5bfad8-fc6b-2952-2485-ed38f1fa9670\">Predicts need for VTE prophylaxis in admitted patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: this score is different from the <calculator id=\"1750\">Geneva Score (Revised) for PE</calculator>, which <em>diagnoses</em> PE in patients presenting with relevant signs and symptoms.</p>","Before Use":"","Favorite ID":"10,073","Short Title En":"Geneva Score (VTE Prophylaxis)","Cme Release Date":"","Slug":"geneva-risk-score-venous-thromboembolism-vte-prophylaxis","Short Description En":"<p>Inpatient VTE prophylaxis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Stanford Sleepiness Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:09 PM","Medium Description En":"<p>Quantifies subjective degrees of sleepiness.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,074","Short Title En":"Stanford Sleepiness Scale","Cme Release Date":"","Slug":"stanford-sleepiness-scale","Short Description En":"<p>Quantifies sleepiness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ACEF II Risk Score for Cardiac Surgery","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:10 PM","Medium Description En":"<p><span id=\"docs-internal-guid-0a6719ae-0105-a4b7-0af5-0507b8d53096\">Predicts 30-day mortality after elective or emergency cardiac surgery.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,075","Short Title En":"ACEF II Risk Score","Cme Release Date":"","Slug":"acef-ii-risk-score-cardiac-surgery","Short Description En":"<p>Cardiac surgery mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ocular Surface Disease Index (OSDI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Diagnoses ocular surface damage in patients with dry eye.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,076","Short Title En":"OSDI","Cme Release Date":"","Slug":"ocular-surface-disease-index-osdi","Short Description En":"Ocular surface damage in dry eye."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+101","Full Title En":"Newsom Score for Non-traumatic Chest Pain","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:11 PM","Medium Description En":"<p><span id=\"docs-internal-guid-c8ad5943-1072-4605-48cd-f4617d2555d0\">Rules out need for chest x-ray in chest pain patients (non-traumatic).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+101","Cme Version":"10077.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-d446a735-1197-f353-bff0-4c3eb6aee57c\">Use in patients presenting to the emergency department for non-traumatic chest pain.</span></p>","Before Use":"","Favorite ID":"10,077","Short Title En":"Newsom Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"newsom-score-non-traumatic-chest-pain","Short Description En":"<p>Chest x-ray in non-traumatic chest pain.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+112","Full Title En":"Pediatric NEXUS II Head CT Decision Instrument for Blunt Trauma","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 28, 2023, 9:12 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5618b604-1081-30e8-1d62-363ecb1f3d62\">Predicts need for head CT after pediatric blunt head injury, similar to <calculator id=\"589\">PECARN</calculator>.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+112","Cme Version":"10078.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &lt;18 years old who have sustained blunt head trauma within the past 24 hours and in whom head CT is being considered.&nbsp;</p>\n<p>Note: We recommend using <calculator id=\"589\">PECARN</calculator> over other pediatric head trauma rules, as it is the most widely validated (see <a href=\"#next-steps\">Next Steps</a> for details).</p>","Before Use":"","Favorite ID":"10,078","Short Title En":"Peds NEXUS II Head CT Decision Instrument","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"pediatric-nexus-ii-head-ct-decision-instrument-blunt-trauma","Short Description En":"<p>Pediatric head trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+157","Full Title En":"Subtle Anterior STEMI Calculator (4-Variable)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 3:55 PM","Medium Description En":"<p><span id=\"docs-internal-guid-1ac8c104-7fff-d196-916e-85ff28dd4eea\">Differentiates normal variant ST elevation (benign early repolarization) from anterior STEMI, more sensitive than 3-variable version.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+157","Cme Version":"10079.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: this calculator replaces the older 3-variable version and is recommended by MDCalc and Dr. Stephen Smith. Before using this calculator, make sure the EKG shows &ge;1 mm ST elevation (STE)&nbsp;in&nbsp;&ge;1 of the precordial leads V2-V4. If it shows any one of the following, then it is NOT normal variant, and is very likely to be LAD occlusion; such cases were excluded from the study as \"obvious\" MI:</p>\n<ul>\n<li>&gt;5 mm STE.</li>\n<li>Non-concave STE.</li>\n<li>Inferior reciprocal changes.</li>\n<li>Anterior ST depression.</li>\n<li>Terminal QRS distortion in V2 or V3:</li>\n<li style=\"list-style-type: none;\"><img src=\"https://cdn-web-img.mdcalc.com/content/subtle-stemi-qrs.png\" alt=\"\" width=\"50%\"></li>\n<li>Q waves in any of V2 to V4.</li>\n<li>Any T wave inversion from V2 to V6.</li>\n</ul>","Before Use":"","Favorite ID":"10,079","Short Title En":"Subtle Anterior STEMI (4-Variable)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"subtle-anterior-stemi-calculator-4-variable","Short Description En":"<p>Normal variant ST elevation vs true anterior STEMI.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+69","Full Title En":"Hydroxychloroquine (Plaquenil) Dosing Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 29, 2023, 4:01 PM","Medium Description En":"<p>Calculates maximum daily dose of hydroxychloroquine to reduce of retinopathy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+69","Cme Version":"10080.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator is for double-checking hydroxychloroquine dosing, and should NOT be used as the primary means for ordering.</p>","Before Use":"<ul>\n<li>Note: Neither hydroxychloroquine NOR chloroquine are FDA approved to treat COVID-19. No drugs are FDA approved to treat COVID-19 (<a href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\" target=\"_blank\" rel=\"noopener\">Coronavirus Disease 2019</a>).</li>\n<li>Short term Plaquenil has none/minimal risk for retinopathy. See the <a href=\"https://www.ajo.com/article/S0002-9394(20)30132-X/pdf\" target=\"_blank\" rel=\"noopener\">American Journal of Ophthalmology</a> for more information.</li>\n</ul>","Favorite ID":"10,080","Short Title En":"Hydroxychloroquine (Plaquenil) Dosing","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"hydroxychloroquine-plaquenil-dosing-calculator","Short Description En":"<p>Doses hydroxychloroquine, to reduce retinopathy risk.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+107","Full Title En":"Paradise Criteria for Tonsillectomy in Children","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:02 PM","Medium Description En":"<p><span id=\"docs-internal-guid-8ede9652-7fff-aedc-e364-d179f66de8f5\">Predicts which patients with recurring sore throat will benefit from tonsillectomy.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+107","Cme Version":"10081.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-0d69f7ea-7fff-e92b-5678-16587ef31bf4\">Use only in patients aged 1-18 years in whom tonsillectomy is being considered. Do not use in children with diabetes mellitus, cardiopulmonary disease, craniofacial disorders, congenital anomalies of the head/neck, sickle cell disease or other coagulopathies, or immunodeficiency disorders.</span></p>","Before Use":"","Favorite ID":"10,081","Short Title En":"Paradise Criteria","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"paradise-criteria-tonsillectomy-children","Short Description En":"<p>Tonsillectomy patient selection.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"WPSS (WHO classification-based Prognostic Scoring System) for Myelodysplastic Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Evaluates prognosis of patients with myelodysplastic syndrome (MDS).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,082","Short Title En":"WPSS","Cme Release Date":"","Slug":"wpss-classification-based-prognostic-scoring-system-myelodysplastic-syndrome","Short Description En":"MDS survival."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"National Early Warning Score (NEWS) 2","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:14 PM","Medium Description En":"<p><span id=\"docs-internal-guid-96e58532-7fff-12a6-749e-93d26dfa7e62\">Determines the degree of illness of a patient and prompts critical care intervention (recommended by NHS over original NEWS).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Recommended by the <abbr title=\"National Health Service\" style=\"color: #ffb600;\">NHS</abbr> (UK) over the original <calculator id=\"1873\">NEWS</calculator>.&nbsp;</p>","Before Use":"<p><strong>Tips for COVID-19:</strong>&nbsp;Use for Crisis Standards of Care.&nbsp;Used for subgroup analyses (not for Crises Standards of Care) in <a href=\"https://www.nejm.org/doi/pdf/10.1056/NEJMoa2001282?articleTools=true\" target=\"_blank\" rel=\"noopener\">Cao et al (2020) NEJM&rsquo;s Lopinavir-Ritonavir study in COVID-19</a>.</p>","Favorite ID":"10,083","Short Title En":"NEWS2 Score","Cme Release Date":"","Slug":"national-early-warning-score-news-2","Short Description En":"<p>Severity screening of declining conditions, recommended over original NEWS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RegiSCAR Score for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span id=\"docs-internal-guid-05809cb0-7fff-2e44-828a-9b140e1bf474\">Diagnoses drug reaction with eosinophilia and systemic symptoms (DRESS).</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,084","Short Title En":"RegiSCAR for DRESS","Cme Release Date":"","Slug":"regiscar-score-drug-reaction-eosinophilia-systemic-symptoms-dress","Short Description En":"DRESS diagnosis."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Subaxial Injury Classification and Severity Scale (SLICS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:03 PM","Medium Description En":"<p>Classifies subaxial cervical spine injury and provides treatment recommendations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>May be used with x-ray or MRI.</p>","Before Use":"","Favorite ID":"10,085","Short Title En":"SLICS","Cme Release Date":"","Slug":"subaxial-injury-classification-severity-scale-slics","Short Description En":"<p>Cervical spine injury.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+22","Full Title En":"BARD Score for NAFLD Fibrosis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:04 PM","Medium Description En":"<p>Predicts risk of advanced fibrosis in NAFLD patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+22","Cme Version":"10086.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,086","Short Title En":"BARD Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"bard-score-nafld-fibrosis","Short Description En":"<p>Advanced fibrosis risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Mehran Score for Post-PCI Contrast Nephropathy","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:05 PM","Medium Description En":"<p>Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).<br><span id=\"docs-internal-guid-767a1d30-7fff-4d48-18b5-97f127910188\"></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use variables at the time of&nbsp;PCI.</p>","Before Use":"","Favorite ID":"10,087","Short Title En":"Mehran Score (Post-PCI Nephropathy)","Cme Release Date":"","Slug":"mehran-score-post-pci-contrast-nephropathy","Short Description En":"<p>Renal failure after cath.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Cumulative Illness Rating Scale-Geriatric (CIRS-G)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:06 PM","Medium Description En":"<p><span id=\"docs-internal-guid-fc8092d6-7fff-6179-246b-2a4068cd2484\">Quantifies burden of disease in elderly patients (comorbidity scale).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,088","Short Title En":"CIRS-G","Cme Release Date":"","Slug":"cumulative-illness-rating-scale-geriatric-cirs-g","Short Description En":"<p>Geriatric comorbidity scale.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HScore for Reactive Hemophagocytic Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:54 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5e66a879-7fff-dee3-17d2-41b1a7e6eabd\">Diagnoses reactive hemophagocytic syndrome. </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Tips for COVID-19:</strong> Screens for cytokine storm (<a href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30628-0/fulltext\" target=\"_blank\" rel=\"noopener\">including in COVID-19</a>), when immunosuppression <em>may</em> be helpful (immunosuppression not yet shown to be beneficial).</p>","Favorite ID":"10,089","Short Title En":"HScore","Cme Release Date":"","Slug":"hscore-reactive-hemophagocytic-syndrome","Short Description En":"<p>Hemophagocytic syndrome diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"AWOL Score for Delirium","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:54 PM","Medium Description En":"<p><span id=\"docs-internal-guid-6295b8ee-7fff-a9b0-cf80-f52c39cf4f03\">Predicts risk of delirium during hospitalization.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,090","Short Title En":"AWOL Score for Delirium","Cme Release Date":"","Slug":"awol-score-delirium","Short Description En":"<p>Delirium risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-11 00:00:00+00+00","Full Title En":"Benzodiazepine Conversion Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"September 29, 2023, 4:56 PM","Medium Description En":"<p><span id=\"docs-internal-guid-1521c044-7fff-0fa2-49b4-3b1ade6b71ff\">Provides equivalents between different benzodiazepines.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-11 00:00:00+00+00","Cme Version":"10091.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-45731312-7fff-8938-f5c5-429acbe2d8fe\">Do not use to calculate initial dose for a benzo-na&iuml;ve patient.</span></p>","Before Use":"<p><span id=\"docs-internal-guid-261967d6-7fff-5786-91e0-dbef6f66fee3\">This calculator should be used as a reference for oral benzodiazepine conversions. Equipotent benzodiazepine doses are reported as ranges due to paucity of literature supporting exact conversions, thus reported ranges are based on expert opinion and clinical experience published in psychiatric literature.</span></p>","Favorite ID":"10,091","Short Title En":"Benzodiazepine Conversion Calculator","Cme Release Date":"2022-10-14 00:00:00+00+00","Slug":"benzodiazepine-conversion-calculator","Short Description En":"<p>Benzodiazepine conversion.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 4:57 PM","Medium Description En":"<p><span id=\"docs-internal-guid-39fe9749-7fff-380b-a5a4-cde2cd3047c4\">Diagnoses rheumatoid arthritis (RA) in patients with undifferentiated inflammatory synovitis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients who have at least one swollen joint and no better explanation for synovitis.</p>","Before Use":"","Favorite ID":"10,092","Short Title En":"ACR/EULAR Criteria for Rheumatoid Arthritis","Cme Release Date":"","Slug":"acr-eular-2010-rheumatoid-arthritis-classification-criteria","Short Description En":"<p>RA diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Student Loan Repayment Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>MDCalc and First Republic have teamed up to offer the best available interest rates for student loan repayment for medical professionals.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: student loan interest deduction&nbsp;not valid at the attending physician level.</p>","Before Use":"","Favorite ID":"10,093","Short Title En":"Student Loan Repayment Calculator","Cme Release Date":"","Slug":"student-loan-repayment-calculator","Short Description En":"Monthly payments and total loan cost."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"GALAD Model for Hepatocellular Carcinoma (HCC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 5:00 PM","Medium Description En":"<p>Diagnoses HCC based on serum biomarkers in patients with chronic liver disease (CLD).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,094","Short Title En":"GALAD Model for HCC","Cme Release Date":"","Slug":"galad-model-hepatocellular-carcinoma-hcc","Short Description En":"<p>HCC diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+30","Full Title En":"Cardiac Output (Fick’s Formula)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:42 PM","Medium Description En":"<p><span id=\"docs-internal-guid-3f0c999e-7fff-31e1-ff17-3397e9d34a8a\">Calculates cardiac output, cardiac index, and stroke volume.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+30","Cme Version":"10095.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,095","Short Title En":"Fick Cardiac Output","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"cardiac-output-ficks-formula","Short Description En":"<p>Calculates CO, CI, and SV.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"PROMISE Score for Malignant Pleural Effusion","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 8:32 PM","Medium Description En":"<p>Predicts 3-month mortality in patients with malignant pleural effusion.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10096.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,096","Short Title En":"PROMISE Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"promise-score-malignant-pleural-effusion","Short Description En":"<p>Malignant pleural effusion mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Preoperative Mortality Predictor (PMP) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 8:42 PM","Medium Description En":"<p><span id=\"docs-internal-guid-0c8bc11d-7fff-e00b-82f7-d0a4ab8ce57c\">Predicts risk of perioperative mortality in general surgery patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,097","Short Title En":"Preoperative Mortality Predictor Score","Cme Release Date":"","Slug":"preoperative-mortality-predictor-pmp-score","Short Description En":"<p>Perioperative mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Danger Assessment Tool for Domestic Abuse","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 8:46 PM","Medium Description En":"<p><span id=\"docs-internal-guid-a809cd4f-7fff-e854-86e1-70756f8860e5\">Predicts risk of death by an intimate partner (IP) in a violent intimate relationship.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,098","Short Title En":"Danger Assessment Tool","Cme Release Date":"","Slug":"danger-assessment-tool-domestic-abuse","Short Description En":"<p>Death by intimate partner violence.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 8:47 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5b29693b-7fff-ae97-1934-3901058ce457\">Stratifies severity of systemic lupus erythematosus (SLE).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,099","Short Title En":"SLEDAI-2K for Lupus","Cme Release Date":"","Slug":"systemic-lupus-erythematosus-disease-activity-index-2000-sledai-2k","Short Description En":"<p>SLE severity.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Indian Takayasu Clinical Activity Score (ITAS2010)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 29, 2023, 8:48 PM","Medium Description En":"<p>Differentiates between active and inactive disease in Takayasu arteritis (TA).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Select feature only if abnormality is present and new within the past 3 months AND ascribed to current active vasculitis.</p>","Before Use":"","Favorite ID":"10,100","Short Title En":"ITAS2010 for Takayasu Arteritis","Cme Release Date":"","Slug":"indian-takayasu-clinical-activity-score-itas2010","Short Description En":"<p>Takayasu arteritis disease activity.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Breast Cancer (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages breast cancer based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,101","Short Title En":"TNM Breast CA Staging (8th Ed.)","Cme Release Date":"","Slug":"tnm-staging-breast-cancer-8th-edition","Short Description En":"Breast CA staging, recommended as of 2017."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+121","Full Title En":"Prediction of Alcohol Withdrawal Severity Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 2:53 PM","Medium Description En":"<p><span id=\"docs-internal-guid-74617a21-7fff-24c8-17dc-bdc1b553129d\">Screens hospitalized patients for complicated alcohol withdrawal (seizures, delirium tremens).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+121","Cme Version":"10102.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-9d7b5348-7fff-cfa4-a57e-246ce0ea9419\">Use in patients &ge;18 years old admitted to general floor, with or without history of alcohol abuse. Do not use in patients with active or uncontrolled seizure disorder. </span></p>","Before Use":"","Favorite ID":"10,102","Short Title En":"PAWSS","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"prediction-alcohol-withdrawal-severity-scale","Short Description En":"<p>Complicated alcohol withdrawal in inpatients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Risk of Malignancy Index (RMI) for Ovarian Cancer","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 2:54 PM","Medium Description En":"<p><span id=\"docs-internal-guid-6c46abb9-7fff-b288-6cd7-64e98b2b7514\">Predicts risk that an adnexal mass is malignant.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,103","Short Title En":"RMI for Ovarian Cancer","Cme Release Date":"","Slug":"risk-malignancy-index-rmi-ovarian-cancer","Short Description En":"<p>Ovarian cancer risk for adnexal mass.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Apfel Score for Postoperative Nausea and Vomiting","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 2:56 PM","Medium Description En":"<p><span id=\"docs-internal-guid-d5a689a2-7fff-106e-bd7e-717e4a440167\">Predicts risk of postoperative nausea and vomiting (PONV).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,104","Short Title En":"Apfel Score","Cme Release Date":"","Slug":"apfel-score-postoperative-nausea-vomiting","Short Description En":"<p>Postoperative nausea and vomiting.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"H2FPEF Score for Heart Failure with Preserved Ejection Fraction","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 3:04 PM","Medium Description En":"<p>Estimates probability of underlying heart failure in patients with preserved ejection fraction on echo.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,105","Short Title En":"H2FPEF Score","Cme Release Date":"","Slug":"h2fpef-score-for-heart-failure-with-preserved-ejection-fraction","Short Description En":"<p>Heart failure diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"FIGO Staging for Ovarian Cancer (2014)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 3:06 PM","Medium Description En":"<p><span id=\"docs-internal-guid-a838d9f6-7fff-a3cd-3b55-f3aa70899bd0\">Stages cancer of the ovary, fallopian tube, and peritoneum.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,108","Short Title En":"FIGO Staging for Ovarian Cancer","Cme Release Date":"","Slug":"figo-staging-ovarian-cancer-2014","Short Description En":"<p>Ovarian CA staging.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+154","Full Title En":"STONE Score for Uncomplicated Ureteral Stone","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 4:24 PM","Medium Description En":"<p><span id=\"docs-internal-guid-5c0cc5ab-7fff-7e67-9253-7b3753614f59\">Predicts likelihood of ureteral stone in nontoxic-appearing patients with flank pain.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+154","Cme Version":"10110.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-13f26b40-7fff-ee3c-b2f7-fce7239ce7a3\">Use in patients with suspected kidney stones and normal renal function. Do not use in patients with fever or other signs of infection, recent trauma or urologic surgery, or active malignancy. </span></p>","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same other inputs, this calculator estimates lower risk of ureteral stone for Black patients.</p>","Favorite ID":"10,110","Short Title En":"STONE Score (Pre-Ultrasound, Ureteral)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"stone-score-uncomplicated-ureteral-stone","Short Description En":"<p>Predicts ureteral stones, before ultrasound.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+126","Full Title En":"Radiation Biologically Effective Dose (BED) Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 12, 2023, 4:39 PM","Medium Description En":"<p>Calculates biologically effective dose (BED) and equivalent dose (EQD2) for cancer radiotherapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+126","Cme Version":"10111.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,111","Short Title En":"Radiation BED Calculator","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"radiation-biologically-effective-dose-bed-calculator","Short Description En":"<p>BED and EQD<sub>2</sub> for radiation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"TNM Staging for Melanoma (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span id=\"docs-internal-guid-172843ca-7fff-375c-9358-b31cb0c389a5\">Stages melanoma based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10113.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,113","Short Title En":"TNM Melanoma Staging (8th Ed.)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"tnm-staging-melanoma-8th-edition","Short Description En":"Melanoma staging, recommended as of 2017."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Hepatocellular Carcinoma (HCC) (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages HCC based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,116","Short Title En":"TNM HCC Staging (8th Ed.)","Cme Release Date":"","Slug":"tnm-staging-hepatocellular-carcinoma-hcc-8th-edition","Short Description En":"HCC staging, recommended as of 2017."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"TNM Staging for Renal Cell Carcinoma (RCC) (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages RCC based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10122.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-f5db3f6d-7fff-f9f6-f978-c19616365bca\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Should be used to classify all RCC patients at the time of diagnosis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The TNM staging is evaluated at diagnosis and is unchanged with disease progression or development of metastasis (TNM stage at diagnosis remains the one).</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,122","Short Title En":"TNM RCC Staging (8th Ed.)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"tnm-staging-renal-cell-carcinoma-rcc-8th-edition","Short Description En":"RCC staging, recommended as of 2017."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Short Opiate Withdrawal Scale (SOWS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p><span id=\"docs-internal-guid-1bac2854-7fff-f527-9e59-4b046cae1375\">Quantifies symptoms of opiate withdrawal.</span></p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: the Short Opiate Withdrawal Scale is the rounded average of the selected points.<br /><span id=\"docs-internal-guid-736d38cf-7fff-55ed-3022-02fe099e0ae3\"></span></p>","Before Use":"","Favorite ID":"10,124","Short Title En":"Short Opiate Withdrawal Scale (SOWS)","Cme Release Date":"","Slug":"short-opiate-withdrawal-scale-sows","Short Description En":"Opiate withdrawal."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Villalta Score for Post-thrombotic Syndrome (PTS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:40 PM","Medium Description En":"<p>Stratifies severity of post-thrombotic syndrome in lower extremity DVT.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10125.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with lower extremity DVT. Note: all symptoms and signs refer to the affected leg.</p>","Before Use":"","Favorite ID":"10,125","Short Title En":"Villalta Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"villalta-score-post-thrombotic-syndrome-pts","Short Description En":"<p>Post-thrombotic syndrome severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+158","Full Title En":"Thoracolumbar Injury Classification and Severity Scale (TLICS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:41 PM","Medium Description En":"<p><span id=\"docs-internal-guid-e9d9f907-7fff-9d89-ee7b-5b0959af3944\">Classifies thoracolumbar spine injury and provides treatment recommendations.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+158","Cme Version":"10126.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-c4af0d47-7fff-94de-1cfb-e3592aa44589\">Requires appropriate imaging (at least CT) to determine posterior instability for accurate interpretation.</span></p>","Before Use":"","Favorite ID":"10,126","Short Title En":"TLICS","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"thoracolumbar-injury-classification-severity-scale-tlics","Short Description En":"<p>Thoracolumbar trauma.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Patient Activity Scale (PAS) for RA","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:43 PM","Medium Description En":"<p><span id=\"docs-internal-guid-00e5b5d4-7fff-c018-0d94-ede9c48cf7db\">Quantifies severity of rheumatoid arthritis (RA) using patient-reported symptoms.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: the <calculator id=\"10128\">PAS II</calculator> is an alternative to the PAS. PAS II uses a slightly different questionnaire with fewer questions than the original PAS, though the overall accuracy of the two is the same.</p>","Before Use":"","Favorite ID":"10,127","Short Title En":"Patient Activity Scale for RA","Cme Release Date":"","Slug":"patient-activity-scale-pas-ra","Short Description En":"<p>RA severity, more extensive than PAS II.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Patient Activity Scale II (PAS II) for RA","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:44 PM","Medium Description En":"<p><span id=\"docs-internal-guid-9e1d7a17-7fff-d33c-586e-bd51d57d6edd\">Quantifies severity of rheumatoid arthritis (RA) and has fewer questions than PAS.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: the PAS II is an alternative to the <calculator id=\"10127\">PAS</calculator>. PAS II uses a slightly different questionnaire with fewer questions than the original PAS, though the overall accuracy of the two is the same.</p>","Before Use":"","Favorite ID":"10,128","Short Title En":"Patient Activity Scale II for RA","Cme Release Date":"","Slug":"patient-activity-scale-ii-pas-ii-ra","Short Description En":"<p>RA severity, less extensive than PAS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+95","Full Title En":"Mumtaz Score for Readmission in Cirrhosis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:45 PM","Medium Description En":"<p><span id=\"docs-internal-guid-bd1794d2-7fff-383e-f553-e983c37d20a3\">Predicts 30-day readmission risk in patients with cirrhosis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+95","Cme Version":"10129.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-346e60d8-7fff-d8bd-4f47-2f4fc3ebaaa5\">Use in patients &gt;18 years old with decompensated cirrhosis at the time of discharge. Do not use in patients on mechanical ventilation, under palliative care consult, status post liver transplant, or admitted electively for any reason. Use variables from the index admission.</span></p>","Before Use":"","Favorite ID":"10,129","Short Title En":"Mumtaz Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"mumtaz-score-readmission-cirrhosis","Short Description En":"<p>30-day readmission in cirrhosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+161","Full Title En":"Tokyo Guidelines for Acute Cholecystitis 2018","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:47 PM","Medium Description En":"<p><span id=\"docs-internal-guid-21529dff-7fff-2c70-b4de-fd0bd3116dfb\">Provides diagnostic criteria and severity grading for acute cholecystitis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+161","Cme Version":"10130.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,130","Short Title En":"Tokyo Cholecystitis Guidelines","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"tokyo-guidelines-acute-cholecystitis-2018","Short Description En":"<p>Acute cholecystitis diagnosis and grading.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ABIC Score for Alcoholic Hepatitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:49 PM","Medium Description En":"<p><span id=\"docs-internal-guid-e1968915-7fff-03d6-f4bf-834aed92e040\">Predicts survival in alcoholic hepatitis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,136","Short Title En":"ABIC Score for Alcoholic Hepatitis","Cme Release Date":"","Slug":"abic-score-alcoholic-hepatitis","Short Description En":"<p>Alcohol hepatitis survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+09","Full Title En":"Age-Adjusted D-dimer for Venous Thromboembolism (VTE)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"September 27, 2023, 4:20 PM","Medium Description En":"<p>Adjusts D-dimer cutoffs by age to help rule out VTE.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+09","Cme Version":"10138.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-934a19d4-7fff-05d8-56fe-f3f206cbe79f\">Use in patients &ge;50 years old presenting to emergency department as outpatients and are being worked up for PE&nbsp;with low to intermediate pretest probability. Do not use in high-risk patients (i.e., those who would proceed to imaging regardless of D-dimer result).</span></p>","Before Use":"","Favorite ID":"10,138","Short Title En":"Age-Adjusted D-dimer","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"age-adjusted-d-dimer-venous-thromboembolism-vte","Short Description En":"<p>Rules out VTE.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ganzoni Equation for Iron Deficiency Anemia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 8:02 PM","Medium Description En":"<p><span id=\"docs-internal-guid-8c673c1e-7fff-54e7-8f71-7d00f961d8c1\">Calculates iron deficit for dosing iron.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,139","Short Title En":"Ganzoni Equation for Anemia","Cme Release Date":"","Slug":"ganzoni-equation-iron-deficiency-anemia","Short Description En":"<p>Iron deficit calculation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"GCS-Pupils Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:51 PM","Medium Description En":"<p><span id=\"docs-internal-guid-32be6d1a-7fff-8624-2674-b4aa6d99fae0\">Combines GCS and pupil reactivity for greater accuracy at low GCS.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,140","Short Title En":"GCS-Pupils Score","Cme Release Date":"","Slug":"gcs-pupils-score","Short Description En":"<p>GCS incorporating pupil reactivity.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+160","Full Title En":"Tokyo Guidelines for Acute Cholangitis 2018","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2023, 6:52 PM","Medium Description En":"<p><span id=\"docs-internal-guid-26e43dfa-7fff-9bf1-7415-52f2f4915433\">Provides diagnostic criteria and severity grading for acute cholangitis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+160","Cme Version":"10142.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,142","Short Title En":"Tokyo Cholangitis Guidelines","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"tokyo-guidelines-acute-cholangitis-2018","Short Description En":"<p>Acute cholangitis diagnosis and grading.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+131","Full Title En":"RESP (Respiratory ECMO Survival Prediction) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:17 PM","Medium Description En":"<p><span id=\"docs-internal-guid-ca5dfaee-7fff-b07d-b418-c7e94d0de3bd\">Predicts in-hospital survival in adult patients after ECMO for acute respiratory failure.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+131","Cme Version":"10143.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Tips for COVID-19:</strong> Use to determine ECMO. Predicts chances of mortality after on ECMO, performing better in validations than PRESET Score. Maybe helpful as one of many factors in Crisis Standards of Care decisions.&nbsp;See <a href=\"https://www.mdcalc.com/covid-19/calculators-extreme-resource-limited-situations\" target=\"_blank\" rel=\"noopener\">MDCalc Review: Calcs for Resource Limited Situations</a>.</p>","Favorite ID":"10,143","Short Title En":"RESP Score for ECMO","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"resp-respiratory-ecmo-survival-prediction-score","Short Description En":"<p>Survival after VA/VV ECMO for acute respiratory failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"SAVE (Survival after Veno-Arterial ECMO) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:22 PM","Medium Description En":"<p><span id=\"docs-internal-guid-51426a60-7fff-1044-4feb-dfab6ce3b8c7\">Predicts in-hospital survival in adult patients after VA ECMO for refractory cardiogenic shock.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10144.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,144","Short Title En":"SAVE Score for ECMO","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"save-survival-veno-arterial-ecmo-score","Short Description En":"<p>Survival after VA ECMO for cardiogenic shock.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Rapid Emergency Medicine Score (REMS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:23 PM","Medium Description En":"<p>Predicts in-hospital mortality in nonsurgical adult patients presenting to the ED.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10145.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,145","Short Title En":"REMS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"rapid-emergency-medicine-score-rems","Short Description En":"<p>In-hospital mortality in emergency patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+164","Full Title En":"United Kingdom Model for End-Stage Liver Disease (UKELD)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:24 PM","Medium Description En":"<p><span id=\"docs-internal-guid-7fa48a2e-7fff-3c63-a00c-173198f773df\">Predicts mortality in end-stage liver disease patients for transplant planning (UK-specific).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+164","Cme Version":"10147.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-c25984ba-7fff-90a6-3d2b-ce4b0645595b\">Use in context of national liver transplantation guidelines. In the UK, refer to <a href=\"https://www.odt.nhs.uk/transplantation/tools-policies-and-guidance/policies-and-guidance/\" target=\"_blank\" rel=\"noopener\">NHS Blood and Transplant policy</a>.</span></p>","Before Use":"","Favorite ID":"10,147","Short Title En":"UKELD Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"united-kingdom-model-end-stage-liver-disease-ukeld","Short Description En":"<p>Mortality for liver transplant planning (UK).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"READMITS Score for Readmissions in Acute MI","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:24 PM","Medium Description En":"<p><span id=\"docs-internal-guid-592df9fd-7fff-9813-7998-f668eacfb225\">Predicts 30-day readmission risk in patients admitted for ST-elevation myocardial infarction (not externally validated).</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10148.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><span id=\"docs-internal-guid-82429f7f-7fff-d313-5065-a6989db4e8d5\">This calculator is not externally validated, and as such, should be used with caution.</span></p>","Favorite ID":"10,148","Short Title En":"Acute MI READMITS Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"readmits-score-readmissions-acute-mi","Short Description En":"<p>30-day readmission risk after STEMI (not externally validated).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"El-Ganzouri Risk Index (EGRI) for Difficult Airway","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:34 PM","Medium Description En":"<p><span id=\"docs-internal-guid-ed16a30a-7fff-568f-5e52-31d871151cad\">Predicts risk of difficult airway.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,149","Short Title En":"El-Ganzouri Risk Index (EGRI)","Cme Release Date":"","Slug":"el-ganzouri-risk-index-egri-difficult-airway","Short Description En":"<p>Difficult airway risk.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"NINCDS-ADRDA Criteria for Alzheimer’s Disease","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 4:36 PM","Medium Description En":"<p><span id=\"docs-internal-guid-f68fd2fc-7fff-ddc3-39b9-700e431cf91d\">Diagnoses Alzheimer's disease (AD), alternative to <calculator id=\"10154\">IWG-2 Criteria</calculator>.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,151","Short Title En":"NINCDS-ADRDA Criteria for Alzheimer’s","Cme Release Date":"","Slug":"nincds-adrda-criteria-alzheimers-disease","Short Description En":"<p>Alzheimer's diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"DSM-5 Criteria for Binge Eating Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 5:13 PM","Medium Description En":"<p>Diagnostic criteria for binge eating disorder (BED).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,153","Short Title En":"DSM-5 Criteria for Binge Eating Disorder","Cme Release Date":"","Slug":"dsmv-diagnostic-criteria-for-binge-eating-disorder","Short Description En":"<p>Diagnosis of BED.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"International Working Group (IWG) 2 Criteria for Alzheimer's Disease Diagnosis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 5:25 PM","Medium Description En":"<p><span id=\"docs-internal-guid-19dc0de2-7fff-dbdb-ee73-f372c63b7840\">Diagnoses Alzheimer's disease (AD), newer than <calculator id=\"10151\">NINCDS-ADRDA Criteria</calculator>.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,154","Short Title En":"IWG 2 Criteria for Alzheimer's","Cme Release Date":"","Slug":"international-working-group-iwg-2-criteria-alzheimers-disease-diagnosis","Short Description En":"<p>Alzheimer's diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Clinical Dementia Rating (CDR) Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 5:26 PM","Medium Description En":"<p><span id=\"docs-internal-guid-0111ea9a-7fff-267c-6db6-b21d2e11c282\">Stages dementia, including Alzheimer's, in elderly patients.</span></p>","Logic Language":"javascript","Published At":"January 5, 2023, 10:17 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,160","Short Title En":"Clinical Dementia Rating (CDR) Scale","Cme Release Date":"","Slug":"clinical-dementia-rating-cdr-scale","Short Description En":"<p>Dementia staging.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+128","Full Title En":"RAPID Score for Acetabular Chondrolabral Disruption","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 5:34 PM","Medium Description En":"<p><span id=\"docs-internal-guid-120976bc-7fff-0a83-bb8b-bc71cc2fe41e\">Predicts probability of finding high-grade hip cartilage damage intraoperatively.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+128","Cme Version":"10163.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients with high-grade degenerative changes and obliteration of the joint space (T&ouml;nnis grade 3).</p>","Before Use":"","Favorite ID":"10,163","Short Title En":"RAPID Score (Hip)","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rapid-score-acetabular-chondrolabral-disruption","Short Description En":"<p>High-grade hip cartilage damage.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+26","Full Title En":"Brain Metastasis Velocity (BMV) Model","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:13 PM","Medium Description En":"<p>Calculates rate of distant brain failure after stereotactic radiosurgery for brain metastasis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+26","Cme Version":"10164.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,164","Short Title En":"Brain Metastasis Velocity (BMV) Model","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"brain-metastasis-velocity-bmv-model","Short Description En":"<p>Distant brain failure after SRS for brain metastasis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"History and Electrocardiogram-only Manchester Acute Coronary Syndromes (HE-MACS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:14 PM","Medium Description En":"<p>Stratifies ACS risk with history and EKG only (not yet externally validated).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10165.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old presenting with suspected cardiac chest pain (symptoms within the last 24 hours).</p>","Before Use":"","Favorite ID":"10,165","Short Title En":"HE-MACS","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"history-electrocardiogram-manchester-acute-coronary-syndromes-macs","Short Description En":"<p>Stratifies ACS risk (history and EKG, not externally validated).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:17 PM","Medium Description En":"<p>Stratifies severity of amyotrophic lateral sclerosis (ALS), including respiratory function.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10166.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,166","Short Title En":"ALSFRS-R for Amyotrophic Lateral Sclerosis","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"revised-amyotrophic-lateral-sclerosis-functional-rating-scale-alsfrs-r","Short Description En":"<p>ALS severity and mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hour-Specific Risk for Neonatal Hyperbilirubinemia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:19 PM","Medium Description En":"<p>Predicts risk of hyperbilirubinemia in neonates.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>Use in otherwise healthy neonates &ge;35 weeks gestational age (GA) at the time of discharge. Do not use in neonates with positive direct Coombs test, or in those requiring phototherapy before 60 hours of age. Do not use to determine need for exchange transfusion.</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The recommendations listed here for starting phototherapy are based on <a href=\"https://pediatrics.aappublications.org/content/114/1/297\" target=\"_blank\" rel=\"noopener\">AAP guidelines</a>. Always use clinical judgment, in addition to considering evidence-based clinical guidelines, in making treatment decisions.&nbsp;</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,167","Short Title En":"Neonatal Hyperbilirubinemia Risk","Cme Release Date":"","Slug":"hour-specific-risk-neonatal-hyperbilirubinemia","Short Description En":"<p>Neonatal hyperbilirubinemia risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+170","Full Title En":"Withdrawal Assessment Tool (WAT-1) for Pediatric Withdrawal","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:22 PM","Medium Description En":"<p>Estimates severity of opioid and benzodiazepine withdrawal in children.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+170","Cme Version":"10168.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,168","Short Title En":"WAT-1 for Peds Withdrawal","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"withdrawal-assessment-tool-wat-1-pediatric-withdrawal","Short Description En":"<p>Pediatric opioid and benzodiazepine withdrawal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-11 00:00:00+00+00","Full Title En":"Columbia Suicide Severity Rating Scale (C-SSRS Screener)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:23 PM","Medium Description En":"<p><span id=\"docs-internal-guid-019132b0-7fff-73e8-12e1-5708394899de\">Screens for suicidal ideation and behavior.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-11 00:00:00+00+00","Cme Version":"10169.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note there are several versions of the C-SSRS; this is the screener version, which is a truncated version of the full scale intended for emergency settings.</p>","Before Use":"","Favorite ID":"10,169","Short Title En":"Columbia Suicide Severity Rating Scale Screener","Cme Release Date":"2022-10-14 00:00:00+00+00","Slug":"columbia-suicide-severity-rating-scale-c-ssrs","Short Description En":"<p>Suicidal ideation and behavior.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Morphine Milligram Equivalents (MME) Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"August 25, 2023, 4:24 PM","Medium Description En":"<p>Calculates total daily morphine milligram equivalents.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10170.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: This is for converting oral opioids only, and should not be used for IV to oral conversions.&nbsp;</p>\n<p>For combination drugs (e.g. Percocet = acetaminophen + oxyCODONE), enter only the dose of the opioid component (e.g. if 5 mg/325 mg, enter \"5\"). Do not use in pediatric patients, due to unpredictable rates of absorption and risk of overdose.</p>\n<p>As a partial opioid agonist, buprenorphine is not expected to be associated with overdose risk in the same dose-dependent manner as doses for full agonist opioids and is therefore omitted from the calculator.</p>","Before Use":"<p><span id=\"docs-internal-guid-b79c5c2e-7fff-66fc-662a-5b733597712d\">There is no completely safe opioid dose, and this calculator does not substitute for clinical judgment. Use caution when prescribing opioids at any dosage, and prescribe the lowest effective dose.</span></p>\n<p><span>Conversions are based on the <a href=\"https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm\" target=\"_blank\" rel=\"noopener\">CDC Clinical Practice Guideline for Prescribing Opioids for Pain &mdash; United States, 2022</a>.</span></p>","Favorite ID":"10,170","Short Title En":"Morphine Milligram Equivalents","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"morphine-milligram-equivalents-mme-calculator","Short Description En":"<p>Calculates MME.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+45","Full Title En":"ED-SAFE Patient Safety Screener 3 (PSS-3)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:26 PM","Medium Description En":"<p>Screens for suicidality in emergency patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+45","Cme Version":"10171.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-96d8625a-7fff-0a06-3422-75e6a6da9953\">Use as an initial quick screen for suicide risk.</span></p>","Before Use":"","Favorite ID":"10,171","Short Title En":"ED-SAFE PSS-3","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"patient-safety-screener-3-pss-3","Short Description En":"<p>Suicidality screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+35","Full Title En":"Cornell Assessment of Pediatric Delirium (CAPD)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:33 PM","Medium Description En":"<p>Screens for pediatric delirium.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+35","Cme Version":"10172.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in patients with <calculator id=\"1872\">Richmond Agitation-Sedation Scale (RASS)</calculator>&nbsp;&le;-4 (deep sedation: no response to voice, but movement or eye opening to physical stimulation, or unarousable: no response to voice or physical stimulation). Includes developmental anchor points for children at 8 weeks and 1 year to improve screening accuracy in very young patients.</p>","Before Use":"","Favorite ID":"10,172","Short Title En":"Cornell Assessment of Pediatric Delirium (CAPD)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"cornell-assessment-pediatric-delirium-capd","Short Description En":"<p>Pediatric delirium screen.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+49","Full Title En":"EVendo Score for Esophageal Varices","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:34 PM","Medium Description En":"<p>Predicts presence and size of esophageal varices before screening endoscopy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+49","Cme Version":"10175.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &gt;18 years of age with known or suspected cirrhosis. Do not use in patients with overt GI bleeding or with history of acute variceal hemorrhage.</p>","Before Use":"","Favorite ID":"10,175","Short Title En":"EVendo Score for Esophageal Varices","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"evendo-score-esophageal-varices","Short Description En":"<p>Pre-endoscopy esophageal varices diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Strong Ion Difference (SID) and Stewart Approach to Acid-Base Disorders","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Analyzes acid-base disorders (physicochemical approach), alternative to <calculator id=\"1669\">anion gap</calculator>.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-774d2a12-7fff-9d66-f706-cef297a35e7d\">Interpretation can be complex. Identify causes of acid-base disturbances.</p>","Before Use":"","Favorite ID":"10,176","Short Title En":"SID and Stewart Approach to Acid-Base Disorders","Cme Release Date":"","Slug":"strong-ion-difference-sid-stewart-approach-acid-base-disorders","Short Description En":"Analyzes acid-base disorders."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Recurrent Instability of the Patella (RIP) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:35 PM","Medium Description En":"<p>Predicts risk of recurrent instability after primary patellar dislocation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10177.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,177","Short Title En":"RIP Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"recurrent-instability-patella-rip-score","Short Description En":"<p>Recurrent patellar instability risk prediction.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Pancreatic Cancer (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages pancreatic cancer based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,178","Short Title En":"TNM Pancreatic CA Staging (8th Ed.)","Cme Release Date":"","Slug":"tnm-staging-pancreatic-cancer-8th-edition","Short Description En":"Pancreatic CA staging, recommended as of 2017."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"European System for Cardiac Operative Risk Evaluation (EuroSCORE) II","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:37 PM","Medium Description En":"<p>Predicts risk of in-hospital mortality after major cardiac surgery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,179","Short Title En":"EuroSCORE II","Cme Release Date":"","Slug":"european-system-cardiac-operative-risk-evaluation-euroscore-ii","Short Description En":"<p>In-hospital mortality after major cardiac surgery.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+123","Full Title En":"Psoriasis Area and Severity Index (PASI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:37 PM","Medium Description En":"<p>Quantifies severity of psoriasis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+123","Cme Version":"10182.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,182","Short Title En":"Psoriasis Area and Severity Index (PASI)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"psoriasis-area-severity-index-pasi","Short Description En":"<p>Psoriasis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HINTS for Stroke in Acute Vestibular Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:39 PM","Medium Description En":"<p>Identifies potential stroke in patients with acute vestibular syndrome (AVS).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-708f4279-7fff-0bb9-cbc8-9ae1c6231e11\">Proper administration of the test itself is critical to using this calculator. See a <a href=\"https://vimeo.com/133033089\" target=\"_blank\" rel=\"noopener\">video from the authors here</a>.</span></p>","Before Use":"","Favorite ID":"10,184","Short Title En":"HINTS for Stroke (Acute Vestibular Syndrome)","Cme Release Date":"","Slug":"hints-stroke-acute-vestibular-syndrome","Short Description En":"<p>Stroke in AVS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Pediatric Trauma Score (PTS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:40 PM","Medium Description En":"<p>Stratifies severity of traumatic injury in children.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10185.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in pediatric patients (age &lt;18 years) presenting with trauma.&nbsp;Poorly validated&nbsp;in blunt abdominal trauma.</p>","Before Use":"","Favorite ID":"10,185","Short Title En":"Pediatric Trauma Score (PTS)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"pediatric-trauma-score-pts","Short Description En":"<p>Trauma severity in children.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Bone Cancer (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stages bone cancers (excluding pelvis and spine) based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use for primary tumors of the appendicular skeleton, trunk, skull, and facial bones. Do not use in primary tumors of pelvis or spine.</p>","Before Use":"","Favorite ID":"10,186","Short Title En":"TNM Bone CA Staging (8th Ed.)","Cme Release Date":"","Slug":"tnm-staging-bone-cancer-8th-edition","Short Description En":"Bone CA staging, recommended as of 2017."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pack Years Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 26, 2023, 7:27 PM","Medium Description En":"<p>Calculates pack years in patients with any smoking history.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,187","Short Title En":"Pack Years Calculator","Cme Release Date":"","Slug":"pack-years-calculator","Short Description En":"<p>Quantify smoking history.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ottawa COPD Risk Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:44 PM","Medium Description En":"<p>Predicts 30-day mortality or serious adverse events (MI, intubation, etc) in ED patients with COPD.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,188","Short Title En":"Ottawa COPD Risk Scale","Cme Release Date":"","Slug":"ottawa-copd-risk-scale","Short Description En":"<p>Death or serious adverse events in COPD (ED setting).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Body Fluid Balance Calculator by Inputs and Outputs","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"October 18, 2023, 7:49 PM","Medium Description En":"<p>Calculates fluid balance from sodium concentrations which indicate net 0.9% saline, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>All entries for fluids and solutions should be entered as positive numbers.</p>","Before Use":"","Favorite ID":"10,189","Short Title En":"Body Fluid Balance Calculator","Cme Release Date":"","Slug":"body-fluid-balance-calculator-inputs-outputs","Short Description En":"<p>Fluid balance.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+81","Full Title En":"Malnutrition Universal Screening Tool (MUST)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:50 PM","Medium Description En":"<p>Identifies patients who are malnourished or at risk of malnutrition.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+81","Cme Version":"10190.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old. May be applied in either a hospital or community setting.</p>","Before Use":"","Favorite ID":"10,190","Short Title En":"Malnutrition Universal Screening Tool (MUST)","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"malnutrition-universal-screening-tool-must","Short Description En":"<p>Malnutrition risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Kinetic Estimated Glomerular Filtration Rate (keGFR)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:56 PM","Medium Description En":"<p>Estimates GFR in patients with acutely changing creatinine.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Take two serum creatinine measurements (Cr<sub>1</sub> and Cr<sub>2</sub>), at two different time points (time<sub>1</sub> and time<sub>2</sub>). Note: uses <calculator id=\"76\">MDRD</calculator> equation for calculating GFR.</p>","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, so we have decided to make race optional.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing&nbsp;race and bias on MDCalc.</p>\n<p>For the same creatinine value, this calculator estimates a higher GFR for Black patients.</p>","Favorite ID":"10,191","Short Title En":"Kinetic Estimated Glomerular Filtration Rate (keGFR)","Cme Release Date":"","Slug":"kinetic-estimated-glomerular-filtration-rate-kegfr","Short Description En":"<p>keGFR estimation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Gupta Postoperative Respiratory Failure Risk","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:56 PM","Medium Description En":"<p>Predicts risk of mechanical ventilation for longer than 48 hrs postop or reintubation within 30 days.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,193","Short Title En":"Gupta Postop Respiratory Failure Risk","Cme Release Date":"","Slug":"gupta-postoperative-respiratory-failure-risk","Short Description En":"<p>Risk of vent &gt;48 hrs postop or reintubated &le;30 days.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pancreatic Fistula Risk Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 7:57 PM","Medium Description En":"<p>Predicts postoperative pancreatic fistula, based on intraoperative findings, after pancreatic resection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,194","Short Title En":"Pancreatic Fistula Risk Score","Cme Release Date":"","Slug":"pancreatic-fistula-risk-score","Short Description En":"<p>Postop fistula risk.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"DSM-5 Criteria for Major Depressive Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:45 PM","Medium Description En":"<p>Diagnostic criteria for major depressive disorder (MDD).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,195","Short Title En":"DSM-5 Criteria for Major Depressive Disorder","Cme Release Date":"","Slug":"dsm-5-criteria-major-depressive-disorder","Short Description En":"<p>Diagnosis of MDD.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"DSM-5 Criteria for Bipolar Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"January 18, 2023, 7:04 PM","Medium Description En":"<p>Diagnostic criteria for bipolar disorder (BPD).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Episode(s) not better explained by schizoaffective disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specified or unspecified schizophrenia spectrum and other psychotic disorder.</p>","Before Use":"","Favorite ID":"10,196","Short Title En":"DSM-5 Criteria for BPD","Cme Release Date":"","Slug":"dsm-5-criteria-bipolar-disorder","Short Description En":"<p>Diagnosis of BPD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"PSA Doubling Time (PSADT) Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 8:03 PM","Medium Description En":"<p>Calculates rate of PSA doubling in prostate cancer (correlates with survival).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10198.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with prostate cancer. Do not use for screening or diagnosis.</p>","Before Use":"","Favorite ID":"10,198","Short Title En":"PSA Doubling Time (PSADT) Calculator","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"psa-doubling-time-psadt-calculator","Short Description En":"<p>PSA survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Gupta Postoperative Pneumonia Risk","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 8:05 PM","Medium Description En":"<p>Predicts risk of pneumonia after surgery.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,199","Short Title En":"Gupta Postop Pneumonia Risk","Cme Release Date":"","Slug":"gupta-postoperative-pneumonia-risk","Short Description En":"<p>Postop pneumonia risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+118","Full Title En":"PLASMIC Score for TTP","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 18, 2023, 8:05 PM","Medium Description En":"<p>Predicts ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura (TTP) with high discrimination.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+118","Cme Version":"10200.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in hospitalized adult inpatients with suspected thrombotic thrombocytopenic purpura (TTP) who might benefit from early initiation of plasma exchange while awaiting ADAMTS-13 results. Do not use in patients who have already undergone plasma exchange (i.e., intermediate and high risk groups, in whom therapeutic plasma exchange must be initiated immediately).</p>","Before Use":"","Favorite ID":"10,200","Short Title En":"PLASMIC Score for TTP","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"plasmic-score-ttp","Short Description En":"<p>TTP probability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Appendicitis Risk Calculator (pARC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:23 PM","Medium Description En":"<p>Quantifies appendicitis risk in pediatric patients with abdominal pain, possibly better than the <calculator id=\"3926\">Pediatric Appendicitis Score</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in children &ge;5 years old presenting to the emergency department or outpatient setting with acute abdominal pain (duration &lt;96 hours).</p>","Before Use":"","Favorite ID":"10,201","Short Title En":"Pediatric Appendicitis Risk Calculator","Cme Release Date":"","Slug":"pediatric-appendicitis-risk-calculator-parc","Short Description En":"<p>Appendicitis risk in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Nutritional Risk Index (NRI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:28 PM","Medium Description En":"<p>Quantifies malnutrition, validated in many populations.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: although weight and&nbsp;nutritional status are not always correlated (e.g. obese patients may&nbsp;have malnutrition), for the purposes of this calculator, patients with increased weight from baseline&nbsp;(present weight &gt; usual weight) are unlikely to have malnutrition. Always use clinical judgment.</p>","Before Use":"","Favorite ID":"10,202","Short Title En":"Nutritional Risk Index (NRI)","Cme Release Date":"","Slug":"nutritional-risk-index-nri","Short Description En":"<p>Quantifies malnutrition.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+76","Full Title En":"ISTH Criteria for Disseminated Intravascular Coagulation (DIC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:35 PM","Medium Description En":"<p>Diagnoses overt disseminated intravascular coagulation (DIC).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+76","Cme Version":"10203.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in patients with clinical suspicion for&nbsp;DIC (e.g. excessive bleeding in the setting of malignancy, severe infection or sepsis, obstetric complications, trauma).</p>","Before Use":"<p><strong>Tips for COVID-19</strong>:&nbsp;This is one measure of COVID-19 associated coagulopathy, which was associated with poor prognosis (<a target=\"_blank\" delay=\"150\" aria-describedby=\"slack-kit-tooltip\" href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166509/\" rel=\"noopener noreferrer\">Tang 2020</a>).</p>","Favorite ID":"10,203","Short Title En":"ISTH Criteria for DIC","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"isth-criteria-disseminated-intravascular-coagulation-dic","Short Description En":"<p>DIC diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Local Anesthetic Dosing Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"true","Updated At":"October 19, 2023, 4:37 PM","Medium Description En":"<p>Doses local anesthetics to help avoid toxic doses.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><strong>Note:</strong> Previous versions of Goldfrank&rsquo;s reported an increased maximum allowable dosage due to the vasoconstrictive effects of epinephrine when added to local anesthetics. The most recent version no longer includes this adjustment. While there likely is a higher safe dose when epinephrine is added, we no longer include that estimate on this calculator, and as always, dosages should be double-checked and reviewed using your local pharmacy and policies.</p>","Before Use":"<p>This calculator provides guidance for maximum dosing of local anesthetic and should not be used as the primary means of dosing. Always double check and err on the side of caution.</p>","Favorite ID":"10,205","Short Title En":"Local Anesthetic Dosing","Cme Release Date":"","Slug":"local-anesthetic-dosing-calculator","Short Description En":"<p>Local anesthetic toxicity prevention.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Abbreviated Mental Test (AMT-10)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:38 PM","Medium Description En":"<p>Assesses mental impairment in elderly patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,208","Short Title En":"AMT-10","Cme Release Date":"","Slug":"abbreviated-mental-test-amt-10","Short Description En":"<p>Mental status.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RiskE Score for Cardiac Surgery in Active Infective Endocarditis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:39 PM","Medium Description En":"<p>Predicts perioperative mortality in patients with active left-sided endocarditis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,209","Short Title En":"RiskE Score for Cardiac Surgery in Endocarditis","Cme Release Date":"","Slug":"riske-score-cardiac-surgery-active-infective-endocarditis","Short Description En":"<p>Cardiac surgery mortality in endocarditis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PREVAIL Model for Prostate Cancer Survival","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:55 PM","Medium Description En":"<p>Predicts overall survival in chemotherapy-naive patients with metastatic castration-resistant prostate cancer.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator has not been externally validated.</p>","Favorite ID":"10,210","Short Title En":"PREVAIL Model for Prostate Cancer","Cme Release Date":"","Slug":"prevail-model-prostate-cancer-survival","Short Description En":"<p>Overall survival in metastatic prostate cancer.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"DSM-5 Criteria for Posttraumatic Stress Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:56 PM","Medium Description En":"<p>Diagnostic criteria for posttraumatic stress disorder (PTSD).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,211","Short Title En":"DSM-5 Criteria for PTSD","Cme Release Date":"","Slug":"dsm-5-criteria-posttraumatic-stress-disorder","Short Description En":"<p>Diagnosis of PTSD.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ATLAS Score for Clostridium Difficile Infection","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:57 PM","Medium Description En":"<p>Predicts response to therapy in patients with C. diff.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,218","Short Title En":"ATLAS Score for C. Diff. Colitis","Cme Release Date":"","Slug":"atlas-score-clostridium-difficile-infection","Short Description En":"<p>C. diff therapy response.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+72","Full Title En":"INTERCHEST Clinical Prediction Rule for Chest Pain in Primary Care","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 4:58 PM","Medium Description En":"<p>Rules out coronary artery disease (CAD) in primary care patients with chest pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+72","Cme Version":"10225.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Do not use in an emergency setting.</p>","Before Use":"","Favorite ID":"10,225","Short Title En":"INTERCHEST Rule for Chest Pain","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"interchest-clinical-prediction-rule-chest-pain-primary-care","Short Description En":"<p>Rules out CAD (primary care).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Urticaria Activity Score (UAS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:11 PM","Medium Description En":"<p>Stratifies severity of urticaria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>UAS is presented below. UAS7, also used clinically, is the sum of UAS scores over 7 consecutive days.</p>","Before Use":"","Favorite ID":"10,226","Short Title En":"Urticaria Activity Score (UAS)","Cme Release Date":"","Slug":"urticaria-activity-score-uas","Short Description En":"<p>Urticaria severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Performance Status After Critical Illness in Elderly Patients","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts performance status in patients 80 years and older after ICU care.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,229","Short Title En":"Performance Status After Critical Illness (Elderly)","Cme Release Date":"","Slug":"performance-status-critical-illness-elderly-patients","Short Description En":"Performance after ICU care (patients ≥80 years)."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Multiple Myeloma Response Criteria","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:12 PM","Medium Description En":"<p>Predicts disease response in multiple myeloma, from the International Myeloma Working Group (IMWG).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,232","Short Title En":"Multiple Myeloma Response Criteria","Cme Release Date":"","Slug":"multiple-myeloma-response-criteria","Short Description En":"<p>Multiple myeloma response assessment.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Multiple Myeloma Diagnostic Criteria","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:12 PM","Medium Description En":"<p>Diagnoses multiple myeloma, according to the International Myeloma Working Group (IMWG).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,233","Short Title En":"Multiple Myeloma Diagnostic Criteria","Cme Release Date":"","Slug":"multiple-myeloma-diagnostic-criteria","Short Description En":"<p>Multiple myeloma diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Graded Prognostic Assessment for Prognosis in Brain Metastasis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,234","Short Title En":"Graded Prognostic Assessment","Cme Release Date":"","Slug":"graded-prognostic-assessment-prognosis-brain-metastasis","Short Description En":""},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Truelove and Witts Severity Index for Ulcerative Colitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:17 PM","Medium Description En":"<p>Stratifies severity of ulcerative colitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,235","Short Title En":"Truelove/Witts Severity Index for UC","Cme Release Date":"","Slug":"truelove-witts-severity-index-ulcerative-colitis","Short Description En":"<p>Ulcerative colitis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Respiratory Score for Asthma (Liu et al)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stratifies severity of asthma exacerbation in pediatric patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,236","Short Title En":"Respiratory Score for Asthma","Cme Release Date":"","Slug":"respiratory-score-asthma-liu-et-al","Short Description En":"Asthma severity (pediatric)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Montreal Classification for Inflammatory Bowel Disease (IBD)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:17 PM","Medium Description En":"<p>Classifies severity of Crohn's disease and ulcerative colitis.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,237","Short Title En":"Montreal Classification for IBD","Cme Release Date":"","Slug":"montreal-classification-inflammatory-bowel-disease-ibd","Short Description En":"<p>Crohn's and ulcerative colitis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Zwolle Risk Score for STEMI","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,238","Short Title En":"Zwolle Risk Score for STEMI","Cme Release Date":"","Slug":"zwolle-risk-score-stemi","Short Description En":""},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Bush-Francis Catatonia Rating Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:18 PM","Medium Description En":"<p>Assesses severity of catatonia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,239","Short Title En":"Bush-Francis Catatonia Rating Scale","Cme Release Date":"","Slug":"bush-francis-catatonia-rating-scale","Short Description En":"<p>Catatonia screening and severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CLIF-C ACLF (Acute-on-Chronic Liver Failure)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:19 PM","Medium Description En":"<p>Predicts mortality in acute-on-chronic liver failure.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with decompensated chronic (cirrhotic) liver disease; it does not predict outcome in acute liver failure.</p>","Before Use":"","Favorite ID":"10,240","Short Title En":"CLIF-C ACLF","Cme Release Date":"","Slug":"clif-c-aclf-acute-chronic-liver-failure","Short Description En":"<p>Mortality in liver failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HeRS Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,241","Short Title En":"HeRS Score","Cme Release Date":"","Slug":"hers-score","Short Description En":""},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Overall Neuropathy Limitations Scale (ONLS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:19 PM","Medium Description En":"<p>Quantifies severity of peripheral neuropathy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,242","Short Title En":"Overall Neuropathy Limitations Scale (ONLS)","Cme Release Date":"","Slug":"overall-neuropathy-limitations-scale-onls","Short Description En":"<p>Peripheral neuropathy severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Myasthenia Gravis Composite Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,243","Short Title En":"Myasthenia Gravis Composite Score","Cme Release Date":"","Slug":"myasthenia-gravis-composite-score","Short Description En":""},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for GI Toxicity - Colitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:20 PM","Medium Description En":"<p>Grades severity of colitis secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with colitis symptoms that developed while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,245","Short Title En":"Immune-Related Adverse Events (IRAE) - Colitis","Cme Release Date":"","Slug":"immune-related-adverse-events-gi-toxicity-colitis","Short Description En":"<p>Colitis severity (immune checkpoint inhibitors).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"SCreening for Occult REnal Disease (SCORED)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Identifies patients with a high likelihood of occult kidney disease.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,246","Short Title En":"SCreening for Occult REnal Disease (SCORED)","Cme Release Date":"","Slug":"screening-occult-renal-disease-scored","Short Description En":"Occult kidney disease risk."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"TNM Staging for Thyroid Cancer (8th Edition)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"April 12, 2023, 6:17 PM","Medium Description En":"<p>Stages differentiated and anaplastic thyroid cancer based on tumor, lymph nodes, and metastases (recommended as of 2017).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,259","Short Title En":"TNM Thyroid CA Staging (8th Ed.)","Cme Release Date":"","Slug":"tnm-staging-thyroid-cancer-8th-edition","Short Description En":"<p>Thyroid CA staging, recommended as of 2017.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Epidemiology-based Mortality Score in Status Epilepticus (EMSE)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts mortality in status epilepticus (SE).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,268","Short Title En":"EMSE for Status Epilepticus","Cme Release Date":"","Slug":"epidemiology-based-mortality-score-status-epilepticus-emse","Short Description En":"Status epilepticus mortality."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Frontal Lobe Epilepsy and Parasomnias (FLEP) Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Distinguishes nocturnal frontal lobe epilepsy from nonepileptic parasomnias using clinical factors.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,269","Short Title En":"FLEP Scale","Cme Release Date":"","Slug":"frontal-lobe-epilepsy-parasomnias-flep-scale","Short Description En":"Nocturnal frontal lobe epilepsy diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Diarrhea","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:21 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional diarrhea.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms of chronic diarrhea for at least the last 6 months where there is not a clear systemic cause for diarrhea (e.g. secondary diarrhea).</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional diarrhea may be present:</p>\n<p><span id=\"docs-internal-guid-d0ca4ade-7fff-7299-6c66-88003e2216c6\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss or evidence of malnutrition.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of colon cancer and have not had age-appropriate colon cancer screening. Family history of inflammatory bowel disease or celiac disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Diarrhea awakening the patient at night.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Recent antibiotic use.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">High volume diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,271","Short Title En":"Rome IV for Diarrhea","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-diarrhea","Short Description En":"<p>Diarrhea diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Abdominal Bloating/Distension","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:22 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional abdominal bloating or distension.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms of abdominal bloating and/or distension for at least the last 6 months where there is not a clear systemic cause for their symptoms.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional abdominal bloating/distension may be present:</p>\n<p><span id=\"docs-internal-guid-4c577d63-7fff-e93e-4fbc-d78fc885993e\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of colon cancer and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms suggestive of bowel obstruction.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,272","Short Title En":"Rome IV for Abdominal Bloating","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-abdominal-bloating-distension","Short Description En":"<p>Abdominal bloating/distension diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Unspecified Functional Bowel Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:22 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of unspecified functional bowel disorder.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients who present with bowel symptoms for at least 6 months for which there is no systemic cause or other functional bowel disorder.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional constipation may be present:</p>\n<p><span id=\"docs-internal-guid-c9ec1f35-7fff-cd15-c2e1-a7cb09388f21\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of colon cancer and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,273","Short Title En":"Rome IV for Bowel Disorder","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-unspecified-functional-bowel-disorder","Short Description En":"<p>Unspecified bowel disorder diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Opioid-Induced Constipation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:23 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of opioid-induced constipation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of constipation in the setting of opioid use.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though opioid induced constipation may be present:</p>\n<p><span id=\"docs-internal-guid-79156c8e-7fff-d0df-244c-1b556b83efc5\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of colon cancer and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit that occurred prior to initiation or dose change of an opioid.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,274","Short Title En":"Rome IV for Opioid-Induced Constipation","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-opioid-induced-constipation","Short Description En":"<p>Opioid-induced constipation diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Chest Pain","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:24 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional chest pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of functional chest pain such as recurrent, unexplained chest pain or discomfort for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional chest pain may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms suggestive of cardiac ischemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-6897c0b8-7fff-4b77-c5be-46fe3ac5df1f\"></span></p>","Before Use":"","Favorite ID":"10,275","Short Title En":"Rome IV for Chest Pain","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-chest-pain","Short Description En":"<p>Chest pain diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnosis Criteria for Functional Heartburn","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:25 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional heartburn.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of functional heartburn, such as recurrent burning retrosternal discomfort or pain for at least 6 months, which is not responsive to antisecretory therapy.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional heartburn may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms suggestive of cardiac ischemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-8af6be34-7fff-760d-14a8-5a6a925ac134\"></span></p>","Before Use":"","Favorite ID":"10,276","Short Title En":"Rome IV for Heartburn","Cme Release Date":"","Slug":"rome-iv-diagnosis-criteria-functional-heartburn","Short Description En":"<p>Heartburn diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Reflux Hypersensitivity","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:25 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of reflux hypersensitivity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of reflux hypersensitivity, such as unexplained recurrent retrosternal symptoms (including heartburn and chest pain), for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional heartburn may be present:</p>\n<p></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms suggestive of cardiac ischemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,277","Short Title En":"Rome IV for Reflux Hypersensitivity","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-reflux-hypersensitivity","Short Description En":"<p>Reflux hypersensitivity diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PIRO Score for Community-Acquired Pneumonia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 23, 2023, 8:52 PM","Medium Description En":"<p><span id=\"docs-internal-guid-8c75a5b9-7fff-cfbe-a1f7-19487421f5c3\">Predicts ICU mortality in patients with community-acquired pneumonia.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,278","Short Title En":"PIRO Score for CAP","Cme Release Date":"","Slug":"piro-score-community-acquired-pneumonia","Short Description En":"<p>ICU mortality in CAP.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MuLBSTA Score for Viral Pneumonia Mortality","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:25 PM","Medium Description En":"<p>Predicts 90-day mortality in patients with viral pneumonia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated.&nbsp;Use with caution.</p>\n<p><strong>Tips for COVID-19:&nbsp;</strong>Use after diagnosis to determine dispo.&nbsp;Specific for Viral PNA and similar inputs as known COVID-19 mortality risk factors, but not externally validated.</p>","Favorite ID":"10,279","Short Title En":"MuLBSTA Score","Cme Release Date":"","Slug":"mulbsta-score-viral-pneumonia-mortality","Short Description En":"<p>Viral pneumonia mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Severe Community-Acquired Pneumonia (SCAP) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:26 PM","Medium Description En":"<p>Predicts risk of adverse outcomes in CAP patients in the ED.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>\n<p><strong>Tips for COVID-19:</strong> Use to determine floor vs. ICU. Likely similar performance to <calculator id=\"3914\">SMART-COP</calculator>.</p>","Favorite ID":"10,280","Short Title En":"SCAP Score","Cme Release Date":"","Slug":"severe-community-acquired-pneumonia-scap-score","Short Description En":"<p>Severe community-acquired pneumonia risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Lung Injury Prediction Score (LIPS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 23, 2023, 8:26 PM","Medium Description En":"<p>Identifies patients at high risk for developing acute lung injury (ALI).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,281","Short Title En":"Lung Injury Prediction Score (LIPS)","Cme Release Date":"","Slug":"lung-injury-prediction-score-lips","Short Description En":"<p>Acute lung injury risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PREdiction of Survival on ECMO Therapy (PRESET) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 24, 2023, 4:19 PM","Medium Description En":"<p>Predicts survival after ECMO for acute respiratory distress syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,282","Short Title En":"PRESET Score","Cme Release Date":"","Slug":"prediction-survival-ecmo-therapy-preset-score","Short Description En":"<p>Survival after ECMO for ARDS.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Dysphagia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:27 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional dysphagia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of functional dysphagia, such as a recurrent sense of solid and/or liquid foods passing abnormally through the esophagus, for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional dysphagia may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sore throat.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Heartburn or esophageal reflux/regurgitation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-ad22c6e4-7fff-1abb-287d-c7e8b7d39276\"></span></p>","Before Use":"","Favorite ID":"10,283","Short Title En":"Rome IV for Functional Dysphagia","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-dysphagia","Short Description En":"<p>Dysphagia diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Globus","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 5:27 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of globus.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of globus, such as a persistent or intermittent non-painful sensation of a lump or foreign body in the throat, for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though globus may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sore throat.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable cervical lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-a2dc515d-7fff-6ac2-7046-7ad6ab6cf085\"></span></p>","Before Use":"","Favorite ID":"10,284","Short Title En":"Rome IV for Globus","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-globus","Short Description En":"<p>Globus diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Brescia-COVID Respiratory Severity Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Quantifies clinical severity in COVID-19 patients, as of March 12, 2020.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>This is an easy to use, clinical, at-the-bedside score that can be calculated initially or trended over time to summarize overall respiratory status; in Italy it is primarily being used in association with a <calculator id=\"10286\">treatment/management algorithm</calculator>.&nbsp;</li>\n<li>If you are an Italian physician and would like to help MDCalc update this score or provide additional or clarifying information, please email us directly at <a href=\"mailto:mdcalc+covid19@gmail.com\" target=\"_blank\" rel=\"noopener\">mdcalc+covid19@gmail.com</a>.</li>\n</ul>","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated. Use with caution; this is being used in Italy for assessment, trending, and treatment recommendations.&nbsp;See also&nbsp;<calculator id=\"10286\">treatment/management algorithm</calculator>.</p>","Favorite ID":"10,285","Short Title En":"Brescia-COVID Score","Cme Release Date":"","Slug":"brescia-covid-respiratory-severity-score","Short Description En":"<p>COVID-19 clinical severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:17 PM","Medium Description En":"<p>Step-wise management approach to COVID-19 patients based on clinical severity as of June 2, 2020.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-6252e30f-7fff-c501-6fa1-b0acff3e4206\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">This algorithm is a step-wise approach to managing patients with confirmed/presumed COVID-19 pneumonia.&nbsp;</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">If not intubated, follow management and then each 4 testing criteria should be repeated to assess for improvement or deterioration. Repetition frequency based on clinical judgment&nbsp;to downgrade/upgrade score.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Not only is the management important; the numerical score is used to easily compare and summarize patients to treating clinicians.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">NIV concerning for aerosolization; included in score due to ventilator scarcity in Italy.</p>\n</li>\n</ul>","Before Use":"<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Launched during COVID-19 crisis. Not externally validated. Use with caution; this is being used in Italy for assessment, trending, and treatment recommendations.</p>\n</li>\n<li><a href=\"https://www.mdcalc.com/covid-19/brescia-covid-respiratory-severity-scale-bcrss-interview\" target=\"_blank\" rel=\"noopener\">See&nbsp;our expert interview</a> with Italian intensivist, Dr. Simone Piva, for an in-depth discussion of how the BCRSS is being used practically to simplify and communicate the respiratory status of patients.</li>\n</ul>","Favorite ID":"10,286","Short Title En":"Brescia-COVID Severity Scale","Cme Release Date":"","Slug":"brescia-covid-respiratory-severity-scale-bcrss-algorithm","Short Description En":"<p>COVID-19 pathway/approach from Italy.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Sequential Organ Failure Assessment (mSOFA) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:18 PM","Medium Description En":"<p>Predicts ICU mortality using mostly clinical variables and fewer labs (similar to <calculator id=\"691\">SOFA Score</calculator>).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,287","Short Title En":"mSOFA Score","Cme Release Date":"","Slug":"modified-sequential-organ-failure-assessment-msofa-score","Short Description En":"<p>ICU mortality (only one lab parameter).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Roth Score for Hypoxia Screening","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Screens for hypoxia in dyspneic patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Instruct patient:</p>\n<ol>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">Take a deep breath.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">In your native language, count clearly from 1 to 30 out loud, as fast as possible without stopping, until you are either out of breath or reach 30.</p>\n</li>\n</ol>\n<p dir=\"ltr\">Clinician: <strong>Time how many seconds </strong>it takes the patient to reach 30, or until they must take another breath.</p>\n<p><span id=\"docs-internal-guid-2db1baad-7fff-b16b-4b9c-1dc5a10f8c87\">Also,&nbsp;<strong>record the highest number</strong> they can reach before they have to take another breath.</span></p>","Before Use":"<p><span id=\"docs-internal-guid-49de13ec-7fff-b5a6-90df-4cc8df210e6e\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">This score has been proposed as a gross attempt to suggest hypoxia via voice/telephone, and has <strong>not</strong> been validated. Launched during COVID-19 crisis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">It obviously does not at all substitute for pulse oximetry or an in-person evaluation of a patient, but these are very challenging times and it is difficult to assess hypoxia without exposing healthcare workers to possible COVID, expending PPE, etc.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\" role=\"presentation\">The score is based on only 93 patients being admitted for pulmonary reasons (pneumonia, COPD, CHF, etc).</p>\n</li>\n</ul>","Favorite ID":"10,288","Short Title En":"Roth Score for Hypoxia Screening","Cme Release Date":"","Slug":"roth-score-hypoxia-screening","Short Description En":"<p>Hypoxia screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Static Lung Compliance (Cstat) Calculation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:18 PM","Medium Description En":"<p>Calculates pressure needed to overcome elastic resistance to ventilation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,289","Short Title En":"Static Lung Compliance","Cme Release Date":"","Slug":"static-lung-compliance-cstat-calculation","Short Description En":"<p>Ventilation pressure calculation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IV Drip Rate Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 5:26 PM","Medium Description En":"<p><span id=\"docs-internal-guid-4953bbc9-7fff-d0ad-32fe-fb5b91028f09\">Calculates IV infusion rate using drip counting when IV pumps are unavailable. </span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,290","Short Title En":"IV Drip Rate Calculator","Cme Release Date":"","Slug":"iv-drip-rate-calculator","Short Description En":"<p>IV drip infusion rate.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"SCCM COVID-19 Guidelines for Hypoxia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Provides recommendations for management of hypoxic COVID-19 patients, official guideline of the SCCM.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,291","Short Title En":"SCCM COVID-19 Guidelines (Hypoxia)","Cme Release Date":"","Slug":"sccm-covid-19-guidelines-hypoxia","Short Description En":"<p>COVID-19 management by SCCM.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Rumination Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:19 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of rumination syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of rumination syndrome, such as persistent or recurrent regurgitation of recently ingested food into the mouth with subsequent spitting or remastication and swallowing, for at least the past 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though rumination syndrome may be present:</p>\n<p></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of GI bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Heartburn.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Esophageal reflux/regurgitation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of gastric cancer and no recent upper endoscopy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,292","Short Title En":"Rome IV for Rumination Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-rumination-syndrome","Short Description En":"<p>Rumination syndrome diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Tisdale Risk Score for QT Prolongation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:19 PM","Medium Description En":"<p>Predicts risk of QT prolongation greater than 500 msec in hospitalized patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>\n<p><a href=\"https://www.mdcalc.com/covid-19\" target=\"_blank\" rel=\"noopener\"></a>This score was derived and internally validated for hospitalized patients, and may not predict outpatient risk of QT prolongation as accurately (but has not been studied in this population).</p>","Favorite ID":"10,293","Short Title En":"Tisdale Risk Score for QT","Cme Release Date":"","Slug":"tisdale-risk-score-qt-prolongation","Short Description En":"<p>Risk of QT prolongation.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Berlin Criteria for Acute Respiratory Distress Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:20 PM","Medium Description En":"<p>Provides diagnostic criteria for acute respiratory distress syndrome (ARDS).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,294","Short Title En":"Berlin Criteria for ARDS","Cme Release Date":"","Slug":"berlin-criteria-acute-respiratory-distress-syndrome","Short Description En":"<p>ARDS diagnostic criteria.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Belching Disorders","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:21 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of excessive supragastric or gastric belching.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of a belching disorder, such as bothersome belching from the esophagus or stomach more than 3 days per week for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though a belching disorder may be present:&nbsp;</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of GI bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of gastric cancer and no recent upper endoscopy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-37be29ff-7fff-c708-a15b-f75b292e1d6f\"></span></p>","Before Use":"","Favorite ID":"10,295","Short Title En":"Rome IV for Belching Disorders","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-belching-disorders","Short Description En":"<p>Supragastric or gastric belching.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Chronic Nausea Vomiting Syndrome (CNVS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:22 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of chronic nausea vomiting syndrome (CNVS).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of chronic nausea and vomiting syndrome (CNVS), such as bothersome nausea and vomiting for at least 6 months.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though CNVS may be present:</p>\n<p></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of GI bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of GI cancer and no recent abdominal imaging.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Acute change in GI symptoms.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,296","Short Title En":"Rome IV for Chronic Nausea Vomiting Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-chronic-nausea-vomiting-syndrome-cnvs","Short Description En":"<p>CNVS diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CAHP (Cardiac Arrest Hospital Prognosis) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:23 PM","Medium Description En":"<p>Predicts poor prognosis after out-of-hospital cardiac arrest and guides utility of cardiac catheterization.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with out-of-hospital cardiac arrest (OHCA) of suspected cardiac etiology. Do not use for other causes of arrest, e.g. trauma, hanging, drowning, intoxication, overdose.</p>","Before Use":"","Favorite ID":"10,297","Short Title En":"CAHP Score","Cme Release Date":"","Slug":"cahp-cardiac-arrest-hospital-prognosis-score","Short Description En":"<p>Cardiac arrest prognosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Cannabinoid Hyperemesis Syndrome (CHS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:23 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of cannabinoid hyperemesis syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of cannabinoid hyperemesis syndrome (CHS) such as stereotypical episodes of vomiting, resembling <calculator id=\"10299\">cyclic vomiting syndrome (CVS)</calculator>, for at least the past 6 months, in the setting of prolonged cannabis use.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though CHS may be present:</p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of GI bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of GI cancer and no recent upper endoscopy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Neurologic symptoms.</p>\n</li>\n</ul>\n<p><span id=\"docs-internal-guid-d626c4e4-7fff-77d1-b145-9beef8100db0\"></span></p>","Before Use":"","Favorite ID":"10,298","Short Title En":"Rome IV for Cannabinoid Hyperemesis Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-cannabinoid-hyperemesis-syndrome-chs","Short Description En":"<p>CHS diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Cyclic Vomiting Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:23 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of cyclic vomiting syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of cyclic vomiting syndrome (CVS) such as stereotypical episodes of vomiting with at least 3 discrete episodes in the prior year and 2 episodes in the past 6 months, occurring at least 1 week apart.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though CVS may be present:</p>\n<p></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of GI bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of gastric cancer and no recent upper endoscopy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Neurologic symptoms.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,299","Short Title En":"Rome IV for Cyclic Vomiting Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-cyclic-vomiting-syndrome","Short Description En":"<p>Cyclic vomiting syndrome diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CSHA Clinical Frailty Scale (CFS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:28 PM","Medium Description En":"<p>Measures frailty to predict survival.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,300","Short Title En":"Clinical Frailty Scale","Cme Release Date":"","Slug":"csha-clinical-frailty-scale-cfs","Short Description En":"<p>Frailty measurement.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sepsis-Induced Coagulopathy (SIC) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:29 PM","Medium Description En":"<p>Predicts likelihood of sepsis-induced coagulopathy.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>\"Total SOFA\" is the summation of the SOFA Score's Respiratory, Cardiovascular, Hepatic, and Renal SOFA components.</p>","Before Use":"<p dir=\"ltr\">Launched during COVID-19 crisis.</p>\n<p dir=\"ltr\">The SIC Score has been evaluated in the COVID-19 crisis given concerns that COVID-19 may cause thrombosis, but this has only been evaluated in one study in China for now.</p>","Favorite ID":"10,301","Short Title En":"Sepsis-Induced Coagulopathy (SIC) Score","Cme Release Date":"","Slug":"sepsis-induced-coagulopathy-sic-score","Short Description En":"<p>Likelihood of sepsis-induced coagulopathy.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ROX Index for Intubation after HFNC","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:39 PM","Medium Description En":"<p>Predicts high-flow nasal cannula (HFNC) failure/need for intubation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>In the original paper, patients started on HFNC were reassessed at 2, 6, and 12 hours; patients whose scores were in the \"indeterminate\" range (3.85-4.87) were reassessed two hours later. These scores were trended over time in patients.</p>","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,302","Short Title En":"ROX Index for Intubation","Cme Release Date":"","Slug":"rox-index-intubation-hfnc","Short Description En":"<p>HFNC failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"COVID-GRAM Critical Illness Risk Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:40 PM","Medium Description En":"<p><span id=\"docs-internal-guid-88f86071-7fff-09ef-9545-880ee3083044\">Predicts risk of critical illness in hospitalized COVID-19 patients.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score was developed in China and includes hospitalized inpatients and their risk of critical illness; the authors do not state the indications for admission.</p>\n<p></p>","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,303","Short Title En":"COVID-GRAM Risk Score","Cme Release Date":"","Slug":"covid-gram-critical-illness-risk-score","Short Description En":"<p>COVID-19 risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Quick COVID-19 Severity Index (qCSI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:41 PM","Medium Description En":"<p>Predicts 24-hr risk of critical respiratory illness in patients admitted from ED with COVID-19.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><span id=\"docs-internal-guid-694e1ef7-7fff-def2-46af-3829207d7c08\">Launched during COVID-19 crisis.</span></p>","Favorite ID":"10,304","Short Title En":"Quick COVID-19 Severity Index (qCSI)","Cme Release Date":"","Slug":"quick-covid-19-severity-index-qcsi","Short Description En":"<p>24 hr ED COVID-19 respiratory risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Neutrophil-Lymphocyte Ratio (NLR) Calculator","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:41 PM","Medium Description En":"<p>Calculates neutrophil-lymphocyte ratio.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Using either the absolute count or the percentage/relative count from a CBC with differential will yield the same NLR result.</p>","Before Use":"<p><span id=\"docs-internal-guid-3b66cdec-7fff-90dc-7dd7-5b76b20d84f4\">Launched during COVID-19 crisis.</span></p>","Favorite ID":"10,305","Short Title En":"Neutrophil-Lymphocyte Ratio (NLR)","Cme Release Date":"","Slug":"neutrophil-lymphocyte-ratio-nlr-calculator","Short Description En":"<p>Neutrophil-lymphocyte ratio calculation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Coronavirus Anxiety Scale (CAS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:42 PM","Medium Description En":"<p><span id=\"docs-internal-guid-bcff70ba-7fff-2593-a248-44fcb57ad9bf\"><span id=\"docs-internal-guid-bcff70ba-7fff-2593-a248-44fcb57ad9bf\">Assesses dysfunctional anxiety associated with the COVID-19 crisis.<span id=\"docs-internal-guid-bcff70ba-7fff-2593-a248-44fcb57ad9bf\"></span></span></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>","Favorite ID":"10,306","Short Title En":"Coronavirus Anxiety Scale (CAS)","Cme Release Date":"","Slug":"coronavirus-anxiety-scale-cas","Short Description En":"<p>COVID-19 anxiety assessment.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Centrally Mediated Abdominal Pain Syndrome (CAPS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:42 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of centrally mediated abdominal pain syndrome (CAPS).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with chronic abdominal pain that is poorly related to gut function for at least 6 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses to explain their abdominal pain even though centrally mediated abdominal pain syndrome may be present:</p>\n<p><span id=\"docs-internal-guid-7cf7176d-7fff-8511-7716-a34ab1a03e13\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of GI cancer.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset or new change in bowel habit.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Recurrent nausea and vomiting.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,308","Short Title En":"Rome IV for Centrally Mediated Abdominal Pain Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-centrally-mediated-abdominal-pain-syndrome-caps","Short Description En":"<p>Centrally mediated abdominal pain syndrome diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Regurgitation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:43 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant regurgitation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in infants 3 weeks to 12 months with regurgitation for at least 3 weeks.</p>\n<p dir=\"ltr\">Patients with any of the following alarm features should be evaluated clinically for other diagnoses:</p>\n<p><span id=\"docs-internal-guid-4d9a538b-7fff-4dfc-1a09-429678bdc118\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Excessive irritability.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset &lt;3 weeks, &gt; 6 months or persistence &gt;12 months of age.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Retching and/or persistent forceful vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bilious or nocturnal vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hematemesis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Aspiration.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Respiratory symptoms (wheezing, stridor, cough, hoarseness).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Apnea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">BRUE (Brief Resolved Unexplained Event).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Weight loss or failure to thrive.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Feeding or swallowing difficulties including food refusal.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal neurologic exam, posturin or seizures</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dystonic neck posturing (Sandifer syndrome).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Chronic diarrhea or constipation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Rectal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Macro or Microcephaly.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bulging fontanelle.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hepatosplenomegaly.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abdominal tenderness or distension.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Documented or suspected genetic/metabolic syndrome.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Lethargy.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,309","Short Title En":"Rome IV for Infant Regurgitation","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-regurgitation","Short Description En":"<p>Infant regurgitation diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Fecal Incontinence","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:43 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of fecal incontinence.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with recurrent fecal staining or uncontrolled passage of stool for the past 3 months.</p>\n<p dir=\"ltr\">Do NOT use in patients with:</p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-2d9e6a15-7fff-e092-cf2d-3fd176783ca5\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Clear mucous secretion alone.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Remote, isolated episodes of fecal incontinence.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Developmental age &lt;4 years old or before toilet training has occurred.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,310","Short Title En":"Rome IV for Fecal Incontinence","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-fecal-incontinence","Short Description En":"<p>Fecal incontinence diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Functional Constipation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:44 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant functional constipation.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in infants and toddlers (&lt;4 years of age) with symptoms suggestive of constipation such as passing hard, painful stools and exhibiting withholding behaviors for at least 1 month.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional constipation may be present:</p>\n<p><span id=\"docs-internal-guid-21397609-7fff-4bcf-e8cb-d2077ee5927c\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Constipation starting extremely early in life (&lt;1 month).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Passage of meconium &gt;48.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of Hirschsprung disease.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Ribbon stools.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Blood in the stool in the absence of anal fissures.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Failure to thrive or unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bilious vomiting.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Severe abdominal distension.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal physical exam findings including:</p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Tuft of hair on spine or sacral dimple.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Gluteal cleft deviation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Perianal fistula.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal position of anus.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Absent anal or cremasteric reflex.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Anal scars.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Decreased lower extremity strength/tone/reflex.</p>\n</li>\n</ul>\n</ul>","Before Use":"","Favorite ID":"10,311","Short Title En":"Rome IV for Infant Constipation","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-functional-constipation","Short Description En":"<p>Infant constipation diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Pancreatic Sphincter of Oddi Disorder (SOD)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:44 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional pancreatic sphincter of oddi disorder.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with recurrent episodes of pancreatitis with characteristic pain and appropriate lab elevations. Other common etiologies of pancreatitis must be excluded with a negative endoscopic ultrasound (EUS).&nbsp;</p>\n<p>Do NOT use in patients with:</p>\n<ul>\n<li>Pancreatic type pain without objective evidence of pancreatitis.</li>\n<li>Single episode of idiopathic pancreatitis.</li>\n<li>Gallstones or sludge on imaging.</li>\n<li>Culprit drugs associated with pancreatitis (including over the counter, supplements, narcotics).</li>\n</ul>","Before Use":"","Favorite ID":"10,312","Short Title En":"Rome IV for Pancreatic SOD","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-pancreatic-sphincter-oddi-disorder-sod","Short Description En":"<p>Pancreatic SOD diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Narcotic Bowel Syndrome ","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:44 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of narcotic bowel syndrome.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with onset or increase of chronic abdominal pain treated with narcotics in which the pain worsens or does not resolve.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though narcotic bowel syndrome may be present:</p>\n<p><span id=\"docs-internal-guid-f47e82ee-7fff-c2a0-ae9e-941d2cb8b1f1\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs or symptoms of gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained iron deficiency anemia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Palpable abdominal mass or lymphadenopathy on exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of GI cancer.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Onset of symptoms age &ge;50 years and have not had age-appropriate colon cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Sudden or acute onset of new change in bowel habit.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,313","Short Title En":"Rome IV for Narcotic Bowel Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-narcotic-bowel-syndrome-","Short Description En":"<p>Narcotic bowel syndrome diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Dyschezia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:45 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant dyschezia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in an otherwise healthy infant &lt;9 months with symptoms of infant dyschezia such as crying, turning red and straining for several minutes before successfully or unsuccessfully having a bowel movement.&nbsp;</p>\n<p dir=\"ltr\">Infants with any of the following alarm features must be evaluated further:</p>\n<p><span id=\"docs-internal-guid-26c90d21-7fff-2d59-f71d-eb10eaf9aad8\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Constipation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Failure to thrive.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bloody stools.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Excessive irritability or crying.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms after 9 months of age.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abdominal distension.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal physical exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever or illness.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,314","Short Title En":"Rome IV for Infant Dyschezia","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-dyschezia","Short Description En":"<p>Infant dyschezia diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Functional Diarrhea","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:45 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant functional diarrhea.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in otherwise healthy infants, toddlers and pre-school children with symptoms suggestive of functional diarrhea including daily painless diarrhea for at least 4 weeks.&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features should be evaluated clinically for other diagnoses:</p>\n<p><span id=\"docs-internal-guid-8c1bd1be-7fff-3f9c-6414-b663bfbaa2d7\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Failure to thrive.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abdominal pain or distension.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bloody stools.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Respiratory symptoms.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal perianal exam.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of celiac disease, pancreatitis, inflammatory bowel disease.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,315","Short Title En":"Rome IV for Infant Diarrhea","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-functional-diarrhea","Short Description En":"<p>Infant diarrhea diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Colic","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:46 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant colic.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in infants &lt; 5 months with symptoms of infant colic such as recurrent and prolonged, unsoothable episodes of crying, fussing, or irritability that occur without obvious cause.</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other anatomic, metabolic, infectious, neurological, or behavioral conditions:</p>\n<p><span id=\"docs-internal-guid-f3f01488-7fff-5042-c70d-2d7bb22bb2a8\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Extreme or high-pitched cry.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Symptoms after 4 months of age.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Failure to thrive.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Developmental delays.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Maternal drug use.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever or illness.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Parental anxiety or maternal depression.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal physical examination.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bloody stools.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,316","Short Title En":"Rome IV for Infant Colic","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-colic","Short Description En":"<p>Infant colic diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Cyclic Vomiting Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant cyclic vomiting syndrome.</p>\n<p></p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,317","Short Title En":"Rome IV for Infant Cyclic Vomiting Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-cyclic-vomiting-syndrome","Short Description En":"Infant cyclic vomiting syndrome diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Infant Rumination Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of infant rumination syndrome.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,318","Short Title En":"Rome IV for Infant Rumination ","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-infant-rumination-syndrome","Short Description En":"Infant rumination syndrome diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Biliary Pain","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:46 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of biliary pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms characteristic of typical biliary pain as defined by Rome IV criteria.</p>\n<p dir=\"ltr\"><strong>If gallbladder present:</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Supportive criteria such as low ejection fraction on gallbladder scintigraphy and normal liver transaminases, conjugated bilirubin, and amylase/lipase can aid in diagnosis of functional gallbladder disorder.</p>\n</li>\n</ul>\n<p dir=\"ltr\"><strong>If gallbladder absent:</strong></p>\n<p><span id=\"docs-internal-guid-4cd8f3f1-7fff-1772-505e-dfd46cdd4fb5\">Supportive criteria such as normal amylase/lipase, abnormal sphincter of Oddi (SOD) manometry, or abnormal hepatobiliary scintigraphy can aid in diagnosis of sphincter of Oddi disorder.</span></p>","Before Use":"","Favorite ID":"10,319","Short Title En":"Rome IV for Biliary Pain","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-biliary-pain","Short Description En":"<p>Biliary pain diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Gallbladder Disorder","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:47 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional gallbladder disorder.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms characteristic of typical biliary pain as defined by Rome IV criteria <strong>with gallbladder present</strong>.</p>\n<p dir=\"ltr\">Supportive criteria such as low ejection fraction on gallbladder scintigraphy (&lt;40%) and normal liver enzymes, conjugated bilirubin, and amylase/lipase can aid in diagnosis.</p>\n<p dir=\"ltr\">Do NOT use these criteria in patients with:</p>\n<p><span id=\"docs-internal-guid-028bcbb5-7fff-eecb-8f36-c5ad97e62969\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Atypical symptoms for biliary colic (mild, transient, constant, daily).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Visualized cholelithiasis or microlithiasis/sludge on ultrasound or endoscopic ultrasound (EUS).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Structural abnormalities, especially biliary dilation or liver enzymes not explained by other cause: should consider EUS or magnetic resonance cholangiopancreaticography (MRCP).</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,320","Short Title En":"Rome IV for Gallbladder Disorder","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-gallbladder-disorder","Short Description En":"<p>Functional gallbladder disorder diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Biliary Sphincter of Oddi Disorder (SOD)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:47 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional biliary sphincter of Oddi disorder.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients <strong>post-cholecystectomy</strong> with symptoms characteristic of typical biliary pain as defined by Rome IV criteria with elevated liver enzymes or dilated common bile duct, but NOT both. Supportive criteria such as normal amylase/lipase, abnormal sphincter of Oddi (SOD) manometry, or abnormal hepatobiliary scintigraphy can aid in diagnosis if available.</p>\n<p dir=\"ltr\">Do NOT use these criteria in patients with:</p>\n<p><span id=\"docs-internal-guid-18204329-7fff-51f9-9b8d-fb2b8758f1b6\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Atypical symptoms for biliary colic (mild, transient, constant, or daily pain).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Daily opiate use (can dilate bile ducts).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Structural diagnosis that explains symptoms (stones, pancreatitis, pancreatic or liver lesion).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">With neither dilated common bile duct nor elevated liver tests.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">With both dilated common bile duct and elevated liver tests.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,321","Short Title En":"Rome IV for Biliary SOD","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-biliary-sphincter-oddi-disorder-sod","Short Description En":"<p>Biliary SOD diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Anorectal Pain","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 19, 2023, 6:47 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of levator ani syndrome or unspecified functional anorectal pain.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with chronic, recurrent anorectal pain lasting &gt;30 minutes that is often worse with sitting than standing or lying down, often described as a vague, dull ache, or pressure high in rectum.</p>\n<p dir=\"ltr\"><strong>Digital rectal exam:</strong></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Levator Ani Syndrome: tenderness on palpation of pelvic floor or vagina.</p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Pain during posterior traction of puborectalis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Pain often asymmetric, more often on left side (but not universally).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Posterior massage may elicit characteristic discomfort.</p>\n</li>\n</ul>\n</ul>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unspecified Functional Anorectal Pain:</p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">NO pain during posterior traction of puborectalis.</p>\n</li>\n</ul>\n</ul>\n<p dir=\"ltr\"><strong>Do NOT use in patients with:</strong></p>\n<p><span id=\"docs-internal-guid-beb61a79-7fff-00ee-c31d-3b305395d56d\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anorectal or pelvic floor structural pathology explaining symptoms.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,322","Short Title En":"Rome IV for Anorectal Pain","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-anorectal-pain","Short Description En":"<p>Anorectal pain diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Proctalgia Fugax","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of proctalgia fugax.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Use in patients with sudden, infrequent anorectal pain lasting &lt;30 minutes (often seconds to minutes) and often described as cramping, gnawing, aching, or stabbing with severity ranging from uncomfortable to intolerable.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Can interrupt normal activities and even awaken patients from sleep.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Can be triggered by stress or anxiety.</p>\n</li>\n</ul>\n<p dir=\"ltr\">&nbsp;</p>\n<p dir=\"ltr\">Do NOT use these criteria in patients with:</p>\n<p><span id=\"docs-internal-guid-a5db88ff-7fff-c691-a112-80ad593de50a\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Tenderness on posterior traction of rectum when not having symptoms.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anorectal or pelvic floor structural pathology explaining symptoms.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Frequent pain related to defecation</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,323","Short Title En":"Rome IV for Proctalgia Fugax","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-proctalgia-fugax","Short Description En":"Proctalgia fugax diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Cyclic Vomiting Syndrome ","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child cyclic vomiting syndrome.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of cyclic vomiting such as intense, paroxysmal, stereotypical episodes of vomiting, separated by weeks or months of usual health.</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though cyclic vomiting may be present:</p>\n<ul>\n<li dir=\"ltr\">Severe abdominal pain.</li>\n<li dir=\"ltr\">Persistent right upper or right lower quadrant pain.</li>\n<li dir=\"ltr\">Pain radiating to the back.</li>\n<li dir=\"ltr\">Dysphagia or odynophagia.</li>\n<li dir=\"ltr\">Persistent or bilious vomiting.</li>\n<li dir=\"ltr\">Gastrointestinal blood loss.</li>\n<li dir=\"ltr\">Chronic, unexplained or nocturnal diarrhea.</li>\n<li dir=\"ltr\">Involuntary weight loss.</li>\n<li dir=\"ltr\">Deceleration of linear growth.</li>\n<li dir=\"ltr\">Delayed puberty.</li>\n<li dir=\"ltr\">Recurrent or unexplained fever.</li>\n<li dir=\"ltr\">Dysuria or hematuria.</li>\n<li dir=\"ltr\">Personality changes.</li>\n<li dir=\"ltr\">Severe headaches.</li>\n<li dir=\"ltr\">Ataxia.</li>\n<li dir=\"ltr\">Altered mental status.</li>\n<li dir=\"ltr\">Any neurologic abnormality.</li>\n</ul>","Before Use":"","Favorite ID":"10,324","Short Title En":"Rome IV for Child Cyclic Vomiting Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-cyclic-vomiting-syndrome-","Short Description En":"Child cyclic vomiting syndrome diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Functional Nausea and Vomiting","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child functional nausea and vomiting.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in a child or adolescent with chronic nausea unrelated to meals, or vomiting in the absence of an eating disorder, of at least 2 months duration.</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though functional nausea or functional vomiting may be present:</p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-1834cd50-7fff-3c6e-c5d6-3bb3422ccbc0\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Severe nausea and vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting occurs during the night or upon awakening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Headaches, visual disturbances, endocrine abnormalities or behavior changes along with the nausea or vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hematemesis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bilious emesis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abdominal distension.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Severe abdominal pain.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,325","Short Title En":"Rome IV for Child Nausea and Vomiting","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-functional-nausea-vomiting","Short Description En":"Child nausea and vomiting diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Rumination Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child rumination syndrome.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in children and adolescents with symptoms suggestive of rumination, such as persistent or recurrent regurgitation of recently ingested food into the mouth with subsequent spitting or rechewing and re-swallowing for at least 2 months.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though rumination syndrome may be present:</p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-402ac1f3-7fff-7f07-c42f-3f00cfa8db6b\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting later than 4h after a meal.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Signs of upper gastrointestinal bleeding.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Severe abdominal pain.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,326","Short Title En":"Rome IV for Child Rumination Syndrome","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-rumination-syndrome","Short Description En":"Child rumination syndrome diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Aerophagia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child aerophagia.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-e5127a1c-7fff-34f5-af54-feeca584067c\">Use in a child or adolescent with symptoms suggestive of aerophagia, such as excessive air swallowing, abdominal distension which increases throughout the day, repetitive belching or increased flatus of at least 2 months duration. </p>","Before Use":"","Favorite ID":"10,327","Short Title En":"Rome IV for Child Aerophagia","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-aerophagia","Short Description En":"Child aerophagia diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Irritable Bowel Syndrome (IBS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child irritable bowel syndrome (IBS).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in a child or adolescent with symptoms suggestive of irritable bowel syndrome (IBS), such as chronic and recurrent abdominal pain related to defecation and/or changes in stool frequency or form for at least 2 months.&nbsp; &nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though IBS may be present:</p>\n<p><span id=\"docs-internal-guid-bca01afb-7fff-580a-acc3-fba504cebcc5\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of inflammatory bowel disease, celiac disease, or peptic ulcer disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent right upper or right lower quadrant pain.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Gastrointestinal blood loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Arthritis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Perirectal disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Involuntary weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Deceleration of linear growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Delayed puberty.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained fever.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,328","Short Title En":"Rome IV for Child IBS","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-irritable-bowel-syndrome-ibs","Short Description En":"Child IBS diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Abdominal Migraine","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child abdominal migraine.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in patients with symptoms suggestive of abdominal migraine such as intense, paroxysmal, stereotypical episodes of abdominal pain severe enough to interfere with activities, separated by weeks or months of usual health.</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though abdominal migraines may be present:</p>\n<p></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent right upper or right lower quadrant pain.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Pain radiating to the back.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent or bilious vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Gastrointestinal blood loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Chronic and unexplained diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal pain or diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Arthritis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Perirectal disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Involuntary weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Deceleration of linear growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Delayed puberty.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Recurrent or unexplained fever.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysuria or Hematuria.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of inflammatory bowel disease, celiac disease, or peptic ulcer disease.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,329","Short Title En":"Rome IV for Child Abdominal Migraine","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-abdominal-migraine","Short Description En":"Child abdominal migraine diagnosis. "},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Functional Abdominal Pain","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child functional abdominal pain.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in a child or adolescent with symptoms suggestive of functional abdominal pain such as episodic recurrent or chronic abdominal pain for at least 2 months.&nbsp;&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though functional abdominal pain may be present:</p>\n<p><span id=\"docs-internal-guid-fb9c5bc9-7fff-1d73-4b0f-d288b174f402\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of <calculator id=\"10328\">inflammatory bowel disease</calculator>, celiac disease, or peptic ulcer disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent right upper or right lower quadrant pain.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Gastrointestinal blood loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Arthritis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Perirectal disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Involuntary weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Deceleration of linear growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Delayed puberty.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained fever.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,330","Short Title En":"Rome IV for Child Abdominal Pain","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-functional-abdominal-pain","Short Description En":"Child abdominal pain diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Functional Constipation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child functional constipation.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in children (&gt; 4 years) and adolescents with symptoms suggestive of constipation such as passing hard, painful stools, fecal incontinence and/or showing withholding behaviors for at least 1 month.</p>\n<p dir=\"ltr\">Patients with any of the following features must be evaluated clinically for other diagnoses even though functional constipation may be present:</p>\n<p><span id=\"docs-internal-guid-8416e99b-7fff-cab6-243e-bd58f01d3275\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Constipation onset extremely early in life (&lt;1 mo).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Passage of meconium &gt;48 hours after delivery.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of Hirschsprung disease.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Ribbon stools.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Blood in the stools in the absence of anal fissures.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Failure to thrive or unintentional weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fever.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Bilious vomiting.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Severe abdominal distension.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Fecal incontinence in the absence of rectal impaction.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abnormal physical exam findings.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Simultaneous urinary retention or incontinence.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,331","Short Title En":"Rome IV for Child Constipation","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-functional-constipation","Short Description En":"Constipation diagnosis. "},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Non-retentive Fecal Incontinence","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child nonretentive fecal incontinence.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in a child or adolescent with fecal incontinence for at least 1 month.&nbsp;&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though nonretentive fecal incontinence may be present:</p>\n<p><span id=\"docs-internal-guid-3283158d-7fff-f3cd-7a7e-09aa77e67377\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Physical exam findings suggesting structural disease, such as:</p>\n</li>\n<ul>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Fistulous opening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Abnormalities of the back (Hair tuft, gluteal cleft deviation, sacral dimple).</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Anal tenderness or tags.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Absent anal or cremasteric reflex.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"2\">\n<p dir=\"ltr\" role=\"presentation\">Decreased lower extremity strength/tone/reflexes.</p>\n</li>\n</ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Anal scars.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hematochezia or melena.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Abdominal distension.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Urinary retention or incontinence.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,332","Short Title En":"Rome IV for Child Fecal Incontinence","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-non-retentive-fecal-incontinence","Short Description En":"Fecal incontinence diagnosis."},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Child Functional Dyspepsia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of child functional dyspepsia.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Use in a child or adolescent with symptoms suggestive of functional dyspepsia for at least 2 months. The diagnosis of functional dyspepsia should be made by clinical history, positive symptom criteria, physical examination, minimal diagnostic testing as clinically indicated.&nbsp;&nbsp;</p>\n<p dir=\"ltr\">Patients with any of the following alarm features must be evaluated clinically for other diagnoses even though functional dyspepsia may be present:</p>\n<p><span id=\"docs-internal-guid-3e2e5447-7fff-9e19-fac2-8cf93506efc5\"></span></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent right upper or right lower quadrant pain.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Dysphagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Odynophagia.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Persistent vomiting.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Gastrointestinal blood loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Nocturnal pain or diarrhea.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Arthritis.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Perirectal disease.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Involuntary weight loss.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Deceleration of linear growth.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Delayed puberty.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Unexplained fever.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Family history of inflammatory bowel disease, celiac disease, or peptic ulcer disease.</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,334","Short Title En":"Rome IV for Child Dyspepsia","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-child-functional-dyspepsia","Short Description En":"<p>Child dyspepsia diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Rome IV Diagnostic Criteria for Functional Defecation Disorders","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Official Rome IV criteria for the diagnosis of functional defecation disorders.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Patients who have symptoms consistent with functional constipation or IBS with constipation and in whom a defecation disorder is suspected.&nbsp;</p>\n<p dir=\"ltr\">Do NOT use in patients:</p>\n<p><span id=\"docs-internal-guid-25c1da49-7fff-00af-8678-109db5d133fb\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Without age appropriate colorectal cancer screening.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">With secondary intervenable causes for constipation (e.g. medications).</p>\n</li>\n</ul>","Before Use":"","Favorite ID":"10,335","Short Title En":"Rome IV for Defecation Disorders","Cme Release Date":"","Slug":"rome-iv-diagnostic-criteria-functional-defecation-disorders","Short Description En":"Defecation disorders diagnosis."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"4C Mortality Score for COVID-19","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"December 6, 2022, 7:52 PM","Medium Description En":"<p>Predicts in-hospital mortality in patients admitted with COVID-19.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use with admitted patients diagnosed with COVID-19.</p>","Before Use":"","Favorite ID":"10,338","Short Title En":"4C Mortality Score for COVID-19","Cme Release Date":"","Slug":"4c-mortality-score-covid-19","Short Description En":"<p>In-hospital COVID-19 mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Altitude-Adjusted PERC Rule","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Rules out PE if no criteria are present; includes SaO2 adjustment for altitude.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool is intended for patients with low risk for PE and who live at high altitude (&gt;4000 ft).&nbsp;</p>","Before Use":"","Favorite ID":"10,343","Short Title En":"Altitude-Adjusted PERC Rule","Cme Release Date":"","Slug":"altitude-adjusted-perc-rule","Short Description En":"Rules out PE (altitude-adjusted)"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Salivary Gland Cancer Model for Survival +/- Postoperative Radiotherapy (PORT)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 19, 2023, 1:12 AM","Medium Description En":"<p>Predicts overall survival with and without postoperative radiotherapy (PORT) for resected major salivary gland cancers.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator has not been externally validated. Use with caution.</p>","Favorite ID":"10,345","Short Title En":"Salivary Gland Cancer PORT Survival","Cme Release Date":"","Slug":"salivary-gland-cancer-model-survival-postoperative-radiotherapy-port","Short Description En":"<p>Salivary gland cancer PORT survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Veterans Health Administration COVID-19 (VACO) Index for COVID-19 Mortality","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 18, 2023, 10:52 PM","Medium Description En":"<p>Estimates risk of 30-day mortality after COVID-19 infection using pre-COVID health status.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><strong>Developed in collaboration with the US Department of Health and Human Services (HHS), including the CDC, NIH, VA, and the ASPR.</strong></p>\n<p>This calculator was developed and validated in VA cohorts, and then externally validated in a non-VA patient population, noteworthy because of the VA's predominantly male population. The VACO Index predicts well in all subpopulations in which it was studied.&nbsp;</p>\n<p></p>","Favorite ID":"10,346","Short Title En":"VACO Index","Cme Release Date":"","Slug":"veterans-health-administration-covid-19-vaco-index-covid-19-mortality","Short Description En":"<p>Estimates 30d COVID-19 mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RCVS<sub>2</sub> Score for Reversible Cerebral Vasoconstriction Syndrome","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Distinguishes reversible cerebral vasoconstriction syndrome from other intracranial arteriopathies at admission.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>To use the score, patients must have a first presentation of abnormal intracranial vascular imaging and be 18&ndash;55 years old. The score has not been tested outside this age range.</p>","Before Use":"","Favorite ID":"10,347","Short Title En":"RCVS<sub>2</sub> Score","Cme Release Date":"","Slug":"rcvs2-score-reversible-cerebral-vasoconstriction-syndrome","Short Description En":"Reversible cerebral vasoconstriction syndrome diagnosis."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"For Patients: VACO Index COVID-19 Mortality Risk","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"July 17, 2023, 9:53 PM","Medium Description En":"<p>For use by non-clinicians. Calculate your or a loved one's risk of dying within 30 days of contracting COVID-19. See risk visualization in results for more info.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>After calculating a result, see our helpful aid to visualize your covid risk (link in the results box).</p>","Before Use":"<p>This is a patient-facing tool. The healthcare provider version of the VACO Index is available <a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/veterans-health-administration-covid-19-vaco-index-covid-19-mortality\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/veterans-health-administration-covid-19-vaco-index-covid-19-mortality\" rel=\"noopener noreferrer\">here</a>. Developed in collaboration with the US Department of Health and Human Services (HHS), including the CDC, NIH, VA, and the Assistant Secretary of Preparedness and Response.</p>","Favorite ID":"10,348","Short Title En":"For Patients: VACO Index COVID-19 Mortality Risk","Cme Release Date":"","Slug":"covid-risk","Short Description En":"<p>Chance of dying from COVID-19.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPROVE Risk Score for Venous Thromboembolism (VTE)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts 3-month risk of VTE in hospitalized patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,349","Short Title En":"IMPROVE for VTE","Cme Release Date":"","Slug":"improve-risk-score-venous-thromboembolism-vte","Short Description En":"3-month inpatient VTE risk."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPROVEDD Risk Score for Venous Thromboembolism (VTE)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts risk of VTE in hospitalized patients, adding D-dimer to IMPROVE Risk Score.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,350","Short Title En":"IMPROVEDD for VTE","Cme Release Date":"","Slug":"improvedd-risk-score-venous-thromboembolism-vte","Short Description En":"<p>Inpatient VTE risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Sgarbossa's Criteria for MI in Left Bundle Branch Block","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Diagnoses acute MI in patients with prior LBBB.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,353","Short Title En":"Modified Sgarbossa's Criteria for MI","Cme Release Date":"","Slug":"modified-sgarbossas-criteria-mi-left-bundle-branch-block","Short Description En":"Acute MI diagnosis in LBBB."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"COVID Home Safely Now (CHOSEN) Risk Score for COVID-19","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts suitability for discharge in COVID-19 patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><span id=\"docs-internal-guid-4129e612-7fff-1d78-8664-8a602f12dbb4\">Launched during COVID-19 crisis. Not externally validated. Use with caution.</span></p>","Favorite ID":"10,354","Short Title En":"CHOSEN Risk Score","Cme Release Date":"","Slug":"covid-home-safely-now-chosen-risk-score-covid-19","Short Description En":"<p>COVID-19 discharge suitability.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PRIEST COVID-19 Clinical Severity Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts adverse outcome in adults presenting to ED with suspected COVID-19.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated. Use with caution.</p>","Favorite ID":"10,369","Short Title En":"PRIEST Score for COVID-19","Cme Release Date":"","Slug":"priest-covid-19-clinical-severity-score","Short Description En":"<p>Suspected COVID-19 prognosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"4-Level Pulmonary Embolism Clinical Probability Score (4PEPS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Rules out PE based on clinical criteria.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The timing of vital sign values were not formally assessed by this study; we recommend using clinician judgment to assess which vital sign should be used for the 4PEPS score.</p>","Before Use":"","Favorite ID":"10,370","Short Title En":"4PEPS Score for PE","Cme Release Date":"","Slug":"4-level-pulmonary-embolism-clinical-probability-score-4peps","Short Description En":"Rules out PE."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"COVID-19 Inpatient Risk Calculator (CIRC)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts likelihood of inpatient mortality or severe disease progression in COVID patients.</p>","Logic Language":"r","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates; this calculator cannot be run without the &ldquo;White Yes/No&rdquo; answer. Non-white patients tend to have higher mortalities in this score.&nbsp;<a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\">See here</a>&nbsp;for more on our approach to addressing race and bias on MDCalc.</p>\n<p>Launched during COVID-19 crisis. Not externally validated. Use with caution.</p>","Favorite ID":"10,371","Short Title En":"CIRC","Cme Release Date":"","Slug":"covid-19-inpatient-risk-calculator-circ","Short Description En":"<p>Inpatient COVID mortality or severe disease progression.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for Endocrine Toxicities - Diabetes Mellitus","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of hyperglycemia secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-08a1bb22-7fff-3a1e-ff4d-b174ebcaf9d9\">Use in adult patients with signs and symptoms of new or worsening hyperglycemia that developed while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,377","Short Title En":"IRAE for Endocrine Toxicities - Diabetes","Cme Release Date":"","Slug":"immune-related-adverse-events-endocrine-toxicities-diabetes-mellitus","Short Description En":"Hyperglycemia severity (ICPi therapy)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for Renal Toxicities - Nephritis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of nephritis secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with elevations in creatinine levels or symptoms suggesting nephritis while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,378","Short Title En":"IRAE for Renal Toxicities - Nephritis","Cme Release Date":"","Slug":"immune-related-adverse-events-renal-toxicities-nephritis","Short Description En":"Nephritis severity (ICPi therapy)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for Cardiovascular Toxicities - Myocarditis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of myocarditis secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,381","Short Title En":"IRAE for Cardiovascular Toxicities - Myocarditis","Cme Release Date":"","Slug":"immune-related-adverse-events-cardiovascular-toxicities-myocarditis","Short Description En":"Myocarditis severity (ICPi therapy)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for Endocrine Toxicities - Hypothyroidism","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of hypothyroidism secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with symptoms of hypothyroidism and/or abnormalities of TSH or free thyroxine level that developed while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,382","Short Title En":"IRAE for Endocrine Toxicities - Hypothyroidism","Cme Release Date":"","Slug":"immune-related-adverse-events-endocrine-toxicities-hypothyroidism","Short Description En":"Hypothyroidism severity (ICPi therapy)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for Lung Toxicity - Pneumonitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of pneumonitis secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with symptoms of pneumonitis or focal or diffuse inflammation of the lung parenchyma typically identified on CT imaging while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,383","Short Title En":"IRAE for Lung Toxicity - Pneumonitis","Cme Release Date":"","Slug":"immune-related-adverse-events-lung-toxicity-pneumonitis","Short Description En":"Pneumonitis severity (ICPi therapy)."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Immune-Related Adverse Events for GI Toxicity - Hepatitis","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Grades severity of hepatitis secondary to immune checkpoint inhibitor therapy.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with symptoms of hepatitis or AST, ALT, or total bilirubin elevation that developed while on treatment with immune checkpoint inhibitors.</p>","Before Use":"","Favorite ID":"10,389","Short Title En":"IRAE for GI Toxicity - Hepatitis","Cme Release Date":"","Slug":"immune-related-adverse-events-gi-toxicity-hepatitis","Short Description En":"Grades severity of hepatitis secondary to immune checkpoint inhibitor therapy."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Refractory Epilepsy Screening Tool for Lennox–Gastaut Syndrome (REST-LGS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Provides diagnostic criteria for Lennox-Gastaut Syndrome (LGS).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Lennox-Gastaut Syndrome can be one of the most challenging epileptic disorders to identify. Because of this, this study used expert consensus to develop criteria to aid in its diagnosis. This study still requires external validation.</p>","Before Use":"","Favorite ID":"10,390","Short Title En":"REST-LGS","Cme Release Date":"","Slug":"refractory-epilepsy-screening-tool-lennox-gastaut-syndrome-rest-lgs","Short Description En":"<p>LGS diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Graded Prognostic Assessment for Gastrointestinal Cancer (GI-GPA)","Created At":"April 22, 2022, 5:24 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Estimates survival in patients with gastrointestinal cancers and brain metastases.</p>","Logic Language":"","Published At":"April 22, 2022, 5:24 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,393","Short Title En":"GI-GPA","Cme Release Date":"","Slug":"graded-prognostic-assessment-for-gastrointestinal-cancer-gigpa","Short Description En":"<p>Brain metastasis assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Novel Pneumonia Risk Score (PRS)","Created At":"April 29, 2022, 7:03 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts radiographic pneumonia in children.</p>","Logic Language":"","Published At":"April 29, 2022, 7:03 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Apply this calculator to children 3 months to 18 years of age in whom pneumonia is suspected.</p>","Before Use":"","Favorite ID":"10,394","Short Title En":"Pneumonia Risk Score (PRS)","Cme Release Date":"","Slug":"novel-pneumonia-risk-score-prs","Short Description En":"<p>Pneumonia risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ulcerative Colitis Endoscopic Index of Severity (UCEIS)","Created At":"May 3, 2022, 5:23 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Assesses the endoscopic severity of ulcerative colitis.</p>","Logic Language":"","Published At":"May 3, 2022, 5:23 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,395","Short Title En":"UCEIS","Cme Release Date":"","Slug":"ulcerative-colitis-endoscopic-index-of-severity-uceis","Short Description En":"<p>Ulcerative colitis severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Woman Abuse Screening Tool (WAST)","Created At":"May 3, 2022, 5:56 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 9:41 PM","Medium Description En":"<p>Detects domestic abuse (intimate partner violence) in women in healthcare settings.</p>","Logic Language":"javascript","Published At":"May 3, 2022, 5:56 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>WAST-Short can be used as a short screener for intimate partner violence. If positive, asking additional questions may provide more insight into your patient&rsquo;s condition.</p>\n<p>&nbsp;<br>If the short form is negative, it is unknown what clinical utility can be gained by asking further questions. Research is ongoing.</p>","Before Use":"","Favorite ID":"10,396","Short Title En":"WAST","Cme Release Date":"","Slug":"woman-abuse-screening-tool-wast","Short Description En":"<p>Detects domestic abuse in women.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Rebound Hyperbilirubinemia Risk Score","Created At":"May 3, 2022, 8:47 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 9:35 PM","Medium Description En":"<p>Estimates risk of rebound hyperbilirubinemia after inpatient phototherapy.</p>","Logic Language":"javascript","Published At":"May 3, 2022, 8:47 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use only in neonates &ge;35 weeks gestational age (GA) treated with first episode inpatient phototherapy.</p>","Before Use":"","Favorite ID":"10,397","Short Title En":"Rebound Hyperbilirubinemia Risk Score","Cme Release Date":"","Slug":"rebound-hyperbilirubinemia-risk-score","Short Description En":"<p>Rebound hyperbilirubinemia risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PREDICT Prostate Model for Nonmetastatic Prostate Cancer","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts survival in nonmetastatic prostate cancer patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,401","Short Title En":"PREDICT Prostate","Cme Release Date":"","Slug":"predict-prostate-model-nonmetastatic-prostate-cancer","Short Description En":"Prostate cancer survival."},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Veterans Aging Cohort Study (VACS) 2.0 Index","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 9:07 PM","Medium Description En":"<p>Estimates risk of 5-year all-cause mortality in patients with HIV, an update to the <a href=\"https://www.mdcalc.com/veterans-aging-cohort-study-vacs-index\" title=\"Veterans Aging Cohort Study (VACS) Index\" target=\"_blank\" rel=\"noopener\">Veterans Aging Cohort Study (VACS) 1.0 Index</a>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,402","Short Title En":"VACS 2.0 Index","Cme Release Date":"","Slug":"veterans-aging-cohort-study-vacs-2.0-index","Short Description En":"<p>All-cause mortality for patients with HIV.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Simplified Acute Physiology Score (SAPS) 3","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Estimates the probability of mortality for ICU patients on admission.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>The SAPS 3 Score predicts hospital mortality upon ICU admission, using patient characteristics, indication for ICU admission, and physiologic derangement upon ICU admission.</p>","Before Use":"","Favorite ID":"10,403","Short Title En":"SAPS 3","Cme Release Date":"","Slug":"simplified-acute-physiology-score-saps-3","Short Description En":"<p>ICU mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Trauma Score and Injury Severity Score (TRISS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Estimates the probability of survival for trauma patients.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,404","Short Title En":"TRISS","Cme Release Date":"","Slug":"trauma-score-injury-severity-score-triss","Short Description En":"<p>Trauma survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pain, Enjoyment of Life and General Activity (PEG) Scale","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 4:30 PM","Medium Description En":"<p>Assesses chronic pain in primary care patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,405","Short Title En":"PEG Scale","Cme Release Date":"","Slug":"pain-enjoyment-life-general-activity-peg-scale","Short Description En":"<p>Chronic pain assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Beck Anxiety Inventory (BAI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 4:29 PM","Medium Description En":"<p>Measures severity of anxiety.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,406","Short Title En":"Beck Anxiety Inventory (BAI)","Cme Release Date":"","Slug":"beck-anxiety-inventory-bai","Short Description En":"<p>Anxiety severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Beck Depression Inventory (BDI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Measures severity of depression.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,407","Short Title En":"Beck Depression Inventory (BDI)","Cme Release Date":"","Slug":"beck-depression-inventory-bdi","Short Description En":"<p>Depression severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Beck Scale for Suicide Ideation (BSSI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Measures severity of suicidal intention.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,408","Short Title En":"Beck Scale for Suicide Ideation (BSSI)","Cme Release Date":"","Slug":"beck-scale-for-suicide-ideation-bssi","Short Description En":"<p>Suicidal intention severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Beck Hopelessness Inventory (BHI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"April 5, 2023, 5:14 PM","Medium Description En":"<p>Measures severity of hopelessness.</p>","Logic Language":"javascript","Published At":"April 5, 2023, 5:14 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,409","Short Title En":"Beck Hopelessness Inventory (BHI)","Cme Release Date":"","Slug":"beck-hopelessness-inventory-bhi","Short Description En":"<p>Hopelessness severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Utah COVID-19 Risk Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Recommends oral antivirals for COVID-19 treatment (updated January 28, 2022).</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated. Use with caution; this is being used in Utah for assessment, trending, and treatment recommendations.</p>","Favorite ID":"10,410","Short Title En":"Utah COVID-19 Risk Score","Cme Release Date":"","Slug":"utah-covid19-risk-score","Short Description En":"<p>Oral antiviral recommendation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Paxlovid Eligibility Tool","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Recommends oral antivirals for COVID-19 treatment.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated. Use with caution; this is being used in Massachusetts for assessment, trending, and treatment recommendations.</p>","Favorite ID":"10,411","Short Title En":"Paxlovid Eligibility Tool","Cme Release Date":"","Slug":"paxlovid-eligibility-tool","Short Description En":"<p>Oral antiviral recommendation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Clark-Beck Obsessive Compulsive Inventory (CBOCI)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 4:27 PM","Medium Description En":"<p>Measures severity of obsessive compulsions.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,412","Short Title En":"Clark-Beck Obsessive Compulsive Inventory (CBOCI)","Cme Release Date":"","Slug":"clarkbeck-obsessive-compulsive-inventory-cboci","Short Description En":"<p>Obsessive compulsion severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"COVID-19 Rule Out Criteria (CORC) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts the probability of SARS-CoV-2 infection.</p>","Logic Language":"","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis. Not externally validated. Use with caution.</p>\n<p>This calculator includes inputs based on race and ethnicity, which may or may not provide better estimates, so we have decided to make these inputs optional. See <a href=\"https://www.mdcalc.com/race\" target=\"_blank\" rel=\"noopener\">here</a> for more on our approach to addressing race and bias on MDCalc.</p>\n<p>This calculator estimates a higher probability of SARS-CoV-2 infection for patients who identify as Black and for patients who are Latino or Hispanic.</p>","Favorite ID":"10,413","Short Title En":"CORC Score","Cme Release Date":"","Slug":"covid19-rule-out-criteria-corc-score","Short Description En":"<p>Probability of SARS-CoV-2 infection.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Positive and Negative Syndrome Scale (PANSS) for Schizophrenia","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"November 17, 2023, 8:04 PM","Medium Description En":"<p>Measures the prevalence of positive and negative syndromes in schizophrenia.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,414","Short Title En":"PANSS for Schizophrenia","Cme Release Date":"","Slug":"positive-negative-syndrome-scale-panss-schizophrenia","Short Description En":"<p>Schizophrenia assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hack’s Impairment Index (HII)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 4:21 PM","Medium Description En":"<p>Provides a quantitative and standardized assessment of the degree of alcohol-induced impairment in emergency department patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score to objectively track and monitor symptoms of impairment in patients who present to the Emergency Department with alcohol-induced impairment.</p>\n<p></p>","Before Use":"","Favorite ID":"10,415","Short Title En":"HII","Cme Release Date":"","Slug":"hacks-impairment-index-hii","Short Description En":"<p>Assessment of alcohol-induced impairment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hurt, Insult, Threaten, Scream (HITS) Score","Created At":"May 11, 2022, 6:25 PM","Is Manual":"false","Dosing":"false","Updated At":"May 23, 2023, 4:03 PM","Medium Description En":"<p>Detects domestic abuse (intimate partner violence) in women and men in healthcare settings.</p>","Logic Language":"javascript","Published At":"May 11, 2022, 6:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,417","Short Title En":"HITS","Cme Release Date":"","Slug":"hurt-insult-threaten-scream-hits-score","Short Description En":"<p>Detects domestic abuse in healthcare settings.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ongoing Violence Assessment Tool (OVAT)","Created At":"May 11, 2022, 7:13 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Detects domestic abuse (intimate partner violence) in women and men in emergency department settings.</p>","Logic Language":"","Published At":"May 11, 2022, 7:13 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,418","Short Title En":"OVAT","Cme Release Date":"","Slug":"ongoing-violence-assessment-tool-ovat","Short Description En":"<p>Detects domestic abuse in ED.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Abuse Assessment Screen (AAS)","Created At":"May 12, 2022, 4:42 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Detects domestic abuse (intimate partner violence) in pregnant and nonpregnant women in healthcare settings.</p>","Logic Language":"","Published At":"May 12, 2022, 4:42 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,419","Short Title En":"AAS","Cme Release Date":"","Slug":"abuse-assessment-screen-aas","Short Description En":"<p>Detects domestic abuse in healthcare settings.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Humiliation, Afraid, Rape, Kick (HARK)","Created At":"May 12, 2022, 5:08 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Detects domestic abuse (intimate partner violence) in women in primary care settings.</p>","Logic Language":"","Published At":"May 12, 2022, 5:08 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,420","Short Title En":"HARK","Cme Release Date":"","Slug":"humiliation-afraid-rape-kick-hark","Short Description En":"<p>Primary care domestic abuse detection.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Canadian Transient Ischemic Attack (TIA) Score","Created At":"May 24, 2022, 4:25 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 8:30 PM","Medium Description En":"<p>Identifies risk of stroke in the next 7 days in patients who experienced symptoms of TIA.</p>","Logic Language":"javascript","Published At":"May 24, 2022, 4:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,421","Short Title En":"Canadian TIA Score","Cme Release Date":"","Slug":"canadian-transient-ischemic-attack-tia-score","Short Description En":"<p>Stroke prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Penicillin Allergy Decision Rule (PEN-FAST)","Created At":"May 24, 2022, 6:47 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 8:28 PM","Medium Description En":"<p>Identifies low-risk penicillin allergies.</p>","Logic Language":"javascript","Published At":"May 24, 2022, 6:47 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Apply this calculator to patients who have reported a penicillin allergy.</p>","Before Use":"","Favorite ID":"10,422","Short Title En":"PEN-FAST","Cme Release Date":"","Slug":"penicillin-allergy-decision-rule-pen-fast","Short Description En":"<p>Penicillin allergy identification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"NEXUS Head CT Instrument","Created At":"June 2, 2022, 8:47 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Predicts need for head CT after blunt head injury.</p>","Logic Language":"","Published At":"June 2, 2022, 8:47 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;18 years old who have sustained blunt head trauma within the past 24 hours and in whom head CT is being considered.</p>","Before Use":"","Favorite ID":"10,423","Short Title En":"NEXUS Head CT Instrument","Cme Release Date":"","Slug":"nexus-head-ct-instrument","Short Description En":"<p>Predicts head CT need.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) Score","Created At":"June 3, 2022, 9:14 PM","Is Manual":"false","Dosing":"false","Updated At":"July 17, 2023, 7:29 PM","Medium Description En":"<p>Assesses the individual risk of severe toxicity from chemotherapy in older patients.</p>","Logic Language":"javascript","Published At":"June 3, 2022, 9:14 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,425","Short Title En":"CRASH","Cme Release Date":"","Slug":"chemotherapy-risk-assessment-scale-high-age-patients-crash-score","Short Description En":"<p>Assesses chemotherapy toxicity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"G8 Geriatric Screening Tool","Created At":"June 6, 2022, 4:02 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 8:08 PM","Medium Description En":"<p>Identifies elderly cancer patients who could benefit from comprehensive geriatric assessment (CGA).</p>","Logic Language":"javascript","Published At":"June 6, 2022, 4:02 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,426","Short Title En":"G8 Screening Tool","Cme Release Date":"","Slug":"g8-geriatric-screening-tool","Short Description En":"<p>CGA benefit identification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Eczema Area and Severity Index (EASI)","Created At":"June 7, 2022, 3:49 PM","Is Manual":"false","Dosing":"false","Updated At":"October 13, 2022, 3:15 PM","Medium Description En":"<p>Stratifies severity of eczema.</p>","Logic Language":"","Published At":"June 7, 2022, 3:49 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &gt;8 years old with atopic dermatitis.</p>","Before Use":"","Favorite ID":"10,427","Short Title En":"Eczema Area and Severity Index (EASI)","Cme Release Date":"","Slug":"eczema-area-severity-index-easi","Short Description En":"<p>Eczema severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Current Opioid Misuse Measure (COMM)","Created At":"June 27, 2022, 5:20 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 8:04 PM","Medium Description En":"<p>Identifies potential medication misuse in patients who are on long-term opioid therapy.</p>","Logic Language":"javascript","Published At":"June 27, 2022, 5:20 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,428","Short Title En":"COMM","Cme Release Date":"","Slug":"current-opioid-misuse-measure-comm","Short Description En":"<p>Opioid medication misuse identification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Edmonton Symptom Assessment System-revised (ESAS-r)","Created At":"June 28, 2022, 5:52 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 4:50 PM","Medium Description En":"<p>Assesses symptoms of patients receiving palliative care.</p>","Logic Language":"javascript","Published At":"June 28, 2022, 5:52 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>For each prompt, the healthcare professional, caregiver, or patient should select a number based on how the patient feels now.&nbsp;</p>","Before Use":"","Favorite ID":"10,429","Short Title En":"ESAS-r","Cme Release Date":"","Slug":"edmonton-symptom-assessment-system-revised-esas-r","Short Description En":"<p>Palliative care symptom assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Rankin Score-9Q (mRS-9Q)","Created At":"June 28, 2022, 7:39 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 4:36 PM","Medium Description En":"<p>Assesses level of function in neurological disease.</p>","Logic Language":"javascript","Published At":"June 28, 2022, 7:39 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Click <a href=\"https://drive.google.com/drive/folders/1h392APPSNsrqCSqAbQIo31Tqluy-quTP\" target=\"_blank\" rel=\"noopener\">here</a> for translations of the mRS-9Q into multiple languages.</p>","Before Use":"","Favorite ID":"10,430","Short Title En":"mRS-9Q","Cme Release Date":"","Slug":"modified-rankin-score-9q-mrs","Short Description En":"<p>Level of function assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Modified Brain Injury Guideline (mBIG)","Created At":"July 13, 2022, 5:11 PM","Is Manual":"false","Dosing":"false","Updated At":"August 10, 2023, 3:16 PM","Medium Description En":"<p>Defines the management of traumatic brain injury.</p>","Logic Language":"javascript","Published At":"July 13, 2022, 5:11 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in traumatic brain injury patients with intracranial hemorrhage, <calculator id=\"64\">Glasgow Coma Score</calculator> 13-15, and no focal neurologic or pupillary findings.</p>","Before Use":"","Favorite ID":"10,432","Short Title En":"mBIG","Cme Release Date":"","Slug":"modified-brain-injury-guideline-mbig","Short Description En":"<p>Traumatic brain injury management.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Vaginal Birth After Cesarean (MFMU)","Created At":"July 21, 2022, 5:36 PM","Is Manual":"false","Dosing":"false","Updated At":"November 11, 2022, 7:06 PM","Medium Description En":"<p>Predicts chance of successful vaginal birth after cesarean (VBAC) delivery.</p>","Logic Language":"javascript","Published At":"July 21, 2022, 5:36 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Our calculator reflects the published regression analysis and AUC calculations from the original literature, which are available <a href=\"https://www.ajog.org/article/S0002-9378(21)00587-1/pdf\" target=\"_blank\" rel=\"noopener\">here</a>. Due to slight differences in rounding precision, you may notice minimal variations in results provided by this calculator versus others that are available.</p>\n<p></p>","Before Use":"","Favorite ID":"10,433","Short Title En":"VBAC (MFMU)","Cme Release Date":"","Slug":"vaginal-birth-after-cesarean-vbac","Short Description En":"<p>Successful vaginal birth prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Abnormal Involuntary Movement Scale (AIMS)","Created At":"August 9, 2022, 4:52 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 4:28 PM","Medium Description En":"<p>Measures involuntary movements of tardive dyskinesia (TD).</p>","Logic Language":"javascript","Published At":"August 9, 2022, 4:52 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Rate highest severity observed. Rate movements that occur upon activation one less than those observed spontaneously.</p>\n<p>Complete the <a href=\"https://cdn-web-img.mdcalc.com/aims.png\" target=\"_blank\" rel=\"noopener\">examination procedure</a> prior to making ratings. Note that the total AIMS score is not reported to the patient.</p>","Before Use":"","Favorite ID":"10,435","Short Title En":"AIMS","Cme Release Date":"","Slug":"abnormal-involuntary-movement-scale-aims","Short Description En":"<p>Tardive dyskinesia (TD) movement measurement.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Precision Medicine for Cardiomyopathy (PRIMaCY) Score","Created At":"August 31, 2022, 4:03 PM","Is Manual":"true","Dosing":"false","Updated At":"October 9, 2023, 5:32 PM","Medium Description En":"<p>Predicts sudden cardiac death (SCD) risk in pediatric patients with hypertrophic cardiomyopathy (HCM).</p>","Logic Language":"r","Published At":"August 31, 2022, 4:03 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &lt;18 years old at diagnosis with primary <abbr title=\"hypertrophic cardiomyopathy\">HCM</abbr>. Treatment decisions should be made with patient physician shared decision making.</p>","Before Use":"","Favorite ID":"10,438","Short Title En":"PRIMaCY Score","Cme Release Date":"","Slug":"precision-medicine-cardiomyopathy-primacy-score","Short Description En":"<p>SCD prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"American University of Beirut (AUB)-HAS2 Cardiovascular Risk Index","Created At":"August 31, 2022, 4:31 PM","Is Manual":"false","Dosing":"false","Updated At":"May 18, 2023, 8:59 PM","Medium Description En":"<p>Stratifies cardiovascular risk of patients undergoing noncardiac surgery.</p>","Logic Language":"javascript","Published At":"August 31, 2022, 4:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,439","Short Title En":"AUB-HAS2","Cme Release Date":"","Slug":"american-university-beirut-aub-has2-cardiovascular-risk-index","Short Description En":"<p>Cardiovascular risk stratification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Testicular Workup for Ischemia and Suspected Torsion (TWIST)","Created At":"October 14, 2022, 3:38 PM","Is Manual":"false","Dosing":"false","Updated At":"May 18, 2023, 8:57 PM","Medium Description En":"<p>Diagnoses testicular torsion, decreasing indication for ultrasound.</p>","Logic Language":"javascript","Published At":"May 18, 2023, 8:57 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,440","Short Title En":"TWIST","Cme Release Date":"","Slug":"testicular-workup-ischemia-suspected-torsion-twist","Short Description En":"<p>Testicular torsion diagnosis.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Indications for Paxlovid","Created At":"November 8, 2022, 7:27 PM","Is Manual":"false","Dosing":"true","Updated At":"September 25, 2023, 3:42 PM","Medium Description En":"<p>Assists in determining if Paxlovid (ritonovir-boosted nirmatrelvir) is appropriate therapy in a COVID positive adult patient.</p>","Logic Language":"javascript","Published At":"November 10, 2022, 2:27 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>In the United States, Paxlovid (ritonovir-boosted nirmatrelvir), is now approved by the Food and Drug Administration (FDA) for the treatment of COVID-19. Drug approval status may vary by country and is subject to change.</p>","Before Use":"","Favorite ID":"10,444","Short Title En":"Indications for Paxlovid","Cme Release Date":"","Slug":"indications-paxlovid-prescribing","Short Description En":"<p>Paxlovid indication.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Brief Alcohol Withdrawal Scale (BAWS)","Created At":"December 9, 2022, 3:23 PM","Is Manual":"false","Dosing":"false","Updated At":"February 22, 2023, 2:31 PM","Medium Description En":"<p>Assesses alcohol withdrawal symptoms.</p>","Logic Language":"javascript","Published At":"December 9, 2022, 6:12 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,446","Short Title En":"BAWS","Cme Release Date":"","Slug":"brief-alcohol-withdrawal-scale-baws","Short Description En":"<p>Assesses alcohol withdrawal.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+156","Full Title En":"STOP-BANG Score for Obstructive Sleep Apnea","Created At":"January 3, 2023, 4:44 PM","Is Manual":"false","Dosing":"false","Updated At":"May 31, 2023, 9:39 PM","Medium Description En":"<p>Screens for obstructive sleep apnea.</p>","Logic Language":"javascript","Published At":"January 3, 2023, 4:46 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+156","Cme Version":"3992.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: The STOP-BANG questionnaire screens for obstructive sleep apnea (OSA) only, not central sleep apnea.</p>","Before Use":"","Favorite ID":"3,992","Short Title En":"STOP-BANG","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"stop-bang-score-obstructive-sleep-apnea","Short Description En":"<p>Obstructive sleep apnea diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PHASES Score","Created At":"February 3, 2023, 4:13 PM","Is Manual":"false","Dosing":"false","Updated At":"May 19, 2023, 4:01 PM","Medium Description En":"<p>Predicts 5-year risk of rupture of intracranial aneurysms.</p>","Logic Language":"javascript","Published At":"February 3, 2023, 4:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\"><span>Use this score to calculate the 5-year risk of rupture of cerebral aneurysms that are found incidentally on imaging.&nbsp;</span></p>\n<p dir=\"ltr\"><span>This score was derived only from North American, European, Japanese, and Finnish populations. Score should be interpreted with caution if using outside of these populations. </span></p>\n<p></p>","Before Use":"","Favorite ID":"10,459","Short Title En":"PHASES Score","Cme Release Date":"","Slug":"phases-score","Short Description En":"<p>Aneurysm risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HACOR Score","Created At":"February 3, 2023, 6:50 PM","Is Manual":"false","Dosing":"false","Updated At":"May 18, 2023, 8:28 PM","Medium Description En":"<p>Predicts failure of noninvasive ventilation (NIV) in hypoxemic patients.</p>","Logic Language":"javascript","Published At":"February 3, 2023, 6:50 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score in patients who have undergone 1 hour of NIV to assist in predicting failure of NIV.</p>","Before Use":"","Favorite ID":"10,460","Short Title En":"HACOR Score","Cme Release Date":"","Slug":"hacor-score","Short Description En":"<p>NIV failure.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"American Urological Association Symptom Index (AUA-SI)/International Prostate Symptom Score (IPSS)","Created At":"February 10, 2023, 6:49 PM","Is Manual":"false","Dosing":"false","Updated At":"May 18, 2023, 8:24 PM","Medium Description En":"<p>Measures severity of benign prostatic hyperplasia (BPH) symptoms.</p>","Logic Language":"javascript","Published At":"February 10, 2023, 6:56 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,462","Short Title En":"AUA-SI/IPSS","Cme Release Date":"","Slug":"american-urological-association-symptom-index-aua-si","Short Description En":"<p>BPH severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HEADS-ED","Created At":"February 14, 2023, 6:15 PM","Is Manual":"false","Dosing":"false","Updated At":"May 16, 2023, 1:28 AM","Medium Description En":"<p>Screens for pediatric mental health needs.</p>","Logic Language":"javascript","Published At":"February 14, 2023, 6:16 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool provides individual recommendations for each item, along with a total score.&nbsp;</p>","Before Use":"","Favorite ID":"10,463","Short Title En":"HEADS-ED","Cme Release Date":"","Slug":"heads-ed","Short Description En":"<p>Pediatric mental health screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Adverse Childhood Experiences (ACE) Score","Created At":"February 22, 2023, 8:06 PM","Is Manual":"false","Dosing":"false","Updated At":"May 15, 2023, 9:15 PM","Medium Description En":"<p>Screens for adverse childhood experiences.</p>","Logic Language":"javascript","Published At":"February 22, 2023, 8:06 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to screen for adverse childhood experiences in adults and children. As the ACE score increases, so does the potential risk for chronic health problems. Identifying ACEs early can help with prevention and early intervention.</p>","Before Use":"","Favorite ID":"10,464","Short Title En":"ACE Score","Cme Release Date":"","Slug":"adverse-childhood-experiences-ace-score","Short Description En":"<p>ACE screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"IMPROVE Bleeding Risk Score","Created At":"February 22, 2023, 9:27 PM","Is Manual":"false","Dosing":"false","Updated At":"May 15, 2023, 9:01 PM","Medium Description En":"<p>Evaluates bleeding risk at hospital admission.</p>","Logic Language":"javascript","Published At":"February 22, 2023, 9:27 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to calculate the probability of major and clinically important bleeding from hospital admission to 14 days after admission. See <a href=\"#evidence\">Evidence</a> section for important definitions.</p>","Before Use":"","Favorite ID":"10,465","Short Title En":"IMPROVE Bleeding Risk Score","Cme Release Date":"","Slug":"improve-bleeding-risk-score","Short Description En":"<p>Bleeding risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Edinburgh Postnatal Depression Scale (EPDS)","Created At":"February 23, 2023, 6:25 PM","Is Manual":"false","Dosing":"false","Updated At":"May 15, 2023, 4:55 PM","Medium Description En":"<p>Screens for depression in the postnatal period.</p>","Logic Language":"javascript","Published At":"February 23, 2023, 6:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to screen for depression in the postpartum period. The original literature uses a cutoff score of 10 for a positive screen, as does our calculator. However, some studies and institutions use other cutoffs for a positive screen.</p>","Before Use":"","Favorite ID":"10,466","Short Title En":"EPDS","Cme Release Date":"","Slug":"edinburgh-postnatal-depression-scale-epds","Short Description En":"<p>Postnatal depression screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Shanghai Score","Created At":"June 10, 2024, 3:20 PM","Is Manual":"false","Dosing":"false","Updated At":"June 18, 2024, 9:00 PM","Medium Description En":"<p>Stratifies risk in suspected Brugada syndrome.</p>","Logic Language":"javascript","Published At":"June 10, 2024, 3:36 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,535","Short Title En":"Shanghai Score","Cme Release Date":"","Slug":"shanghai-score","Short Description En":"<p>Brugada syndrome risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Edmonton Obesity Staging System (EOSS)","Created At":"June 12, 2024, 2:03 PM","Is Manual":"false","Dosing":"false","Updated At":"June 18, 2024, 8:49 PM","Medium Description En":"<p>Stratifies the presence and severity of obesity-related health impairments.</p>","Logic Language":"javascript","Published At":"June 12, 2024, 2:54 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,536","Short Title En":"EOSS","Cme Release Date":"","Slug":"edmonton-obesity-staging-system-eoss","Short Description En":"<p>Obesity-related disease extent and severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Estimated/Expected Peak Expiratory Flow (Peak Flow)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 18, 2024, 3:11 PM","Medium Description En":"<p>Quantifies asthma exacerbation severity.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"790.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes inputs based on race, which may or may not provide better estimates, but cannot be run without inputting race due to how the formulae were developed by the CDC&rsquo;s&nbsp;<a href=\"https://wwwn.cdc.gov/nchs/nhanes/nhanes3/default.aspx\" target=\"_blank\" data-saferedirecturl=\"https://www.google.com/url?q=https://wwwn.cdc.gov/nchs/nhanes/nhanes3/default.aspx&amp;source=gmail&amp;ust=1632945061987000&amp;usg=AFQjCNEtD7jiifEUQ1hBE5GIAXdLuUIlUA\" rel=\"noopener\">Third National Health and Nutrition Examination Survey</a>&nbsp;<a href=\"https://www.mdcalc.com/race\" rel=\"noopener noreferrer\" target=\"_blank\" data-saferedirecturl=\"https://www.google.com/url?q=https://www.mdcalc.com/race&amp;source=gmail&amp;ust=1632945061987000&amp;usg=AFQjCNFHRRxG7_ZvVdEhZIQz2LsJKodMKw\">See here</a> for more on our approach to addressing race and bias on MDCalc.</p>","Favorite ID":"790","Short Title En":"Estimated Peak Flow","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"estimated-expected-peak-expiratory-flow-peak-flow","Short Description En":"<p>Quantifies asthma severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"VTE-BLEED Score","Created At":"March 1, 2023, 3:46 PM","Is Manual":"false","Dosing":"false","Updated At":"June 18, 2024, 9:22 PM","Medium Description En":"<p>Assesses risk of bleeding while on anticoagulation.</p>","Logic Language":"javascript","Published At":"March 1, 2023, 3:55 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to estimate the risk of major or clinically relevant bleeding after day 30 of anticoagulation administration for acute VTE. The original study enrolled patients who were taking either warfarin or dabigatran.</p>","Before Use":"","Favorite ID":"10,467","Short Title En":"VTE-BLEED Score","Cme Release Date":"","Slug":"vte-bleed-score","Short Description En":"<p>Anticoagulation bleeding risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"STUMBL/Battle Score","Created At":"March 20, 2023, 4:51 PM","Is Manual":"false","Dosing":"false","Updated At":"June 19, 2024, 4:47 PM","Medium Description En":"<p>Predicts morbidity in patients with blunt chest wall trauma.</p>","Logic Language":"javascript","Published At":"March 20, 2023, 4:51 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score in patients who present with blunt chest wall trauma to determine their risk of complications</p>","Before Use":"","Favorite ID":"10,468","Short Title En":"STUMBL/Battle Score","Cme Release Date":"","Slug":"stumbl-battle-score","Short Description En":"<p>Blunt chest wall trauma morbidity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"VIRSTA Score","Created At":"April 5, 2023, 4:55 PM","Is Manual":"false","Dosing":"false","Updated At":"May 12, 2023, 5:53 PM","Medium Description En":"<p>Estimates risk of infective endocarditis (IE) and determines priority for echocardiography.</p>","Logic Language":"javascript","Published At":"April 5, 2023, 4:55 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use to assess the risk of infective endocarditis within 48 hours of a diagnosis of Staphylococcus aureus bacteremia.</p>","Before Use":"","Favorite ID":"10,470","Short Title En":"VIRSTA Score","Cme Release Date":"","Slug":"virsta-score","Short Description En":"<p>IE risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Acute Renal Failure after Cardiac Surgery (Thakar Score)","Created At":"April 5, 2023, 6:41 PM","Is Manual":"false","Dosing":"false","Updated At":"May 12, 2023, 5:51 PM","Medium Description En":"<p>Predicts risk of acute renal failure (ARF) requiring dialysis after cardiac surgery.</p>","Logic Language":"javascript","Published At":"April 5, 2023, 6:52 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This score predicts development of acute renal failure that requires dialysis after cardiac surgery. Use in the preoperative setting to assist in risk stratification.</p>","Before Use":"","Favorite ID":"10,471","Short Title En":"Thakar Score","Cme Release Date":"","Slug":"acute-renal-failure-cardiac-surgery-thakar-score","Short Description En":"<p>ARF dialysis risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Relative Fat Mass (RFM)","Created At":"April 6, 2023, 5:49 PM","Is Manual":"false","Dosing":"false","Updated At":"May 12, 2023, 5:47 PM","Medium Description En":"<p>Estimates whole body fat percentage among adults.</p>","Logic Language":"javascript","Published At":"April 6, 2023, 5:49 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to estimate body adiposity in adult patients &ge;20 years.</p>","Before Use":"","Favorite ID":"10,472","Short Title En":"RFM","Cme Release Date":"","Slug":"relative-fat-mass-rfm","Short Description En":"<p>Body fat estimation.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Primary Care PTSD Screen for DSM-5 (PC-PTSD-5)","Created At":"April 6, 2023, 7:20 PM","Is Manual":"false","Dosing":"false","Updated At":"July 27, 2023, 10:04 PM","Medium Description En":"<p>Screens for PTSD in primary care populations.</p>","Logic Language":"javascript","Published At":"April 6, 2023, 7:21 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to screen for PTSD in your primary care patient. If the screen is positive, further assessment is necessary.</p>","Before Use":"","Favorite ID":"10,473","Short Title En":"PC-PTSD-5","Cme Release Date":"","Slug":"primary-care-ptsd-screen-dsm-5-pc-ptsd","Short Description En":"<p>PTSD screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"2HELPS2B Score","Created At":"April 6, 2023, 9:21 PM","Is Manual":"false","Dosing":"false","Updated At":"May 12, 2023, 5:37 PM","Medium Description En":"<p>Estimates seizure risk in acutely ill patients undergoing continuous EEG (cEEG).</p>","Logic Language":"javascript","Published At":"April 6, 2023, 9:22 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use after 1 hour of cEEG monitoring.</p>","Before Use":"","Favorite ID":"10,474","Short Title En":"2HELPS2B Score","Cme Release Date":"","Slug":"2helps2b-score","Short Description En":"<p>Seizure risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Tokuhashi Scoring System","Created At":"April 7, 2023, 8:01 PM","Is Manual":"false","Dosing":"false","Updated At":"May 12, 2023, 5:30 PM","Medium Description En":"<p>Predicts survival in patients with spinal tumors.</p>","Logic Language":"javascript","Published At":"April 7, 2023, 8:02 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this score to predict survival in patients with metastatic spinal disease.</p>","Before Use":"","Favorite ID":"10,475","Short Title En":"Revised Tokuhashi Scoring System","Cme Release Date":"","Slug":"revised-tokuhashi-scoring-system","Short Description En":"<p>Spinal tumor survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"MACOCHA Score","Created At":"May 10, 2023, 5:51 PM","Is Manual":"false","Dosing":"false","Updated At":"May 10, 2023, 6:02 PM","Medium Description En":"<p>Predicts difficult intubation in ICU patients.</p>","Logic Language":"javascript","Published At":"May 10, 2023, 5:51 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,476","Short Title En":"MACOCHA Score","Cme Release Date":"","Slug":"macocha-score","Short Description En":"<p>Difficult intubation prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"EUROMACS-RHF Score","Created At":"May 10, 2023, 9:25 PM","Is Manual":"false","Dosing":"false","Updated At":"June 6, 2023, 3:18 PM","Medium Description En":"<p>Determines risk of right ventricular HF in patients after LVAD implantation.</p>","Logic Language":"javascript","Published At":"May 10, 2023, 9:25 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,477","Short Title En":"EUROMACS-RHF Score","Cme Release Date":"","Slug":"euromacs-rhf-score","Short Description En":"<p>RHF risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Vesicoureteral Reflux Index (VURx)","Created At":"May 11, 2023, 4:37 PM","Is Manual":"false","Dosing":"false","Updated At":"May 11, 2023, 4:44 PM","Medium Description En":"<p>Predicts resolution of VUR in children.</p>","Logic Language":"javascript","Published At":"May 11, 2023, 4:37 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in children &lt;2 years to predict primary reflux improvement and resolution.</p>","Before Use":"","Favorite ID":"10,478","Short Title En":"VURx","Cme Release Date":"","Slug":"vesicoureteral-reflux-index-vurx","Short Description En":"<p>VUR resolution.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"CHADS-65 (Canadian Society of Cardiology Guideline)","Created At":"May 11, 2023, 8:41 PM","Is Manual":"false","Dosing":"false","Updated At":"July 17, 2023, 7:32 PM","Medium Description En":"<p>Guides antithrombotic therapy for patients with nonvalvular atrial fibrillation or atrial flutter.</p>","Logic Language":"javascript","Published At":"May 11, 2023, 8:41 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This tool is based only on expert opinion from the Canadian Cardiovascular Society and is included in their 2020 guidelines for atrial fibrillation care.</p>","Favorite ID":"10,479","Short Title En":"CHADS-65","Cme Release Date":"","Slug":"chads-65-canadian-society-of-cardiology","Short Description En":"<p>Antithrombotic therapy guide.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Tenecteplase (TNK) Dosing for Ischemic Stroke Calculator","Created At":"June 26, 2023, 3:02 PM","Is Manual":"false","Dosing":"true","Updated At":"August 15, 2023, 1:14 PM","Medium Description En":"<p>Doses tenecteplase (a type of tPA) for use in ischemic stroke.</p>","Logic Language":"javascript","Published At":"June 26, 2023, 3:50 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<ul>\n<li>Tenecteplase approval and recommendations for use vary by country. In the US, tenecteplase use in ischemic stroke is off-label.</li>\n<li>This calculator is for use in ischemic stroke patients only. Do NOT use for calculating doses in STEMI or PE.</li>\n</ul>","Favorite ID":"10,480","Short Title En":"TNKase Dosing","Cme Release Date":"","Slug":"tenecteplase-dosing","Short Description En":"<p>Tenecteplase dosing for ischemic stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Hypothermia Outcome Prediction after ECLS (HOPE) Score","Created At":"July 14, 2023, 3:09 PM","Is Manual":"false","Dosing":"false","Updated At":"October 10, 2023, 1:30 PM","Medium Description En":"<p>Predicts survival following rewarming of hypothermic cardiac arrest patients.</p>","Logic Language":"javascript","Published At":"July 14, 2023, 3:12 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,482","Short Title En":"HOPE Score","Cme Release Date":"","Slug":"hypothermia-outcome-prediction-after-ecls-hope-score","Short Description En":"<p>Hypothermic cardiac arrest survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Revised Opioid Risk Tool (ORT-OUD)","Created At":"July 20, 2023, 4:49 PM","Is Manual":"false","Dosing":"false","Updated At":"July 21, 2023, 4:41 PM","Medium Description En":"<p>Measures risk of opioid drug abuse in patients with chronic pain.</p>","Logic Language":"javascript","Published At":"July 20, 2023, 4:49 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This is an updated version of the previously published <calculator id=\"1757\">Opioid Risk Tool</calculator>. Based on new research, the input of history of preadolescent sexual abuse has been removed, along with the sex based scoring system. Please see <a href=\"#evidence\">Evidence</a> for more information.</p>","Before Use":"","Favorite ID":"10,483","Short Title En":"ORT-OUD","Cme Release Date":"","Slug":"revised-opioid-risk-tool-ort-oud","Short Description En":"<p>Opioid abuse risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Menza Score","Created At":"May 1, 2024, 5:38 PM","Is Manual":"false","Dosing":"false","Updated At":"May 29, 2024, 9:09 PM","Medium Description En":"<p>Predicts 4-year risk of HIV for MSM.</p>","Logic Language":"javascript","Published At":"May 1, 2024, 5:44 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,519","Short Title En":"Menza Score","Cme Release Date":"","Slug":"menza-score","Short Description En":"<p>4-year HIV risk for MSM.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"McDonald Criteria for Multiple Sclerosis (2017 Revision)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 29, 2024, 6:18 PM","Medium Description En":"<p><span id=\"docs-internal-guid-b21a6433-7fff-ffea-899a-8e2ef396b96f\">Diagnoses multiple sclerosis.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p dir=\"ltr\">Changes from the 2010 McDonald Criteria:</p>\n<ol>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Presence of <abbr title=\"Cerebrospinal fluid\">CSF</abbr>-specific oligoclonal bands may now substitute for dissemination in time (DIT) even if baseline MRI findings do not meet DIT criteria.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In patients with brainstem or spinal cord attacks, symptomatic lesions may now be included as MRI evidence of dissemination in space (DIS) or DIT.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cortical lesions may now fulfill MRI criteria for DIS (in addition to juxtacortical lesions).</p>\n</li>\n</ol>","Before Use":"","Favorite ID":"10,162","Short Title En":"McDonald Criteria (2017 Revision)","Cme Release Date":"","Slug":"mcdonald-criteria-multiple-sclerosis-2017-revision","Short Description En":"<p>MS diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"PECARN Rule for Low Risk Febrile Infants 29-60 Days Old","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 29, 2024, 6:01 PM","Medium Description En":"<p>Predicts risk of urinary tract infection, bacteremia, or bacterial meningitis in febrile infants age 29-60 days old.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10204.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Does not apply to ill-appearing infants. The rule is intended to be one-directional: it may help rule out serious bacterial infection (SBI) in patients who are &ldquo;low risk&rdquo;, but the converse is not true (i.e., patients who are &ldquo;not low risk&rdquo; by the rule do not necessarily have SBI).</p>","Before Use":"<p><span id=\"docs-internal-guid-93dab61e-7fff-d8e3-d587-2e77394d27f3\">This calculator is not yet externally validated.&nbsp;While&nbsp;derived in infants aged 0-60 days, the creators recommend using this calculator <strong>only</strong> in infants aged 29-60 days (i.e., do not use in infants 28 days or younger), due to&nbsp;elevated herpes meningoencephalitis risk and and limited numbers of episodes of bacterial meningitis in that age group (see <a href=\"#pearls-pitfalls\">Pearls/Pitfalls</a> and <a href=\"#creator-insights\">Creator Insights</a> for details).</span></p>","Favorite ID":"10,204","Short Title En":"PECARN Febrile Infants (29-60 Days Old)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"pecarn-rule-low-risk-febrile-infants-29-60-days-old","Short Description En":"<p>Serious bacterial infection risk in febrile infants 29-60 days old.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+13","Full Title En":"Aortic Dissection Detection Risk Score (ADD-RS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 20, 2023, 6:46 PM","Medium Description En":"<p>Rules out aortic dissection.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+13","Cme Version":"4060.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This tool assumes lab reporting of d-dimer in fibrinogen equivalent units (FEU). Know how your institution reports d-dimer levels and adjust accordingly.&nbsp;</p>\n<p>ADD-RS + D-dimer (the ADvISED study algorithm) has not been externally validated in ruling out acute aortic dissection and should thus be used with caution. The ADD-RS itself is validated.</p>","Favorite ID":"4,060","Short Title En":"ADD-RS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"aortic-dissection-detection-risk-score-add-rs","Short Description En":"<p>Rules out aortic dissection.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Oakland Score for Safe Discharge After Lower GI Bleed","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"November 14, 2023, 8:53 PM","Medium Description En":"<p>Predicts readmission risk in patients with acute lower GI bleeding.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients presenting with lower GI bleed (urgent, emergent, or primary care setting) to help determine if outpatient management is feasible.</p>","Before Use":"","Favorite ID":"10,042","Short Title En":"Oakland Score","Cme Release Date":"","Slug":"oakland-score-safe-discharge-lower-gi-bleed","Short Description En":"<p>Lower GI bleed readmission risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Pediatric Early Warning Score (PEWS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 7:52 PM","Medium Description En":"<p>Identifies pediatric patients at risk for clinical deterioration.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,901","Short Title En":"PEWS Score","Cme Release Date":"","Slug":"pediatric-early-warning-score-pews","Short Description En":"<p>Identifies pediatric patients at risk for deterioration.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Additional Nodal Metastasis Nomogram","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 7:31 PM","Medium Description En":"<p>Predicts likelihood of breast cancer with sentinel lymph node metastasis has also spread to additional lymph nodes.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,909","Short Title En":"Additional Nodal Metastasis Nomogram","Cme Release Date":"","Slug":"additional-nodal-metastasis-nomogram","Short Description En":"<p>Additional lymph node mets in breast CA.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Charlson Comorbidity Index (CCI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 6, 2024, 4:37 PM","Medium Description En":"<p>Predicts 10-year survival in patients with multiple comorbidities.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,917","Short Title En":"Charlson Comorbidity Index","Cme Release Date":"","Slug":"charlson-comorbidity-index-cci","Short Description En":"<p>10-year survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+31","Full Title En":"CATCH (Canadian Assessment of Tomography for Childhood Head injury) Rule","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 6, 2024, 7:26 PM","Medium Description En":"<p><span>Predicts clinically significant head injuries in children.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+31","Cme Version":"3954.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Use in patients up to 16 yrs with minor head injury and initial <calculator id=\"64\">Glasgow Coma Scale</calculator> at least 13, injury within 24 hrs, plus at least one of the following: blunt trauma with witnessed <abbr title=\"loss of consciousness\">LOC</abbr>, amnesia, witnessed disorientation, vomiting 2+ times at least 15 mins apart, persistent irritability if under 2 years old. Do NOT use if: penetrating skull injury, depressed fx, focal neuro deficit, developmental delay, child abuse, re-eval after prior head injury, pregnant patient. Note: We recommend using <calculator id=\"589\">PECARN</calculator>, as it is more widely validated.</span></p>","Before Use":"","Favorite ID":"3,954","Short Title En":"CATCH Rule","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"catch-canadian-assessment-tomography-childhood-head-injury-rule","Short Description En":"<p>Clinically significant head injuries in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Urinary Protein Excretion Estimation","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 24, 2024, 8:19 PM","Medium Description En":"<p>Quantifies 24-hour proteinuria with protein/creatinine ratio from a single urine sample.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3945.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Avoid using overnight or first morning void as urine sample.</p>","Before Use":"","Favorite ID":"3,945","Short Title En":"Urinary Protein Excretion Estimation","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"urinary-protein-excretion-estimation","Short Description En":"<p>Quantifies 24-hour proteinuria.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Prague C & M Classification for Barrett's Esophagus","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 3, 2024, 4:10 PM","Medium Description En":"<p>Stratifies severity of Barrett's esophagus according to endoscopic findings.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,041","Short Title En":"Prague C & M Classification","Cme Release Date":"","Slug":"prague-c-m-classification-barretts-esophagus","Short Description En":"<p>Stratifies severity of Barrett's esophagus.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+58","Full Title En":"Functional Outcome in Patients With Primary Intracerebral Hemorrhage (FUNC) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 10:59 PM","Medium Description En":"<p>Identifies patients with ICH who will attain functional independence and assists in clinical decision-making.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+58","Cme Version":"3883.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use when the diagnosis of ICH is made, NOT as a continuously changing marker of neurologic status as <calculator id=\"64\">GCS</calculator> is used. Use only in patients with primary ICH. Do not use in patients with ICH from trauma, conversion from ischemic stroke, supratherapeutic INR (see Evidence section for full exclusion criteria).</p>","Before Use":"","Favorite ID":"3,883","Short Title En":"FUNC Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"functional-outcome-patients-primary-intracerebral-hemorrhage-func-score","Short Description En":"<p>Likelihood of functional independence after ICH.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+136","Full Title En":"Risk of Paradoxical Embolism (RoPE) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:00 PM","Medium Description En":"<p>Identifies stroke-related PFO in patients with cryptogenic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+136","Cme Version":"3902.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with cryptogenic stroke found to have PFO and no other compelling cause for stroke.</p>","Before Use":"","Favorite ID":"3,902","Short Title En":"RoPE Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"risk-paradoxical-embolism-rope-score","Short Description En":"<p>Identifies stroke-related PFO in cryptogenic stroke patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+133","Full Title En":"Reynolds Risk Score for Cardiovascular Risk in Women","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:02 PM","Medium Description En":"<p>Estimates 10-year cardiovascular risk in women over age 45 years.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+133","Cme Version":"3932.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,932","Short Title En":"Reynolds Risk Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"reynolds-risk-score-cardiovascular-risk-women","Short Description En":"<p>Estimates cardiac risk in women over 45.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+162","Full Title En":"tPA (Alteplase) Dosing for Ischemic Stroke Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"true","Updated At":"February 14, 2024, 11:02 PM","Medium Description En":"<p>Doses alteplase (a type of tPA) for ischemic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+162","Cme Version":"3940.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator is for double-checking tPA dosing, and should NOT be used as the primary means for ordering tPA.</p>\n<p>Use in ischemic stroke patients only. Do NOT use in acute coronary syndrome or PE.</p>","Favorite ID":"3,940","Short Title En":"tPA Dosing for Stroke Calculator","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"tpa-tissue-plasminogen-activator-dosing-stroke-calculator","Short Description En":"<p>Doses tPA for stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+80","Full Title En":"Los Angeles Motor Scale (LAMS)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:04 PM","Medium Description En":"<p><span>Stratifies stroke severity in the field.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+80","Cme Version":"3959.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,959","Short Title En":"LAMS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"los-angeles-motor-scale-lams","Short Description En":"<p>Stroke severity in the field.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+92","Full Title En":"Modified SOAR Score for Stroke","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:06 PM","Medium Description En":"<p>Predicts short-term mortality in acute ischemic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+92","Cme Version":"3966.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use admission data for calculation. Do not use in patients with transient ischemic attack, subarachnoid hemorrhage, or subdural hemorrhage.</p>","Before Use":"","Favorite ID":"3,966","Short Title En":"mSOAR Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"modified-soar-score-stroke","Short Description En":"<p>Early stroke mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+16","Full Title En":"ASTRAL Score for Ischemic Stroke","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:06 PM","Medium Description En":"<p>Predicts 90-day poor outcome in patients with acute ischemic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+16","Cme Version":"3967.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with acute ischemic stroke admitted within 24 hours of stroke onset.</p>","Before Use":"","Favorite ID":"3,967","Short Title En":"ASTRAL Score","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"astral-score-stroke","Short Description En":"<p>90-day poor outcome in stroke.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+57","Full Title En":"FOUR (Full Outline of UnResponsiveness) Score","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:07 PM","Medium Description En":"<p>Grades coma severity; may be more accurate than the Glasgow Coma Scale.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+57","Cme Version":"10028.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-24dd94e7-ffd5-5be0-0de8-a0f395663213\">Grade the best response in each category.</span></p>","Before Use":"","Favorite ID":"10,028","Short Title En":"FOUR Score","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"four-full-outline-unresponsiveness-score","Short Description En":"<p>Coma severity (better than GCS).</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+104","Full Title En":"ORBIT Bleeding Risk Score for Atrial Fibrillation","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:08 PM","Medium Description En":"<p>Predicts bleeding risk in patients on anticoagulation for afib, similar to <calculator id=\"807\">HAS-BLED</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+104","Cme Version":"10227.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in adult patients with atrial fibrillation, to assess risk of major bleeding with anticoagulation.</p>","Before Use":"","Favorite ID":"10,227","Short Title En":"ORBIT Score for Afib","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"orbit-bleeding-risk-score-atrial-fibrillation","Short Description En":"<p>Anticoagulation bleeding risk in afib.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+113","Full Title En":"Pediatric NIH Stroke Scale (NIHSS)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:08 PM","Medium Description En":"<p>Quantifies stroke severity using a child-specific version of the <calculator id=\"715\">NIH Stroke Score</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+113","Cme Version":"10270.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Administer the questions in the order below. In order to improve score accuracy, emphasize with family members the need to refrain from hinting at the correct responses to questions asked.</p>","Before Use":"","Favorite ID":"10,270","Short Title En":"PedNIHSS","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"pediatric-nih-stroke-scale-nihss","Short Description En":"<p>Pediatric modification of the NIHSS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"tPA Contraindications for Ischemic Stroke","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 15, 2024, 5:10 PM","Medium Description En":"<p>Provides inclusion/exclusion criteria when deciding to use tPA on a patient with acute ischemic stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"1934.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Institutions may have slightly different absolute and relative contraindications to Tissue Plasminogen Activator (tPA); this list is meant to be a quick reference, but practice should be guided by institutional protocol and consultation with neurology.&nbsp;Reflects recommendations from <a href=\"https://stroke.ahajournals.org/content/early/2015/12/22/STR.0000000000000086.full.pdf+html\" target=\"_blank\" rel=\"noopener\">Demaerschalk et al, Stroke 2015</a>.</p>","Before Use":"","Favorite ID":"1,934","Short Title En":"tPA Contraindications","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"tpa-contraindications-ischemic-stroke","Short Description En":"<p>Inclusion and exclusion criteria for tPA.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"International IgA Nephropathy Prediction Tool","Created At":"June 6, 2024, 6:37 PM","Is Manual":"false","Dosing":"false","Updated At":"June 20, 2024, 9:40 PM","Medium Description En":"<p>Predicts risk of 50% decline in eGFR or end-stage kidney disease in patients with IgA nephropathy.</p>","Logic Language":"javascript","Published At":"June 6, 2024, 9:04 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This calculator includes models which contain race as an input. Study authors have also developed a model which does not include race, making the input optional. <a target=\"_blank\" data-stringify-link=\"https://www.mdcalc.com/race\" delay=\"150\" data-sk=\"tooltip_parent\" href=\"https://www.mdcalc.com/race\" rel=\"noopener\">See here</a> for more on our approach to addressing race and bias on MDCalc.</p>","Favorite ID":"10,533","Short Title En":"International IgA Nephropathy Prediction Tool","Cme Release Date":"","Slug":"international-iga-nephropathy-prediction-tool","Short Description En":"<p>IgAN disease progression risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Neonatal Early-Onset Sepsis Calculator","Created At":"May 30, 2024, 7:36 PM","Is Manual":"false","Dosing":"false","Updated At":"June 20, 2024, 8:05 PM","Medium Description En":"<p>Calculates neonatal early-onset sepsis risk based on maternal intrapartum risk factors.</p>","Logic Language":"javascript","Published At":"May 30, 2024, 7:57 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to predict the risk of early-onset sepsis in newborns who are born <span style=\"text-decoration: underline;\">&gt;</span>34 weeks gestation.</p>","Before Use":"","Favorite ID":"10,528","Short Title En":"Neonatal Early-Onset Sepsis Calculator","Cme Release Date":"","Slug":"neonatal-early-onset-sepsis-calculator","Short Description En":"<p>Neonatal early-onset sepsis risk.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"","Full Title En":"Brief Resolved Unexplained Events 2.0 (BRUE 2.0) Criteria for Infants","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"June 11, 2024, 5:32 PM","Medium Description En":"<p>Classifies unexplained events, improves on the <calculator id=\"4016\">BRUE Criteria</calculator>.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in infants &lt;1 year old who are asymptomatic and in their normal state of health at the time of evaluation. Do not use in symptomatic patients (e.g. fever, respiratory distress) or those with obvious cause for prior symptoms.</p>","Before Use":"","Favorite ID":"10,400","Short Title En":"BRUE 2.0","Cme Release Date":"","Slug":"brief-resolved-unexplained-events-2.0-brue-2.0-criteria-infants","Short Description En":"<p>Classifies unexplained events.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"The Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT) Questionnaire","Created At":"May 30, 2024, 6:23 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 3:13 PM","Medium Description En":"<p>Screens for substance use risk in adolescents.</p>","Logic Language":"javascript","Published At":"May 30, 2024, 6:42 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool reflects CRAFFT 2.1.</p>","Before Use":"","Favorite ID":"10,527","Short Title En":"CRAFFT","Cme Release Date":"","Slug":"car-relax-alone-forget-friends-trouble-crafft-questionnaire","Short Description En":"<p>Adolescent substance use risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"C-Peptide to Glucose Ratio","Created At":"May 31, 2024, 5:46 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 3:20 PM","Medium Description En":"<p>Assesses beta cell secretory function in patients with diabetes/prediabetes.</p>","Logic Language":"javascript","Published At":"May 31, 2024, 6:45 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,529","Short Title En":"C-Peptide to Glucose Ratio","Cme Release Date":"","Slug":"c-peptide-glucose-ratio","Short Description En":"<p>Beta cell secretory function.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Swede Score","Created At":"May 31, 2024, 8:20 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 4:59 PM","Medium Description En":"<p>Colposcopically ​​predicts high-grade lesions (HGL) in histology.</p>","Logic Language":"javascript","Published At":"May 31, 2024, 8:34 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,531","Short Title En":"Swede Score","Cme Release Date":"","Slug":"swede-score","Short Description En":"<p>High-grade lesion prediction.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Reid's Colposcopic Index (RCI)","Created At":"May 31, 2024, 7:45 PM","Is Manual":"false","Dosing":"false","Updated At":"June 14, 2024, 9:42 PM","Medium Description En":"<p>Colposcopically predicts histological grade of premalignant cervical lesions.</p>","Logic Language":"javascript","Published At":"May 31, 2024, 8:03 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,530","Short Title En":"RCI","Cme Release Date":"","Slug":"reids-colposcopic-index-rci","Short Description En":"<p>Premalignant cervical lesion grading.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Metabolic Score for Insulin Resistance (METS-IR)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"June 14, 2024, 6:00 PM","Medium Description En":"<p>Predicts risk of type 2 diabetes in previously undiagnosed patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,181","Short Title En":"METS-IR ","Cme Release Date":"","Slug":"metabolic-score-insulin-resistance-mets-ir","Short Description En":"<p>Type 2 diabetes risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Drug Abuse Screening Test-10 (DAST-10)","Created At":"May 29, 2024, 8:27 PM","Is Manual":"false","Dosing":"false","Updated At":"June 10, 2024, 4:25 PM","Medium Description En":"<p>Assesses illicit drug use in the past year.</p>","Logic Language":"javascript","Published At":"May 29, 2024, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,526","Short Title En":"DAST-10","Cme Release Date":"","Slug":"drug-abuse-screening-test-10-dast-10","Short Description En":"<p>Illicit drug use.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Diabetes Distress Scale (DDS17)","Created At":"May 23, 2024, 5:30 PM","Is Manual":"false","Dosing":"false","Updated At":"June 7, 2024, 5:18 PM","Medium Description En":"<p>Evaluates diabetes-related emotional distress.</p>","Logic Language":"javascript","Published At":"May 23, 2024, 6:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,523","Short Title En":"DDS17","Cme Release Date":"","Slug":"diabetes-distress-scale-dds17","Short Description En":"<p>Diabetes distress.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"HEART Pathway for Early Discharge in Acute Chest Pain","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 26, 2024, 9:55 PM","Medium Description En":"<p>Identifies emergency department patients with acute chest pain for early discharge.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3975.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;21 years old presenting with symptoms suggestive of ACS. Do not use if new ST-segment elevation &ge;1 mm or other new EKG changes, hypotension, life expectancy less than 1 year, or noncardiac medical/surgical/psychiatric illness determined by the provider to require admission.</p>","Before Use":"","Favorite ID":"3,975","Short Title En":"HEART Pathway","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"heart-pathway-early-discharge-acute-chest-pain","Short Description En":"<p>Early discharge in acute chest pain.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Palchak (UC Davis) Rule for Pediatric Head Trauma","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 26, 2024, 9:54 PM","Medium Description En":"<p><span>Identifies children at low risk for brain injuries after blunt head trauma.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: We recommend using <calculator id=\"589\">PECARN</calculator> over other pediatric head trauma rules, as it is the most widely validated.</p>","Before Use":"","Favorite ID":"3,955","Short Title En":"Palchak (UC Davis) Rule","Cme Release Date":"","Slug":"palchak-uc-davis-rule-pediatric-head-trauma","Short Description En":"<p>Clinically significant head injuries in children.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PELD Score (Pediatric End-Stage Liver Disease) (younger than 12)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 29, 2024, 7:09 PM","Medium Description En":"<p>Calculates the pediatric version of the MELD score for liver cirrhosis severity and transplant planning.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"87","Short Title En":"PELD Score","Cme Release Date":"","Slug":"peld-score-pediatric-end-stage-liver-disease-younger-12","Short Description En":"<p>Peds version of MELD Score.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"RENAL Nephrometry Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:28 PM","Medium Description En":"<p>Categorizes renal masses by complexity for surgical decision-making.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3908.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use cross-sectional imaging (CT or MRI, not ultrasound).</p>","Before Use":"","Favorite ID":"3,908","Short Title En":"RENAL Nephrometry Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"renal-nephrometry-score","Short Description En":"<p>Renal mass anatomic complexity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:29 PM","Medium Description En":"<p>Predicts likelihood that syncope is from cardiac cause.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span>Note: We recommend the <calculator id=\"93\">San Francisco Syncope Rule</calculator> over other syncope risk stratification scores, as it is the most widely validated.</span></p>","Before Use":"","Favorite ID":"3,948","Short Title En":"EGSYS Score","Cme Release Date":"","Slug":"egsys-evaluation-guidelines-syncope-study-score-syncope","Short Description En":"<p>Identifies cardiac syncope.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"OESIL Score for Syncope","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:31 PM","Medium Description En":"<p>Estimates 12-month all-cause mortality in patients presenting with syncope.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"3,950","Short Title En":"OESIL Score","Cme Release Date":"","Slug":"oesil-score-syncope","Short Description En":"<p>Mortality in syncope patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Cambridge Diabetes Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:35 PM","Medium Description En":"<p>Predicts risk of having previously undiagnosed type 2 diabetes.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use to estimate risk that patient currently has undiagnosed diabetes (i.e., NOT future risk of developing diabetes). Study cohort involved mostly white English patients, so use with caution in other populations.</p>","Before Use":"","Favorite ID":"4,001","Short Title En":"Cambridge Diabetes Risk Score","Cme Release Date":"","Slug":"cambridge-diabetes-risk-score","Short Description En":"<p>T2DM risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Diabetic Ketoacidosis Mortality Prediction Model (DKA MPM) Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:35 PM","Medium Description En":"<p><span>Predicts in-hospital mortality in DKA.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Note: This calculator is not externally validated and should be used with caution. It is not intended to routinely disposition patients. The <calculator id=\"1868\">APACHE II Score</calculator> may be a better mortality predictor. Use in patients with DKA.</p>","Before Use":"","Favorite ID":"4,003","Short Title En":"DKA MPM Score","Cme Release Date":"","Slug":"diabetic-ketoacidosis-mortality-prediction-model-dka-mpm-score","Short Description En":"<p>In-hospital DKA mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"American Diabetes Association (ADA) Risk Calculator","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:37 PM","Medium Description En":"<p>Predicts risk of undiagnosed diabetes to determine who should be screened.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"4,020","Short Title En":"ADA Diabetes Risk Calculator","Cme Release Date":"","Slug":"american-diabetes-association-ada-risk-calculator","Short Description En":"<p>T2DM risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Canadian Syncope Risk Score","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:32 PM","Medium Description En":"<p>Predicts 30-day serious adverse events in patients presenting with syncope.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3951.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Applicable to patients &ge;16 years old presenting &le;24 hours of syncope. Do not use if: prolonged (&gt;5 min) <abbr style=\"color: #ffb600;\" title=\"Loss of consciousness\">LOC</abbr>, change in mental status from baseline, obvious witnessed seizure, major trauma, intoxication, language barrier, or head trauma causing LOC. This calculator is externally validated, according to data presented at the Society for Academic Emergency Medicine Annual Meeting 2018.</p>","Before Use":"","Favorite ID":"3,951","Short Title En":"Canadian Syncope Risk Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"canadian-syncope-risk-score","Short Description En":"<p>Morbidity and mortality in syncope patients.</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+77","Full Title En":"Jones Criteria for Acute Rheumatic Fever Diagnosis","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"May 2, 2024, 4:43 PM","Medium Description En":"<p>Diagnoses acute rheumatic fever based on major and minor criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+77","Cme Version":"4027.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p><span id=\"docs-internal-guid-902d712b-7fff-54c5-d116-131b1fc25a90\">Note: As of 2015, the Jones Criteria have been updated to include the use of doppler echocardiography. See <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25908771\" target=\"_blank\" rel=\"noopener\">AHA's update</a>.</span></p>","Favorite ID":"4,027","Short Title En":"Jones Criteria for ARF","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"jones-criteria-acute-rheumatic-fever-diagnosis","Short Description En":"<p>Rheumatic fever diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Model for End-Stage Liver Disease (Combined MELD)","Created At":"August 10, 2022, 6:48 PM","Is Manual":"false","Dosing":"false","Updated At":"May 6, 2024, 4:34 PM","Medium Description En":"<p><span>Offers multiple versions of MELD for liver transplant planning.</span></p>","Logic Language":"javascript","Published At":"August 10, 2022, 6:48 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>MDCalc has streamlined the MELD calculator collection.</p>\n<p>On this page, you'll find the original MELD Score (Pre-2016), MELD Na (previously UNOS/OPTN standard), and MELD 3.0. MELD 3.0 is the current standard calculation for organ transplantation consideration in the United States and better accounts for disparities in organ allotment based on sex.&nbsp;</p>","Favorite ID":"10,437","Short Title En":"Combined MELD","Cme Release Date":"","Slug":"model-end-stage-liver-disease-meld","Short Description En":"<p>MELD models for liver transplant planning.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Phoenix Sepsis Score","Created At":"February 28, 2024, 5:51 PM","Is Manual":"false","Dosing":"false","Updated At":"April 8, 2024, 6:51 PM","Medium Description En":"<p>Evaluates for sepsis and septic shock in children.</p>","Logic Language":"javascript","Published At":"February 28, 2024, 6:00 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in pediatric patients with suspected sepsis. Age is not adjusted for prematurity and the criteria should not be used in patients who are &ge;<span style=\"text-decoration: underline;\"></span>18 years of age or preterm (&lt;37 weeks gestation at birth). The score should not be used during birth hospitalizations.</p>","Before Use":"","Favorite ID":"10,509","Short Title En":"Phoenix Sepsis Score","Cme Release Date":"","Slug":"phoenix-sepsis-score","Short Description En":"<p>Pediatric sepsis and septic shock.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"2023 Emergency Medicine Coding Guide","Created At":"January 26, 2023, 10:30 PM","Is Manual":"false","Dosing":"false","Updated At":"March 21, 2024, 4:03 PM","Medium Description En":"<p>Rates level of service required in emergency medicine.</p>","Logic Language":"javascript","Published At":"January 26, 2023, 10:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This guide reflects the 2023 AMA CPT Evaluation and Management (E/M) coding changes for Emergency Medicine. Definitions have been simplified and are based on the full coding guideline available <a href=\"https://www.ama-assn.org/system/files/2023-e-m-descriptors-guidelines.pdf\" target=\"_blank\" rel=\"noopener\">here</a>.</p>\n<p class=\"p1\">Click the Copy MDM button in the results box below to paste the narrative MDM (web only).</p>","Before Use":"","Favorite ID":"10,454","Short Title En":"2023 EM Coding Guide","Cme Release Date":"","Slug":"2023-emergency-medicine-coding-guide","Short Description En":"<p>EM service rating.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ACEP ED COVID-19 Management Tool","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"May 15, 2024, 6:16 PM","Medium Description En":"<p>Emergency department classification and management tool for adult patients (greater than 18 years old) with suspected or confirmed SARS-CoV-2 (v3.0, updated Fall 2023).</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<ul>\n<li>This is intended for patients 18 years and older.</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Evidence on this topic is evolving quickly and may change.</p>\n</li>\n</ul>","Before Use":"<p>Launched during COVID-19 crisis. <a href=\"https://www.acep.org/globalassets/sites/acep/media/covid-19-main/acep-covid-19-ed-management-tool.pdf\" target=\"_blank\" rel=\"noopener\">This tool</a> is an expert consensus flowsheet based on evidence based studies, but has not been validated as an evidence based tool itself. <a href=\"https://www.acep.org/corona/COVID-19-alert/covid-19-articles/covid-19-ED-management-tool-now-available/\" target=\"_blank\" rel=\"noopener\"><strong>See more</strong></a>.<br><br>This ACEP ED COVID-19 Management Tool was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (<a href=\"https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=NU50CK000570&amp;arg_ProgOfficeCode=252\" target=\"_blank\" rel=\"noopener\">grant number 1 NU50CK000570</a>). The CDC is an agency within the Department of Health and Human Services (HHS). The contents of this ACEP tool do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.</p>","Favorite ID":"10,373","Short Title En":"ACEP ED COVID-19 Management Tool","Cme Release Date":"","Slug":"acep-ed-covid-19-management-tool","Short Description En":"<p>ED management tool for COVID-19.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Systematic Coronary Risk Evaluation 2-Older Persons (SCORE2-OP)","Created At":"February 2, 2024, 6:38 PM","Is Manual":"false","Dosing":"false","Updated At":"March 4, 2024, 10:37 PM","Medium Description En":"<p>Predicts 10-year CVD risk in older patients.</p>","Logic Language":"javascript","Published At":"February 2, 2024, 8:05 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;70 years.</p>","Before Use":"","Favorite ID":"10,503","Short Title En":"SCORE2-OP","Cme Release Date":"","Slug":"score2-older-persons-score2-op","Short Description En":"<p>Older patients' 10-yr CVD risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Therapy-Disability-Neurology (TDN) Grade","Created At":"February 10, 2023, 3:32 PM","Is Manual":"false","Dosing":"false","Updated At":"February 19, 2024, 6:55 PM","Medium Description En":"<p>Classifies severity of adverse events after neurosurgery.</p>","Logic Language":"javascript","Published At":"February 10, 2023, 3:32 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,461","Short Title En":"TDN Grade","Cme Release Date":"","Slug":"therapy-disability-neurology-tdn-grade","Short Description En":"<p>Neurosurgery adverse events classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Dropdown Test","Created At":"November 15, 2022, 8:40 PM","Is Manual":"false","Dosing":"false","Updated At":"November 16, 2022, 8:21 PM","Medium Description En":"<p>dropdown test</p>","Logic Language":"javascript","Published At":"November 15, 2022, 8:41 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,445","Short Title En":"Drop Test","Cme Release Date":"","Slug":"dropdown-test","Short Description En":"<p>dropdown test</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"smoke test #1","Created At":"March 31, 2023, 7:59 PM","Is Manual":"false","Dosing":"false","Updated At":"July 26, 2023, 10:36 PM","Medium Description En":"<p>Mid descrip - HTML</p>\n<p>Test 2</p>","Logic Language":"javascript","Published At":"July 26, 2023, 10:33 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,469","Short Title En":"smoke test #1","Cme Release Date":"","Slug":"smoke-test-1","Short Description En":"<p>Short descrip - HTML</p>"},
{"Diagnostic Criteria":"true","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+46","Full Title En":"Embolic Stroke of Undetermined Source (ESUS) Criteria","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:07 PM","Medium Description En":"<p>Diagnoses embolic stroke of undetermined source.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+46","Cme Version":"10007.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients with ischemic stroke only, not hemorrhagic stroke.</p>","Before Use":"","Favorite ID":"10,007","Short Title En":"ESUS Criteria","Cme Release Date":"2020-10-08 00:00:00+00+00","Slug":"embolic-stroke-undetermined-source-esus-criteria","Short Description En":"<p>Embolic stroke of undetermined source diagnosis.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"Pediatric Crohn’s Disease Activity Index (PCDAI)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 7, 2024, 3:45 PM","Medium Description En":"<p>Stratifies severity of Crohn's disease in pediatric patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"3907.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &le;19 years old.</p>","Before Use":"","Favorite ID":"3,907","Short Title En":"PCDAI Score","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"pediatric-crohns-disease-activity-index-pcdai","Short Description En":"<p>Pediatric Crohn's severity.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Systematic Coronary Risk Evaluation 2 (SCORE2)","Created At":"January 16, 2024, 9:40 PM","Is Manual":"false","Dosing":"false","Updated At":"March 4, 2024, 10:27 PM","Medium Description En":"<p>Predicts 10-year CVD risk in patients without prior CVD or diabetes.</p>","Logic Language":"javascript","Published At":"January 16, 2024, 10:55 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients aged 40-69 years without prior CVD or diabetes.</p>","Before Use":"","Favorite ID":"10,499","Short Title En":"SCORE2","Cme Release Date":"","Slug":"systematic-coronary-risk-evaluation-score2","Short Description En":"<p>10-yr CVD risk w/out prior CVD or diabetes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Cancer and Aging Research Group Chemotherapy Toxicity Tool (CARG-TT)","Created At":"June 2, 2022, 9:33 PM","Is Manual":"false","Dosing":"false","Updated At":"January 29, 2024, 5:00 PM","Medium Description En":"<p>Estimates the risk of severe chemotherapy-related side effects (Grade 3 or greater toxicity) in older cancer patients.</p>","Logic Language":"javascript","Published At":"June 2, 2022, 9:33 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,424","Short Title En":"CARG-TT","Cme Release Date":"","Slug":"cancer-aging-research-group-chemotherapy-toxicity-tool-carg-tt","Short Description En":"<p>Estimates severe chemotherapy toxicity risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-07-25 00:00:00+00+127","Full Title En":"Rapid Arterial oCclusion Evaluation (RACE) Scale for Stroke","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"February 14, 2024, 11:04 PM","Medium Description En":"<p>Predicts large vessel occlusion (LVO) in patients with acute stroke.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"2022-07-25 00:00:00+00+127","Cme Version":"3941.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in the prehospital setting (i.e., by EMS providers) in patients with stroke symptoms.</p>","Before Use":"","Favorite ID":"3,941","Short Title En":"RACE Scale","Cme Release Date":"2020-06-07 00:00:00+00+00","Slug":"rapid-arterial-occlusion-evaluation-race-scale-stroke","Short Description En":"<p>Predicts large vessel occlusion (LVO) in stroke patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Short Michigan Alcoholism Screening Test (SMAST)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"January 23, 2024, 10:42 PM","Medium Description En":"<p><span>Screens for alcohol abuse.</span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool should only be used in non-geriatric populations.</p>","Before Use":"","Favorite ID":"4,013","Short Title En":"SMAST","Cme Release Date":"","Slug":"short-michigan-alcoholism-screening-test","Short Description En":"<p>Alcoholism screening.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Horowitz Index for Lung Function (P/F Ratio)","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 7:25 PM","Medium Description En":"<p>Assesses lung function, particularly in intubated patients.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>Launched during COVID-19 crisis.</p>\n<p><strong>Tips for COVID-19:</strong> Use to determine floor vs. ICU. Assesses lung functions, especially for patients on ventilators.</p>\n<p></p>","Favorite ID":"4,062","Short Title En":"Horowitz Index (P/F Ratio)","Cme Release Date":"","Slug":"horowitz-index-lung-function-p-f-ratio","Short Description En":"<p>Lung function assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"ASAS Criteria for Peripheral SpondyloArthritis (SpA)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"February 15, 2024, 5:30 PM","Medium Description En":"<p>Classifies peripheral spondyloarthritis according to Assessment of SpondyloArthritis International Society (ASAS) criteria.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,032","Short Title En":"ASAS Criteria for Peripheral SpA","Cme Release Date":"","Slug":"asas-criteria-peripheral-spondyloarthritis-spa","Short Description En":"<p>Peripheral SpA classification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HCM Risk-SCD","Created At":"July 11, 2023, 9:35 PM","Is Manual":"false","Dosing":"false","Updated At":"February 2, 2024, 10:30 PM","Medium Description En":"<p>Estimates risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.</p>","Logic Language":"javascript","Published At":"July 11, 2023, 9:36 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool estimates the 5-year risk of sudden cardiac death in patients &ge;16 years of age after their initial evaluation.</p>","Before Use":"","Favorite ID":"10,481","Short Title En":"HCM Risk-SCD","Cme Release Date":"","Slug":"hcm-risk-scd","Short Description En":"<p>SCD risk in HCM patients.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"2025-10-03 00:00:00+00+00","Full Title En":"COPD Assessment Test (CAT)","Created At":"April 21, 2022, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"December 13, 2023, 3:34 PM","Medium Description En":"<p><span id=\"docs-internal-guid-09b40bf6-7fff-1350-3356-cdad2c5106bb\">Quantifies impact o<span id=\"docs-internal-guid-09b40bf6-7fff-1350-3356-cdad2c5106bb\">f COPD symptoms on patients' overall health.</span></span></p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:28 PM","Cme Last Reviewed":"2022-10-03 00:00:00+00+00","Cme Version":"10161.1","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>The <a href=\"https://goldcopd.org/2023-gold-report-2/\">2023 GOLD Guidelines</a> propose a new grouping schema based on CAT scores and exacerbations, in addition to the GOLD Grade levels. The groups &ldquo;ABE&rdquo; have been proposed as replacements to &ldquo;ABCD&rdquo;. Prospective research is ongoing.</p>","Favorite ID":"10,161","Short Title En":"COPD Assessment Test (CAT)","Cme Release Date":"2022-10-07 00:00:00+00+00","Slug":"copd-assessment-test-cat","Short Description En":"<p>COPD symptom impact.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Resuscitation Using ECPR During In-Hospital Cardiac Arrest (RESCUE-IHCA)","Created At":"July 12, 2022, 3:06 PM","Is Manual":"false","Dosing":"false","Updated At":"December 19, 2023, 7:18 PM","Medium Description En":"<p>Predicts the probability of death for adult extracorporeal cardiopulmonary resuscitation (ECPR).</p>","Logic Language":"javascript","Published At":"July 12, 2022, 3:06 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,431","Short Title En":"RESCUE-IHCA","Cme Release Date":"","Slug":"resuscitation-using-ecpr-during-hospital-cardiac-arrest-rescue-ihca","Short Description En":"<p>ECPR mortality.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Emergency Department-Initiated Buprenorphine for Opioid Use Disorder (EMBED)","Created At":"August 8, 2023, 4:51 PM","Is Manual":"false","Dosing":"false","Updated At":"August 21, 2023, 8:08 PM","Medium Description En":"<p>Assess OUD, opioid withdrawal, and treatment readiness for ED-initiated buprenorphine.</p>","Logic Language":"javascript","Published At":"August 8, 2023, 4:52 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,484","Short Title En":"EMBED","Cme Release Date":"","Slug":"emergency-department-initiated-buprenorphine-opioid-use-disorder-embed","Short Description En":"<p>Buprenorphine readiness assessment.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"SETscore","Created At":"September 13, 2023, 9:15 PM","Is Manual":"false","Dosing":"false","Updated At":"September 14, 2023, 3:21 PM","Medium Description En":"<p>Predicts tracheostomy need in neurocritical care patients.</p>","Logic Language":"javascript","Published At":"September 13, 2023, 9:16 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients who have had a severe stroke and who are currently in the Neurointensive Care Unit (NICU) on a ventilator.</p>","Before Use":"","Favorite ID":"10,487","Short Title En":"SETscore","Cme Release Date":"","Slug":"setscore","Short Description En":"<p>Tracheostomy need.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Central Nervous System International Prognostic Index (CNS-IPI)","Created At":"October 5, 2023, 6:41 PM","Is Manual":"false","Dosing":"false","Updated At":"October 11, 2023, 7:19 PM","Medium Description En":"<p>Predicts relapse in the CNS in patients with diffuse large B-cell lymphoma (DLBCL).</p>","Logic Language":"javascript","Published At":"October 5, 2023, 7:06 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This calculator assists in risk stratifying patients who have been diagnosed with diffuse large B-cell lymphoma. The risk of relapse is determined by which of the three prognostic groups your patient falls into.</p>","Before Use":"","Favorite ID":"10,488","Short Title En":"CNS-IPI","Cme Release Date":"","Slug":"central-nervous-system-international-prognostic-index-cns-ipi","Short Description En":"<p>DLBCL relapse in CNS.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"National Comprehensive Cancer Network International Prognostic Index (NCCN-IPI)","Created At":"October 11, 2023, 7:21 PM","Is Manual":"false","Dosing":"false","Updated At":"May 6, 2024, 5:12 PM","Medium Description En":"<p>Predicts survival in patients with diffuse large B-cell lymphoma (DLBCL).</p>","Logic Language":"javascript","Published At":"October 11, 2023, 7:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool helps predict prognosis for patients diagnosed with diffuse large B-cell lymphoma. It is an update to the original IPI score and enhances risk stratification for those patients who receive rituximab treatment.&nbsp;</p>","Before Use":"","Favorite ID":"10,490","Short Title En":"NCCN-IPI","Cme Release Date":"","Slug":"national-comprehensive-cancer-network-international-prognostic-index-nccn-ipi","Short Description En":"<p>DLBCL survival.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Nomogram for Breast Cancer Brain Metastasis","Created At":"December 11, 2023, 7:39 PM","Is Manual":"false","Dosing":"false","Updated At":"February 1, 2024, 4:37 PM","Medium Description En":"<p>Predicts risk of brain metastasis in patients with stage IV breast cancer.</p>","Logic Language":"javascript","Published At":"December 11, 2023, 7:46 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"<p>This tool contains the nomogram as well as&nbsp;<span style=\"text-decoration: underline;\"><strong>estimates</strong></span> for some input values. Know the limitations of nomograms prior to use.</p>","Favorite ID":"10,492","Short Title En":"Breast Cancer Brain Metastasis","Cme Release Date":"","Slug":"nomogram-breast-cancer-brain-metastasis","Short Description En":"<p>Brain metastasis risk for breast cancer.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Asthma Impairment and Risk Questionnaire (AIRQ)","Created At":"December 27, 2023, 5:49 PM","Is Manual":"false","Dosing":"false","Updated At":"January 2, 2024, 4:16 PM","Medium Description En":"<p>Measures asthma impairment and risk.</p>","Logic Language":"javascript","Published At":"December 27, 2023, 5:49 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use in patients &ge;12 years who have been diagnosed with asthma.</p>","Before Use":"","Favorite ID":"10,495","Short Title En":"AIRQ","Cme Release Date":"","Slug":"asthma-impairment-risk-questionnaire-airq","Short Description En":"<p>Asthma impairment and risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"RibScore","Created At":"August 16, 2023, 8:28 PM","Is Manual":"false","Dosing":"false","Updated At":"January 4, 2024, 6:57 PM","Medium Description En":"<p>Predicts adverse pulmonary outcomes from rib fracture.</p>","Logic Language":"javascript","Published At":"August 16, 2023, 8:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span role=\"presentation\" dir=\"ltr\">Use to predict adverse outcomes in patients with confirmed rib fractures on </span><span role=\"presentation\" dir=\"ltr\">imaging.</span></p>","Before Use":"","Favorite ID":"10,485","Short Title En":"RibScore","Cme Release Date":"","Slug":"ribscore","Short Description En":"<p>Rib fracture outcome.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Sequential Clinical Assessment of Respiratory Function (SCARF) Score","Created At":"August 17, 2023, 4:14 PM","Is Manual":"false","Dosing":"false","Updated At":"January 4, 2024, 7:00 PM","Medium Description En":"<p>Predicts adverse outcomes in critically ill rib fracture patients.</p>","Logic Language":"javascript","Published At":"August 17, 2023, 4:14 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span role=\"presentation\" dir=\"ltr\">Use to assess management of pain in patients with acute traumatic rib </span><span role=\"presentation\" dir=\"ltr\">fractures. If patients&rsquo; SCARF score remains &gt;2 then increasing level of&nbsp;</span><span role=\"presentation\" dir=\"ltr\">analgesia should be considered.</span></p>","Before Use":"","Favorite ID":"10,486","Short Title En":"SCARF Score","Cme Release Date":"","Slug":"sequential-clinical-assessment-of-respiratory-function-scarf-score","Short Description En":"<p>Rib fracture outcomes.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Migraine Treatment Optimization Questionnaire-4 (mTOQ-4)","Created At":"January 3, 2024, 4:39 PM","Is Manual":"false","Dosing":"false","Updated At":"March 19, 2024, 7:31 PM","Medium Description En":"<p>Determines effectiveness of current migraine treatment plan.</p>","Logic Language":"javascript","Published At":"January 3, 2024, 4:59 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool can be used to gauge symptom control of acute migraine therapy. There are a few validated versions of the mTOQ; we present the 4-question version below.</p>","Before Use":"","Favorite ID":"10,496","Short Title En":"mTOQ-4","Cme Release Date":"","Slug":"migraine-treatment-optimization-questionnaire-mtoq-4","Short Description En":"<p>Migraine treatment effectiveness.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Ho Index","Created At":"March 6, 2024, 4:19 PM","Is Manual":"false","Dosing":"false","Updated At":"March 20, 2024, 8:55 PM","Medium Description En":"<p>Predicts outcome of medical therapy in severe ulcerative colitis.</p>","Logic Language":"javascript","Published At":"March 6, 2024, 4:31 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to predict failure of medical therapy on day 3 of admission for acute severe ulcerative colitis. Requires radiographic, laboratory, and clinical symptoms to calculate risk.&nbsp;</p>","Before Use":"","Favorite ID":"10,511","Short Title En":"Ho Index","Cme Release Date":"","Slug":"ho-index","Short Description En":"<p>Ulcerative colitis therapy outcome.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Travis Criteria","Created At":"March 6, 2024, 6:52 PM","Is Manual":"false","Dosing":"false","Updated At":"March 7, 2024, 10:19 PM","Medium Description En":"<p>Predicts risk of needing colectomy with severe ulcerative colitis.</p>\n<p></p>","Logic Language":"javascript","Published At":"March 6, 2024, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>Use this tool to predict failure of medical therapy on day 3 of admission for acute severe ulcerative colitis. Requires a lab value and clinical finding to calculate risk.</p>","Before Use":"","Favorite ID":"10,512","Short Title En":"Travis Criteria","Cme Release Date":"","Slug":"travis-criteria","Short Description En":"<p>Colectomy risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Predicting Risk of Cardiovascular Disease EVENTs (PREVENT)","Created At":"November 20, 2023, 4:55 PM","Is Manual":"false","Dosing":"false","Updated At":"May 28, 2024, 4:50 PM","Medium Description En":"<p>Predicts risk for incident CVD and CVD subtypes.</p>","Logic Language":"javascript","Published At":"November 20, 2023, 4:55 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool is an update to the AHA/ACC Pooled Cohort Equations previously published in 2013. It now includes BMI, has expanded the age for which scores can be calculated, and excludes race. Additionally, it includes optional variables that better define the effect of cardiovascular-kidney-metabolic (CKM) conditions. Finally, it can provide risk estimates of total CVD along with subtypes including ASCVD, heart failure, coronary heart disease, and stroke.</p>","Before Use":"<p>Additional validation work is ongoing as of January 2024. Updates will be added here as they are published.&nbsp;</p>","Favorite ID":"10,491","Short Title En":"PREVENT","Cme Release Date":"","Slug":"predicting-risk-cardiovascular-disease-events-prevent","Short Description En":"<p>CVD risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"International Ovarian Tumor Analysis (IOTA) Simple Rules Risk Assessment","Created At":"April 12, 2024, 4:20 PM","Is Manual":"false","Dosing":"false","Updated At":"April 22, 2024, 9:33 PM","Medium Description En":"<p>Predicts risk of malignancy in adnexal masses using ultrasound features.</p>","Logic Language":"javascript","Published At":"April 12, 2024, 7:40 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This tool provides an estimated risk of malignancy in patients who are undergoing adnexal surgery.</p>","Before Use":"","Favorite ID":"10,517","Short Title En":"IOTA Simple Rules Risk Assessment","Cme Release Date":"","Slug":"international-ovarian-tumor-analysis-iota-simple-rules-risk-assessment","Short Description En":"<p>Ovarian cancer risk.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"HIV Incidence Risk Index for MSM (HIRI-MSM)","Created At":"April 18, 2024, 8:53 PM","Is Manual":"false","Dosing":"false","Updated At":"April 22, 2024, 8:47 PM","Medium Description En":"<p>Identifies MSM at risk of HIV infection.</p>","Logic Language":"javascript","Published At":"April 18, 2024, 9:03 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p>This questionnaire can be used to determine risk of acquiring HIV by men who have sex with men (MSM).</p>","Before Use":"","Favorite ID":"10,518","Short Title En":"HIRI-MSM","Cme Release Date":"","Slug":"hiv-incidence-risk-index-hiri-msm","Short Description En":"<p>HIV risk for MSM.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Migraine Disability Assessment (MIDAS)","Created At":"May 17, 2024, 2:31 PM","Is Manual":"false","Dosing":"false","Updated At":"June 7, 2024, 5:17 PM","Medium Description En":"<p>Quantifies the amount of disability due to headache-related symptoms.</p>","Logic Language":"javascript","Published At":"May 17, 2024, 3:37 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,521","Short Title En":"MIDAS","Cme Release Date":"","Slug":"migraine-disability-assessment-midas","Short Description En":"<p>Migraine disability quantification.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"PECARN Pediatric Intra-Abdominal Injury (IAI) Algorithm","Created At":"April 21, 2022, 8:29 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 5:49 PM","Medium Description En":"<p>Identifies children at very low risk of clinically important blunt abdominal injuries.</p>","Logic Language":"javascript","Published At":"April 21, 2022, 8:29 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"<p><span id=\"docs-internal-guid-f9da6742-7fff-26e3-9cfb-5225cc6aac0b\">Use in patients &lt;18 years old presenting with blunt abdominal trauma within 24 hours of injury. Do not use in patients with penetrating trauma, pre-existing neurologic disorders impeding a reliable exam, or pregnancy. Do not use in patients transferred from another hospital where abdominal CT or diagnostic peritoneal lavage was already performed.</span></p>","Before Use":"","Favorite ID":"3,971","Short Title En":"PECARN IAI","Cme Release Date":"","Slug":"pecarn-pediatric-intra-abdominal-injury-iai-algorithm","Short Description En":"<p>Rules out clinically important blunt abdominal injuries.</p>"},
{"Diagnostic Criteria":"false","Disabled":"false","Cme End Date":"","Full Title En":"Neck Disability Index (NDI)","Created At":"June 5, 2024, 3:02 PM","Is Manual":"false","Dosing":"false","Updated At":"June 12, 2024, 3:27 PM","Medium Description En":"<p>Assesses disability in patients with neck pain.</p>","Logic Language":"javascript","Published At":"June 5, 2024, 3:24 PM","Cme Last Reviewed":"","Cme Version":"","Replacement Calc ID":null,"Disabled Reason":"","Instructions En":"","Before Use":"","Favorite ID":"10,532","Short Title En":"NDI","Cme Release Date":"","Slug":"neck-disability-index-ndi","Short Description En":"<p>Evaluates neck pain.</p>"}
]